<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Pathology &amp; Oncology Research | Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.DDmDAI4A.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/XMLFair2Data.B6rECmbm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/5vxm7p2S.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/AwDaiPnW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/xz53jVs2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-bb48b7379d2c17a7e89","applicationID":"551636477","agentToken":null,"applicationTime":3.661158,"transactionName":"NgcEMkNQXEoCUEwPVw9NKAlDXFNVCkldAm0TC0kMXkRAVwJfS0lIABYOCV1eVUBOUlYCFQ4MBQldXlVATkFdFV0AEAUOHlBATQpQVANLTkhJFl5DVxdRAwpSFlBUV1cJAAEWBUZUCg==","queueTime":0,"ttGuid":"b543463b086c7cd0"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594554375",accountID:"2904145",trustKey:"230385",xpid:"Vg8HVVdXDRAFUVBUBAcDUVM=",licenseKey:"NRJS-bb48b7379d2c17a7e89",applicationID:"551636477",browserID:"594554375"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.por-journal.com/static-resources/tenants/por/favicon_16-tenantFavicon-POR2.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.por-journal.com/static-resources/tenants/por/favicon_32-tenantFavicon-POR2.png">
<meta name="apple-mobile-web-app-title" content="Pathology & Oncology Research | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full">
<meta property="description" name="description" content="Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing ...">
<meta property="og:title" name="title" content="Pathology & Oncology Research | Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods">
<meta property="og:description" name="description" content="Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing ...">
<meta name="keywords" content="HBOC,new generation sequencing,multigene panel testing,BRCA1,BRCA2">
<meta property="og:site_name" name="site_name" content="Pathology & Oncology Research">
<meta property="og:image" name="image" content="https://images-provider.por-journal.com/api/ipx/w=1200&f=png/https://www.por-journal.com/files/Articles/1611813/pore-30-1611813-HTML-r1/image_m/pore-30-1611813-t001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="30">
<meta name="citation_journal_title" content="Pathology and Oncology Research">
<meta name="citation_publisher" content="Pathology & Oncology Research">
<meta name="citation_journal_abbrev" content="Pathol. Oncol. Res.">
<meta name="citation_issn" content="1532-2807">
<meta name="citation_doi" content="10.3389/pore.2024.1611813">
<meta name="citation_firstpage" content="1611813">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods">
<meta name="citation_keywords" content="HBOC; new generation sequencing; multigene panel testing; BRCA1; BRCA2">
<meta name="citation_abstract" content="Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine, whether a patient is harbouring mutations in moderate-or high penetrance susceptibility genes.We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our Department. From these patients 74.5% (205/275) were affected by some type of malignancy, while the remaining 25.5% (70/275) had a positive family history of different cancers, suggesting a genetic predisposition.These tests confirmed a genetic variant in 29.8% and 28.6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the BRCA1 and BRCA2 genes proved to be the most common cause among our patients with 41.5%. Our test also detected a novel mutation in the CDH1 gene and three patients with double heterozygosity in two different susceptibility genes.This study demonstrates the relevance of genetic counselling and non-BRCA gene sequencing among cancer patients and patients who fulfil the criteria for genetic testing, while also providing important details about the genetic profile of Hungarian patients.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2024/07/19">
<meta name="citation_publication_date" content="2024/08/01">
<meta name="citation_author" content="Barti, Lszl ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="citation_author" content="Masz, Anita ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="citation_author" content="Mik, Alexandra ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="citation_author" content="Brcesi, va ">
<meta name="citation_author_institution" content="Department of Oncotherapy, Hungary">
<meta name="citation_author" content="Kalbani, Sultan Al ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="citation_author" content="Bene, Judit ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="citation_author" content="Kovcs, Sebestyn ">
<meta name="citation_author_institution" content="Urology Clinic, Hungary">
<meta name="citation_author" content="Mangel, Lszl ">
<meta name="citation_author_institution" content="Department of Oncotherapy, Hungary">
<meta name="citation_author" content="Hadzsiev, Kinga ">
<meta name="citation_author_institution" content="Department of Medical Genetics, Hungary">
<meta name="dc.identifier" content="doi:10.3389/pore.2024.1611813">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods","author":[{"@type":"Person","name":"Lszl Barti","affiliation":["Department of Medical Genetics, Hungary"]},{"@type":"Person","name":"Anita Masz","affiliation":["Department of Medical Genetics, Hungary"]},{"@type":"Person","name":"Alexandra Mik","affiliation":["Department of Medical Genetics, Hungary","Institute for Translational Medicine, Hungary"]},{"@type":"Person","name":"va Brcesi","affiliation":["Department of Oncotherapy, Hungary"]},{"@type":"Person","name":"Sultan Al Kalbani","affiliation":["Department of Medical Genetics, Hungary"]},{"@type":"Person","name":"Judit Bene","affiliation":["Department of Medical Genetics, Hungary"]},{"@type":"Person","name":"Sebestyn Kovcs","affiliation":["Urology Clinic, Hungary"]},{"@type":"Person","name":"Lszl Mangel","affiliation":["Department of Oncotherapy, Hungary"]},{"@type":"Person","name":"Kinga Hadzsiev","affiliation":["Department of Medical Genetics, Hungary"]}],"datePublished":"2024-08-01","dateModified":"2025-11-26","publisher":{"@type":"Organization","name":"Pathology & Oncology Research"},"isPartOf":{"@type":"PublicationVolume","volumeNumber":"30","isPartOf":{"@type":"Periodical","name":"Pathology and Oncology Research"}},"citation":["https://doi.org/10.3389/pore.2024.1611813"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v4"><div id="__nuxt"><!--[--><!----><div theme="green"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo Ibar__logo--tenant"><a href="//www.por-journal.com/" aria-label="Pathology &amp; Oncology Researchhome" data-event="iBar-a-home" class="Ibar__logo__link"><img src="https://brand.frontiersin.org/m/54cf682e9cbe653/original/POR-Logo.svg" alt="Pathology &amp; Oncology Research" class="Ibar__logo__link__tenantLogo"></a></div><a href="//www.por-journal.com/journals/pathology-and-oncology-research" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container Ibar__journalName__container--tenant" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><!----><span>Pathology and Oncology Research</span></div></div></a><!----><!--[--><a class="Ibar__link" href="https://www.por-journal.com/journals/pathology-and-oncology-research/about" data-event="iBar-a-about">About</a><a class="Ibar__link" href="https://www.por-journal.com/articles" data-event="iBar-a-allArticles">All articles</a><a class="Ibar__link" href="https://www.por-journal.com/research-topics" data-event="iBar-a-specialIssues">Special issues</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.por-journal.com/submission/submit?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.por-journal.com/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo Ibar__logo--tenant"><a href="//www.por-journal.com/" aria-label="Pathology &amp; Oncology Researchhome" data-event="iBar-a-home" class="Ibar__logo__link"><img src="https://brand.frontiersin.org/m/54cf682e9cbe653/original/POR-Logo.svg" alt="Pathology &amp; Oncology Research" class="Ibar__logo__link__tenantLogo"></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.por-journal.com/journals/pathology-and-oncology-research" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container Ibar__journalName__container--tenant"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><!----><span>Pathology and Oncology Research</span></div></div></a><!----><!--[--><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/special-issues" target="_self" data-event="iBar-a-specialIssues">Special issues</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_editorsInChief">Editors-in-chief</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#submission" target="_self" data-event="iBar-aboutJournal_3-a_submission">Submission</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_editorial &amp;Quality">Editorial &amp; quality processes</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#contact" target="_self" data-event="iBar-aboutJournal_7-a_contact">Contact</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_2-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/review-guidelines" target="_self" data-event="iBar-aboutJournal_4-a_reviewGuidelines">Review guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/policies-and-publication-ethics" target="_self" data-event="iBar-aboutJournal_5-a_policiesAndPublica">Policies and publication ethics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_6-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_7-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For reviewers</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-reviewers" target="_self" data-event="iBar-aboutJournal_0-a_forReviewers">For reviewers</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For the community</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/become-a-reviewer" target="_self" data-event="iBar-aboutJournal_0-a_becomeAPorReviewer">Become a POR Reviewer</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/newsletter" target="_self" data-event="iBar-aboutJournal_1-a_newsletter">Newsletter</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/retrospective-ebooks" target="_self" data-event="iBar-aboutJournal_2-a_retrospectiveEBook">Retrospective eBooks</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/propose-a-special-issue" target="_self" data-event="iBar-aboutJournal_3-a_proposeASpecialIss">Propose a special issue</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><!----><!--[--><a class="Ibar__link" href="https://www.por-journal.com/journals/pathology-and-oncology-research/about" data-event="iBar-a-about">About</a><a class="Ibar__link" href="https://www.por-journal.com/articles" data-event="iBar-a-allArticles">All articles</a><a class="Ibar__link" href="https://www.por-journal.com/research-topics" data-event="iBar-a-specialIssues">Special issues</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.por-journal.com/submission/submit?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.por-journal.com/journals/pathology-and-oncology-research" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container Ibar__journalName__container--tenant"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><!----><span>Pathology and Oncology Research</span></div></div></a><!----><!--[--><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/special-issues" target="_self" data-event="iBar-a-specialIssues">Special issues</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_editorsInChief">Editors-in-chief</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#submission" target="_self" data-event="iBar-aboutJournal_3-a_submission">Submission</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_editorial &amp;Quality">Editorial &amp; quality processes</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#contact" target="_self" data-event="iBar-aboutJournal_7-a_contact">Contact</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_2-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/review-guidelines" target="_self" data-event="iBar-aboutJournal_4-a_reviewGuidelines">Review guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/policies-and-publication-ethics" target="_self" data-event="iBar-aboutJournal_5-a_policiesAndPublica">Policies and publication ethics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_6-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_7-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For reviewers</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-reviewers" target="_self" data-event="iBar-aboutJournal_0-a_forReviewers">For reviewers</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For the community</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/become-a-reviewer" target="_self" data-event="iBar-aboutJournal_0-a_becomeAPorReviewer">Become a POR Reviewer</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/newsletter" target="_self" data-event="iBar-aboutJournal_1-a_newsletter">Newsletter</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/retrospective-ebooks" target="_self" data-event="iBar-aboutJournal_2-a_retrospectiveEBook">Retrospective eBooks</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/propose-a-special-issue" target="_self" data-event="iBar-aboutJournal_3-a_proposeASpecialIss">Propose a special issue</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo Ibar__logo--tenant"><a href="//www.por-journal.com/" aria-label="Pathology &amp; Oncology Researchhome" data-event="iBar-a-home" class="Ibar__logo__link"><img src="https://brand.frontiersin.org/m/54cf682e9cbe653/original/POR-Logo.svg" alt="Pathology &amp; Oncology Research" class="Ibar__logo__link__tenantLogo"></a></div><a href="//www.por-journal.com/journals/pathology-and-oncology-research" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container Ibar__journalName__container--tenant" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><!----><span>Pathology and Oncology Research</span></div></div></a><div class="Ibar__spacer"></div><!----><!--[--><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><a class="Ibar__link" href="//www.por-journal.com/journals/pathology-and-oncology-research/special-issues" target="_self" data-event="iBar-a-specialIssues">Special issues</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_editorsInChief">Editors-in-chief</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#submission" target="_self" data-event="iBar-aboutJournal_3-a_submission">Submission</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_editorial &amp;Quality">Editorial &amp; quality processes</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/about#contact" target="_self" data-event="iBar-aboutJournal_7-a_contact">Contact</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_1-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_2-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/review-guidelines" target="_self" data-event="iBar-aboutJournal_4-a_reviewGuidelines">Review guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/policies-and-publication-ethics" target="_self" data-event="iBar-aboutJournal_5-a_policiesAndPublica">Policies and publication ethics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_6-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_7-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For reviewers</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-reviewers" target="_self" data-event="iBar-aboutJournal_0-a_forReviewers">For reviewers</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For the community</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/become-a-reviewer" target="_self" data-event="iBar-aboutJournal_0-a_becomeAPorReviewer">Become a POR Reviewer</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/newsletter" target="_self" data-event="iBar-aboutJournal_1-a_newsletter">Newsletter</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/retrospective-ebooks" target="_self" data-event="iBar-aboutJournal_2-a_retrospectiveEBook">Retrospective eBooks</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/propose-a-special-issue" target="_self" data-event="iBar-aboutJournal_3-a_proposeASpecialIss">Propose a special issue</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.por-journal.com/submission/submit?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.por-journal.com/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><div class="ArticleDetailsV4"><!----><!--[--><aside class="ArticleDetailsV4__asideLeft"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><h2 class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH</h2><p class="ArticleLayoutHeader__info__journalDate"><span>Pathol. Oncol. Res.</span><span>, 01 August 2024</span></p><!----><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 30 - 2024 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/pore.2024.1611813">https://doi.org/10.3389/pore.2024.1611813</a></p><!----></div><!----><!----></div><div class="ArticleDetailsV4__cards"><article class="CardJournal"><a class="CardJournal__Link" href="https://www.por-journal.com/journals/pathology-and-oncology-research" aria-label="Go to section page" data-event="cardJournal-a" target="_blank"><div class="CardJournal__Header">Published in</div><div class="CardJournal__ImgWrapper"><figure class="FrontiersImage CardJournal__Img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.por-journal.com/api/ipx/s=72x72&amp;fit=cover&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png" media="(max-width: 1024px)"><source srcset="https://images-provider.por-journal.com/api/ipx/s=284x160&amp;fit=cover&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png" media="(max-width: 1441px)"><source srcset="https://images-provider.por-journal.com/api/ipx/s=326x184&amp;fit=cover&amp;f=webp/https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png" media><source srcset="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png" media><!--]--><img src="https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png" class="is-inside-mask" alt="Pathology and Oncology Research" loading="eager"></picture><!----></figure><div class="CardJournal__ImgBorder"></div></div><div class="CardJournal__Body"><p class="CardJournal__Title CardJournal__Title--journal"><span>Pathology and Oncology Research </span><!----></p><ul class="CardJournal__sections"><!--[--><!--]--></ul></div><div class="CardJournal__Footer"><ul class="Metrics"><!--[--><li class="Metrics__Item"><b>2.3</b> impact factor</li><li class="Metrics__Item"><b>4.6</b> citescore</li><!--]--></ul></div></a></article><article class="Card CardRT2"><a class="Card__link" href="https://www.por-journal.com/research-topics/13/hereditary-cancer-syndromes" aria-label="Go to main RT page" data-event="card-a" target="_blank"><!----><div class="Card__body"><!--[--><p class="CardRT2__partOf">Part of a Research Topic</p><div class="CardRT2__wrap"><p class="Title CardRT2__title">Hereditary Cancer Syndromes</p><i></i><span>Submission open</span><ul class="Metrics"><!--[--><li class="Metrics__Item"><b>9561</b> views</li><li class="Metrics__Item"><b>3</b> articles</li><!--]--></ul><div class="CardRT2__wrap--line"></div></div><!--]--></div><!----></a></article></div><div class="ExpandablePanel EditorReviewers"><button class="ExpandablePanel__headline" data-event="expandablePanel-button-editor"><span class="ExpandablePanel__arrow"></span><h3 class="ExpandablePanel__title">Editor</h3></button><div class="ExpandablePanel__content"><div class="ExpandablePanel__slot"><!--[--><!----><!--[--><p class="EditorReviewers__subtitle">Edited by</p><a class="PeopleAffiliations" href="https://loop.frontiersin.org/people/701717" data-event="peopleAffiliation-a-editorReviewers"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey"><!--[--><span class="notranslate">J</span><span class="notranslate">T</span><!--]--></div><div class="PeopleAffiliations__info"><p class="PeopleAffiliations__name notranslate">Jzsef Tmr</p><!--[--><p class="PeopleAffiliations__aff notranslate">Semmelweis University, Hungary</p><!--]--></div></a><!--]--><!----><!--]--></div></div></div><!----><div class="ArticleDetailsV4__sticky--equalOverflown ArticleDetailsV4__sticky"><div id="outline-desktop-wrapper" class="OutlineWrapper"><div class="Outline"><p class="Outline__title"><span class="Outline__icon"></span>Outline </p><nav class="Outline__nav"><ul class="Outline__list"><!--[--><li class="Outline__item Outline__item--active"><a href="#h1" class="Outline__link Outline__link--active" data-event="outlineItem-a-h1"><span></span><p class="Outline__link__text">Abstract</p></a></li><li class="Outline__item"><a href="#s1" class="Outline__link" data-event="outlineItem-a-s1"><span></span><p class="Outline__link__text">Introduction</p></a></li><li class="Outline__item"><a href="#s2" class="Outline__link" data-event="outlineItem-a-s2"><span></span><p class="Outline__link__text">Subjects and methods</p></a></li><li class="Outline__item"><a href="#s3" class="Outline__link" data-event="outlineItem-a-s3"><span></span><p class="Outline__link__text">Results</p></a></li><li class="Outline__item"><a href="#s4" class="Outline__link" data-event="outlineItem-a-s4"><span></span><p class="Outline__link__text">Discussion</p></a></li><li class="Outline__item"><a href="#s5" class="Outline__link" data-event="outlineItem-a-s5"><span></span><p class="Outline__link__text">Conclusion</p></a></li><li class="Outline__item"><a href="#s6" class="Outline__link" data-event="outlineItem-a-s6"><span></span><p class="Outline__link__text">Data availability statement</p></a></li><li class="Outline__item"><a href="#s7" class="Outline__link" data-event="outlineItem-a-s7"><span></span><p class="Outline__link__text">Ethics statement</p></a></li><li class="Outline__item"><a href="#s8" class="Outline__link" data-event="outlineItem-a-s8"><span></span><p class="Outline__link__text">Author contributions</p></a></li><li class="Outline__item"><a href="#s9" class="Outline__link" data-event="outlineItem-a-s9"><span></span><p class="Outline__link__text">Funding</p></a></li><li class="Outline__item"><a href="#s10" class="Outline__link" data-event="outlineItem-a-s10"><span></span><p class="Outline__link__text">Conflict of interest</p></a></li><li class="Outline__item"><a href="#s11" class="Outline__link" data-event="outlineItem-a-s11"><span></span><p class="Outline__link__text">Supplementary material</p></a></li><li class="Outline__item"><a href="#h13" class="Outline__link" data-event="outlineItem-a-h13"><span></span><p class="Outline__link__text">Footnotes</p></a></li><li class="Outline__item"><a href="#h14" class="Outline__link" data-event="outlineItem-a-h14"><span></span><p class="Outline__link__text">References</p></a></li><!--]--></ul><div class="Outline__activeBg" style="opacity:0;"></div></nav></div></div><div id="figures-desktop-wrapper" class="FiguresOutlineWrapper"><div class="FiguresOutline"><div class="FiguresOutline__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M3.84 2.88h40.32a.96.96 0 0 1 .96.96v40.32a.96.96 0 0 1-.96.96H3.84a.96.96 0 0 1-.96-.96V3.84a.96.96 0 0 1 .96-.96Zm37.44 35.683V6.72H6.72v16.483l8.241-8.241a1.92 1.92 0 0 1 2.717 0L41.28 38.563ZM16.32 19.037l-9.6 9.6V41.28h31.843L16.32 19.037Zm18.56.152a5.76 5.76 0 1 1-6.4-9.58 5.76 5.76 0 0 1 6.4 9.58Zm-2.133-6.385a1.92 1.92 0 1 0-2.134 3.193 1.92 1.92 0 0 0 2.134-3.193Z" clip-rule="evenodd"></path></svg>Figures and Tables </div><ul class="FiguresOutline__list"><!--[--><li class="FiguresOutlineItem"><p class="FiguresOutlineItem__title">TABLE 1</p><button class="FiguresOutlineItem__table" data-event="figureOutline-button-openTable"><div class="FiguresOutlineItem__table__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg></div><p class="FiguresOutlineItem__table__description">Genetic risk stratification for HBOC patients.</p></button><a href="#T1" class="FiguresOutlineItem__link" aria-label="View TABLE 1 in article" data-event="figureOutline-a-viewInArticle"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="m28.446 11.85-1.359 1.353a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.94.94 0 0 0 .21.3l7.563 7.563H6.96a.962.962 0 0 0-.96.96v1.92a.963.963 0 0 0 .96.96h27.69l-7.563 7.566a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.98.98 0 0 0 .21.3l1.359 1.353a.96.96 0 0 0 1.356 0L42 23.997 29.802 11.802a.942.942 0 0 0-.3-.21.982.982 0 0 0-.738 0 .942.942 0 0 0-.3.21l-.018.048Z"></path></svg>View in article</a></li><li class="FiguresOutlineItem"><p class="FiguresOutlineItem__title">TABLE 2</p><button class="FiguresOutlineItem__table" data-event="figureOutline-button-openTable"><div class="FiguresOutlineItem__table__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg></div><p class="FiguresOutlineItem__table__description">Patient cohorts characteristics.</p></button><a href="#T2" class="FiguresOutlineItem__link" aria-label="View TABLE 2 in article" data-event="figureOutline-a-viewInArticle"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="m28.446 11.85-1.359 1.353a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.94.94 0 0 0 .21.3l7.563 7.563H6.96a.962.962 0 0 0-.96.96v1.92a.963.963 0 0 0 .96.96h27.69l-7.563 7.566a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.98.98 0 0 0 .21.3l1.359 1.353a.96.96 0 0 0 1.356 0L42 23.997 29.802 11.802a.942.942 0 0 0-.3-.21.982.982 0 0 0-.738 0 .942.942 0 0 0-.3.21l-.018.048Z"></path></svg>View in article</a></li><li class="FiguresOutlineItem"><p class="FiguresOutlineItem__title">TABLE 3</p><button class="FiguresOutlineItem__table" data-event="figureOutline-button-openTable"><div class="FiguresOutlineItem__table__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg></div><p class="FiguresOutlineItem__table__description">Distribution of carriers and non-carriers in the cohorts.</p></button><a href="#T3" class="FiguresOutlineItem__link" aria-label="View TABLE 3 in article" data-event="figureOutline-a-viewInArticle"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="m28.446 11.85-1.359 1.353a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.94.94 0 0 0 .21.3l7.563 7.563H6.96a.962.962 0 0 0-.96.96v1.92a.963.963 0 0 0 .96.96h27.69l-7.563 7.566a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.98.98 0 0 0 .21.3l1.359 1.353a.96.96 0 0 0 1.356 0L42 23.997 29.802 11.802a.942.942 0 0 0-.3-.21.982.982 0 0 0-.738 0 .942.942 0 0 0-.3.21l-.018.048Z"></path></svg>View in article</a></li><li class="FiguresOutlineItem"><p class="FiguresOutlineItem__title">TABLE 4</p><button class="FiguresOutlineItem__table" data-event="figureOutline-button-openTable"><div class="FiguresOutlineItem__table__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg></div><p class="FiguresOutlineItem__table__description">Carriers of pathogenic/likely pathogenic variants and variants of uncertain significance (VUS) according to tumour types in the HBOC cohort.</p></button><a href="#T4" class="FiguresOutlineItem__link" aria-label="View TABLE 4 in article" data-event="figureOutline-a-viewInArticle"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="m28.446 11.85-1.359 1.353a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.94.94 0 0 0 .21.3l7.563 7.563H6.96a.962.962 0 0 0-.96.96v1.92a.963.963 0 0 0 .96.96h27.69l-7.563 7.566a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.98.98 0 0 0 .21.3l1.359 1.353a.96.96 0 0 0 1.356 0L42 23.997 29.802 11.802a.942.942 0 0 0-.3-.21.982.982 0 0 0-.738 0 .942.942 0 0 0-.3.21l-.018.048Z"></path></svg>View in article</a></li><li class="FiguresOutlineItem"><p class="FiguresOutlineItem__title">TABLE 5</p><button class="FiguresOutlineItem__table" data-event="figureOutline-button-openTable"><div class="FiguresOutlineItem__table__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg></div><p class="FiguresOutlineItem__table__description">Detection ratio of BRCA1, BRCA2, PALB2, ATM, CHEK2, MUTYH, MSH6, RAD51C, BARD1, CDH1, POLE and ERCC3 P/LP variants in the study groups and gnomAD non-cancer population.</p></button><a href="#T5" class="FiguresOutlineItem__link" aria-label="View TABLE 5 in article" data-event="figureOutline-a-viewInArticle"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="m28.446 11.85-1.359 1.353a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.94.94 0 0 0 .21.3l7.563 7.563H6.96a.962.962 0 0 0-.96.96v1.92a.963.963 0 0 0 .96.96h27.69l-7.563 7.566a.925.925 0 0 0-.21.3.974.974 0 0 0 0 .735.98.98 0 0 0 .21.3l1.359 1.353a.96.96 0 0 0 1.356 0L42 23.997 29.802 11.802a.942.942 0 0 0-.3-.21.982.982 0 0 0-.738 0 .942.942 0 0 0-.3.21l-.018.048Z"></path></svg>View in article</a></li><!--]--></ul></div></div></div></aside><!----><!--]--><main class="ArticleDetailsV4__main"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><h2 class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH</h2><p class="ArticleLayoutHeader__info__journalDate"><span>Pathol. Oncol. Res.</span><span>, 01 August 2024</span></p><!----><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 30 - 2024 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/pore.2024.1611813">https://doi.org/10.3389/pore.2024.1611813</a></p><!----></div><!----><!----></div><!----><h1 class="ArticleDetailsV4__main__title"><!--[-->Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods<!--]--></h1><div class="PeopleList"><ul class="PeopleList__list PeopleList__list--hidden PeopleList__list--0"><!--[--><a class="PeopleListItem" href="https://loop.frontiersin.org/people/2728589" data-event="peopleListItem-a"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">L</span><span class="notranslate">B</span><!--]--></div><p class="PeopleListItem__name notranslate">Lszl Barti  <sup>1</sup><!----><sup>*</sup></p></a><div class="PeopleListItem" href><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">A</span><span class="notranslate">M</span><!--]--></div><p class="PeopleListItem__name notranslate">Anita Masz  <sup>1</sup><!----><!----></p></div><a class="PeopleListItem" href="https://loop.frontiersin.org/people/2726429" data-event="peopleListItem-a"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">A</span><span class="notranslate">M</span><!--]--></div><p class="PeopleListItem__name notranslate">Alexandra Mik  <sup>1,2</sup><!----><!----></p></a><div class="PeopleListItem" href><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate"></span><span class="notranslate">B</span><!--]--></div><p class="PeopleListItem__name notranslate">va Brcesi  <sup>3</sup><!----><!----></p></div><div class="PeopleListItem" href><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">S</span><span class="notranslate">A</span><!--]--></div><p class="PeopleListItem__name notranslate">Sultan Al Kalbani  <sup>1</sup><!----><!----></p></div><a class="PeopleListItem" href="https://loop.frontiersin.org/people/1023886" data-event="peopleListItem-a"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">J</span><span class="notranslate">B</span><!--]--></div><p class="PeopleListItem__name notranslate">Judit Bene  <sup>1</sup><!----><!----></p></a><a class="PeopleListItem" href="https://loop.frontiersin.org/people/2738283" data-event="peopleListItem-a"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">S</span><span class="notranslate">K</span><!--]--></div><p class="PeopleListItem__name notranslate">Sebestyn Kovcs  <sup>4</sup><!----><!----></p></a><div class="PeopleListItem" href><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">L</span><span class="notranslate">M</span><!--]--></div><p class="PeopleListItem__name notranslate">Lszl Mangel  <sup>3</sup><!----><!----></p></div><!--]--><!----><a class="PeopleListItem last-people" href="https://loop.frontiersin.org/people/2429540" data-event="peopleListItem-a"><div class="Avatar Avatar--size-40 Avatar--text Avatar--grey PeopleListItem__Avatar"><!--[--><span class="notranslate">K</span><span class="notranslate">H</span><!--]--></div><p class="PeopleListItem__name notranslate">Kinga Hadzsiev  <sup>1</sup><!----><!----></p></a><span class="PeopleList__spacer"></span></ul><!----><div class="AffiliationList AffiliationList--hidden"><ul class="AffiliationList__list"><!--[--><li class="AffiliationList__item"><p class="AffiliationList__name notranslate"><span>1.</span> Department of Medical Genetics, Clinical Centre, Medical School, University of Pcs, Pcs, Hungary</p></li><li class="AffiliationList__item"><p class="AffiliationList__name notranslate"><span>2.</span> Institute for Translational Medicine, Medical School, University of Pcs, Pcs, Hungary</p></li><li class="AffiliationList__item AffiliationList__item--visibility"><p class="AffiliationList__name notranslate"><span>3.</span> Department of Oncotherapy, Clinical Centre, Medical School, University of Pcs, Pcs, Hungary</p></li><li class="AffiliationList__item AffiliationList__item--visibility"><p class="AffiliationList__name notranslate"><span>4.</span> Urology Clinic, Clinical Centre, University of Pcs, Pcs, Hungary</p></li><!--]--><button class="AffiliationList__button">See more</button></ul></div></div><div style="" class="ArticleMetrics"><p class="ArticleMetrics__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.798 40.512a1.227 1.227 0 0 0 1.2-1.233v-1.434a1.22 1.22 0 0 0-1.2-1.224H37.02l.024-24.402a1.2 1.2 0 0 0-1.2-1.2h-6.93a1.2 1.2 0 0 0-1.2 1.2v24.45h-3.732V21.54a1.2 1.2 0 0 0-1.2-1.2h-6.98a1.2 1.2 0 0 0-1.2 1.2v15.117h-3.778V8.7a1.2 1.2 0 0 0-1.2-1.2H8.19a1.2 1.2 0 0 0-1.2 1.2v30.615a1.2 1.2 0 0 0 1.2 1.2l31.608-.003Zm-21.444-3.9V24.105h1.89V36.6l-1.89.012Zm13.098 0V14.82h1.866v21.792h-1.866Z"></path></svg> Article metrics </p><!----><div class="MetricsTotals"><!----><div class="MetricsTotals__item"><p class="MetricsTotals__number">1,7k</p><p class="MetricsTotals__label">Views</p></div><div class="MetricsTotals__item"><p class="MetricsTotals__number">895</p><p class="MetricsTotals__label">Downloads</p></div></div></div><!----><div class="ArticleDetailsV4__main__content"><div class="ArticleContent"><!--[--><!--]--><div id="h1"><h2>Abstract</h2><!--[-->
        <p>Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine whether a patient is harbouring mutations in moderate- or high penetrance susceptibility genes. We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our department. From these patients 74.5% (205/275) were affected by some type of malignancy, while the remaining 25.5% (70/275) had a positive family history of different cancers, suggesting a genetic predisposition. These tests confirmed a genetic variant in 29.8% and 28.6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> genes proved to be the most common cause among our patients with 41.5%. Our test also detected a novel mutation in the <!--[--><i>CDH1</i><!--]--> gene and three patients with double heterozygosity in two different susceptibility genes. This study demonstrates the relevance of genetic counselling and non-<!--[--><i>BRCA</i><!--]--> gene sequencing among cancer patients and patients who fulfil the criteria for genetic testing, while also providing important details about the genetic profile of Hungarian patients.</p>
      <!--]--></div><!--[-->
    <div id="s1"><!--[-->
      <h2>Introduction</h2>
      <p>Cancer is among the leading causes of mortality all over the world. Over the last decade, the incidence of malignancies has been growing worldwide, resulting in an estimated 20 million new cases and 9.7 million deaths in 2022. In most types of cancer, mortality has decreased due to preventive measures, improved diagnostic tests, screening programmes and more effective treatment options [<a class="ArticleReference" href="#B1" id="B1a" data-event="articleReference-a-b1"><!--[-->1<!--]--></a>, <a class="ArticleReference" href="#B2" id="B2a" data-event="articleReference-a-b2"><!--[-->2<!--]--></a>]. Unfortunately, predictions lead us to believe, that we can expect a steady increase in the number of new cases in the upcoming years [<a class="ArticleReference" href="#B3" id="B3a" data-event="articleReference-a-b3"><!--[-->3<!--]--></a>].</p>
      <p>In Hungary, breast cancer is the third most common malignancy after lung cancer and colorectal cancer, and the leading cause of cancer incidence in the female population, resulting in approximately 8,000 new cases and 2,000 deaths every year according to the Hungarian Cancer Registry [<a class="ArticleReference" href="#B4" id="B4a" data-event="articleReference-a-b4"><!--[-->4<!--]--></a>].</p>
      <p>Until recently, environmental causes were viewed as the main reason for the occurrence of malignancies. Akin to most multifactorial diseases, breast cancer is known to be associated with certain factors, that affect ones risk to develop the disease in their lifetime. Modifiable risk factors include obesity, consumption of tobacco and alcohol, and taking hormones, while reproductive history, increasing age and a positive family history belong to non-modifiable risk factors [<a class="ArticleReference" href="#B5" id="B5a" data-event="articleReference-a-b5"><!--[-->5<!--]--></a><a class="ArticleReference" href="#B7" id="B7a" data-event="articleReference-a-b7"><!--[-->7<!--]--></a>].</p>
      <p>In recent decades it has become apparent, that genetic variants play a considerable role in the development of breast- and ovarian cancer. While malignancies in general are usually a result of somatic mutations [<a class="ArticleReference" href="#B8" id="B8a" data-event="articleReference-a-b8"><!--[-->8<!--]--></a>, <a class="ArticleReference" href="#B9" id="B9a" data-event="articleReference-a-b9"><!--[-->9<!--]--></a>], approximately 5%10% are caused by germline mutations in moderate- or high penetrance cancer susceptibility genes [<a class="ArticleReference" href="#B10" id="B10a" data-event="articleReference-a-b10"><!--[-->10<!--]--></a>]. These predisposing genetic traits usually follow an autosomal dominant inheritance, leading to patients having a highly elevated cumulative risk of developing different types of malignancies, and a 50% chance of passing the mutation onto their offspring [<a class="ArticleReference" href="#B11" id="B11a" data-event="articleReference-a-b11"><!--[-->11<!--]--></a>].</p>
      <p>Over the last few decades, diagnosis of hereditary cancer syndromes has shown promising progress. With rapid advances in molecular testing and next-generation sequencing, a great number of individuals and families have been identified, who are affected by mutations in cancer susceptibility genes. While the BRCA-related hereditary breast- and ovarian cancer (HBOC) is among the most well-known tumour syndromes, one cannot skim over the importance of other, less common predisposition genes.</p>
      <p>Due to a lack of data on genetic spectrum of the Hungarian HBOC population, we aimed to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort and in healthy relatives with family history of cancer; to evaluate the associations of detected variants with clinical features; to evaluate how worthwhile it is to use a larger gene panel (including other genes beside <!--[--><i>BRCA</i><!--]-->s) in routine genetic diagnostics of Hungarians; and to evaluate the association between familial history of cancer and familial accumulation of the genetic variants in the cohort.</p>
    <!--]--></div>
    <div id="s2"><!--[-->
      <h2>Subjects and methods</h2>
      <!--[--><!--[-->
        <!--[--><h3>Subjects</h3><!--]-->
        <!--[--><p>The examinations related to this retrospective study were carried out in the Department of Medical Genetics in the University of Pcs. The patients and relatives that were involved into this study derived from the joint genetic counselling facility of Department of Medical Genetics and Department of Oncotherapy at the University of Pcs (Oncogenetic Counselling and Family Screening Centre). Patients data (personal history of cancer, tumour type, and age at diagnosis) were obtained from clinical records, while the family history of cancer was obtained from interviews with the probands. People referred to the genetic counselling went through a cancer genetic risk assessment. The purpose was to identify individuals at elevated cancer risk who may benefit from genetic testing, additional screening or preventive interventions. Using clues from the personal and family history, the genetic counsellor classified individuals as average (general population), increased (moderate), or high (strong) risk patients according to the widely accepted National Comprehensive Cancer Centre (NCCN) Clinical Practice Guidelines in Oncology, which are available online for experts<a class="ArticleReference" href="#fn1" id="fn1a" data-event="articleReference-a-fn1"><!--[--><!--[--><sup>1</sup><!--]--><!--]--></a>. After risk assessment, individuals classified into the average risk level group were excluded from the study. We highlight the genetic risk stratification for HBOC in <a class="ArticleReference" href="#T1" id="T1a" data-event="articleReference-a-t1"><!--[-->Table 1<!--]--></a>.</p><!--]-->
        <div class="ArticleTable" id="T1"><div class="ArticleTable__header"><p class="ArticleTable__title">TABLE 1</p><!----><button data-tootip-position="top center" class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Expand Table" data-event="articleTable-button-openLightbox"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg><!--]--></button></div><div class="ArticleTable__content"><table><!--[-->
            <thead valign="top">
              <!--[--><tr>
                <!--[--><th align="left">Risk level</th><!--]-->
                <!--[--><th align="left">Personal and family history evidence</th><!--]-->
              </tr><!--]-->
            </thead>
            <tbody valign="top">
              <!--[--><tr>
                <!--[--><td rowspan="2" align="left">Average</td><!--]-->
                <!--[--><td align="left">No first- or second-degree relatives<a class="ArticleReference" href="#Tfn1" id="Tfn1a" data-event="articleReference-a-tfn1"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a> with breast or ovarian cancer; OR</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">More distant relatives with a breast cancer diagnosis or diagnoses after age 50</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td rowspan="4" align="left">Increased (moderate)</td><!--]-->
                <!--[--><td align="left">Prior history of breast cancer, lobular neoplasia (LCIS/ALH), or atypical ductal hyperplasia</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">5-year risk 1.7% in women 35years using the Gail model, or 20% lifetime risk defined by risk models</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Thoracic radiotherapy &lt;30years</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">One or two first- or second-degree relatives with breast cancer diagnosis after age 50</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td rowspan="11" align="left">High (strong)</td><!--]-->
                <!--[--><td align="left">Known pathogenic variant (mutation) in the family</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Somatic tumor testing suggesting a hereditary cancer syndrome</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Patient or first-degree relative diagnosed with exocrine pancreatic cancer</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Diagnosis in patient, or first- or second-degree relative with</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">breast cancer at age 45 or younger</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">triple negative breast cancer diagnosed at any age</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">multiple primary breast cancers</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">ovarian, certain prostate cancers, or male breast cancer at any age</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">breast cancer or prostate cancer diagnosis at any age and Ashkenazi<!--[--><br><!--]-->Jewish ancestry</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Two or more first- or second-degree relatives on same side of family with breast cancer, if at least one was diagnosed  age 50</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Three or more total diagnoses of breast cancer in patient, first- or second-degree relatives on the same side of the family</td><!--]-->
              </tr><!--]-->
            </tbody>
          <!--]--></table></div><div class="ArticleTable__description"><!--[-->
            <p>Genetic risk stratification for HBOC patients.</p>
          <!--]--></div><div class="ArticleTable__foot"><!--[-->
            <div id="Tfn1">
              <!--[--><strong>
                <!--[--><sup>a</sup><!--]-->
              </strong><!--]-->
              <!--[--><p>First-degree relatives are parents, children, and siblings. Second-degree relatives are grandparents, grandchildren, uncles and aunts.</p><!--]-->
            </div>
          <!--]--></div></div>
        <!--[--><p>Blood samples were taken from individuals with increased (moderate) and high (strong) risk for cancer and they were included in the study and for further examination. We collected 370 samples from patients with any cancer type. We classified the samples according to cancer types and we assorted 205 HBOC patients for further examination. Patients with other cancer types were excluded from the current analyses. Besides, we involved 70 healthy persons with a positive family history of HBOC-related cancer, e.g., breast, ovarian, prostate or pancreatic cancer into our examination.</p><!--]-->
        <!--[--><p>All individuals gave their consent to genetic testing and biobanking, which were conducted following the WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects (2013) and the Hungarian genetic law (XXI/2008). The study was approved by the Regional Research Ethics Committee of the University of Pcs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU).</p><!--]-->
      <!--]--><!--]-->
      <!--[--><!--[-->
        <!--[--><h3>Methods</h3><!--]-->
        <!--[--><p>Whole peripheral blood samples were taken from all patients. DNA was extracted from the blood leukocytes using E.Z.N.A. Blood DNA Maxi Kit (Omega Biotek, Norcross, GA, United States) according to the protocol. QubitTM 2.0 Fluorometric Quantitation system (Thermo Fisher Scientific Inc., Waltham, MA United States) was used to calculate the quantity and quality of genomic DNA samples (Qubit 1X dsDNA HS (High Sensitivity) Assay Kits) according to the protocol. The DNA samples were deposited into the biobank of the department.</p><!--]-->
        <!--[--><p>The patients were examined using Agilent SureMASTR Hereditary Cancer Kit previously, which was no longer manufactured (Agilent Technologies, Santa Clara, CA United States), thereafter we used TruSight Hereditary Cancer Kit (Illumina Inc., San Diego, CA United States). Both Kits are targeted sequencing panels. The SureMASTR Hereditary Cancer Kit contained 26 cancer-associated genes (<!--[--><i>ATM</i><!--]-->, <!--[--><i>BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM (3UTR), FAM175A, MEN1, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53,</i><!--]--> and <!--[--><i>XRCC2</i><!--]-->), the TruSight Hereditary Cancer Kit designed to assess germline mutations across 113 genes (<!--[--><i>ACD, AIP, AKT1, APC, ATM, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTRC, DDB2, DICER1, DIS3L2, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FAM175A, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HOXB13, KIF1B, KIT, LZTR1, MAX, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NSD1, NTHL1, PALB2, PDGFRA, PHOX2B, PIK3CA, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RINT1, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPINK1, SPRED1, STK11, SUFU, TERF2IP, TERT, TMEM127, TP53, TSC1, TSC2, VHL, WT1, XPA, XPC,</i><!--]--> and <!--[--><i>XRCC2</i><!--]-->) commonly associated with hereditary predisposition to several cancers like breast, ovarian, colon, and gastric and tumour associated syndromes like tuberous sclerosis and neurofibromatosis. The SureMASTR Hereditary Cancer Kit assay uses amplicon sequencing method. The TruSight Hereditary Cancer Kit assay uses hybrid-capture chemistry integrated with Nextera Flex for Enrichment. We performed the assays according to the description of the manufacturer.</p><!--]-->
        <!--[--><p>After sequencing reactions base called raw sequencing data was transformed into FASTQ format using Illuminas software (bcl2fastq). Sequence reads of each sample were mapped to the human reference genome (GRCh37/hg19). Burrows-Wheeler Aligner (BWA-MEM) software was used for reading alignment. Duplicate read marking, local realignment around indels, base quality score recalibration and variant calling were performed using GATK algorithms (Sentieon Inc., California, United States). Variant data was annotated using a collection of tools (VcfAnno and VEP) with a variety of public variant databases including but not limited to gnomAD<a class="ArticleReference" href="#fn2" id="fn2a" data-event="articleReference-a-fn2"><!--[--><!--[--><sup>2</sup><!--]--><!--]--></a>, ClinVar<a class="ArticleReference" href="#fn3" id="fn3a" data-event="articleReference-a-fn3"><!--[--><!--[--><sup>3</sup><!--]--><!--]--></a> and HGMD<a class="ArticleReference" href="#fn4" id="fn4a" data-event="articleReference-a-fn4"><!--[--><!--[--><sup>4</sup><!--]--><!--]--></a>. The variants detected were adapted to available public databases, depositories like Ensembl<a class="ArticleReference" href="#fn5" id="fn5a" data-event="articleReference-a-fn5"><!--[--><!--[--><sup>5</sup><!--]--><!--]--></a>, Varsome<a class="ArticleReference" href="#fn6" id="fn6a" data-event="articleReference-a-fn6"><!--[--><!--[--><sup>6</sup><!--]--><!--]--></a>, Franklin<a class="ArticleReference" href="#fn7" id="fn7a" data-event="articleReference-a-fn7"><!--[--><!--[--><sup>7</sup><!--]--><!--]--></a>; and HGMD<a class="ArticleReference" href="#fn8" id="fn8a" data-event="articleReference-a-fn8"><!--[--><!--[--><sup>8</sup><!--]--><!--]--></a> and were classified according to the latest guidelines and interpretation criteria established by the American College of Medical Genetics and Genomics. The variants received were matched to the clinical features of the patients and the persons with positive family history.</p><!--]-->
        <!--[--><p>We used PCR for validation of variants detected by NGS. The accession numbers of the gene reference sequences applied for designing methods were summarized in <a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Table S1<!--]--></a> (<a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Material<!--]--></a>). For amplification of the region of interest, we designed specific primers (Integrated DNA Technologies Inc., Coralville, IA, United States) using the NCBI-PRIMER-BLAST tool (NCBI, Bethesda, MD, United States). The sequences of the applied oligonucleotide primers were summarized in <a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Table S1<!--]--></a> (<a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Material<!--]--></a>).</p><!--]-->
        <!--[--><p>We performed PCR reactions according to the protocol below:</p><!--]-->
        <!--[--><p>Final volume was 50L, which contained 200M of each dNTP (1L), 0.2mM of each primer (11L), 5L of reaction buffer (containing 500mM KCl, 10mM Tris-HCl, 14mmol/L MgCl2, pH 9.0), 1U of Taq polymerase (1L of 10U/L) and 1g extracted DNA as template (1L). The conditions of the polymerase chain reactions for the detection of HBOC variants were as follows: initial denaturation at 96C followed by 35 cycles of 30s at 95C; 30s at the annealing temperature; 30s at 72C and a final extension at 72C. The annealing temperatures applied for certain variants are indicated in <a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Table S1<!--]--></a> (<a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Material<!--]--></a>). The polymerase chain reactions were carried out using a SensoQuest Labcycler (SensoQuest GmBH, Gttingen, Germany).</p><!--]-->
        <!--[--><p>After the amplification reaction, the products were electrophoresed through an ethidium-bromide-stained 1.5%2% agarose gel and visualized by UVIdoc gel documentation system (UVITEC, Cambridge, UK).</p><!--]-->
        <!--[--><p>The sequencing reactions were performed by Sanger sequencing on an Applied BiosystemsTM 3500 Genetic Analyzer (Thermo Fisher Scientific Inc., Waltham, MA, United States) using BigDye Terminator Chemistry. The sequence alignments were made using the Winstar genetic program (DNASTAR Inc., Madison, WI, United States).</p><!--]-->
      <!--]--><!--]-->
    <!--]--></div>
    <div id="s3"><!--[-->
      <h2>Results</h2>
      <!--[--><!--[-->
        <!--[--><h3>General characterization</h3><!--]-->
        <!--[--><p>We summarized the general characteristics of the study groups in <a class="ArticleReference" href="#T2" id="T2a" data-event="articleReference-a-t2"><!--[-->Table 2<!--]--></a>. We have analysed a total of 275 samples with targeted next-generation sequencing panels of which, 205 agreed with HBOC criteria (HBOC cohort) and 70 were the sample of healthy persons with a positive family history of different cancers (non-HBOC cohort). The samples derived from non-consanguineous Hungarian people. HBOC patients data (age, tumour type and age at diagnosis) and non-HBOC persons data were summarized in <a class="ArticleReference" href="#T2" id="T2a" data-event="articleReference-a-t2"><!--[-->Table 2<!--]--></a>. Among the HBOC cases, 193 (94.1%) were females and 12 (5.85%) were males, all with a history of HBOC-related cancer. The average age of HBOC cases was 56.0  15.0years. The lowest age discovered was 21years while the highest was 84years. The average age at diagnosis for HBOC cases was 46.3  11.7years (range = 1578years). Among HBOC patients, 51.2% had their primary cancer diagnosis at age 45years or younger. The types of cancers identified within the HBOC group were breast cancer (n = 179; 87.3%), ovarian cancer (n = 16; 7.81%), prostate cancer (n = 6; 2.93%), uterus cancer (n = 3; 1.47%) and endocervix cancer (n = 1; 0.49%).</p><!--]-->
        <div class="ArticleTable" id="T2"><div class="ArticleTable__header"><p class="ArticleTable__title">TABLE 2</p><!----><button data-tootip-position="top center" class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Expand Table" data-event="articleTable-button-openLightbox"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg><!--]--></button></div><div class="ArticleTable__content"><table><!--[-->
            <thead valign="top">
              <!--[--><tr>
                <!--[--><th colspan="2" align="left">Cohort of HBOC patients<a class="ArticleReference" href="#Tfn2" id="Tfn2a" data-event="articleReference-a-tfn2"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></th><!--]-->
              </tr><!--]-->
            </thead>
            <tbody valign="top">
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Gender n (%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Female</td><!--]-->
                <!--[--><td align="left">193 (94.1%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Male</td><!--]-->
                <!--[--><td align="left">12 (5.85%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">total</td><!--]-->
                <!--[--><td align="left">205</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Age (years)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Average SD</td><!--]-->
                <!--[--><td align="left">56.0  15.0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Minmax</td><!--]-->
                <!--[--><td align="left">2184</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Age at diagnosis (years)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Average SD</td><!--]-->
                <!--[--><td align="left">46.3  11.7</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Minmax</td><!--]-->
                <!--[--><td align="left">1578</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">45</td><!--]-->
                <!--[--><td align="left">n = 105 (51.2%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">4560</td><!--]-->
                <!--[--><td align="left">n = 70 (34.2%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">&gt;60</td><!--]-->
                <!--[--><td align="left">n = 30 (14.6%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Tumour types n (%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Breast cancer</td><!--]-->
                <!--[--><td align="left">179 (87.3%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Ovarian cancer</td><!--]-->
                <!--[--><td align="left">16 (7.81%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Uterus cancer</td><!--]-->
                <!--[--><td align="left">3 (1.47%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Prostate cancer</td><!--]-->
                <!--[--><td align="left">6 (2.93%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Endocervix</td><!--]-->
                <!--[--><td align="left">1 (0.49%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Cohort of non-HBOC persons<a class="ArticleReference" href="#Tfn3" id="Tfn3a" data-event="articleReference-a-tfn3"><!--[--><!--[--><sup>b</sup><!--]--><!--]--></a></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Gender n (%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Female</td><!--]-->
                <!--[--><td align="left">60 (85.7%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Male</td><!--]-->
                <!--[--><td align="left">10 (14.3%)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">total</td><!--]-->
                <!--[--><td align="left">70</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td colspan="2" align="left">Age (years)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Average SD</td><!--]-->
                <!--[--><td align="left">49.0  14.0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Minmax</td><!--]-->
                <!--[--><td align="left">2081</td><!--]-->
              </tr><!--]-->
            </tbody>
          <!--]--></table></div><div class="ArticleTable__description"><!--[-->
            <p>Patient cohorts characteristics.</p>
          <!--]--></div><div class="ArticleTable__foot"><!--[-->
            <div id="Tfn2">
              <!--[--><strong>
                <!--[--><sup>a</sup><!--]-->
              </strong><!--]-->
              <!--[--><p>HBOC, cohort: hereditary breast and ovarian cancer.</p><!--]-->
            </div>
            <div id="Tfn3">
              <!--[--><strong>
                <!--[--><sup>b</sup><!--]-->
              </strong><!--]-->
              <!--[--><p>non-HBOC: healthy persons with hereditary cancer relatives.</p><!--]-->
            </div>
          <!--]--></div></div>
        <!--[--><p>Among the healthy non-HBOC cases, there were 60 (85.7%) females and 10 (14.3%) males, all without personal breast and ovarian cancer history but with a positive family history of any cancer. The average age of non-HBOC cases was 49.0  14.0years, ranging from 20 to 81years.</p><!--]-->
        <!--[--><p>In <a class="ArticleReference" href="#T3" id="T3a" data-event="articleReference-a-t3"><!--[-->Table 3<!--]--></a>, we summarized the distribution of genetic variants in all cohorts and the age at diagnosis in the HBOC cohort. The average age at diagnosis in the carrier HBOC group was 44.1  10.9years, where 25years was the minimum and 72years was the maximum age at diagnosis. The average age at diagnosis in non-carriers was 47.3  11.9years. The minimum age at diagnosis was 15years; however, the maximum age at diagnosis was 78years. There was no significant difference in the age at diagnosis between carrier and non-carrier HBOC groups.</p><!--]-->
        <div class="ArticleTable" id="T3"><div class="ArticleTable__header"><p class="ArticleTable__title">TABLE 3</p><!----><button data-tootip-position="top center" class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Expand Table" data-event="articleTable-button-openLightbox"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg><!--]--></button></div><div class="ArticleTable__content"><table><!--[-->
            <thead valign="top">
              <!--[--><tr>
                <!--[--><th colspan="3" align="left"></th><!--]-->
                <!--[--><th colspan="2" align="left">Age at diagnosis</th><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><th align="left"></th><!--]-->
                <!--[--><th align="center"></th><!--]-->
                <!--[--><th align="left">Number of cases n (%)</th><!--]-->
                <!--[--><th align="left">Average SD (years)</th><!--]-->
                <!--[--><th align="left">Minmax (years)</th><!--]-->
              </tr><!--]-->
            </thead>
            <tbody valign="top">
              <!--[--><tr>
                <!--[--><td rowspan="2" align="left">HBOC patients (n = 205)</td><!--]-->
                <!--[--><td align="left">Variant carriers</td><!--]-->
                <!--[--><td align="left">62 (29.8)</td><!--]-->
                <!--[--><td align="left">44.1  10.9</td><!--]-->
                <!--[--><td align="left">2572</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Non-carriers</td><!--]-->
                <!--[--><td align="left">143 (70.2)</td><!--]-->
                <!--[--><td align="left">47.3  11.9</td><!--]-->
                <!--[--><td align="left">1578</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td rowspan="2" align="left">non-HBOC persons (n = 70)</td><!--]-->
                <!--[--><td align="left">Variant carriers</td><!--]-->
                <!--[--><td align="left">20 (28.6)</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Non-carriers</td><!--]-->
                <!--[--><td align="left">50 (71.4)</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td rowspan="2" align="left">All participants (n = 275)</td><!--]-->
                <!--[--><td align="left">Variant carriers</td><!--]-->
                <!--[--><td align="left">82 (29.8)</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Non-carriers</td><!--]-->
                <!--[--><td align="left">193 (70.2)</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
                <!--[--><td align="left">-</td><!--]-->
              </tr><!--]-->
            </tbody>
          <!--]--></table></div><div class="ArticleTable__description"><!--[-->
            <p>Distribution of carriers and non-carriers in the cohorts.</p>
          <!--]--></div><div class="ArticleTable__foot"><!--[--><!--]--></div></div>
      <!--]--><!--]-->
      <!--[--><!--[-->
        <!--[--><h3>Mutational profile of HBOC and non-HBOC study groups</h3><!--]-->
        <!--[--><p>The number of cases of HBOC patients carrying any genetic variants were 61, which is 29.8% of all HBOC patients tested. In the non-HBOC study group, 20 individuals were found carrying any genetic variant in association of cancer predisposition, which is 28.6% of the tested non-HBOC persons. The total number of all variant carriers was 82 cases, which is the 29.8% of all cases.</p><!--]-->
        <!--[--><p>The complete record of the positive results of different tumour types is summarized in <a class="ArticleReference" href="#T4" id="T4a" data-event="articleReference-a-t4"><!--[-->Table 4<!--]--></a>. The table shows the genes in which we detected variants and it contains the most prevalent variants, as well. Breast cancer was diagnosed in most of our cases (179/205; 87.3%), of which we identified genetic variants in 51 cases, representing 28.5% of the breast cancer patients: twelve <!--[--><i>BRCA2</i><!--]--> (6.70%), eight <!--[--><i>CHEK2</i><!--]--> (4.47%), eight <!--[--><i>BRCA1</i><!--]--> (4.47%), seven <!--[--><i>ATM</i><!--]--> (3.91%), three <!--[--><i>PALB2</i><!--]--> (1.68%), and 2-2 variants in <!--[--><i>BARD1, FANCI</i><!--]--> and <!--[--><i>RAD51C</i><!--]--> genes (1.12%), and 1-1 variant in <!--[--><i>APC, BLM, CDH1, ERCC2, KIT, MSH6,, PMS2, RAD50, RAD51B,</i><!--]--> and <!--[--><i>RET</i><!--]--> genes (0.56%). Besides, 9 out of 16 ovarian cancer cases (56.3%) harboured genetic variants: six <!--[--><i>BRCA1</i><!--]--> (37.5%), two <!--[--><i>RAD51C</i><!--]--> (12.5%) and in one case <!--[--><i>BRCA2</i><!--]--> (6.25%). The most prevalent variant was <!--[--><i>BRCA1</i><!--]--> c.5266dupC in the cohorts. Of the six prostate cancer cases, only one carried a genetic variant in the oncogenes (16.7%). From the three cases diagnosed with uterus cancer, only one case revealed positivity, where a pathogenic variant was found in the <!--[--><i>BRCA1</i><!--]--> gene. We could not detect any genetic alteration in the patients diagnosed with endocervix cancer by oncogenetic testing.</p><!--]-->
        <div class="ArticleTable" id="T4"><div class="ArticleTable__header"><p class="ArticleTable__title">TABLE 4</p><!----><button data-tootip-position="top center" class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Expand Table" data-event="articleTable-button-openLightbox"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg><!--]--></button></div><div class="ArticleTable__content"><table><!--[-->
            <thead valign="top">
              <!--[--><tr>
                <!--[--><th align="left">Tumour types</th><!--]-->
                <!--[--><th align="left">Gene<!--[--><br><!--]-->Variant detected</th><!--]-->
                <!--[--><th align="left">All carriers n (%)</th><!--]-->
                <!--[--><th align="left">Carriers of p/LP n (%)</th><!--]-->
                <!--[--><th align="left">Carriers of VUS n (%)</th><!--]-->
              </tr><!--]-->
            </thead>
            <tbody valign="top">
              <!--[--><tr>
                <!--[--><td rowspan="21" align="left">Breast cancer (n = 179)</td><!--]-->
                <!--[--><td align="left"></td><!--]-->
                <!--[--><td align="left">51 (28.5)</td><!--]-->
                <!--[--><td align="left">34 (19.0)</td><!--]-->
                <!--[--><td align="left">17 (9.50)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">12 (6.70)</td><!--]-->
                <!--[--><td align="left">9 (5.03)</td><!--]-->
                <!--[--><td align="left">3 (1.68)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">8 (4.47)</td><!--]-->
                <!--[--><td align="left">8 (4.47)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA1 c.5266dupC</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">3 (1.68)</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>CHEK2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">8 (4.47)</td><!--]-->
                <!--[--><td align="left">7 (3.91)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>CHEK2 c.599T&gt;C</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">3 (1.68)</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>ATM</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">7 (3.91)</td><!--]-->
                <!--[--><td align="left">4 (2.23)</td><!--]-->
                <!--[--><td align="left">3 (1.68)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>PALB2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">3 (1.68)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">2 (1.12)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BARD1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">2 (1.12)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>FANCI</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">2 (1.12)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RAD51C</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">2 (1.12)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>APC</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BLM</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>CDH1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>ERCC2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>KIT</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>MSH6</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>PMS2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RAD50</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RAD51B</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RET</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1 (0.56)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td rowspan="5" align="left">Ovarian cancer (n = 16)</td><!--]-->
                <!--[--><td align="left"></td><!--]-->
                <!--[--><td align="left">9 (56.3)</td><!--]-->
                <!--[--><td align="left">7 (43.8)</td><!--]-->
                <!--[--><td align="left">2 (12.5)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">6 (37.5)</td><!--]-->
                <!--[--><td align="left">5 (31.3)</td><!--]-->
                <!--[--><td align="left">1 (6.25)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA1</i><!--]--> c.5266dupC</td><!--]-->
                <!--[--><td align="left">3 (18.8)</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RAD51C</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">2 (12.5)</td><!--]-->
                <!--[--><td align="left">1 (6.25)</td><!--]-->
                <!--[--><td align="left">1 (6.25)</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (6.25)</td><!--]-->
                <!--[--><td align="left">1 (6.25)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Prostate cancer (n = 6)</td><!--]-->
                <!--[--><td align="left">
                  <!--[--><i>CHEK2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (16.7)</td><!--]-->
                <!--[--><td align="left">1 (16.7)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Uterus cancer (n = 3)</td><!--]-->
                <!--[--><td align="left">
                  <!--[--><i>BRCA1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1 (33.3)</td><!--]-->
                <!--[--><td align="left">1 (33.3)</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">Endocervix (n = 1)</td><!--]-->
                <!--[--><td align="left"></td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
              </tr><!--]-->
            </tbody>
          <!--]--></table></div><div class="ArticleTable__description"><!--[-->
            <p>Carriers of pathogenic/likely pathogenic variants and variants of uncertain significance (VUS) according to tumour types in the HBOC cohort.</p>
          <!--]--></div><div class="ArticleTable__foot"><!--[--><!--]--></div></div>
        <!--[--><p>The identified genetic variants in the HBOC and non-HBOC groups are listed in <a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Table S2<!--]--></a> (<a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Material<!--]--></a>). The table contains the clinical significance of the variants, which were predicted by the ClinVar database and Franklin interpretation tool. The clinical significance of most of the variants can be determined unanimously based on the data from ClinVar and Franklin. In some cases, there were discrepancies between the interpretation of ClinVar and Franklin (pathogenic-likely pathogenic, pathogenic-VUS). Based on the analysis, Franklin proved to be more permissive in most cases. In the ClinVar database, no records were found for the <!--[--><i>CDH1</i><!--]--> c.2499delT variant; however, after classification according to the ACMG guidelines, we interpreted it as a likely pathogenic/pathogenic variant, as was predicted by the Franklin prediction tool.</p><!--]-->
        <!--[--><p>We identified pathogenic/likely pathogenic and VUS genetic variants in <!--[--><i>APC, ATM</i><!--]-->, <!--[--><i>BARD1</i><!--]-->, <!--[--><i>BLM, BRCA1</i><!--]-->, <!--[--><i>BRCA2</i><!--]-->, <!--[--><i>CHEK2</i><!--]-->, <!--[--><i>CDH1</i><!--]-->, <!--[--><i>ERCC2, FANCI, KIT</i><!--]-->, <!--[--><i>MSH6</i><!--]-->, <!--[--><i>PALB2</i><!--]-->, <!--[--><i>PMS2</i><!--]-->, <!--[--><i>RAD50, RAD51B, RAD51C,</i><!--]--> and <!--[--><i>RET</i><!--]--> in the HBOC group. The non-HBOC patients harbour pathogenic/likely pathogenic and VUS genetic variants in <!--[--><i>BRCA1</i><!--]-->, <!--[--><i>BRCA2</i><!--]-->, <!--[--><i>CHEK2</i><!--]-->, <!--[--><i>EPCAM, ERCC3, FANCD2, MSH6</i><!--]-->, <!--[--><i>MUTYH, PALB2</i><!--]-->, <!--[--><i>POLE, PTCH1,</i><!--]--> and <!--[--><i>RAD51C.</i><!--]--> Genetic variants in <!--[--><i>BARD1</i><!--]-->, <!--[--><i>CDH1</i><!--]-->, <!--[--><i>PMS2</i><!--]-->, <!--[--><i>KIT</i><!--]--> and <!--[--><i>RET</i><!--]--> genes were identified in HBOC patients only. Variants in <!--[--><i>MUTYH</i><!--]-->, <!--[--><i>EPCAM</i><!--]-->, <!--[--><i>FANCD2</i><!--]-->, <!--[--><i>POLE</i><!--]-->, <!--[--><i>ERCC3,</i><!--]--> and <!--[--><i>PTCH1</i><!--]--> were reported in the non-HBOC persons only. Overall, we identified 67 unique pathogenic/likely pathogenic variants and VUS carried by 82 individuals: 35 missense (52.2%), 15 frameshift (22.4%), 10 nonsense (14.9%), 2 synonymous (2.99%), 4 splice site variants (5.97%) and one three basepair deletion (1.49%), which cause one amino acid deletion, but not frameshift.</p><!--]-->
        <!--[--><p>For <!--[--><i>BRCA2</i><!--]-->, 16 distinct variants in the association of cancer were identified in 17 individuals. The majority of the variants had pathogenic or likely pathogenic clinical significance. Only two variants were VUS (c.1012 G&gt;A; c.3042 T&gt;G). The most prevalent variant was the c.1408dupG, which were detected in two breast cancer cases, representing 2.98% of all variants detected.</p><!--]-->
        <!--[--><p>For <!--[--><i>BRCA1</i><!--]-->, 10 different variants in association of cancer were identified in 17 individuals. Almost all variants were predicted to be pathogenic, and only one was predicted to be VUS (c.734 A&gt;T). In the case of c.845 C&gt;T, Franklin predicted it as VUS; however, it was mentioned as pathogenic in ClinVar. One of the variants (c.5266dupC) was present in seven samples, representing approximately 10.4% of all variants detected.</p><!--]-->
        <!--[--><p>
          <!--[--><i>CHEK2</i><!--]--> is the third gene, in which we most frequently identified variants in association with cancer. We detected 6 different variants in 11 individuals, from which five were pathogenic/likely pathogenic, one was VUS (c.1039 A&gt;G) and one had conflicting interpretations of pathogenicity (c.1684 C&gt;G; ClinVar: pathogenic/likely pathogenic, Franklin: VUS). One of the variants (c.599 T&gt;C) was present in six samples, representing approximately 8.96% of all variants detected.</p><!--]-->
        <!--[--><p>For <!--[--><i>ATM</i><!--]--> gene, 7 distinct variants in the association of cancer were identified in 7 individuals, from which three were pathogenic/likely pathogenic and four were VUS according to ClinVar and Franklin.</p><!--]-->
        <!--[--><p>We compared the numbers of detected cases and allele frequencies of the pathogenic/likely pathogenic variants for each gene in the study groups, which are summarized in <a class="ArticleReference" href="#T5" id="T5a" data-event="articleReference-a-t5"><!--[-->Table 5<!--]--></a>. Pathogenic/likely pathogenic variants of <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> showed similar allele frequencies, which shared the highest frequencies among the genes in the HBOC cohort. In the non-HBOC group, <!--[--><i>BRCA1</i><!--]--> showed the highest frequency. Additionally, we assessed the allele frequencies of the genes in the gnomAD non-cancer cohort (n = 134 187), which showed significant differences in <!--[--><i>BRCA1, BRCA2, CHEK2, MUTYH, MSH6, POLE, and ERCC3</i><!--]--> genes in comparison to our non-HBOC groups.</p><!--]-->
        <div class="ArticleTable" id="T5"><div class="ArticleTable__header"><p class="ArticleTable__title">TABLE 5</p><!----><button data-tootip-position="top center" class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Expand Table" data-event="articleTable-button-openLightbox"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M28 10V6h14v14h-4v-7.171L27.414 23.413l-2.828-2.828L35.172 10H28ZM6 28h4v7.172l10.586-10.586 2.828 2.828L12.828 38H20v4H6V28Z"></path></svg><!--]--></button></div><div class="ArticleTable__content"><table><!--[-->
            <thead valign="top">
              <!--[--><tr>
                <!--[--><th rowspan="2" align="left">Gene name</th><!--]-->
                <!--[--><th colspan="2" align="left">HBOC cohort (n = 205)</th><!--]-->
                <!--[--><th colspan="2" align="left">Non-HBOC cohort (n = 70)</th><!--]-->
                <!--[--><th colspan="2" align="left">All participants (n = 275)</th><!--]-->
                <!--[--><th colspan="2" align="left">GnomAD non-cancer cohort (n = 134 187)</th><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><th align="left">Detected cases</th><!--]-->
                <!--[--><th align="left">Allele frequency</th><!--]-->
                <!--[--><th align="left">Detected cases</th><!--]-->
                <!--[--><th align="left">Allele frequency</th><!--]-->
                <!--[--><th align="left">Detected cases</th><!--]-->
                <!--[--><th align="left">Allele frequency</th><!--]-->
                <!--[--><th align="left">Detected cases</th><!--]-->
                <!--[--><th align="left">Allele frequency</th><!--]-->
              </tr><!--]-->
            </thead>
            <tbody valign="top">
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">13</td><!--]-->
                <!--[--><td align="left">0.03170</td><!--]-->
                <!--[--><td align="left">3</td><!--]-->
                <!--[--><td align="left">0.02143<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">16</td><!--]-->
                <!--[--><td align="left">0.02909</td><!--]-->
                <!--[--><td align="left">295</td><!--]-->
                <!--[--><td align="left">0.00110</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BRCA2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">13</td><!--]-->
                <!--[--><td align="left">0.03170</td><!--]-->
                <!--[--><td align="left">2</td><!--]-->
                <!--[--><td align="left">0.01429<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">15</td><!--]-->
                <!--[--><td align="left">0.02727</td><!--]-->
                <!--[--><td align="left">411</td><!--]-->
                <!--[--><td align="left">0.00153</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>PALB2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">200</td><!--]-->
                <!--[--><td align="left">0.00075</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>ATM</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">3</td><!--]-->
                <!--[--><td align="left">0.00730</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">3</td><!--]-->
                <!--[--><td align="left">0.00545</td><!--]-->
                <!--[--><td align="left">428</td><!--]-->
                <!--[--><td align="left">0.00160</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>CHEK2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">8</td><!--]-->
                <!--[--><td align="left">0.01950</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00714<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">9</td><!--]-->
                <!--[--><td align="left">0.01636</td><!--]-->
                <!--[--><td align="left">207</td><!--]-->
                <!--[--><td align="left">0.00077</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>MUTYH</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.01429<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">1,536</td><!--]-->
                <!--[--><td align="left">0.00572</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>MSH6</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">2</td><!--]-->
                <!--[--><td align="left">0.01429<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">2</td><!--]-->
                <!--[--><td align="left">0.00363</td><!--]-->
                <!--[--><td align="left">119</td><!--]-->
                <!--[--><td align="left">0.00044</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>RAD51C</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">118</td><!--]-->
                <!--[--><td align="left">0.00044</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BARD1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">84</td><!--]-->
                <!--[--><td align="left">0.00031</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>CDH1</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">9</td><!--]-->
                <!--[--><td align="left">0.00003</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>POLE</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00714<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">48</td><!--]-->
                <!--[--><td align="left">0.00018</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>ERCC3</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00714<a class="ArticleReference" href="#Tfn4" id="Tfn4a" data-event="articleReference-a-tfn4"><!--[--><!--[--><sup>a</sup><!--]--><!--]--></a></td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="left">247</td><!--]-->
                <!--[--><td align="left">0.00092</td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>FANCI</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>ERCC2</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00244</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
              <!--[--><tr>
                <!--[--><td align="left">
                  <!--[--><i>BLM</i><!--]-->
                </td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">0</td><!--]-->
                <!--[--><td align="left">1</td><!--]-->
                <!--[--><td align="left">0.00182</td><!--]-->
                <!--[--><td align="center"></td><!--]-->
                <!--[--><td align="center"></td><!--]-->
              </tr><!--]-->
            </tbody>
          <!--]--></table></div><div class="ArticleTable__description"><!--[-->
            <p>Detection ratio of <!--[--><i>BRCA1</i><!--]-->, <!--[--><i>BRCA2</i><!--]-->, <!--[--><i>PALB2</i><!--]-->, <!--[--><i>ATM</i><!--]-->, <!--[--><i>CHEK2</i><!--]-->, <!--[--><i>MUTYH</i><!--]-->, <!--[--><i>MSH6</i><!--]-->, <!--[--><i>RAD51C</i><!--]-->, <!--[--><i>BARD1</i><!--]-->, <!--[--><i>CDH1</i><!--]-->, <!--[--><i>POLE and ERCC3</i><!--]--> P/LP variants in the study groups and gnomAD non-cancer population.</p>
          <!--]--></div><div class="ArticleTable__foot"><!--[-->
            <div>
              <!--[--><p>All individuals carried the variants in heterozygous form.</p><!--]-->
            </div>
            <div id="Tfn4">
              <!--[--><strong>
                <!--[--><sup>a</sup><!--]-->
              </strong><!--]-->
              <!--[--><p>Chi-square tests were used for comparison of the allele frequencies between GnomAD, Non-Cancer Group and our non-HBOC, group.</p><!--]-->
            </div>
          <!--]--></div></div>
        <!--[--><p>Remarkably, <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> are the genes that explain almost half of the positive cases (17 + 17/82; 41.5%). <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> were the genes with the highest rate of pathogenic/likely pathogenic variants. Three patients diagnosed with breast cancer in the HBOC group harboured two genetic variants concomitantly (double heterozygotes; DH): 1. patient: <!--[--><i>BRCA1</i><!--]--> c.5266dupC het, p.Gln1756Profs*74 and <!--[--><i>BLM</i><!--]--> c.1642C&gt;T het, p.Gln548Ter, which are known pathogenic variants; the patient was diagnosed with Grade 3 triple negative, invasive ductal carcinoma at the age of 32years. 2. patient: <!--[--><i>BRCA2</i><!--]--> c.7976G&gt;A het, p.Arg2659Lys and <!--[--><i>RAD50</i><!--]--> c.287T&gt;C het, p.Val96Ala, which are pathogenic and VUS, respectively; the patient has been receiving treatment for Grade 3 triple negative, invasive ductal carcinoma as well, which was diagnosed at the age of 29years. 3. patient: <!--[--><i>BRCA2</i><!--]--> c.3042T&gt;G het, p.Asn1014Lys and <!--[--><i>ATM</i><!--]--> c.5890A&gt;G het, p.Lys1964Glu, which are VUSs. The patient was first diagnosed with Grade 3 triple negative invasive ductal carcinoma at the age of 35years, and a contralateral Grade 3 triple negative ductal breast cancer at the age of 44years. Though there were suspicions for causality based on the patients phenotype, the initial classification of these variants remained unchanged upon reevaluation.</p><!--]-->
        <!--[--><p>Besides, we identified other variants with benign clinical significance by next-generation testing, which were not confirmed by Sanger sequencing and they are not the part of this study.</p><!--]-->
      <!--]--><!--]-->
    <!--]--></div>
    <div id="s4"><!--[-->
      <h2>Discussion</h2>
      <p>Over the last decade, the spreading of new techniques such as NGS that allows the simultaneous analysis of multiple genes in panels as well as whole exome/genome are more cost-effective and efficient compared to Sanger sequencing. The use of these techniques probably contributes to faster recognition of the genetic cause of rare or ultra-rare disorders and to broadening the genetic screening of certain disorders, like cancers, where rapid diagnosis is extremely important for further care and the selection of appropriate therapy.</p>
      <p>In our work, NGS allows us to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort. Such data were not available for the Hungarian population, so far. We focused on the prevalence of genetic variants, predominantly pathogenic/likely pathogenic variants in cancer susceptibility genes in a Hungarian patient cohort selected from gathering increased (moderate) and high (strong) risk criteria for HBOC and a healthy individuals cohort, whose family history was positive for any cancer.</p>
      <p>Pathogenic/likely pathogenic variants and VUSs were found in almost 50% of all individuals in HBOC as well as in non-HBOC groups. We found variants in the following genes: <!--[--><i>APC</i><!--]-->, <!--[--><i>ATM</i><!--]-->, <!--[--><i>BARD1</i><!--]-->, <!--[--><i>BLM</i><!--]-->, <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2, CDH1, CHEK2, EPCAM, ERCC3, FANCD2, KIT, MSH6, MUTYH, PALB2, PMS2, POLE, PTCH1, RAD, RAD51B, RAD51C,</i><!--]--> and <!--[--><i>RET.</i><!--]--> These genes are involved in repairing DNA damage and maintaining the stability of the cells genetic material [<a class="ArticleReference" href="#B12" id="B12a" data-event="articleReference-a-b12"><!--[-->12<!--]--></a>]. Some of these genes play important roles particularly in the homologous recombination-, base excision- and mismatch repair pathway (HRR, BER, MMR), which are important for maintaining genomic stability [<a class="ArticleReference" href="#B13" id="B13a" data-event="articleReference-a-b13"><!--[-->13<!--]--></a><a class="ArticleReference" href="#B15" id="B15a" data-event="articleReference-a-b15"><!--[-->15<!--]--></a>].</p>
      <p>It is well-established that due to pathogenic germline variants detected in these genes, cells can grow uncontrolled and carrying these variants can confer predisposition for the development of hereditary cancer syndromes, which affects 5% of all HBOC cases. In the Hungarian HBOC group, <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> genes proved to be highly penetrant genes with their pathogenic detection rate of 6.34% (13/205, each). While <!--[--><i>CHEK2</i><!--]--> and <!--[--><i>ATM</i><!--]--> have moderate penetrance in HBOC (3.90%, 8/205; 1.46%, 3/205, respectively); in turn, the <!--[--><i>PALB2</i><!--]--> gene has a lower detection rate of 0.48% (1/205). These results are consistent with others findings in European populations with HBOC [<a class="ArticleReference" href="#B16" id="B16a" data-event="articleReference-a-b16"><!--[-->16<!--]--></a>, <a class="ArticleReference" href="#B17" id="B17a" data-event="articleReference-a-b17"><!--[-->17<!--]--></a>]. In the non-HBOC group, we obtained similar results regarding the <!--[--><i>BRCA1</i><!--]--> gene (4.29%, 3/70); however, there are differences in the prevalence of other genes. These differences can result from the fact, that in this group there were healthy people, who have a positive family history with a wide range of tumour spectrum including colorectal, pancreatic or gastric cancers, which have been associated with other genes such as <!--[--><i>MUTYH</i><!--]--> and <!--[--><i>MSH6</i><!--]-->.</p>
      <p>Furthermore, the HBOC group was divided into subgroups according to the type of cancer: breast, ovarian, prostate, uterus and endocervix subgroups, and we evaluated the prevalence of genetic variants in each group. In the breast cancer subgroup, variants in <!--[--><i>BRCA2</i><!--]--> and <!--[--><i>BRCA1</i><!--]--> were the most frequently detected. In the ovarian cancer subgroup, <!--[--><i>BRCA1</i><!--]--> variants, mainly c.5266dupC was found. Besides, rare variants in other genes like <!--[--><i>ATM</i><!--]-->, <!--[--><i>CHEK2</i><!--]-->, <!--[--><i>CDH1</i><!--]-->, <!--[--><i>PALB2</i><!--]-->, <!--[--><i>RAD50,</i><!--]--> and <!--[--><i>RAD51C</i><!--]--> have been detected mainly in the breast cancer subgroup. Most of these variants detected are variants of uncertain significance (VUS). In clinical practice, VUSs represent a challenge, because they must be indicated on medical results; however, - according to ACMG recommendations - VUSs are not used to guide clinical management until the clarification of their exact role [<a class="ArticleReference" href="#B18" id="B18a" data-event="articleReference-a-b18"><!--[-->18<!--]--></a>]. Almost all of the VUSs detected in the study are located within important regions of the genes or functional domains of the proteins and could affect biochemical properties and biological functions. Even though we cannot determine their clinical significance with current evidence, functional studies on these variants would be necessary to explore their phenotype consequences. In our study, these variants of uncertain significance account for high percentage of the positive cases, furthermore we detected a surprising number of pathogenic variants in moderate-, and low penetrant genes. There are differences among European countries in the judgement of involving low penetrance genes in the first-line genetic HBOC screening. In some countries (e.g., Austria, Estonia, Finland, Poland), the hotspot and/or founder variants of BRCA or HBOC genes are tested first. In other countries like Finland and the Netherland, WES is executed and evaluated as an oncogenetic panel. However, it may vary among laboratories within a given country. Our findings highlight the possible benefits of including other genes besides <!--[--><i>BRCA</i><!--]-->s in routine genetic testing. However, incorporation testing of several genes into multigene (<!--[--><i>PMS2, RET, KIT</i><!--]-->) for which the evidence of risk-association is weak or absent can result in information that might not be clinically relevant to the affected patients and their families [<a class="ArticleReference" href="#B19" id="B19a" data-event="articleReference-a-b19"><!--[-->19<!--]--></a>, <a class="ArticleReference" href="#B20" id="B20a" data-event="articleReference-a-b20"><!--[-->20<!--]--></a>].</p>
      <p>In the Hungarian cohorts, the c.5266dupC in the <!--[--><i>BRCA1</i><!--]--> gene was detected most frequently (7/82, 8.54%). This variant is an insertion of one cytosine resulting in a frameshift and the creation of a novel translational termination codon after 74 amino acid residues. It is predicted to encode a truncated non-functional protein due to nonsense-mediated mRNA decay, which is a commonly known mechanism for disease. Functional studies have shown activity of the protein is significantly impaired by this variant [<a class="ArticleReference" href="#B21" id="B21a" data-event="articleReference-a-b21"><!--[-->21<!--]--></a>]. This mutation has been described in individuals with HBOC, including individuals with male breast cancer, pancreatic cancer, and prostate cancer [<a class="ArticleReference" href="#B22" id="B22a" data-event="articleReference-a-b22"><!--[-->22<!--]--></a><a class="ArticleReference" href="#B27" id="B27a" data-event="articleReference-a-b27"><!--[-->27<!--]--></a>], and has been shown to be a founder mutation in several ethnic groups [<a class="ArticleReference" href="#B28" id="B28a" data-event="articleReference-a-b28"><!--[-->28<!--]--></a>]. The high prevalence of this variant in our cohort and the fact that this variant has been reported several times in the literature state the probability of being a founder mutation of our population or maybe for a specific ethnicity; however, we did not collect information about the patients origin. To confirm this hypothesis, further studies are required.</p>
      <p>To evaluate the association between familial history of cancer and accumulation of the genetic variants, we assessed allele frequency data between our non-HBOC group and the gnomAD non-cancer non-Finnish European population as a group of healthy (non-cancer) individuals without any family history of cancer [<a class="ArticleReference" href="#B29" id="B29a" data-event="articleReference-a-b29"><!--[-->29<!--]--></a>]. The findings revealed significant differences in allele frequencies between the two study groups, so the healthy persons with elevated risk for cancer (because of positive family history) carry the pathogenic variants in a higher proportion than people in the average population. Generally, indications of testing for high-penetrance susceptibility genes include a personal history of cancer at a young age, triple-negative or male breast cancer, epithelial ovarian cancer, multiple primary malignancies, or a positive family anamnesis. Based on these facts, genetic screening of predisposing genes in healthy but elevated-risk persons would be necessary to prevent developing tumours. After screening, healthy carriers can be easily managed and can be involved in surveillance programs and preventive follow-up care. Recognizing at-risk patients who carry the aforementioned genetic variants has important consequences on an individual level and on a larger scale as well. Affected individuals, who are already undergoing treatment can receive targeted therapy based on their genetic results, which usually leads to better outcomes and higher probability of long-term survival. Since their risk for developing other malignancies is also elevated, a positive genetic result also warrants a multidisciplinary approach to their surveillance. Identification of healthy carriers offers patients an opportunity to attend regular screening from a young age and the possibility of certain, primary preventive measures, including chemoprevention and risk-reducing surgery [<a class="ArticleReference" href="#B30" id="B30a" data-event="articleReference-a-b30"><!--[-->30<!--]--></a><a class="ArticleReference" href="#B33" id="B33a" data-event="articleReference-a-b33"><!--[-->33<!--]--></a>]. These surveillance strategies lead to earlier detection and better prognosis, reducing premature mortality and prolonged disability, while also easing the strain of costs on the healthcare system.</p>
      <p>Besides, we detected a novel germline variant (<!--[--><i>CDH1</i><!--]--> c.2499delT), which is not yet recorded in variant databases. We interpreted and classified this sequence variant according to the standards and guidelines published by the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG-AMP) [<a class="ArticleReference" href="#B34" id="B34a" data-event="articleReference-a-b34"><!--[-->34<!--]--></a>, <a class="ArticleReference" href="#B35" id="B35a" data-event="articleReference-a-b35"><!--[-->35<!--]--></a>]. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay resulting in an absent or non-functional protein product (PVS1). Other frameshift variants in the nearby region have been reported in individuals with hereditary cancer-predisposing syndrome, and Familial cancer of breast, loss-of-function of <!--[--><i>CDH1</i><!--]--> is a well-established mechanism leading to the disorder. This variant has not been observed in the large reference population cohorts of the Genome Aggregation Database (gnomAD, n &gt; 120 000 exomes and n &gt; 15 000 genomes) (PM2). To our knowledge, the variant has not been published in the relevant medical literature or reported in disease-related variation databases such as HGMD or ClinVar. To assess the impact of the missense change, we applied a combination of some of the most widely used <!--[--><i>in silico</i><!--]--> computational prediction tools like PolyPhen, Provean and MutationTaster [<a class="ArticleReference" href="#B36" id="B36a" data-event="articleReference-a-b36"><!--[-->36<!--]--></a>]. These algorithms support obvious evidence that the c.2499delT variant is a protein damaging, disease-causing variant (PP3). To our best knowledge, there are no <!--[--><i>in vitro</i><!--]--> functional studies which investigate the damaging effect of this variant on the gene product (PS3). The classification of this <!--[--><i>CDH1</i><!--]--> variant provides strong evidence of pathogenicity. The patient was diagnosed with metastasizing lobular breast carcinoma at the age of 48years. The histological subtype of her tumour suggests furthermore, that there is a cause-effect relation between her illness and the detected germline variant.</p>
      <p>Double heterozygosity (DH) in a high-, or moderate penetrance gene is a rare event; however, its number is likely to increase due to the use of NGS. In our study, we report three breast cancer cases (3/205; 1.46%) with (1) two VUSs in <!--[--><i>BRCA2</i><!--]--> and <!--[--><i>ATM</i><!--]--> genes; (2) one pathogenic variant in the <!--[--><i>BRCA2</i><!--]--> gene and one VUS in the <!--[--><i>RAD50</i><!--]--> gene; (3) two pathogenic variant in <!--[--><i>BRCA1</i><!--]--> gene. Some studies showed no significant differences in risk for HBOC in DH carriers when compared with those carrying only one germline variant [<a class="ArticleReference" href="#B37" id="B37a" data-event="articleReference-a-b37"><!--[-->37<!--]--></a>, <a class="ArticleReference" href="#B38" id="B38a" data-event="articleReference-a-b38"><!--[-->38<!--]--></a>]. Others suggest that this genotype is not associated with early disease onset or a more severe phenotype [<a class="ArticleReference" href="#B38" id="B38a" data-event="articleReference-a-b38"><!--[-->38<!--]--></a>]. In regards to our patients, all three were diagnosed with high grade, triple negative ductal carcinoma at a very young age. However, ethnic differences have been described as Caucasian DH females might develop breast cancer at an earlier age and have more severe disease in contrast to e.g., Ashkenazi Jewish females [<a class="ArticleReference" href="#B37" id="B37a" data-event="articleReference-a-b37"><!--[-->37<!--]--></a>]. However, despite the little information about phenotype of DH carriers, we should not ignore their assumed risk modifier role and their possible cumulative impact on the development of the phenotype supporting a polygenic risk that should be considered in risk prediction in genetic counselling. Furthermore, DHs should be involved in more intensive surveillance programs/follow-up care and may need more severe prophylactic surgery [<a class="ArticleReference" href="#B39" id="B39a" data-event="articleReference-a-b39"><!--[-->39<!--]--></a>].</p>
      <p>The limitation of our study is the small number of individuals in certain groups with cancer types, which does not allow us to make profound genotype-phenotype associations. Besides, associations assumed in this study can be reliably assessed with information on other extrinsic contributing factors like smoking, alcohol consumption and dietary habits of the patients. These should be evaluated on a larger cohort of cancer patients.</p>
    <!--]--></div>
    <div id="s5"><!--[-->
      <h2>Conclusion</h2>
      <p>The prevalence of hereditary mutations in breast, ovarian, endometrial and prostate cancer highlights the significance of genetic counselling and molecular genetic testing concerning these malignancies. Our study demonstrates a considerable percentage of pathogenic mutation carriers, emphasizing the benefits of molecular screening tests. The expansions of the diagnostic field revealed many other pathogenic variants associated with HBOC cancer that could have been missed if only <!--[--><i>BRCA1</i><!--]--> and <!--[--><i>BRCA2</i><!--]--> genes had been analysed. In this context, the appearance of next-generation sequencing methods has great potential. Thanks to its expansion, many new variants have been discovered in previously undiagnosed patients. Besides, comprehensive genetic diagnostics have long-term clinical benefits like increased patient cure rates, better patient surveillance, reduced cancer mortality rates, more effective treatments, and rapid recognition of high-risk families to reduce the risk of developing cancer. However, new challenges are generated in emerging next-generation sequencing like the interpretation of the huge amount of data derived from NGS, which highlights the need for highly skilled professionals in genetic counselling and molecular diagnostics with close cooperation of a multidisciplinary team.</p>
      <p>Our results provide important new information to ethnic-specific cancer risk profiling and to determining even polygenic risk scores for HBOC, which can increase the sensitivity and specificity of cancer diagnostics as well as lowering the cost. However, several rare variants were identified with uncertain clinical significance, evaluation of the biological impact of these variants, further functional assays or robust segregation studies are needed.</p>
    <!--]--></div>
  <!--]--><!--[--><h2>Statements</h2><!--[--><div id="s6" class="Statement__Dataavailabilitystatement"><h3>Data availability statement</h3><!--[-->
      
      <p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a class="ArticleReference" href="#s11" id="s11a" data-event="articleReference-a-s11"><!--[-->Supplementary Material<!--]--></a>.</p>
    <!--]--></div><div id="s7" class="Statement__Ethicsstatement"><h3>Ethics statement</h3><!--[-->
      
      <p>The studies involving humans were approved by the Regional Research Ethics Committee of the University of Pcs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
    <!--]--></div><div id="s8" class="Statement__Authorcontributions"><h3>Author contributions</h3><!--[-->
      
      <p>AnM and KH devised the main conceptual ideas and the outlines of the manuscript. AlM, LB, and KH conducted genetic counsultations, AnM and JB conducted sample preparation and genetic testing. Data collection about patient cohort and genetic results was performed mainly by SK. Patients of the cohort were referred to our institution by LM and EB as well. Manuscript written mainly by SK, AnM, AlM, LB, and KH. All authors contributed to the article and approved the submitted version.</p>
    <!--]--></div><div id="s9" class="Statement__Funding"><h3>Funding</h3><!--[-->
      
      <p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is supported (not financially) by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS). This study was supported by the Medical School of the University of Pcs, OK-KA Research Program; KA-2023-22.</p>
    <!--]--></div><div id="s10" class="Statement__Conflictofinterest"><h3>Conflict of interest</h3><!--[-->
      
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    <!--]--></div><div id="s11" class="Statement__Supplementarymaterial"><h3>Supplementary material</h3><!--[-->
      
      <p>The Supplementary Material for this article can be found online at: <a href="#supplementary-material">https://www.por-journal.com/articles/10.3389/pore.2024.1611813/full#supplementary-material</a></p>
      <!--[--><!----><!--[--><!--]--><!--]-->
    <!--]--></div><div id="h13" class="Statement__Footnotes"><h3>Footnotes</h3><!--[-->
      <p id="fn1" class="Footnote"><span class="Footnote__label">1.</span><a class="Footnote__anchor" href="#fn1a">^</a><!--[-->
          <a href="http://www.nccn.org" target="_blank">www.nccn.org</a>
        <!--]--></p>
      <p id="fn2" class="Footnote"><span class="Footnote__label">2.</span><a class="Footnote__anchor" href="#fn2a">^</a><!--[-->
          <a href="https://gnomad.broadinstitute.org/" target="_blank">https://gnomad.broadinstitute.org/</a>
        <!--]--></p>
      <p id="fn3" class="Footnote"><span class="Footnote__label">3.</span><a class="Footnote__anchor" href="#fn3a">^</a><!--[-->
          <a href="https://www.ncbi.nlm.nih.gov/clinvar/" target="_blank">https://www.ncbi.nlm.nih.gov/clinvar/</a>
        <!--]--></p>
      <p id="fn4" class="Footnote"><span class="Footnote__label">4.</span><a class="Footnote__anchor" href="#fn4a">^</a><!--[-->
          <a href="https://www.hgmd.cf.ac.uk/ac/index.php" target="_blank">https://www.hgmd.cf.ac.uk/ac/index.php</a>
        <!--]--></p>
      <p id="fn5" class="Footnote"><span class="Footnote__label">5.</span><a class="Footnote__anchor" href="#fn5a">^</a><!--[-->
          <a href="https://ensemble.org" target="_blank">https://ensemble.org</a>
        <!--]--></p>
      <p id="fn6" class="Footnote"><span class="Footnote__label">6.</span><a class="Footnote__anchor" href="#fn6a">^</a><!--[-->
          <a href="https://varsome.com/" target="_blank">https://varsome.com/</a>
        <!--]--></p>
      <p id="fn7" class="Footnote"><span class="Footnote__label">7.</span><a class="Footnote__anchor" href="#fn7a">^</a><!--[-->
          <a href="https://franklin.genoox.com/clinical-db/home" target="_blank">https://franklin.genoox.com/clinical-db/home</a>
        <!--]--></p>
      <p id="fn8" class="Footnote"><span class="Footnote__label">8.</span><a class="Footnote__anchor" href="#fn8a">^</a><!--[-->
          <a href="http://www.hgmd.cf.ac.uk/ac/index.php" target="_blank">http://www.hgmd.cf.ac.uk/ac/index.php</a>
        <!--]--></p>
    <!--]--></div><!--]--><!--]--><!----><div id="h14"><h2>References</h2><ul class="References"><!--[--><li class="References__item" id="B1"><div class="References__label"><p>1.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Mattiuzzi</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lippi</span><!--]--> <!--[--><span class="References__givenNames">G</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Current cancer epidemiology<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Epidemiol Glob Health</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->9<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->4<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->217<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->22<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.2991/jegh.k.191008.001<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.2991/jegh.k.191008.001" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=C.%2BMattiuzzi&amp;author=G.%2BLippi&amp;publication_year=2019&amp;title=Current%2Bcancer%2Bepidemiology&amp;journal=J+Epidemiol+Glob+Health&amp;volume=9&amp;pages=217-22" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B2"><div class="References__label"><p>2.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Sung</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ferlay</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Siegel</span><!--]--> <!--[--><span class="References__givenNames">RL</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Laversanne</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Soerjomataram</span><!--]--> <!--[--><span class="References__givenNames">I</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Jemal</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">CA: a Cancer J clinicians</i><!--]--> (<!--[--><!--[--><!--[-->2021<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->71<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->209<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->49<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.3322/caac.21660<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.3322/caac.21660" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=H.%2BSung&amp;author=J.%2BFerlay&amp;author=RL.%2BSiegel&amp;author=M.%2BLaversanne&amp;author=I.%2BSoerjomataram&amp;author=A.%2BJemal&amp;publication_year=2021&amp;title=Global%2Bcancer%2Bstatistics%2B2020%3A%2BGLOBOCAN%2Bestimates%2Bof%2Bincidence%2Band%2Bmortality%2Bworldwide%2Bfor%2B36%2Bcancers%2Bin%2B185%2Bcountries&amp;journal=CA%3A+a+Cancer+J+clinicians&amp;volume=71&amp;pages=209-49" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B3"><div class="References__label"><p>3.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Garner</span><!--]--> <!--[--><span class="References__givenNames">WB</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Smith</span><!--]--> <!--[--><span class="References__givenNames">BD</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ludmir</span><!--]--> <!--[--><span class="References__givenNames">EB</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wakefield</span><!--]--> <!--[--><span class="References__givenNames">DV</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Shabason</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Williams</span><!--]--> <!--[--><span class="References__givenNames">GR</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Predicting future cancer incidence by age, race, ethnicity, and sex<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Geriatr Oncol</i><!--]--> (<!--[--><!--[--><!--[-->2023<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->14<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->101393<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1016/j.jgo.2022.10.008<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1016/j.jgo.2022.10.008" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=WB.%2BGarner&amp;author=BD.%2BSmith&amp;author=EB.%2BLudmir&amp;author=DV.%2BWakefield&amp;author=J.%2BShabason&amp;author=GR.%2BWilliams&amp;publication_year=2023&amp;title=Predicting%2Bfuture%2Bcancer%2Bincidence%2Bby%2Bage%2C%2Brace%2C%2Bethnicity%2C%2Band%2Bsex&amp;journal=J+Geriatr+Oncol&amp;volume=14" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B4"><div class="References__label"><p>4.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->Nemzeti Rkregiszter<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nemzeti rkregiszter</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->). <!--[--><!--[--><!--[-->Available from: <a href="http://stat.nrr.hu/" target="_blank">http://stat.nrr.hu/</a><!--]--><!--]--><!--]--> (<!--[--><!--[--><!--[-->Accessed May 26, 2022<!--]--><!--]--><!--]-->).<!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><!----><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?publication_year=2022&amp;journal=Nemzeti+r%C3%A1kregiszter" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B5"><div class="References__label"><p>5.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Howell</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Anderson</span><!--]--> <!--[--><span class="References__givenNames">AS</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Clarke</span><!--]--> <!--[--><span class="References__givenNames">RB</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Duffy</span><!--]--> <!--[--><span class="References__givenNames">SW</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Evans</span><!--]--> <!--[--><span class="References__givenNames">DG</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Garcia-Closas</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Risk determination and prevention of breast cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast Cancer Res : BCR</i><!--]--> (<!--[--><!--[--><!--[-->2014<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->16<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->5<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->446<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1186/s13058-014-0446-2<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1186/s13058-014-0446-2" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=A.%2BHowell&amp;author=AS.%2BAnderson&amp;author=RB.%2BClarke&amp;author=SW.%2BDuffy&amp;author=DG.%2BEvans&amp;author=M.%2BGarcia-Closas&amp;publication_year=2014&amp;title=Risk%2Bdetermination%2Band%2Bprevention%2Bof%2Bbreast%2Bcancer&amp;journal=Breast+Cancer+Res+%3A+BCR&amp;volume=16" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B6"><div class="References__label"><p>6.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kruk</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Aboul-Enein</span><!--]--> <!--[--><span class="References__givenNames">HY</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Environmental exposure, and other behavioral risk factors in breast cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Curr Cancer Ther Rev</i><!--]--> (<!--[--><!--[--><!--[-->2006<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->2<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->21<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.2174/157339406775471795<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.2174/157339406775471795" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=J.%2BKruk&amp;author=HY.%2BAboul-Enein&amp;publication_year=2006&amp;title=Environmental%2Bexposure%2C%2Band%2Bother%2Bbehavioral%2Brisk%2Bfactors%2Bin%2Bbreast%2Bcancer&amp;journal=Curr+Cancer+Ther+Rev&amp;volume=2&amp;pages=3-21" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B7"><div class="References__label"><p>7.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Momenimovahed</span><!--]--> <!--[--><span class="References__givenNames">Z</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Salehiniya</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Epidemiological characteristics of and risk factors for breast cancer in the world<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast Cancer (Dove Med Press)</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->11<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->151<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->64<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.2147/BCTT.S176070<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.2147/BCTT.S176070" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=Z.%2BMomenimovahed&amp;author=H.%2BSalehiniya&amp;publication_year=2019&amp;title=Epidemiological%2Bcharacteristics%2Bof%2Band%2Brisk%2Bfactors%2Bfor%2Bbreast%2Bcancer%2Bin%2Bthe%2Bworld&amp;journal=Breast+Cancer+%28Dove+Med+Press%29&amp;volume=11&amp;pages=151-64" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B8"><div class="References__label"><p>8.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Greenman</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Stephens</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Smith</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Dalgliesh</span><!--]--> <!--[--><span class="References__givenNames">GL</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hunter</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bignell</span><!--]--> <!--[--><span class="References__givenNames">G</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Patterns of somatic mutation in human cancer genomes<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nature</i><!--]--> (<!--[--><!--[--><!--[-->2007<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->446<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->7132<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->153<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->8<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/nature05610<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/nature05610" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=C.%2BGreenman&amp;author=P.%2BStephens&amp;author=R.%2BSmith&amp;author=GL.%2BDalgliesh&amp;author=C.%2BHunter&amp;author=G.%2BBignell&amp;publication_year=2007&amp;title=Patterns%2Bof%2Bsomatic%2Bmutation%2Bin%2Bhuman%2Bcancer%2Bgenomes&amp;journal=Nature&amp;volume=446&amp;pages=153-8" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B9"><div class="References__label"><p>9.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Tate</span><!--]--> <!--[--><span class="References__givenNames">JG</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bamford</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Jubb</span><!--]--> <!--[--><span class="References__givenNames">HC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Sondka</span><!--]--> <!--[--><span class="References__givenNames">Z</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Beare</span><!--]--> <!--[--><span class="References__givenNames">DM</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bindal</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->COSMIC: the catalogue of somatic mutations in cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nucleic Acids Res</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->47<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->D1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->D941<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->947<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1093/nar/gky1015<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1093/nar/gky1015" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=JG.%2BTate&amp;author=S.%2BBamford&amp;author=HC.%2BJubb&amp;author=Z.%2BSondka&amp;author=DM.%2BBeare&amp;author=N.%2BBindal&amp;publication_year=2019&amp;title=COSMIC%3A%2Bthe%2Bcatalogue%2Bof%2Bsomatic%2Bmutations%2Bin%2Bcancer&amp;journal=Nucleic+Acids+Res&amp;volume=47&amp;pages=D941-947" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B10"><div class="References__label"><p>10.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Fan</span><!--]--> <!--[--><span class="References__givenNames">X</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wynn</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Shang</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Liu</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Fedotov</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hallquist</span><!--]--> <!--[--><span class="References__givenNames">MLG</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Penetrance of breast cancer susceptibility genes from the eMERGE III Network<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">JNCI Cancer Spectr</i><!--]--> (<!--[--><!--[--><!--[-->2021<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->5<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->4<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->pkab044<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1093/jncics/pkab044<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1093/jncics/pkab044" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=X.%2BFan&amp;author=J.%2BWynn&amp;author=N.%2BShang&amp;author=C.%2BLiu&amp;author=A.%2BFedotov&amp;author=MLG.%2BHallquist&amp;publication_year=2021&amp;title=Penetrance%2Bof%2Bbreast%2Bcancer%2Bsusceptibility%2Bgenes%2Bfrom%2Bthe%2BeMERGE%2BIII%2BNetwork&amp;journal=JNCI+Cancer+Spectr&amp;volume=5" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B11"><div class="References__label"><p>11.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Garber</span><!--]--> <!--[--><span class="References__givenNames">JE</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Offit</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Hereditary cancer predisposition syndromes<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Clin Oncol</i><!--]--> (<!--[--><!--[--><!--[-->2005<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->23<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->2<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->276<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->92<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1200/JCO.2005.10.042<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1200/JCO.2005.10.042" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=JE.%2BGarber&amp;author=K.%2BOffit&amp;publication_year=2005&amp;title=Hereditary%2Bcancer%2Bpredisposition%2Bsyndromes&amp;journal=J+Clin+Oncol&amp;volume=23&amp;pages=276-92" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B12"><div class="References__label"><p>12.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Rebbeck</span><!--]--> <!--[--><span class="References__givenNames">TR</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Friebel</span><!--]--> <!--[--><span class="References__givenNames">TM</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Mitra</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wan</span><!--]--> <!--[--><span class="References__givenNames">F</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Chen</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Andrulis</span><!--]--> <!--[--><span class="References__givenNames">IL</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast Cancer Res : BCR</i><!--]--> (<!--[--><!--[--><!--[-->2016<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->18<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->112<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1186/s13058-016-0768-3<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1186/s13058-016-0768-3" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=TR.%2BRebbeck&amp;author=TM.%2BFriebel&amp;author=N.%2BMitra&amp;author=F.%2BWan&amp;author=S.%2BChen&amp;author=IL.%2BAndrulis&amp;publication_year=2016&amp;title=Inheritance%2Bof%2Bdeleterious%2Bmutations%2Bat%2Bboth%2BBRCA1%2Band%2BBRCA2%2Bin%2Ban%2Binternational%2Bsample%2Bof%2B32%2C295%2Bwomen&amp;journal=Breast+Cancer+Res+%3A+BCR&amp;volume=18" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B13"><div class="References__label"><p>13.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Gohil</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Sarker</span><!--]--> <!--[--><span class="References__givenNames">AH</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Roy</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Base excision repair: mechanisms and impact in biology, disease, and medicine<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Int J Mol Sci</i><!--]--> (<!--[--><!--[--><!--[-->2023<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->24<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->18<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->14186<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.3390/ijms241814186<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.3390/ijms241814186" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=D.%2BGohil&amp;author=AH.%2BSarker&amp;author=R.%2BRoy&amp;publication_year=2023&amp;title=Base%2Bexcision%2Brepair%3A%2Bmechanisms%2Band%2Bimpact%2Bin%2Bbiology%2C%2Bdisease%2C%2Band%2Bmedicine&amp;journal=Int+J+Mol+Sci&amp;volume=24" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B14"><div class="References__label"><p>14.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hirai</span><!--]--> <!--[--><span class="References__givenNames">Y</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Banno</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Suzuki</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ichikawa</span><!--]--> <!--[--><span class="References__givenNames">Y</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Udagawa</span><!--]--> <!--[--><span class="References__givenNames">Y</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Sugano</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Cancer Sci</i><!--]--> (<!--[--><!--[--><!--[-->2008<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->99<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->9<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->1715<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->9<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1111/j.1349-7006.2008.00886.x<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1111/j.1349-7006.2008.00886.x" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=Y.%2BHirai&amp;author=K.%2BBanno&amp;author=M.%2BSuzuki&amp;author=Y.%2BIchikawa&amp;author=Y.%2BUdagawa&amp;author=K.%2BSugano&amp;publication_year=2008&amp;title=Molecular%2Bepidemiological%2Band%2Bmutational%2Banalysis%2Bof%2BDNA%2Bmismatch%2Brepair%2B%28MMR%29%2Bgenes%2Bin%2Bendometrial%2Bcancer%2Bpatients%2Bwith%2BHNPCC-associated%2Bfamilial%2Bpredisposition%2Bto%2Bcancer&amp;journal=Cancer+Sci&amp;volume=99&amp;pages=1715-9" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B15"><div class="References__label"><p>15.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Shao</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wan</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lam</span><!--]--> <!--[--><span class="References__givenNames">FC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Tang</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Marley</span><!--]--> <!--[--><span class="References__givenNames">AR</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Song</span><!--]--> <!--[--><span class="References__givenNames">Y</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Environ Mol mutagenesis</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->63<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->6<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->308<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->16<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1002/em.22505<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1002/em.22505" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=C.%2BShao&amp;author=J.%2BWan&amp;author=FC.%2BLam&amp;author=H.%2BTang&amp;author=AR.%2BMarley&amp;author=Y.%2BSong&amp;publication_year=2022&amp;title=A%2Bcomprehensive%2Bliterature%2Breview%2Band%2Bmeta-analysis%2Bof%2Bthe%2Bprevalence%2Bof%2Bpan-cancer%2BBRCA%2Bmutations%2C%2Bhomologous%2Brecombination%2Brepair%2Bgene%2Bmutations%2C%2Band%2Bhomologous%2Brecombination%2Bdeficiencies&amp;journal=Environ+Mol+mutagenesis&amp;volume=63&amp;pages=308-16" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B16"><div class="References__label"><p>16.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Butz</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Nagy</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Papp</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bozsik</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Grolmusz</span><!--]--> <!--[--><span class="References__givenNames">VK</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pcza</span><!--]--> <!--[--><span class="References__givenNames">T</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->PALB2 variants extend the mutational profile of Hungarian patients with breast and ovarian cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Cancers</i><!--]--> (<!--[--><!--[--><!--[-->2023<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->15<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->17<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->4350<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.3390/cancers15174350<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.3390/cancers15174350" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=H.%2BButz&amp;author=P.%2BNagy&amp;author=J.%2BPapp&amp;author=A.%2BBozsik&amp;author=VK.%2BGrolmusz&amp;author=T.%2BP%C3%B3cza&amp;publication_year=2023&amp;title=PALB2%2Bvariants%2Bextend%2Bthe%2Bmutational%2Bprofile%2Bof%2BHungarian%2Bpatients%2Bwith%2Bbreast%2Band%2Bovarian%2Bcancer&amp;journal=Cancers&amp;volume=15" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B17"><div class="References__label"><p>17.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Slavin</span><!--]--> <!--[--><span class="References__givenNames">TP</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Maxwell</span><!--]--> <!--[--><span class="References__givenNames">KN</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lilyquist</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Vijai</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Neuhausen</span><!--]--> <!--[--><span class="References__givenNames">SL</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hart</span><!--]--> <!--[--><span class="References__givenNames">SN</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">NPJ breast cancer</i><!--]--> (<!--[--><!--[--><!--[-->2017<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->22<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/s41523-017-0024-8<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/s41523-017-0024-8" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=TP.%2BSlavin&amp;author=KN.%2BMaxwell&amp;author=J.%2BLilyquist&amp;author=J.%2BVijai&amp;author=SL.%2BNeuhausen&amp;author=SN.%2BHart&amp;publication_year=2017&amp;title=The%2Bcontribution%2Bof%2Bpathogenic%2Bvariants%2Bin%2Bbreast%2Bcancer%2Bsusceptibility%2Bgenes%2Bto%2Bfamilial%2Bbreast%2Bcancer%2Brisk&amp;journal=NPJ+breast+cancer&amp;volume=3" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B18"><div class="References__label"><p>18.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Tischkowitz</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Balmaa</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Foulkes</span><!--]--> <!--[--><span class="References__givenNames">WD</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">James</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ngeow</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Schmutzler</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Genet Med</i><!--]--> (<!--[--><!--[--><!--[-->2021<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->23<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->8<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->1416<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->23<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/s41436-021-01151-8<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/s41436-021-01151-8" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=M.%2BTischkowitz&amp;author=J.%2BBalma%C3%B1a&amp;author=WD.%2BFoulkes&amp;author=P.%2BJames&amp;author=J.%2BNgeow&amp;author=R.%2BSchmutzler&amp;publication_year=2021&amp;title=Management%2Bof%2Bindividuals%2Bwith%2Bgermline%2Bvariants%2Bin%2BPALB2%3A%2Ba%2Bclinical%2Bpractice%2Bresource%2Bof%2Bthe%2BAmerican%2BCollege%2Bof%2BMedical%2BGenetics%2Band%2BGenomics%2B%28ACMG%29&amp;journal=Genet+Med&amp;volume=23&amp;pages=1416-23" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B19"><div class="References__label"><p>19.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Graffeo</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Rana</span><!--]--> <!--[--><span class="References__givenNames">HQ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Conforti</span><!--]--> <!--[--><span class="References__givenNames">F</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bonanni</span><!--]--> <!--[--><span class="References__givenNames">B</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Cardoso</span><!--]--> <!--[--><span class="References__givenNames">MJ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Paluch-Shimon</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast (Edinburgh, Scotland)</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->65<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->32<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->40<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1016/j.breast.2022.06.003<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1016/j.breast.2022.06.003" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=R.%2BGraffeo&amp;author=HQ.%2BRana&amp;author=F.%2BConforti&amp;author=B.%2BBonanni&amp;author=MJ.%2BCardoso&amp;author=S.%2BPaluch-Shimon&amp;publication_year=2022&amp;title=Moderate%2Bpenetrance%2Bgenes%2Bcomplicate%2Bgenetic%2Btesting%2Bfor%2Bbreast%2Bcancer%2Bdiagnosis%3A%2BATM%2C%2BCHEK2%2C%2BBARD1%2Band%2BRAD51D&amp;journal=Breast+%28Edinburgh%2C+Scotland%29&amp;volume=65&amp;pages=32-40" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B20"><div class="References__label"><p>20.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Grafodatskaya</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">O&#39;Rielly</span><!--]--> <!--[--><span class="References__givenNames">DD</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bedard</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Butcher</span><!--]--> <!--[--><span class="References__givenNames">DT</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Howlett</span><!--]--> <!--[--><span class="References__givenNames">CJ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lytwyn</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Practice guidelines for BRCA1/2 tumour testing in ovarian cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Med Genet</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->59<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->8<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->727<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->36<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1136/jmedgenet-2021-108238<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1136/jmedgenet-2021-108238" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=D.%2BGrafodatskaya&amp;author=DD.%2BO%27Rielly&amp;author=K.%2BBedard&amp;author=DT.%2BButcher&amp;author=CJ.%2BHowlett&amp;author=A.%2BLytwyn&amp;publication_year=2022&amp;title=Practice%2Bguidelines%2Bfor%2BBRCA1%2F2%2Btumour%2Btesting%2Bin%2Bovarian%2Bcancer&amp;journal=J+Med+Genet&amp;volume=59&amp;pages=727-36" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B21"><div class="References__label"><p>21.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bouwman</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">van der Gulden</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">van der Heijden</span><!--]--> <!--[--><span class="References__givenNames">I</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Drost</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Klijn</span><!--]--> <!--[--><span class="References__givenNames">CN</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Prasetyanti</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->A high-throughput functional complementation assay for classification of BRCA1 missense variants<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Cancer Discov</i><!--]--> (<!--[--><!--[--><!--[-->2013<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->10<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->1142<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->55<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1158/2159-8290.CD-13-0094<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1158/2159-8290.CD-13-0094" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=P.%2BBouwman&amp;author=H.%2Bvan%2Bder%2BGulden&amp;author=I.%2Bvan%2Bder%2BHeijden&amp;author=R.%2BDrost&amp;author=CN.%2BKlijn&amp;author=P.%2BPrasetyanti&amp;publication_year=2013&amp;title=A%2Bhigh-throughput%2Bfunctional%2Bcomplementation%2Bassay%2Bfor%2Bclassification%2Bof%2BBRCA1%2Bmissense%2Bvariants&amp;journal=Cancer+Discov&amp;volume=3&amp;pages=1142-55" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B22"><div class="References__label"><p>22.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Antoniou</span><!--]--> <!--[--><span class="References__givenNames">AC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pharoah</span><!--]--> <!--[--><span class="References__givenNames">PD</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Narod</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Risch</span><!--]--> <!--[--><span class="References__givenNames">HA</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Eyfjord</span><!--]--> <!--[--><span class="References__givenNames">JE</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hopper</span><!--]--> <!--[--><span class="References__givenNames">JL</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Med Genet</i><!--]--> (<!--[--><!--[--><!--[-->2005<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->42<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->7<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->602<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1136/jmg.2004.024133<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1136/jmg.2004.024133" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=AC.%2BAntoniou&amp;author=PD.%2BPharoah&amp;author=S.%2BNarod&amp;author=HA.%2BRisch&amp;author=JE.%2BEyfjord&amp;author=JL.%2BHopper&amp;publication_year=2005&amp;title=Breast%2Band%2Bovarian%2Bcancer%2Brisks%2Bto%2Bcarriers%2Bof%2Bthe%2BBRCA1%2B5382insC%2Band%2B185delAG%2Band%2BBRCA2%2B6174delT%2Bmutations%3A%2Ba%2Bcombined%2Banalysis%2Bof%2B22%2Bpopulation%2Bbased%2Bstudies&amp;journal=J+Med+Genet&amp;volume=42&amp;pages=602-3" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B23"><div class="References__label"><p>23.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Finkelman</span><!--]--> <!--[--><span class="References__givenNames">BS</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Rubinstein</span><!--]--> <!--[--><span class="References__givenNames">WS</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Friedman</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Friebel</span><!--]--> <!--[--><span class="References__givenNames">TM</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Dubitsky</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Schonberger</span><!--]--> <!--[--><span class="References__givenNames">NS</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">J Clin Oncol</i><!--]--> (<!--[--><!--[--><!--[-->2012<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->30<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->12<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->1321<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->8<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1200/jco.2011.37.8133<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1200/jco.2011.37.8133" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=BS.%2BFinkelman&amp;author=WS.%2BRubinstein&amp;author=S.%2BFriedman&amp;author=TM.%2BFriebel&amp;author=S.%2BDubitsky&amp;author=NS.%2BSchonberger&amp;publication_year=2012&amp;title=Breast%2Band%2Bovarian%2Bcancer%2Brisk%2Band%2Brisk%2Breduction%2Bin%2BJewish%2BBRCA1%2F2%2Bmutation%2Bcarriers&amp;journal=J+Clin+Oncol&amp;volume=30&amp;pages=1321-8" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B24"><div class="References__label"><p>24.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Fostira</span><!--]--> <!--[--><span class="References__givenNames">F</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Saloustros</span><!--]--> <!--[--><span class="References__givenNames">E</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Apostolou</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Vagena</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kalfakakou</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Mauri</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast Cancer Res Treat</i><!--]--> (<!--[--><!--[--><!--[-->2018<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->169<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->105<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->13<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1007/s10549-018-4661-x<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1007/s10549-018-4661-x" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=F.%2BFostira&amp;author=E.%2BSaloustros&amp;author=P.%2BApostolou&amp;author=A.%2BVagena&amp;author=D.%2BKalfakakou&amp;author=D.%2BMauri&amp;publication_year=2018&amp;title=Germline%2Bdeleterious%2Bmutations%2Bin%2Bgenes%2Bother%2Bthan%2BBRCA2%2Bare%2Binfrequent%2Bin%2Bmale%2Bbreast%2Bcancer&amp;journal=Breast+Cancer+Res+Treat&amp;volume=169&amp;pages=105-13" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B25"><div class="References__label"><p>25.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kluz</span><!--]--> <!--[--><span class="References__givenNames">T</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Jasiewicz</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Marczyk</span><!--]--> <!--[--><span class="References__givenNames">E</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Jach</span><!--]--> <!--[--><span class="References__givenNames">R</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Jakubowska</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lubiski</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Hereditary Cancer Clin Pract</i><!--]--> (<!--[--><!--[--><!--[-->2018<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->16<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->6<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1186/s13053-018-0089-x<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1186/s13053-018-0089-x" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=T.%2BKluz&amp;author=A.%2BJasiewicz&amp;author=E.%2BMarczyk&amp;author=R.%2BJach&amp;author=A.%2BJakubowska&amp;author=J.%2BLubi%C5%84ski&amp;publication_year=2018&amp;title=Frequency%2Bof%2BBRCA1%2Band%2BBRCA2%2Bcausative%2Bfounder%2Bvariants%2Bin%2Bovarian%2Bcancer%2Bpatients%2Bin%2BSouth-East%2BPoland&amp;journal=Hereditary+Cancer+Clin+Pract&amp;volume=16" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B26"><div class="References__label"><p>26.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pritchard</span><!--]--> <!--[--><span class="References__givenNames">CC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Mateo</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Walsh</span><!--]--> <!--[--><span class="References__givenNames">MF</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">De Sarkar</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Abida</span><!--]--> <!--[--><span class="References__givenNames">W</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Beltran</span><!--]--> <!--[--><span class="References__givenNames">H</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Inherited DNA-repair gene mutations in men with metastatic prostate cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">New Engl J Med</i><!--]--> (<!--[--><!--[--><!--[-->2016<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->375<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->5<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->443<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->53<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1056/NEJMoa1603144<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1056/NEJMoa1603144" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=CC.%2BPritchard&amp;author=J.%2BMateo&amp;author=MF.%2BWalsh&amp;author=N.%2BDe%2BSarkar&amp;author=W.%2BAbida&amp;author=H.%2BBeltran&amp;publication_year=2016&amp;title=Inherited%2BDNA-repair%2Bgene%2Bmutations%2Bin%2Bmen%2Bwith%2Bmetastatic%2Bprostate%2Bcancer&amp;journal=New+Engl+J+Med&amp;volume=375&amp;pages=443-53" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B27"><div class="References__label"><p>27.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Yurgelun</span><!--]--> <!--[--><span class="References__givenNames">MB</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Chittenden</span><!--]--> <!--[--><span class="References__givenNames">AB</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Morales-Oyarvide</span><!--]--> <!--[--><span class="References__givenNames">V</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Rubinson</span><!--]--> <!--[--><span class="References__givenNames">DA</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Dunne</span><!--]--> <!--[--><span class="References__givenNames">RF</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kozak</span><!--]--> <!--[--><span class="References__givenNames">MM</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Genet Med</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->21<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->213<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->23<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/s41436-018-0009-5<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/s41436-018-0009-5" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=MB.%2BYurgelun&amp;author=AB.%2BChittenden&amp;author=V.%2BMorales-Oyarvide&amp;author=DA.%2BRubinson&amp;author=RF.%2BDunne&amp;author=MM.%2BKozak&amp;publication_year=2019&amp;title=Germline%2Bcancer%2Bsusceptibility%2Bgene%2Bvariants%2C%2Bsomatic%2Bsecond%2Bhits%2C%2Band%2Bsurvival%2Boutcomes%2Bin%2Bpatients%2Bwith%2Bresected%2Bpancreatic%2Bcancer&amp;journal=Genet+Med&amp;volume=21&amp;pages=213-23" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B28"><div class="References__label"><p>28.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ladopoulou</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kroupis</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Konstantopoulou</span><!--]--> <!--[--><span class="References__givenNames">I</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ioannidou-Mouzaka</span><!--]--> <!--[--><span class="References__givenNames">L</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Schofield</span><!--]--> <!--[--><span class="References__givenNames">AC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pantazidis</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Germ line BRCA1 &amp; BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Cancer Lett</i><!--]--> (<!--[--><!--[--><!--[-->2002<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->185<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->61<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->70<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1016/s0304-3835(01)00845-x<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1016/s0304-3835(01)00845-x" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=A.%2BLadopoulou&amp;author=C.%2BKroupis&amp;author=I.%2BKonstantopoulou&amp;author=L.%2BIoannidou-Mouzaka&amp;author=AC.%2BSchofield&amp;author=A.%2BPantazidis&amp;publication_year=2002&amp;title=Germ%2Bline%2BBRCA1%2B%26%2BBRCA2%2Bmutations%2Bin%2BGreek%2Bbreast%2Fovarian%2Bcancer%2Bfamilies%3A%2B5382insC%2Bis%2Bthe%2Bmost%2Bfrequent%2Bmutation%2Bobserved&amp;journal=Cancer+Lett&amp;volume=185&amp;pages=61-70" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B29"><div class="References__label"><p>29.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Chen</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Francioli</span><!--]--> <!--[--><span class="References__givenNames">LC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Goodrich</span><!--]--> <!--[--><span class="References__givenNames">JK</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Collins</span><!--]--> <!--[--><span class="References__givenNames">RL</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kanai</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wang</span><!--]--> <!--[--><span class="References__givenNames">Q</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->A genomic mutational constraint map using variation in 76,156 human genomes<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nature</i><!--]--> (<!--[--><!--[--><!--[-->2024<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->625<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->7993<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->92<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->100<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/s41586-023-06045-0<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/s41586-023-06045-0" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=S.%2BChen&amp;author=LC.%2BFrancioli&amp;author=JK.%2BGoodrich&amp;author=RL.%2BCollins&amp;author=M.%2BKanai&amp;author=Q.%2BWang&amp;publication_year=2024&amp;title=A%2Bgenomic%2Bmutational%2Bconstraint%2Bmap%2Busing%2Bvariation%2Bin%2B76%2C156%2Bhuman%2Bgenomes&amp;journal=Nature&amp;volume=625&amp;pages=92-100" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B30"><div class="References__label"><p>30.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Campeau</span><!--]--> <!--[--><span class="References__givenNames">PM</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Foulkes</span><!--]--> <!--[--><span class="References__givenNames">WD</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Tischkowitz</span><!--]--> <!--[--><span class="References__givenNames">MD</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Hereditary breast cancer: new genetic developments, new therapeutic avenues<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Hum Genet</i><!--]--> (<!--[--><!--[--><!--[-->2008<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->124<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->1<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->31<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->42<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1007/s00439-008-0529-1<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1007/s00439-008-0529-1" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=PM.%2BCampeau&amp;author=WD.%2BFoulkes&amp;author=MD.%2BTischkowitz&amp;publication_year=2008&amp;title=Hereditary%2Bbreast%2Bcancer%3A%2Bnew%2Bgenetic%2Bdevelopments%2C%2Bnew%2Btherapeutic%2Bavenues&amp;journal=Hum+Genet&amp;volume=124&amp;pages=31-42" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B31"><div class="References__label"><p>31.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Marmolejo</span><!--]--> <!--[--><span class="References__givenNames">DH</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Wong</span><!--]--> <!--[--><span class="References__givenNames">MYZ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bajalica-Lagercrantz</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Tischkowitz</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Balmaa</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->, <!--[--><!--[--><!--[-->extended ERN-GENTURIS Thematic Group 3<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Eur J Med Genet</i><!--]--> (<!--[--><!--[--><!--[-->2021<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->64<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->12<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->104350<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1016/j.ejmg.2021.104350<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1016/j.ejmg.2021.104350" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=DH.%2BMarmolejo&amp;author=MYZ.%2BWong&amp;author=S.%2BBajalica-Lagercrantz&amp;author=M.%2BTischkowitz&amp;author=J.%2BBalma%C3%B1a&amp;publication_year=2021&amp;title=Overview%2Bof%2Bhereditary%2Bbreast%2Band%2Bovarian%2Bcancer%2B%28HBOC%29%2Bguidelines%2Bacross%2BEurope&amp;journal=Eur+J+Med+Genet&amp;volume=64" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B32"><div class="References__label"><p>32.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Owens</span><!--]--> <!--[--><span class="References__givenNames">DK</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Davidson</span><!--]--> <!--[--><span class="References__givenNames">KW</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Krist</span><!--]--> <!--[--><span class="References__givenNames">AH</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Barry</span><!--]--> <!--[--><span class="References__givenNames">MJ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Cabana</span><!--]--> <!--[--><span class="References__givenNames">M</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Caughey</span><!--]--> <!--[--><span class="References__givenNames">AB</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Jama</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->322<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->7<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->652<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->65<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1001/jama.2019.10987<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1001/jama.2019.10987" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=DK.%2BOwens&amp;author=KW.%2BDavidson&amp;author=AH.%2BKrist&amp;author=MJ.%2BBarry&amp;author=M.%2BCabana&amp;author=AB.%2BCaughey&amp;publication_year=2019&amp;title=Risk%2Bassessment%2C%2Bgenetic%2Bcounseling%2C%2Band%2Bgenetic%2Btesting%2Bfor%2BBRCA-related%2Bcancer%3A%2BUS%2Bpreventive%2Bservices%2Btask%2Bforce%2Brecommendation%2Bstatement&amp;journal=Jama&amp;volume=322&amp;pages=652-65" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B33"><div class="References__label"><p>33.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pashayan</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Antoniou</span><!--]--> <!--[--><span class="References__givenNames">AC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ivanus</span><!--]--> <!--[--><span class="References__givenNames">U</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Esserman</span><!--]--> <!--[--><span class="References__givenNames">LJ</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Easton</span><!--]--> <!--[--><span class="References__givenNames">DF</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">French</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Personalized early detection and prevention of breast cancer: ENVISION consensus statement<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nat Rev Clin Oncol</i><!--]--> (<!--[--><!--[--><!--[-->2020<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->17<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->11<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->687<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->705<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/s41571-020-0388-9<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/s41571-020-0388-9" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=N.%2BPashayan&amp;author=AC.%2BAntoniou&amp;author=U.%2BIvanus&amp;author=LJ.%2BEsserman&amp;author=DF.%2BEaston&amp;author=D.%2BFrench&amp;publication_year=2020&amp;title=Personalized%2Bearly%2Bdetection%2Band%2Bprevention%2Bof%2Bbreast%2Bcancer%3A%2BENVISION%2Bconsensus%2Bstatement&amp;journal=Nat+Rev+Clin+Oncol&amp;volume=17&amp;pages=687-705" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B34"><div class="References__label"><p>34.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Miller</span><!--]--> <!--[--><span class="References__givenNames">DT</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Lee</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Abul-Husn</span><!--]--> <!--[--><span class="References__givenNames">NS</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Amendola</span><!--]--> <!--[--><span class="References__givenNames">LM</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Brothers</span><!--]--> <!--[--><span class="References__givenNames">K</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Chung</span><!--]--> <!--[--><span class="References__givenNames">WK</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Genet Med</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->24<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->7<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->1407<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->14<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1016/j.gim.2022.04.006<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1016/j.gim.2022.04.006" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=DT.%2BMiller&amp;author=K.%2BLee&amp;author=NS.%2BAbul-Husn&amp;author=LM.%2BAmendola&amp;author=K.%2BBrothers&amp;author=WK.%2BChung&amp;publication_year=2022&amp;title=ACMG%2BSF%2Bv3.1%2Blist%2Bfor%2Breporting%2Bof%2Bsecondary%2Bfindings%2Bin%2Bclinical%2Bexome%2Band%2Bgenome%2Bsequencing%3A%2Ba%2Bpolicy%2Bstatement%2Bof%2Bthe%2BAmerican%2BCollege%2Bof%2BMedical%2BGenetics%2Band%2BGenomics%2B%28ACMG%29&amp;journal=Genet+Med&amp;volume=24&amp;pages=1407-14" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B35"><div class="References__label"><p>35.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Richards</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Aziz</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bale</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bick</span><!--]--> <!--[--><span class="References__givenNames">D</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Das</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Gastier-Foster</span><!--]--> <!--[--><span class="References__givenNames">J</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular Pathology<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Genet Med</i><!--]--> (<!--[--><!--[--><!--[-->2015<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->17<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->5<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->405<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->24<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/gim.2015.30<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/gim.2015.30" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=S.%2BRichards&amp;author=N.%2BAziz&amp;author=S.%2BBale&amp;author=D.%2BBick&amp;author=S.%2BDas&amp;author=J.%2BGastier-Foster&amp;publication_year=2015&amp;title=Standards%2Band%2Bguidelines%2Bfor%2Bthe%2Binterpretation%2Bof%2Bsequence%2Bvariants%3A%2Ba%2Bjoint%2Bconsensus%2Brecommendation%2Bof%2Bthe%2BAmerican%2BCollege%2Bof%2Bmedical%2Bgenetics%2Band%2Bgenomics%2Band%2Bthe%2Bassociation%2Bfor%2Bmolecular%2BPathology&amp;journal=Genet+Med&amp;volume=17&amp;pages=405-24" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B36"><div class="References__label"><p>36.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Adzhubei</span><!--]--> <!--[--><span class="References__givenNames">IA</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Schmidt</span><!--]--> <!--[--><span class="References__givenNames">S</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Peshkin</span><!--]--> <!--[--><span class="References__givenNames">L</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Ramensky</span><!--]--> <!--[--><span class="References__givenNames">VE</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Gerasimova</span><!--]--> <!--[--><span class="References__givenNames">A</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Bork</span><!--]--> <!--[--><span class="References__givenNames">P</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->A method and server for predicting damaging missense mutations<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Nat Methods</i><!--]--> (<!--[--><!--[--><!--[-->2010<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->7<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->4<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->248<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->9<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1038/nmeth0410-248<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1038/nmeth0410-248" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=IA.%2BAdzhubei&amp;author=S.%2BSchmidt&amp;author=L.%2BPeshkin&amp;author=VE.%2BRamensky&amp;author=A.%2BGerasimova&amp;author=P.%2BBork&amp;publication_year=2010&amp;title=A%2Bmethod%2Band%2Bserver%2Bfor%2Bpredicting%2Bdamaging%2Bmissense%2Bmutations&amp;journal=Nat+Methods&amp;volume=7&amp;pages=248-9" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B37"><div class="References__label"><p>37.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Laish</span><!--]--> <!--[--><span class="References__givenNames">I</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Friedman</span><!--]--> <!--[--><span class="References__givenNames">E</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Levi-Reznick</span><!--]--> <!--[--><span class="References__givenNames">G</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Kedar</span><!--]--> <!--[--><span class="References__givenNames">I</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Katz</span><!--]--> <!--[--><span class="References__givenNames">L</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Levi</span><!--]--> <!--[--><span class="References__givenNames">Z</span><!--]--></span><!--]-->
            <!--[--><span class="ReferencesList_etal">et al</span><!--]-->
          <!--]--><!--]--><!--]-->
          <!--[--><!--[--><!--[-->Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Breast Cancer Res Treat</i><!--]--> (<!--[--><!--[--><!--[-->2021<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->188<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->3<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->685<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->94<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1007/s10549-021-06258-9<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1007/s10549-021-06258-9" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=I.%2BLaish&amp;author=E.%2BFriedman&amp;author=G.%2BLevi-Reznick&amp;author=I.%2BKedar&amp;author=L.%2BKatz&amp;author=Z.%2BLevi&amp;publication_year=2021&amp;title=Double%2Bheterozygotes%2Bof%2BBRCA1%2FBRCA2%2Band%2Bmismatch%2Brepair%2Bgene%2Bpathogenic%2Bvariants%3A%2Bcase%2Bseries%2Band%2Bclinical%2Bimplications&amp;journal=Breast+Cancer+Res+Treat&amp;volume=188&amp;pages=685-94" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B38"><div class="References__label"><p>38.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Megid</span><!--]--> <!--[--><span class="References__givenNames">TBC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Barros-Filho</span><!--]--> <!--[--><span class="References__givenNames">MC</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Pisani</span><!--]--> <!--[--><span class="References__givenNames">JP</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Achatz</span><!--]--> <!--[--><span class="References__givenNames">MI</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Front Oncol</i><!--]--> (<!--[--><!--[--><!--[-->2022<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->12<!--]--><!--]--><!--]-->:<!--[--><!--[--><!--[-->873395<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.3389/fonc.2022.873395<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.3389/fonc.2022.873395" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=TBC.%2BMegid&amp;author=MC.%2BBarros-Filho&amp;author=JP.%2BPisani&amp;author=MI.%2BAchatz&amp;publication_year=2022&amp;title=Double%2Bheterozygous%2Bpathogenic%2Bvariants%2Bprevalence%2Bin%2Ba%2Bcohort%2Bof%2Bpatients%2Bwith%2Bhereditary%2Bbreast%2Bcancer&amp;journal=Front+Oncol&amp;volume=12" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><li class="References__item" id="B39"><div class="References__label"><p>39.</p></div><div class="References__content"><p class="notranslate"><!--[-->
        
        <!--[--><!--[-->
          <!--[--><!--[--><!--[-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Vos</span><!--]--> <!--[--><span class="References__givenNames">JR</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Giepmans</span><!--]--> <!--[--><span class="References__givenNames">L</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Rhl</span><!--]--> <!--[--><span class="References__givenNames">C</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Geverink</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
            <!--[--><span class="References__name"><!--[--><span class="References__surname">Hoogerbrugge</span><!--]--> <!--[--><span class="References__givenNames">N</span><!--]--></span><!--]-->
          <!--]--><!--]--><!--]-->, <!--[--><!--[--><!--[-->ERN GENTURIS<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->Boosting care and knowledge about hereditary cancer: European reference Network on genetic tumour risk syndromes<!--]--><!--]--><!--]-->. <!--[--><i class="References__source">Fam Cancer</i><!--]--> (<!--[--><!--[--><!--[-->2019<!--]--><!--]--><!--]-->) <!--[--><!--[--><!--[-->18<!--]--><!--]--><!--]-->(<!--[--><!--[--><!--[-->2<!--]--><!--]--><!--]-->):<!--[--><!--[--><!--[-->281<!--]--><!--]--><!--]--><!--[--><!--[--><!--[-->4<!--]--><!--]--><!--]-->. <!--[--><!--[--><!--[-->10.1007/s10689-018-0110-6<!--]--><!--]--><!--]--><!--]--><!--]-->
      <!--]--></p><ul class="References__links"><!----><li class="References__links__item"><a href="https://doi.org/10.1007/s10689-018-0110-6" target="_blank" data-event="articleReference-a-crossRef">CrossRef </a></li><li class="References__links__item"><a href="http://scholar.google.com/scholar_lookup?author=JR.%2BVos&amp;author=L.%2BGiepmans&amp;author=C.%2BR%C3%B6hl&amp;author=N.%2BGeverink&amp;author=N.%2BHoogerbrugge&amp;publication_year=2019&amp;title=Boosting%2Bcare%2Band%2Bknowledge%2Babout%2Bhereditary%2Bcancer%3A%2BEuropean%2Breference%2BNetwork%2Bon%2Bgenetic%2Btumour%2Brisk%2Bsyndromes&amp;journal=Fam+Cancer&amp;volume=18&amp;pages=281-4" target="_blank" data-event="articleReference-a-googleScholar">Google Scholar</a></li></ul></div></li><!--]--></ul></div><!----><div class="Summary"><h2 class="acc-hidden">Summary</h2><!--[--><p class="h5">Keywords</p><p><!--[--><!--[--><!--[-->HBOC<!--]--><!--[-->, <!--]--><!--]--><!--[--><!--[-->new generation sequencing<!--]--><!--[-->, <!--]--><!--]--><!--[--><!--[-->multigene panel testing<!--]--><!--[-->, <!--]--><!--]--><!--[--><!--[-->BRCA1<!--]--><!--[-->, <!--]--><!--]--><!--[--><!--[-->BRCA2<!--]--><!----><!--]--><!--]--></p><!--]--><!--[--><p class="h5">Citation</p><p>Barti L, Masz A, Mik A, Brcesi , Kalbani SA, Bene J, Kovcs S, Mangel L and Hadzsiev K (2024) <!--[-->Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods<!--]-->. <i>Pathol. Oncol. Res.</i> 30:1611813. doi: <a class="Summary__doi notranslate" target="_blank" href="http://dx.doi.org/10.3389/pore.2024.1611813" data-event="articleSummary-a-doi">10.3389/pore.2024.1611813</a></p><!--]--><!----><!--[--><!--[--><p class="h5">Received</p><p>30 April 2024</p><!--]--><!----><!--[--><p class="h5">Accepted</p><p>19 July 2024</p><!--]--><!--[--><p class="h5">Published</p><p>01 August 2024</p><!--]--><!----><!----><p class="h5">Volume</p><p>30 - 2024</p><!----><!--[--><p class="h5">Edited by</p><!--[-->
          <p class="notranslate">
            
            <a href="https://loop.frontiersin.org/people/701717/overview" target="_blank">Jzsef Tmr</a>, Semmelweis University, Hungary</p>
        <!--]--><!--]--><!----><!--]--><!--[--><p class="h5">Updates</p><button class="CrossmarkUpdates" data-target="crossmark" data-event="crossmarkUpdates-btn-openModalCrossmark"><img class="CrossmarkUpdates__img" src="/ap-2024/images/crossmark_color.webp" alt="Crossmark icon"><p>Check for updates</p></button><!--]--><p class="h5">Copyright</p><div class="Summary__copyright"><p class="Summary__copyright__text"> 2024 Barti, Masz, Mik, Brcesi, Kalbani, Bene, Kovcs, Mangel and Hadzsiev. </p><!--[-->
          <p>This is an open-access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
        <!--]--></div><p class="notranslate correspondence"><!--[-->*Correspondence: Lszl Barti, <!--[--><!--[--><a href="mailto:barati.laszlo@pte.hu" class="email-link">barati.laszlo@pte.hu</a><!----><!--]--><!--]--><!--]--></p><!----><!----><!----><p class="h5">Disclaimer</p><p> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><div class="ArticleDetailsV4__main__divider"></div><!----><!----><!----><!----></div></main><!--[--><aside class="ArticleDetailsV4__asideRight"><div class="ArticleDetailsV4__hiddenDevices"><div style="" class="ArticleMetrics"><p class="ArticleMetrics__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.798 40.512a1.227 1.227 0 0 0 1.2-1.233v-1.434a1.22 1.22 0 0 0-1.2-1.224H37.02l.024-24.402a1.2 1.2 0 0 0-1.2-1.2h-6.93a1.2 1.2 0 0 0-1.2 1.2v24.45h-3.732V21.54a1.2 1.2 0 0 0-1.2-1.2h-6.98a1.2 1.2 0 0 0-1.2 1.2v15.117h-3.778V8.7a1.2 1.2 0 0 0-1.2-1.2H8.19a1.2 1.2 0 0 0-1.2 1.2v30.615a1.2 1.2 0 0 0 1.2 1.2l31.608-.003Zm-21.444-3.9V24.105h1.89V36.6l-1.89.012Zm13.098 0V14.82h1.866v21.792h-1.866Z"></path></svg> Article metrics </p><!----><div class="MetricsTotals"><!----><div class="MetricsTotals__item"><p class="MetricsTotals__number">1,7k</p><p class="MetricsTotals__label">Views</p></div><div class="MetricsTotals__item"><p class="MetricsTotals__number">895</p><p class="MetricsTotals__label">Downloads</p></div></div></div><div class="ArticleDetailsV4__actions"><div class="DownloadArticleButton"><a data-event="download-a-pdf" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/pdf" target="_self" class="DownloadArticleButton__action" rel="noopener noreferrer"><div class="DownloadArticleButton__extra"></div><div class="DownloadArticleButton__flex"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="white" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><p style="" class="DownloadArticleButton__text DownloadArticleButton__text--optional"> Download </p><p class="DownloadArticleButton__text">PDF</p></div></a><div class="DownloadArticleButton__format"><div><button class="DownloadArticleButton__format__trigger" data-event="articleAsideRight-button-formatsTrigger"><p class="TooltipD TooltipD--right"> Download other formats </p><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M41.553 17.7 40.2 16.341a.953.953 0 0 0-.3-.21.975.975 0 0 0-.737 0 .945.945 0 0 0-.31.21l-15 15-15-15a.994.994 0 0 0-.3-.207.975.975 0 0 0-.735 0 .994.994 0 0 0-.3.207L6.165 17.7a.96.96 0 0 0 0 1.353l17.7 17.7 17.718-17.721a.96.96 0 0 0 0-1.353l-.03.021Z"></path></svg></button><ul class="ToolbarContextual"><!--[--><li class="ToolbarContextual__option"><a href="http://www.readcube.com/articles/10.3389/pore.2024.1611813" target="_blank" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-readCube"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>ReadCube</span></a></li><li class="ToolbarContextual__option"><a href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/epub" target="_self" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-epub"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>EPUB</span></a></li><li class="ToolbarContextual__option"><a href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/xml" target="_self" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-xml"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>XML</span></a></li><!--]--></ul></div></div></div><button aria-label="Open dropdown" class="ArticleButton ArticleButton--typeOutline ArticleButton--iconQuote ArticleButton--colorMain" data-event="articleAsideRight-button-citeArticle"><span class="ArticleButton__label">Cite article</span></button><button aria-label="Open dropdown" class="ArticleButton ArticleButton--typeOutline ArticleButton--iconShare ArticleButton--colorMain" data-event="articleAsideRight-button-shareArticle"><span class="ArticleButton__label">Share article</span></button></div><!----><!----></div><button type="button" class="Button Button--iconButton Button--grey Button--small Button--icon Button--arrowUp ScrollToTop" aria-label data-event="articleScrollToTop-button"><span></span></button></aside><div class="InfoDrawer"><button aria-label="Close panel" class="InfoDrawer__overlay"></button><nav class="Toolbar"><ul class="Toolbar__list"><li class="ToolbarDownload"><a data-event="download-a-pdf" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/pdf" class="ToolbarDownload__action" rel="noopener noreferrer" target="_self"><div class="ToolbarDownload__wrapper"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="white" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg></div><p class="ToolbarDownload__text">PDF</p></a><div><div class="ToolbarDownload__format"><button class="ToolbarDownload__format__trigger"><p class="TooltipD TooltipD--bottom TooltipD--right"> Download other format </p><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M41.553 17.7 40.2 16.341a.953.953 0 0 0-.3-.21.975.975 0 0 0-.737 0 .945.945 0 0 0-.31.21l-15 15-15-15a.994.994 0 0 0-.3-.207.975.975 0 0 0-.735 0 .994.994 0 0 0-.3.207L6.165 17.7a.96.96 0 0 0 0 1.353l17.7 17.7 17.718-17.721a.96.96 0 0 0 0-1.353l-.03.021Z"></path></svg></button><ul class="ToolbarContextual"><!--[--><li class="ToolbarContextual__option"><a href="http://www.readcube.com/articles/10.3389/pore.2024.1611813" target="_blank" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-readCube"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>ReadCube</span></a></li><li class="ToolbarContextual__option"><a href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/epub" target="_self" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-epub"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>EPUB</span></a></li><li class="ToolbarContextual__option"><a href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/xml" target="_self" rel="noopener noreferrer" class="ToolbarContextual__btn" data-event="toolbarContextual-xml"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="16px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M39.182 24.218 24 39.405 8.808 24.203a.96.96 0 0 1 0-1.358l1.358-1.354a.96.96 0 0 1 1.354 0l10.56 10.56V1.965a.96.96 0 0 1 .96-.96h1.91a.96.96 0 0 1 .96.96v30.1l10.56-10.56a.962.962 0 0 1 1.359 0l1.353 1.354a.96.96 0 0 1 0 1.359Z"></path><path d="M40.32 35.565h1.92a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96H5.76a.96.96 0 0 1-.96-.96v-9.6a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v6.72h30.72v-6.72a.96.96 0 0 1 .96-.96Z"></path></svg><span>XML</span></a></li><!--]--></ul></div></div></li><!--[--><li class="ToolbarItem" tab="outline"><a class="ToolbarItem__action" data-event="infoDrawer-a-outline" href="#outline"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M39.81 38.049H15.86a.96.96 0 0 1-.959-.96v-1.92a.96.96 0 0 1 .96-.96H39.81a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96Zm-29.7 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.96.96 0 0 1-.969.96h.009Zm5.76-12.117h23.95a.96.96 0 0 0 .959-.96v-1.92a.96.96 0 0 0-.96-.96H15.87a.96.96 0 0 0-.96.96v1.92a.96.96 0 0 0 .95.96h.01Zm-5.76 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.96.96 0 0 1-.969.96h.009ZM15.87 13.8h23.95a.96.96 0 0 0 .959-.96v-1.92a.96.96 0 0 0-.96-.96H15.87a.96.96 0 0 0-.96.96v1.92a.96.96 0 0 0 .95.963l.01-.003Zm-5.76 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.959.959 0 0 1-.969.963l.009-.003Z" clip-rule="evenodd"></path></svg><span class="ToolbarItem__text">Outline</span></a></li><li class="ToolbarItem" tab="cite"><a class="ToolbarItem__action" data-event="infoDrawer-a-cite" href="#cite"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M24 2.88A21.12 21.12 0 1 0 45.12 24 21.144 21.144 0 0 0 24 2.88Zm0 38.4a17.28 17.28 0 1 1 0-34.56 17.28 17.28 0 0 1 0 34.56ZM11.52 23.01v3.6a7.248 7.248 0 0 0 2.65 5.347c1.67 1.31 2.726 1.685 4.665 2.122a.96.96 0 0 0 1.147-.754l.375-1.881a.96.96 0 0 0-.744-1.128c-1.522-.322-2.016-.533-3.053-1.349a3.432 3.432 0 0 1-1.176-2.338h6.696a.96.96 0 0 0 .96-.96v-9.6a.96.96 0 0 0-.96-.96h-9.6a.96.96 0 0 0-.96.96v6.941Zm3.84-4.08h3.84v3.84h-3.84v-3.84Zm10.56-3.84h9.6a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96h-6.706a3.45 3.45 0 0 0 1.176 2.338c1.037.816 1.532 1.027 3.053 1.348a.96.96 0 0 1 .749 1.128l-.38 1.882a.961.961 0 0 1-1.146.754c-1.935-.418-3-.792-4.656-2.103a7.249 7.249 0 0 1-2.65-5.347V16.05a.96.96 0 0 1 .96-.96Zm2.88 7.68h3.84v-3.84H28.8v3.84Z" clip-rule="evenodd"></path></svg><span class="ToolbarItem__text">Cite</span></a></li><li class="ToolbarItem" tab="share"><a class="ToolbarItem__action" data-event="infoDrawer-a-share" href="#share"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M9.565 30.695a6.685 6.685 0 0 0 4.892-2.127l17.28 8.64a7.108 7.108 0 0 0-.092 1.167 6.744 6.744 0 1 0 1.83-4.594l-17.28-8.64c.14-.768.14-1.555 0-2.323l17.28-8.64a6.72 6.72 0 1 0-1.83-4.603c.004.39.039.778.106 1.161l-17.28 8.64a6.72 6.72 0 1 0-4.906 11.319Zm28.8 4.8a2.88 2.88 0 1 1-2.846 3.297.143.143 0 0 0 0-.048 3.224 3.224 0 0 1-.034-.37c.003-.133.012-.266.03-.398v-.09a3.23 3.23 0 0 1 .09-.38c.039-.118.085-.234.14-.346 0-.024.024-.048.033-.067a2.98 2.98 0 0 1 .197-.336c.076-.106.16-.207.25-.302l.023-.029c.199-.211.427-.392.677-.538.123-.072.251-.133.384-.182.335-.14.694-.21 1.056-.211Zm0-28.8a2.88 2.88 0 1 1 0 5.76 2.761 2.761 0 0 1-1.056-.207 2.351 2.351 0 0 1-.384-.182 3 3 0 0 1-.643-.514l-.024-.028a3.008 3.008 0 0 1-.25-.303 2.956 2.956 0 0 1-.196-.336s0-.043-.034-.067a2.738 2.738 0 0 1-.14-.346 3.385 3.385 0 0 1-.09-.379v-.091a3.643 3.643 0 0 1-.063-.427c.001-.124.01-.247.024-.37a.143.143 0 0 0 0-.048 2.88 2.88 0 0 1 2.856-2.462Zm-28.8 14.4a2.77 2.77 0 0 1 1.056.206c.134.05.262.11.384.183.237.14.454.313.643.513v.029c.09.095.174.196.25.302.073.108.139.22.197.336l.034.068c.054.111.1.227.139.345 0 .077.038.159.057.235.02.077.034.144.043.216a2.77 2.77 0 0 1 0 .797c0 .072-.028.144-.043.216a2.39 2.39 0 0 1-.057.235 2.738 2.738 0 0 1-.14.346l-.033.067a2.926 2.926 0 0 1-.197.336 3 3 0 0 1-.25.303v.028c-.183.233-.4.436-.643.605-.122.073-.25.134-.384.183-.334.139-.693.21-1.056.21a2.88 2.88 0 0 1 0-5.76Z"></path></svg><span class="ToolbarItem__text">Share</span></a></li><!--]--><li class="ToolbarItem ToolbarItem--more"><a data-event="infoDrawer-a-moreOptions" class="ToolbarItem__action"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M23.997 12.48a3.84 3.84 0 1 1 0-7.68 3.84 3.84 0 0 1 0 7.68Zm0 15.36a3.84 3.84 0 1 1 0-7.68 3.84 3.84 0 0 1 0 7.68Zm-2.133 14.713a3.84 3.84 0 1 0 4.266-6.385 3.84 3.84 0 0 0-4.266 6.385Z" clip-rule="evenodd"></path></svg><span class="ToolbarItem__text">More</span></a><div><ul class="ToolbarContextual ToolbarContextual--up"><!--[--><!--]--></ul></div></li></ul></nav><div class="SidePanelID"><div class="SidePanelID__close"><button data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--medium" aria-label="Close the panel" data-event="sidePanelId-button-close"><!--[--><span class="ButtonIcon__icon ButtonIcon__icon--close"></span><!--]--></button></div><div class="SidePanelID__headerMobile"><!----><button data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--small" aria-label="Close the panel" data-event="sidePanelId-button-close"><!--[--><span class="ButtonIcon__icon ButtonIcon__icon--close"></span><!--]--></button></div><div class="SidePanelID__body SidePanelID__body--undefined"><!--[--><!--[--><div id="outline" class="SidePanelID__section"><div class="SidePanelID__wrapper"><h2 class="SidePanelID__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="black" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M39.81 38.049H15.86a.96.96 0 0 1-.959-.96v-1.92a.96.96 0 0 1 .96-.96H39.81a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96Zm-29.7 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.96.96 0 0 1-.969.96h.009Zm5.76-12.117h23.95a.96.96 0 0 0 .959-.96v-1.92a.96.96 0 0 0-.96-.96H15.87a.96.96 0 0 0-.96.96v1.92a.96.96 0 0 0 .95.96h.01Zm-5.76 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.96.96 0 0 1-.969.96h.009ZM15.87 13.8h23.95a.96.96 0 0 0 .959-.96v-1.92a.96.96 0 0 0-.96-.96H15.87a.96.96 0 0 0-.96.96v1.92a.96.96 0 0 0 .95.963l.01-.003Zm-5.76 0H8.19a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h1.92a.963.963 0 0 1 .96.96v1.92a.959.959 0 0 1-.969.963l.009-.003Z" clip-rule="evenodd"></path></svg> Outline</h2><div class="SidePanelID__content" id="outline-content"><!--[--><!--]--></div></div></div><!--]--><!--[--><div id="cite" class="SidePanelID__section"><div class="SidePanelID__wrapper"><h2 class="SidePanelID__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="black" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path fill-rule="evenodd" d="M24 2.88A21.12 21.12 0 1 0 45.12 24 21.144 21.144 0 0 0 24 2.88Zm0 38.4a17.28 17.28 0 1 1 0-34.56 17.28 17.28 0 0 1 0 34.56ZM11.52 23.01v3.6a7.248 7.248 0 0 0 2.65 5.347c1.67 1.31 2.726 1.685 4.665 2.122a.96.96 0 0 0 1.147-.754l.375-1.881a.96.96 0 0 0-.744-1.128c-1.522-.322-2.016-.533-3.053-1.349a3.432 3.432 0 0 1-1.176-2.338h6.696a.96.96 0 0 0 .96-.96v-9.6a.96.96 0 0 0-.96-.96h-9.6a.96.96 0 0 0-.96.96v6.941Zm3.84-4.08h3.84v3.84h-3.84v-3.84Zm10.56-3.84h9.6a.96.96 0 0 1 .96.96v9.6a.96.96 0 0 1-.96.96h-6.706a3.45 3.45 0 0 0 1.176 2.338c1.037.816 1.532 1.027 3.053 1.348a.96.96 0 0 1 .749 1.128l-.38 1.882a.961.961 0 0 1-1.146.754c-1.935-.418-3-.792-4.656-2.103a7.249 7.249 0 0 1-2.65-5.347V16.05a.96.96 0 0 1 .96-.96Zm2.88 7.68h3.84v-3.84H28.8v3.84Z" clip-rule="evenodd"></path></svg> Cite article</h2><div class="SidePanelID__content" id="cite-content"><!--[--><!--[--><div class="Citation"><p class="Citation__title">Copy to clipboard</p><span></span><button type="button" class="Button Button--outline Button--maincolor Button--small Citation__button" data-event="articleReference-button-copyCitation"><span>Copy citation</span></button><br><p class="Citation__title">Export citation file</p><ul><!--[--><li><span class="Link__wrapper Citation__link"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--download Link--left" aria-label="BibTex" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/bibTex" target="_blank" data-event="articleReference-button-exportCitation"><span>BibTex</span></a></span></li><li><span class="Link__wrapper Citation__link"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--download Link--left" aria-label="EndNote" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/endNote" target="_blank" data-event="articleReference-button-exportCitation"><span>EndNote</span></a></span></li><li><span class="Link__wrapper Citation__link"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--download Link--left" aria-label="Reference Manager" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/reference" target="_blank" data-event="articleReference-button-exportCitation"><span>Reference Manager</span></a></span></li><li><span class="Link__wrapper Citation__link"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--download Link--left" aria-label="Simple Text file" href="https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/text" target="_blank" data-event="articleReference-button-exportCitation"><span>Simple Text file</span></a></span></li><!--]--></ul><br></div><!--]--><!--]--></div></div></div><!--]--><!--[--><div id="share" class="SidePanelID__section"><div class="SidePanelID__wrapper"><h2 class="SidePanelID__title"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="black" width="24px" style="vertical-align:middle;display:inline-block;height:auto;"><path d="M9.565 30.695a6.685 6.685 0 0 0 4.892-2.127l17.28 8.64a7.108 7.108 0 0 0-.092 1.167 6.744 6.744 0 1 0 1.83-4.594l-17.28-8.64c.14-.768.14-1.555 0-2.323l17.28-8.64a6.72 6.72 0 1 0-1.83-4.603c.004.39.039.778.106 1.161l-17.28 8.64a6.72 6.72 0 1 0-4.906 11.319Zm28.8 4.8a2.88 2.88 0 1 1-2.846 3.297.143.143 0 0 0 0-.048 3.224 3.224 0 0 1-.034-.37c.003-.133.012-.266.03-.398v-.09a3.23 3.23 0 0 1 .09-.38c.039-.118.085-.234.14-.346 0-.024.024-.048.033-.067a2.98 2.98 0 0 1 .197-.336c.076-.106.16-.207.25-.302l.023-.029c.199-.211.427-.392.677-.538.123-.072.251-.133.384-.182.335-.14.694-.21 1.056-.211Zm0-28.8a2.88 2.88 0 1 1 0 5.76 2.761 2.761 0 0 1-1.056-.207 2.351 2.351 0 0 1-.384-.182 3 3 0 0 1-.643-.514l-.024-.028a3.008 3.008 0 0 1-.25-.303 2.956 2.956 0 0 1-.196-.336s0-.043-.034-.067a2.738 2.738 0 0 1-.14-.346 3.385 3.385 0 0 1-.09-.379v-.091a3.643 3.643 0 0 1-.063-.427c.001-.124.01-.247.024-.37a.143.143 0 0 0 0-.048 2.88 2.88 0 0 1 2.856-2.462Zm-28.8 14.4a2.77 2.77 0 0 1 1.056.206c.134.05.262.11.384.183.237.14.454.313.643.513v.029c.09.095.174.196.25.302.073.108.139.22.197.336l.034.068c.054.111.1.227.139.345 0 .077.038.159.057.235.02.077.034.144.043.216a2.77 2.77 0 0 1 0 .797c0 .072-.028.144-.043.216a2.39 2.39 0 0 1-.057.235 2.738 2.738 0 0 1-.14.346l-.033.067a2.926 2.926 0 0 1-.197.336 3 3 0 0 1-.25.303v.028c-.183.233-.4.436-.643.605-.122.073-.25.134-.384.183-.334.139-.693.21-1.056.21a2.88 2.88 0 0 1 0-5.76Z"></path></svg> Share article</h2><div class="SidePanelID__content" id="share-content"><!--[--><!--[--><!--[--><ul class="IDShare"><!--[--><li class="IDShare__item"><a data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--large" aria-label="Go to Facebook" data-event="shareArticleIcon-a-facebook" href="https://www.facebook.com/sharer/sharer.php?u=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="m33.466 25.918 1.13-7.364H27.53v-4.778c0-2.015.987-3.979 4.151-3.979h3.213v-6.27s-2.916-.497-5.703-.497c-5.82 0-9.623 3.527-9.623 9.912v5.612H13.1v7.364h6.468v17.803a25.667 25.667 0 0 0 7.962 0V25.918h5.936Z"></path></svg><!--]--></a><a class="IDShare__link" href="https://www.facebook.com/sharer/sharer.php?u=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank" data-event="shareArticleText-a-facebook">Facebook</a></li><li class="IDShare__item"><a data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--large" aria-label="Go to X" data-event="shareArticleIcon-a-x" href="https://www.twitter.com/share?url=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M36.41 4.5h6.616L28.572 21.02 45.576 43.5H32.26L21.832 29.866 9.9 43.5H3.28l15.46-17.67L2.43 4.5h13.65l9.426 12.462L36.406 4.5h.004Zm-2.322 35.04h3.666L14.09 8.252h-3.934L34.088 39.54Z"></path></svg><!--]--></a><a class="IDShare__link" href="https://www.twitter.com/share?url=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank" data-event="shareArticleText-a-x">X</a></li><li class="IDShare__item"><a data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--large" aria-label="Go to LinkedIn" data-event="shareArticleIcon-a-linkedin" href="https://www.linkedin.com/share?url=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M13.585 42.826H5.76v-25.15h7.824v25.15Zm-3.91-28.587A4.53 4.53 0 0 1 5.14 9.706a4.533 4.533 0 1 1 4.535 4.533ZM42.86 42.826h-7.815v-12.23c0-2.916-.05-6.669-4.062-6.669-4.067 0-4.688 3.18-4.688 6.46v12.439h-7.807v-25.15h7.493v3.438h.107c1.042-1.978 3.592-4.062 7.395-4.062 7.914 0 9.377 5.207 9.377 11.98v13.794Z"></path></svg><!--]--></a><a class="IDShare__link" href="https://www.linkedin.com/share?url=https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank" data-event="shareArticleText-a-linkedin">LinkedIn</a></li><li class="IDShare__item"><a data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--large" aria-label="Go to Email" data-event="shareArticleIcon-a-email" href="mailto:?subject=Interesting science article: Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods&amp;body=Hi!!%0D%0A%0D%0AI think you might find interesting the article &quot;Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods&quot;.%0D%0A%0D%0AYou can read more about it here: https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank"><!--[--><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" fill="currentColor" width="24px" style="vertical-align:middle;display:inline-block;height:auto;" color="black"><path d="M40.614 10.158a.692.692 0 0 0-.495-.204H7.899a.696.696 0 0 0-.699.699v26.7a.702.702 0 0 0 .699.702h32.22a.708.708 0 0 0 .702-.702v-26.7a.7.7 0 0 0-.207-.495Zm-5.721 3.54-9.54 9.54a1.904 1.904 0 0 1-2.7 0l-9.537-9.54h21.777Zm-23.883 3.3 7.296 7.293-7.296 7.29V16.998Zm2.772 17.238 7.242-7.242.132.132a4.038 4.038 0 0 0 5.7 0l.138-.138 7.248 7.248h-20.46Zm23.229-2.664-7.29-7.29 7.29-7.284v14.574Z"></path></svg><!--]--></a><a class="IDShare__link" href="mailto:?subject=Interesting science article: Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods&amp;body=Hi!!%0D%0A%0D%0AI think you might find interesting the article &quot;Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods&quot;.%0D%0A%0D%0AYou can read more about it here: https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full" target="_blank" data-event="shareArticleText-a-email">Email</a></li><!--]--><li class="IDShare__item"><button data-tootip-position class="ButtonIcon ButtonIcon--black ButtonIcon--large" aria-label="Share on WeChat" data-event="shareArticleIcon-a-weChat"><!--[--><svg xmlns="http://www.w3.org/2000/svg" width="128" height="128" viewbox="0 0 128 128" fill="none"><path fill-rule="evenodd" clip-rule="evenodd" d="M112.688 102.779C120.477 97.1419 125.5 88.7369 125.5 79.4606C125.5 62.3944 108.895 48.6081 88.4463 48.6081C67.9975 48.6081 51.3925 62.4456 51.3925 79.4606C51.3925 96.4756 67.9975 110.313 88.4463 110.313C92.7 110.313 96.7487 109.698 100.541 108.622L101.618 108.468C102.335 108.468 102.95 108.673 103.565 109.032L111.662 113.696L112.38 113.952C113.046 113.952 113.61 113.388 113.61 112.722L113.405 111.799L111.714 105.547L111.611 104.778C111.611 103.958 112.021 103.189 112.636 102.779H112.688ZM46.985 14.4756C22.385 14.4756 2.5 31.0806 2.5 51.5294C2.5 62.7019 8.49625 72.7469 17.875 79.5119C18.6438 80.0244 19.105 80.9469 19.105 81.9206L18.9513 82.8431L16.9525 90.3256L16.6962 91.4019C16.6962 92.2219 17.3625 92.8881 18.1825 92.8881L19.0538 92.6319L28.7913 86.9944C29.5088 86.5844 30.2775 86.3281 31.1488 86.3281L32.4812 86.5331C37.0425 87.8144 41.9113 88.5831 46.985 88.5831H49.445C48.4712 85.6106 47.9587 82.5869 47.9587 79.4606C47.9587 60.8056 66.1013 45.6869 88.4975 45.6869H90.9062C87.5237 28.0056 69.125 14.4756 46.985 14.4756ZM76.095 74.4894C73.3787 74.4894 71.175 72.2856 71.175 69.5694C71.175 66.8531 73.3787 64.6494 76.095 64.6494C78.8112 64.6494 81.015 66.8531 81.015 69.5694C81.015 72.2856 78.8112 74.4894 76.095 74.4894ZM100.798 74.4894C98.0813 74.4894 95.8775 72.2856 95.8775 69.5694C95.8775 66.8531 98.0813 64.6494 100.798 64.6494C103.514 64.6494 105.717 66.8531 105.717 69.5694C105.717 72.2856 103.514 74.4894 100.798 74.4894ZM32.1225 45.5844C28.8425 45.5844 26.1775 42.9194 26.1775 39.6394C26.1775 36.3594 28.8425 33.6944 32.1225 33.6944C35.4025 33.6944 38.0675 36.3594 38.0675 39.6394C38.0675 42.9194 35.4025 45.5844 32.1225 45.5844ZM61.7962 45.5844C58.5162 45.5844 55.8512 42.9194 55.8512 39.6394C55.8512 36.3594 58.5162 33.6944 61.7962 33.6944C65.0762 33.6944 67.7412 36.3594 67.7412 39.6394C67.7412 42.9194 65.0762 45.5844 61.7962 45.5844Z" fill="#282828"></path></svg><!--]--></button><a class="IDShare__link" target="_self" data-event="shareArticleText-a-weChat">WeChat</a></li></ul><div class="Modal Modal--noFooter IDShare__modal"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Share on WeChat</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="IDShare__modal__message"><p>Scan with WeChat to share this article</p><canvas width="200" height="200"></canvas></div><!--]--><!----></div><!----><!----></div></div><!--]--><!--]--><!--]--></div></div></div><!--]--><!--]--></div></div><div class="InfoDrawer__refMiddle"></div></div><!--]--></div></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://publishingpartnerships.frontiersin.org/" target="_self" data-event="footer-block_0-a_aboutFrontiersPublishin">About Frontiers Publishing Partnerships</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.por-journal.com/submission/submit?domainid=2&amp;fieldid=164&amp;specialtyid=2370&amp;entitytype=1&amp;entityid=1920" target="_self" data-event="footer-block_1-a_submit">Submit</a></li><li><a href="https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/contact-editorial-office" target="_self" data-event="footer-block_1-a_contact">Contact</a></li><li><a href="https://helpcenter.por-journal.com/" target="_self" data-event="footer-block_1-a_helpCenter">Help center</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><!----></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media S.A. All Rights Reserved</span></div><div><a href="https://www.por-journal.com/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.por-journal.com/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="/ns.html?id=&gtm_auth=&gtm_preview=&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":9,"once":15,"_errors":16,"serverRendered":19,"path":20,"pinia":21},["ShallowReactive",3],{"impact-api-https://impact-ui.por-journal.com/api/articleTotals?articleId=1611813":4},{"articleId":5,"totalViews":6,"totalDownloads":7,"totalCitations":8},1611813,1736,895,0,["Reactive",10],{"$ssite-config":11},{"env":12,"name":13,"url":14},"production","Frontiers articles","https://article-pages-2024.por-journal.com/",["Set"],["ShallowReactive",17],{"impact-api-https://impact-ui.por-journal.com/api/articleTotals?articleId=1611813":18},null,true,"/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full",["Reactive",22],{"main":23,"user":324,"article":325,"articleHub":13028,"mainHeader":13032},{"ibar":24,"footer":134,"newsletterComponent":-1,"snackbarItem":154,"toggleShowSnackbar":155,"contentfulJournal":156,"graphJournal":237,"settingsFeaturesSwitchers":241,"templateToggleBanner":242,"tenantConfig":319},{"tenantLogo":25,"journalLogo":26,"aboutUs":27,"submitUrl":28,"showSubmitButton":19,"journal":29,"sectionTerm":34,"aboutJournal":35,"mainLinks":111,"journalLinks":122,"helpCenterLink":131},"https://brand.frontiersin.org/m/54cf682e9cbe653/original/POR-Logo.svg","",[],"https://www.por-journal.com/submission/submit?domainid=2&fieldid=164&specialtyid=2370&entitytype=1&entityid=1920?domainid=2&fieldid=164&specialtyid=2370&entitytype=1&entityid=1920",{"id":30,"name":31,"slug":32,"sections":33},1920,"Pathology and Oncology Research","pathology-and-oncology-research",[],"Sections",[36,64,91,96],{"title":37,"links":38},"Scope",[39,43,46,49,52,55,58,61],{"text":40,"url":41,"target":42,"ariaLabel":18},"Editors-in-chief","https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-editors","_self",{"text":44,"url":45,"target":42,"ariaLabel":18},"Mission & scope","https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-scope",{"text":47,"url":48,"target":42,"ariaLabel":18},"Facts","https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-facts",{"text":50,"url":51,"target":42,"ariaLabel":18},"Submission","https://www.por-journal.com/journals/pathology-and-oncology-research/about#submission",{"text":53,"url":54,"target":42,"ariaLabel":18},"Open access statement","https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-open",{"text":56,"url":57,"target":42,"ariaLabel":18},"Copyright statement","https://www.por-journal.com/journals/pathology-and-oncology-research/about#copyright-statement",{"text":59,"url":60,"target":42,"ariaLabel":18},"Editorial & quality processes","https://www.por-journal.com/journals/pathology-and-oncology-research/about#about-quality",{"text":62,"url":63,"target":42,"ariaLabel":18},"Contact","https://www.por-journal.com/journals/pathology-and-oncology-research/about#contact",{"title":65,"links":66},"For authors",[67,70,73,76,79,82,85,88],{"text":68,"url":69,"target":42,"ariaLabel":18},"Why submit?","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/why-submit",{"text":71,"url":72,"target":42,"ariaLabel":18},"Publishing fees","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/publishing-fees",{"text":74,"url":75,"target":42,"ariaLabel":18},"Article types","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/article-types",{"text":77,"url":78,"target":42,"ariaLabel":18},"Author guidelines","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/author-guidelines",{"text":80,"url":81,"target":42,"ariaLabel":18},"Review guidelines","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/review-guidelines",{"text":83,"url":84,"target":42,"ariaLabel":18},"Policies and publication ethics","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/policies-and-publication-ethics",{"text":86,"url":87,"target":42,"ariaLabel":18},"Submission checklist","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/submission-checklist",{"text":89,"url":90,"target":42,"ariaLabel":18},"Contact editorial office","https://www.por-journal.com/journals/pathology-and-oncology-research/for-authors/contact-editorial-office",{"title":92,"links":93},"For reviewers",[94],{"text":92,"url":95,"target":42,"ariaLabel":18},"https://www.por-journal.com/journals/pathology-and-oncology-research/for-reviewers",{"title":97,"links":98},"For the community",[99,102,105,108],{"text":100,"url":101,"target":42,"ariaLabel":18},"Become a POR Reviewer","https://www.por-journal.com/journals/pathology-and-oncology-research/become-a-reviewer",{"text":103,"url":104,"target":42,"ariaLabel":18},"Newsletter","https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/newsletter",{"text":106,"url":107,"target":42,"ariaLabel":18},"Retrospective eBooks","https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/retrospective-ebooks",{"text":109,"url":110,"target":42,"ariaLabel":18},"Propose a special issue","https://www.por-journal.com/journals/pathology-and-oncology-research/for-the-community/propose-a-special-issue",[112,116,119],{"text":113,"url":114,"target":42,"ariaLabel":115},"About","https://www.por-journal.com/journals/pathology-and-oncology-research/about","About Aranyi Lajos Foundation",{"text":117,"url":118,"target":42,"ariaLabel":18},"All articles","https://www.por-journal.com/articles",{"text":120,"url":121,"target":42,"ariaLabel":18},"Special issues","https://www.por-journal.com/research-topics",[123,126,129],{"text":124,"url":125,"target":42,"ariaLabel":18},"Articles","articles",{"text":127,"url":128,"target":42,"ariaLabel":18},"Editorial board","editors",{"text":120,"url":130,"target":42,"ariaLabel":18},"special-issues",{"text":132,"url":133,"target":42,"ariaLabel":18},"Help center","https://helpcenter.por-journal.com/",{"blocks":135,"socialLinks":150,"copyright":151,"termsAndConditionsUrl":152,"privacyPolicyUrl":153},[136,142],{"title":137,"links":138},"Explore",[139],{"text":140,"url":141,"target":42,"ariaLabel":18},"About Frontiers Publishing Partnerships","https://publishingpartnerships.frontiersin.org/",{"title":143,"links":144},"Connect",[145,148,149],{"text":146,"url":147,"target":42,"ariaLabel":18},"Submit","https://www.por-journal.com/submission/submit?domainid=2&fieldid=164&specialtyid=2370&entitytype=1&entityid=1920",{"text":62,"url":90,"target":42,"ariaLabel":18},{"text":132,"url":133,"target":42,"ariaLabel":18},[],"Frontiers Media S.A. All Rights Reserved","https://www.por-journal.com/legal/terms-and-conditions","https://www.por-journal.com/legal/privacy-policy",{},false,{"__typename":157,"identifier":30,"name":31,"slug":32,"banner":158,"description":232,"mission":233,"palette":234,"impactFactor":235,"citeScore":236,"citations":235,"showTagline":155,"twitter":18},"Journal",[159],{"id":160,"src":161,"name":162,"tags":163,"type":211,"width":212,"height":213,"archive":8,"brandId":214,"limited":8,"fileSize":215,"isPublic":8,"original":18,"copyright":18,"extension":216,"thumbnails":218,"dateCreated":226,"description":162,"orientation":227,"watermarked":8,"dateModified":228,"datePublished":229,"videoPreviewURLs":230,"textMetaproperties":231},"8DACDA7C-3A0E-452E-81077876F9EB2107","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/webimage-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png"," Dividing Cancer Cell Oncology Research Concept 3d illustration proteins with lymphocytes gene editing  , t cells or cancer cells, meiosis, mitosis 3d rendering ",[164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210],"cells","life","dna","medical","glass","cancer","plant","editing","technology","rendering","genomic","design","cloning","egg","health","crispr","research","biotechnology","mutation","macro","modification","oncology","genome","biology","science","genetic","abstract","chemotherapy","immunotherapy","background","disease","healthcare","3d renderings","illustration","medicine","treatment","gene","3d","shiny","cell","therapy","human","chromosome","engineering","embryo","structure","radiation","image",4096,2160,"22C10171-81B3-4DA6-99342F272A32E8BB",6955918,[217],"jpg",{"mini":219,"thul":220,"webimage":161,"Guidelines":221,"WebsiteJpg_XL":222,"WebsiteWebP_L":223,"WebsiteWebP_M":224,"WebsiteWebP_XL":225},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/mini-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/thul-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/Guidelines-6E80B8A9-FC06-4FB2-871A9D7547F96D30.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/WebsiteJpg_XL-6E80B8A9-FC06-4FB2-871A9D7547F96D30.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/WebsiteWebP_L-6E80B8A9-FC06-4FB2-871A9D7547F96D30.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/WebsiteWebP_M-6E80B8A9-FC06-4FB2-871A9D7547F96D30.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/8DACDA7C-3A0E-452E-81077876F9EB2107/WebsiteWebP_XL-6E80B8A9-FC06-4FB2-871A9D7547F96D30.webp","2022-11-23T18:47:14Z","landscape","2022-11-29T11:01:53Z","2022-11-29T11:01:47Z",[],[],"Pathology and Oncology Research (POR) is the Open Access journal of the Lajos Arnyi Foundation. POR focuses on advances on the fields of experimental and clinical oncology, and pathology, bridging the gap between basic research and clinical medicine. ","\u003Cp>The international journal, Pathology and Oncology Research (POR), was established in 1995 by the founding Editors, Lszl Kopper, Judit Nagy, Zsolt Orosz and Jzsef Tmr. The aim of launching POR was to promote pathological and oncological publishing activity of scientists in Central and East Europe. Those were the years when the 200-year-old conservative science, histopathology, began to transform into a \"rocket science\" discipline with the development of molecular pathology. These developments affected the everyday routine of diagnostic pathology but fundamentally also affected the clinical practice as well. The major beneficiary of that transformation was medical oncology.\u003C/p>\n\n\u003Cp>POR is dedicated to keeping scientists informed of developments in its focused biomedical fields which span the gap between basic research and clinical medicine. A special aim of POR is to promote publishing activity in pathology and oncology of colleagues in the Central and East European region. The journal will interest pathologists, and a broad range of experimental and clinical oncologists, and related experts. Pathology & Oncology Research is supported by distinguished international advisory board and the Arnyi Foundation for modern pathology.\u003C/p>\n\u003Cul>\u003Cli> Presents research, reviews and topical reports at the interface of pathology and oncology\u003C/li>\n\n\u003Cli>Coverage spans the gap between basic research and clinical medicine\u003C/li>\n\n\u003Cli> Promotes the publication of pathology and oncology research by specialists in Central and Eastern Europe\u003C/li>\n\n\u003Cbr>\n\u003Cstrong>Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation \u003Ci>in vitro\u003C/i> or \u003Ci>in vivo\u003C/i>, which are not based on public databases) are not suitable for publication in POR.\u003C/strong>","green","tba","5.7",{"id":30,"name":31,"slug":32,"abbreviation":238,"isOnline":19,"isOpenForSubmissions":19,"citeScore":239,"impactFactor":240},"pore",4.6,2.3,{"displayTitlePillLabels":155,"displayRelatedArticlesBox":19,"showEditors":19,"showReviewers":19,"showLoopImpactLink":155,"enableFigshare":155},{"isPublic":155,"allowCompanyUsers":155,"whiteListEmails":243,"enableAllJournals":19,"whiteListJournals":318},[244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308,309,310,311,312,313,314,315,316,317],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c25laGEubWVAcGl0c29sdXRpb25zLmNvbQ==","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","cHJpc2NpbGEuYnVlbm9AZnJvbnRpZXJzaW4ub3Jn","cmljYXJkby5nb25jYWx2ZXNAZnJvbnRpZXJzaW4ub3Jn","bmF0aGFuLm1hc3RlcnNAZnJvbnRpZXJzaW4ub3Jn","c2ltb24uaG9nZ2FydEBmcm9udGllcnNpbi5vcmc=","dGhpbWVkaS5oZXR0aUBmcm9udGllcnNpbi5vcmc=","cmViZWNjYS5zbWl0aEBmcm9udGllcnNpbi5vcmc=","dmljdG9yaWEuZGF2aWVzQGZyb250aWVyc2luLm9yZw==","bGluZHNheS56YW1wb25pQGZyb250aWVyc2luLm9yZw==","Z2lvcmdpYS5hcHJpbGVAZnJvbnRpZXJzaW4ub3Jn","ZmVsaWNpdHkuYmF4QGZyb250aWVyc2luLm9yZw==","ZmxvcmVuY2UuYnJpZ2dzQGZyb250aWVyc2luLm9yZw==","Zmxvcmlhbm5lLndhdHRAZnJvbnRpZXJzaW4ub3Jn","ZnJhbmNlc2NhLmJyZW50ZWdhbmlAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","aGFubmFoLmVjY2xlc0Bmcm9udGllcnNpbi5vcmc=","bGF1cmEuZGF2aXNAZnJvbnRpZXJzaW4ub3Jn","bGF1cmEubml2ZW5AZnJvbnRpZXJzaW4ub3Jn","bWFuZHkuemhhbmdAZnJvbnRpZXJzaW4ub3Jn","bmlrb2xhb3MuYW5hZ25vc3Rvc0Bmcm9udGllcnNpbi5vcmc=","am9obi5tYWdyaUBmcm9udGllcnNpbi5vcmc=","aG9sbHkuc3RhbmNlckBmcm9udGllcnNpbi5vcmc=","a2F0ZS5ob3JzbmVsbEBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","cGFsbWlyYS5zZWl4YXNAZnJvbnRpZXJzaW4ub3Jn","bWlzdHkucm9ic29uQGZyb250aWVyc2luLm9yZw==","Y3ludGhpYS5zb2Fuc0Bmcm9udGllcnNpbi5vcmc=","cmFjaGFlbC5kdXJoYW1AZnJvbnRpZXJzaW4ub3Jn","YWxpY2UuY294QGZyb250aWVyc2luLm9yZw==","am95Y2UuYWRqZWt1bUBmcm9udGllcnNpbi5vcmc=","YW5uaWthLmplc3NlQGZyb250aWVyc2luLm9yZw==","ZGF3aWQua2VkcmFAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","aGltYS5iaGF0dEBmcm9udGllcnNpbi5vcmc=","anVsaWUubWlsbGFyZEBmcm9udGllcnNpbi5vcmc=","bGFyaXNzYS5zdGVhZEBmcm9udGllcnNpbi5vcmc=","c2FuZGh5YS5wYXRlbEBmcm9udGllcnNpbi5vcmc=","c2Fyb29wLmh1bmRhbEBmcm9udGllcnNpbi5vcmc=","dG9tLmZsaW50QGZyb250aWVyc2luLm9yZw==","dmFsZW50aW5hLm1hcnRpbmlAZnJvbnRpZXJzaW4ub3Jn","YWJpZ2FpbC5yYXNzZXR0ZUBmcm9udGllcnNpbi5vcmc=","Z2lhZGEuemFmZmluQGZyb250aWVyc2luLm9yZw==","Y2hhcmlzLmdyZWVuQGZyb250aWVyc2luLm9yZw==","aW5kaWEuaHVtcGhyZXlzQGZyb250aWVyc2luLm9yZw==","YWRhZXplLmF3b2d1QGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","dGltb3RoeS53ZXN0QGZyb250aWVyc2luLm9yZw==","YWRlZm9sYWtlbWkuYWRlbnVnYmFAZnJvbnRpZXJzaW4ub3Jn","YW15LnRpZ2hlQGZyb250aWVyc2luLm9yZw==","bWFyY2luLnRvbWFzemtvd0Bmcm9udGllcnNpbi5vcmc=","YWxlc3NhbmRyby5zYm9yZG9uaUBmcm9udGllcnNpbi5vcmc=","YW15Lm9uZWlsbEBmcm9udGllcnNpbi5vcmc=","bWVnYW4uYm9uZEBmcm9udGllcnNpbi5vcmc=","bmFpbWVuZy5saXVAZnJvbnRpZXJzaW4ub3Jn","bWljaGFlbC5ib2l0YXJkQGZyb250aWVyc2luLm9yZw==","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","Z2lsbGlhbi5hdHRhcmRAZnJvbnRpZXJzaW4ub3Jn","Y2xhaXJlLnBlcmNpdmFsQGZyb250aWVyc2luLm9yZw==","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","YW5uLmVuZ2VicmV0c2VuQGZyb250aWVyc2luLm9yZw==","c2hhbm5vbi5rZWxseUBmcm9udGllcnNpbi5vcmc=","Y2hpYXJhLnBhcGFjY2lvQGZyb250aWVyc2luLm9yZw==",[],{"spaceId":320,"name":320,"availableJournalPages":321,"announcement":18},4,[125,128,322,323,130],"volumes","about",{"loggedUserInfo":-1},{"currentArticle":326,"isPreviewPage":155,"hasSupplementalData":155,"showCrossmarkWidget":19,"articleTemplate":482,"currentArticlePageMetaInfo":483,"xmlParsedArticleContent":626,"xmlParsingError":-1},{"id":5,"doi":327,"title":328,"acceptanceDate":329,"receptionDate":330,"publicationDate":331,"lastModifiedDate":332,"isPublished":19,"abstract":333,"researchTopic":334,"articleType":340,"stage":343,"keywords":345,"authors":351,"editors":415,"reviewers":424,"journal":441,"section":18,"impactMetrics":449,"volume":452,"articleVolume":453,"relatedArticles":454,"isPublishedV2":155,"contents":455,"files":456},"10.3389/pore.2024.1611813","Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods",["Date","2024-07-19T15:00:28.000Z"],["Date","2024-04-30T13:21:20.000Z"],["Date","2024-08-01T00:00:00.000Z"],["Date","2025-11-26T01:01:35.351Z"],"Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine, whether a patient is harbouring mutations in moderate-or high penetrance susceptibility genes.We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our Department. From these patients 74.5% (205/275) were affected by some type of malignancy, while the remaining 25.5% (70/275) had a positive family history of different cancers, suggesting a genetic predisposition.These tests confirmed a genetic variant in 29.8% and 28.6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the BRCA1 and BRCA2 genes proved to be the most common cause among our patients with 41.5%. Our test also detected a novel mutation in the CDH1 gene and three patients with double heterozygosity in two different susceptibility genes.This study demonstrates the relevance of genetic counselling and non-BRCA gene sequencing among cancer patients and patients who fulfil the criteria for genetic testing, while also providing important details about the genetic profile of Hungarian patients.",{"id":335,"title":336,"articlesCount":337,"isMagazinePage":155,"slug":338,"isOpenForSubmission":19,"views":339},13,"Hereditary Cancer Syndromes",3,"hereditary-cancer-syndromes",9561,{"id":341,"name":342},24,"Original Research",{"id":344,"name":26},18,[346,347,348,349,350],"HBOC","new generation sequencing","multigene panel testing","BRCA1","BRCA2",[352,361,367,376,383,389,396,404,408],{"id":353,"firstName":354,"middleName":26,"lastName":355,"givenNames":356,"isCorresponding":155,"isProfilePublic":19,"userId":353,"email":-1,"affiliations":357},2728589,"Lszl","Barti","Lszl ",[358],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Department of Medical Genetics","Hungary",{"id":8,"firstName":362,"middleName":26,"lastName":363,"givenNames":364,"isCorresponding":155,"isProfilePublic":155,"userId":8,"email":-1,"affiliations":365},"Anita","Masz","Anita ",[366],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},{"id":368,"firstName":369,"middleName":26,"lastName":370,"givenNames":371,"isCorresponding":155,"isProfilePublic":19,"userId":368,"email":-1,"affiliations":372},2726429,"Alexandra","Mik","Alexandra ",[373,374],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},{"organizationName":375,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Institute for Translational Medicine",{"id":8,"firstName":377,"middleName":26,"lastName":378,"givenNames":379,"isCorresponding":155,"isProfilePublic":155,"userId":8,"email":-1,"affiliations":380},"va","Brcesi","va ",[381],{"organizationName":382,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Department of Oncotherapy",{"id":8,"firstName":384,"middleName":26,"lastName":385,"givenNames":386,"isCorresponding":155,"isProfilePublic":155,"userId":8,"email":-1,"affiliations":387},"Sultan Al","Kalbani","Sultan Al ",[388],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},{"id":390,"firstName":391,"middleName":26,"lastName":392,"givenNames":393,"isCorresponding":155,"isProfilePublic":19,"userId":390,"email":-1,"affiliations":394},1023886,"Judit","Bene","Judit ",[395],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},{"id":397,"firstName":398,"middleName":26,"lastName":399,"givenNames":400,"isCorresponding":155,"isProfilePublic":19,"userId":397,"email":-1,"affiliations":401},2738283,"Sebestyn","Kovcs","Sebestyn ",[402],{"organizationName":403,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Urology Clinic",{"id":8,"firstName":354,"middleName":26,"lastName":405,"givenNames":356,"isCorresponding":155,"isProfilePublic":155,"userId":8,"email":-1,"affiliations":406},"Mangel",[407],{"organizationName":382,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},{"id":409,"firstName":410,"middleName":26,"lastName":411,"givenNames":412,"isCorresponding":155,"isProfilePublic":19,"userId":409,"email":-1,"affiliations":413},2429540,"Kinga","Hadzsiev","Kinga ",[414],{"organizationName":359,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},[416],{"id":417,"firstName":418,"middleName":26,"lastName":419,"givenNames":420,"isCorresponding":155,"isProfilePublic":19,"userId":417,"email":-1,"affiliations":421},701717,"Jzsef","Tmr","Jzsef ",[422],{"organizationName":423,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Semmelweis University",[425,433],{"id":426,"firstName":427,"middleName":26,"lastName":428,"givenNames":429,"isCorresponding":155,"isProfilePublic":19,"userId":426,"email":-1,"affiliations":430},1093123,"Tams","Micsik","Tams ",[431],{"organizationName":432,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"Faculty of Medicine, Semmelweis University",{"id":434,"firstName":435,"middleName":26,"lastName":436,"givenNames":437,"isCorresponding":155,"isProfilePublic":19,"userId":434,"email":-1,"affiliations":438},1113670,"Erika","Toth","Erika ",[439],{"organizationName":440,"countryName":360,"cityName":26,"stateName":26,"zipCode":26},"National Institute of Oncology (NIO)",{"id":30,"slug":32,"name":31,"shortName":442,"electronicISSN":443,"field":444,"specialtyId":447,"journalSectionPaths":448},"Pathol. Oncol. Res.","1532-2807",{"id":445,"domainId":446},164,2,2370,[],{"views":450,"downloads":451,"citations":8},1512,822,30,"Volume 30 - 2024",[],{"titleHtml":26,"fullTextHtml":26,"menuHtml":26},[457,462,468,471,477],{"name":458,"fileServerPackageEntryId":26,"fileServerId":459,"fileServerVersionNumber":446,"type":460},"EPUB.epub","1611813/epub",{"code":461,"name":461},"EPUB",{"name":463,"fileServerPackageEntryId":464,"fileServerId":465,"fileServerVersionNumber":446,"type":466},"pore-30-1611813.pdf","pore-30-1611813-r1/pore-30-1611813.pdf","1611813/pubmed-zip",{"code":467,"name":467},"PDF",{"name":463,"fileServerPackageEntryId":26,"fileServerId":469,"fileServerVersionNumber":446,"type":470},"1611813/publishers-proof/pdf",{"code":467,"name":467},{"name":472,"fileServerPackageEntryId":473,"fileServerId":465,"fileServerVersionNumber":446,"type":474},"pore-30-1611813.xml","pore-30-1611813-r1/pore-30-1611813.xml",{"code":475,"name":476},"NLM_XML","XML",{"name":478,"fileServerPackageEntryId":26,"fileServerId":479,"fileServerVersionNumber":480,"type":481},"Provisional PDF.pdf","1611813/provisional-pdf",1,{"code":467,"name":467},"v4",{"title":484,"link":485,"meta":489,"script":614},"Pathology & Oncology Research | Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods",[486],{"rel":487,"href":488},"canonical","https://www.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/full",[490,493,496,498,501,505,508,512,515,518,521,523,525,527,529,531,534,537,539,542,544,546,549,552,555,558,561,565,569,572,574,577,579,582,585,588,590,593,595,598,601,604,606,609,611],{"hid":491,"property":491,"name":491,"content":492},"description","Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing ...",{"hid":494,"property":494,"name":495,"content":484},"og:title","title",{"hid":497,"property":497,"name":491,"content":492},"og:description",{"hid":499,"name":499,"content":500},"keywords","HBOC,new generation sequencing,multigene panel testing,BRCA1,BRCA2",{"hid":502,"property":502,"name":503,"content":504},"og:site_name","site_name","Pathology & Oncology Research",{"hid":506,"property":506,"name":211,"content":507},"og:image","https://images-provider.por-journal.com/api/ipx/w=1200&f=png/https://www.por-journal.com/files/Articles/1611813/pore-30-1611813-HTML-r1/image_m/pore-30-1611813-t001.jpg",{"hid":509,"property":509,"name":510,"content":511},"og:type","type","article",{"hid":513,"property":513,"name":514,"content":488},"og:url","url",{"hid":516,"name":516,"content":517},"twitter:card","summary_large_image",{"hid":519,"name":519,"content":520},"citation_volume","30",{"hid":522,"name":522,"content":31},"citation_journal_title",{"hid":524,"name":524,"content":504},"citation_publisher",{"hid":526,"name":526,"content":442},"citation_journal_abbrev",{"hid":528,"name":528,"content":443},"citation_issn",{"hid":530,"name":530,"content":327},"citation_doi",{"hid":532,"name":532,"content":533},"citation_firstpage","1611813",{"hid":535,"name":535,"content":536},"citation_language","English",{"hid":538,"name":538,"content":328},"citation_title",{"hid":540,"name":540,"content":541},"citation_keywords","HBOC; new generation sequencing; multigene panel testing; BRCA1; BRCA2",{"hid":543,"name":543,"content":333},"citation_abstract",{"hid":545,"name":545,"content":342},"citation_article_type",{"hid":547,"name":547,"content":548},"citation_pdf_url","https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/pdf",{"hid":550,"name":550,"content":551},"citation_xml_url","https://public-pages-files-2025.por-journal.com/journals/pathology-and-oncology-research/articles/10.3389/pore.2024.1611813/xml",{"hid":553,"name":553,"content":554},"citation_fulltext_world_readable","yes",{"hid":556,"name":556,"content":557},"citation_online_date","2024/07/19",{"hid":559,"name":559,"content":560},"citation_publication_date","2024/08/01",{"hid":562,"name":563,"content":564},"citation_author_0","citation_author","Barti, Lszl ",{"hid":566,"name":567,"content":568},"citation_author_institution_0","citation_author_institution","Department of Medical Genetics, Hungary",{"hid":570,"name":563,"content":571},"citation_author_1","Masz, Anita ",{"hid":573,"name":567,"content":568},"citation_author_institution_1",{"hid":575,"name":563,"content":576},"citation_author_2","Mik, Alexandra ",{"hid":578,"name":567,"content":568},"citation_author_institution_2",{"hid":580,"name":563,"content":581},"citation_author_3","Brcesi, va ",{"hid":583,"name":567,"content":584},"citation_author_institution_3","Department of Oncotherapy, Hungary",{"hid":586,"name":563,"content":587},"citation_author_4","Kalbani, Sultan Al ",{"hid":589,"name":567,"content":568},"citation_author_institution_4",{"hid":591,"name":563,"content":592},"citation_author_5","Bene, Judit ",{"hid":594,"name":567,"content":568},"citation_author_institution_5",{"hid":596,"name":563,"content":597},"citation_author_6","Kovcs, Sebestyn ",{"hid":599,"name":567,"content":600},"citation_author_institution_6","Urology Clinic, Hungary",{"hid":602,"name":563,"content":603},"citation_author_7","Mangel, Lszl ",{"hid":605,"name":567,"content":584},"citation_author_institution_7",{"hid":607,"name":563,"content":608},"citation_author_8","Hadzsiev, Kinga ",{"hid":610,"name":567,"content":568},"citation_author_institution_8",{"hid":612,"name":612,"content":613},"dc.identifier","doi:10.3389/pore.2024.1611813",[615,618,620,622,624],{"src":616,"body":19,"type":617,"async":19},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":619,"body":19,"type":617,"async":19},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":621,"body":19,"type":617,"async":19},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":623,"body":19,"type":617,"async":19},"https://api.altmetric.com/v1/doi/10.3389/pore.2024.1611813?callback=_altmetric.embed_callback&domain=www.por-journal.com&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":625,"body":19,"type":617,"async":19},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"journal":627,"doi":533,"articleType":342,"title":629,"authors":631,"onBehalfOf":26,"affiliations":655,"authorNotes":669,"publicationDate":700,"acceptedDate":701,"receivedDate":702,"correctedDate":26,"volume":452,"elocationId":5,"permissions":703,"keywords":722,"relatedArticles":733,"abstractContent":734,"bodyContent":764,"appendixContent":5017,"statements":5018,"references":5274,"otherBackSections":10252,"figures":10253,"toc":12996,"correspondingAuthors":13021},{"title":504,"abbreviation":442,"issn":443,"publisherName":628},"Frontiers Media S.A.",[630],{"#text":328},[632,635,637,640,642,644,647,650,652],{"surname":355,"givenNames":354,"suffix":26,"affiliationsIndexes":633,"isCorresponding":19,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":634,"onBehalfOf":26},[480],"https://loop.frontiersin.org/people/2728589/overview",{"surname":363,"givenNames":362,"suffix":26,"affiliationsIndexes":636,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":26,"onBehalfOf":26},[480],{"surname":370,"givenNames":369,"suffix":26,"affiliationsIndexes":638,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":639,"onBehalfOf":26},[480,446],"https://loop.frontiersin.org/people/2726429/overview",{"surname":378,"givenNames":377,"suffix":26,"affiliationsIndexes":641,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":26,"onBehalfOf":26},[337],{"surname":385,"givenNames":384,"suffix":26,"affiliationsIndexes":643,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":26,"onBehalfOf":26},[480],{"surname":392,"givenNames":391,"suffix":26,"affiliationsIndexes":645,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":646,"onBehalfOf":26},[480],"https://loop.frontiersin.org/people/1023886/overview",{"surname":399,"givenNames":398,"suffix":26,"affiliationsIndexes":648,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":649,"onBehalfOf":26},[320],"https://loop.frontiersin.org/people/2738283/overview",{"surname":405,"givenNames":354,"suffix":26,"affiliationsIndexes":651,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":26,"onBehalfOf":26},[337],{"surname":411,"givenNames":410,"suffix":26,"affiliationsIndexes":653,"isCorresponding":155,"equalContrib":155,"hierarchySymbol":26,"footnoteSymbol":26,"loopUrl":654,"onBehalfOf":26},[480],"https://loop.frontiersin.org/people/2429540/overview",[656,660,663,666],{"index":480,"baseText":26,"institution":657,"country":360,"address":658,"textContent":659},"Department of Medical Genetics, Clinical Centre, Medical School, University of Pcs","Pcs","Department of Medical Genetics, Clinical Centre, Medical School, University of Pcs, Pcs, Hungary",{"index":446,"baseText":26,"institution":661,"country":360,"address":658,"textContent":662},"Institute for Translational Medicine, Medical School, University of Pcs","Institute for Translational Medicine, Medical School, University of Pcs, Pcs, Hungary",{"index":337,"baseText":26,"institution":664,"country":360,"address":658,"textContent":665},"Department of Oncotherapy, Clinical Centre, Medical School, University of Pcs","Department of Oncotherapy, Clinical Centre, Medical School, University of Pcs, Pcs, Hungary",{"index":320,"baseText":26,"institution":667,"country":360,"address":658,"textContent":668},"Urology Clinic, Clinical Centre, University of Pcs","Urology Clinic, Clinical Centre, University of Pcs, Pcs, Hungary",{"editedBy":670,"editedByContent":675,"reviewedBy":693,"reviewedByContent":694,"approvedBy":695,"approvedByContent":696,"correspondence":697,"equalContribution":698,"presentAddress":26,"other":699},[671],{"loopId":672,"fullName":673,"textContent":674},"701717","Jzsef Tmr","\r\n            Edited by:\r\n            Jzsef Tmr, Semmelweis University, Hungary",[676,678,691],{"#text":677},"\n          ",{"p":679},[680,682,689],{"#text":681},"\n            \n            ",{"ext-link":683,":@":685},[684],{"#text":673},{"@_ext-link-type":686,"@_xmlns:xlink":687,"@_xlink:href":688},"uri","http://www.w3.org/1999/xlink","https://loop.frontiersin.org/people/701717/overview",{"#text":690},", Semmelweis University, Hungary",{"#text":692},"\n        ",[],[],[],[],"*Correspondence: Lszl Barti, YmFyYXRpLmxhc3psb0BwdGUuaHU=",[],[],"2024-08-01","2024-07-19","2024-04-30",{"copyrightStatement":704,"copyrightYear":705,"copyrightHolder":706,"licenseUrl":707,"licenseText":708},"Copyright  2024 Barti, Masz, Mik, Brcesi, Kalbani, Bene, Kovcs, Mangel and Hadzsiev.",2024,"Barti, Masz, Mik, Brcesi, Kalbani, Bene, Kovcs, Mangel and Hadzsiev","http://creativecommons.org/licenses/by/4.0/",[709,710,721],{"#text":677},{"p":711},[712,714,719],{"#text":713},"This is an open-access article distributed under the terms of the ",{"ext-link":715,":@":718},[716],{"#text":717},"Creative Commons Attribution License (CC BY)",{"@_ext-link-type":686,"@_xlink:href":707},{"#text":720},". The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.",{"#text":692},[723,725,727,729,731],[724],{"#text":346},[726],{"#text":347},[728],{"#text":348},[730],{"#text":349},[732],{"#text":350},[],[735,736,762],{"#text":692},{"p":737},[738,740,743,745,748,750,754,756,760],{"#text":739},"Hereditary breast and ovarian cancer is a well-known genetic condition, inherited mainly in an autosomal dominant way, which elevates the risk of developing malignancies at a young age in heterozygous carriers. Advances in new generation sequencing have enabled medical professionals to determine whether a patient is harbouring mutations in moderate- or high penetrance susceptibility genes. We conducted a retrospective analysis among 275 patients who underwent genetic counselling and multigene panel testing for hereditary breast and ovarian cancer syndrome in our department. From these patients 74.5% (205/275) were affected by some type of malignancy, while the remaining 25.5% (70/275) had a positive family history of different cancers, suggesting a genetic predisposition. These tests confirmed a genetic variant in 29.8% and 28.6% of these patient groups respectively. The results also mirrored our general knowledge concerning the genetic background of hereditary breast and ovarian cancer, as variants in either one of the ",{"italic":741},[742],{"#text":349},{"#text":744}," and ",{"italic":746},[747],{"#text":350},{"#text":749}," genes proved to be the most common cause among our patients with 41.5%. Our test also detected a novel mutation in the ",{"italic":751},[752],{"#text":753},"CDH1",{"#text":755}," gene and three patients with double heterozygosity in two different susceptibility genes. This study demonstrates the relevance of genetic counselling and non-",{"italic":757},[758],{"#text":759},"BRCA",{"#text":761}," gene sequencing among cancer patients and patients who fulfil the criteria for genetic testing, while also providing important details about the genetic profile of Hungarian patients.",{"#text":763},"\n      ",[765,767,889,890,1405,1406,4582,4583,4984,4985,5015],{"#text":766},"\n    ",{"sec":768,":@":887},[769,770,774,775,804,805,816,817,836,837,871,872,876,877,886],{"#text":763},{"title":771},[772],{"#text":773},"Introduction",{"#text":763},{"p":776},[777,779,786,788,794,796,802],{"#text":778},"Cancer is among the leading causes of mortality all over the world. Over the last decade, the incidence of malignancies has been growing worldwide, resulting in an estimated 20 million new cases and 9.7 million deaths in 2022. In most types of cancer, mortality has decreased due to preventive measures, improved diagnostic tests, screening programmes and more effective treatment options [",{"xref":780,":@":783},[781],{"#text":782},"1",{"@_ref-type":784,"@_rid":785},"bibr","B1",{"#text":787},", ",{"xref":789,":@":792},[790],{"#text":791},"2",{"@_ref-type":784,"@_rid":793},"B2",{"#text":795},"]. Unfortunately, predictions lead us to believe, that we can expect a steady increase in the number of new cases in the upcoming years [",{"xref":797,":@":800},[798],{"#text":799},"3",{"@_ref-type":784,"@_rid":801},"B3",{"#text":803},"].",{"#text":763},{"p":806},[807,809,815],{"#text":808},"In Hungary, breast cancer is the third most common malignancy after lung cancer and colorectal cancer, and the leading cause of cancer incidence in the female population, resulting in approximately 8,000 new cases and 2,000 deaths every year according to the Hungarian Cancer Registry [",{"xref":810,":@":813},[811],{"#text":812},"4",{"@_ref-type":784,"@_rid":814},"B4",{"#text":803},{"#text":763},{"p":818},[819,821,827,829,835],{"#text":820},"Until recently, environmental causes were viewed as the main reason for the occurrence of malignancies. Akin to most multifactorial diseases, breast cancer is known to be associated with certain factors, that affect ones risk to develop the disease in their lifetime. Modifiable risk factors include obesity, consumption of tobacco and alcohol, and taking hormones, while reproductive history, increasing age and a positive family history belong to non-modifiable risk factors [",{"xref":822,":@":825},[823],{"#text":824},"5",{"@_ref-type":784,"@_rid":826},"B5",{"#text":828},"",{"xref":830,":@":833},[831],{"#text":832},"7",{"@_ref-type":784,"@_rid":834},"B7",{"#text":803},{"#text":763},{"p":838},[839,841,847,848,854,856,862,864,870],{"#text":840},"In recent decades it has become apparent, that genetic variants play a considerable role in the development of breast- and ovarian cancer. While malignancies in general are usually a result of somatic mutations [",{"xref":842,":@":845},[843],{"#text":844},"8",{"@_ref-type":784,"@_rid":846},"B8",{"#text":787},{"xref":849,":@":852},[850],{"#text":851},"9",{"@_ref-type":784,"@_rid":853},"B9",{"#text":855},"], approximately 5%10% are caused by germline mutations in moderate- or high penetrance cancer susceptibility genes [",{"xref":857,":@":860},[858],{"#text":859},"10",{"@_ref-type":784,"@_rid":861},"B10",{"#text":863},"]. These predisposing genetic traits usually follow an autosomal dominant inheritance, leading to patients having a highly elevated cumulative risk of developing different types of malignancies, and a 50% chance of passing the mutation onto their offspring [",{"xref":865,":@":868},[866],{"#text":867},"11",{"@_ref-type":784,"@_rid":869},"B11",{"#text":803},{"#text":763},{"p":873},[874],{"#text":875},"Over the last few decades, diagnosis of hereditary cancer syndromes has shown promising progress. With rapid advances in molecular testing and next-generation sequencing, a great number of individuals and families have been identified, who are affected by mutations in cancer susceptibility genes. While the BRCA-related hereditary breast- and ovarian cancer (HBOC) is among the most well-known tumour syndromes, one cannot skim over the importance of other, less common predisposition genes.",{"#text":763},{"p":878},[879,881,884],{"#text":880},"Due to a lack of data on genetic spectrum of the Hungarian HBOC population, we aimed to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort and in healthy relatives with family history of cancer; to evaluate the associations of detected variants with clinical features; to evaluate how worthwhile it is to use a larger gene panel (including other genes beside ",{"italic":882},[883],{"#text":759},{"#text":885},"s) in routine genetic diagnostics of Hungarians; and to evaluate the association between familial history of cancer and familial accumulation of the genetic variants in the cohort.",{"#text":766},{"@_id":888},"s1",{"#text":766},{"sec":891,":@":1403},[892,893,897,898,1223,1224,1402],{"#text":763},{"title":894},[895],{"#text":896},"Subjects and methods",{"#text":763},{"sec":899,":@":1221},[900,901,905,906,929,930,1210,1211,1215,1216,1220],{"#text":692},{"title":902},[903],{"#text":904},"Subjects",{"#text":692},{"p":907},[908,910,918,920,927],{"#text":909},"The examinations related to this retrospective study were carried out in the Department of Medical Genetics in the University of Pcs. The patients and relatives that were involved into this study derived from the joint genetic counselling facility of Department of Medical Genetics and Department of Oncotherapy at the University of Pcs (Oncogenetic Counselling and Family Screening Centre). Patients data (personal history of cancer, tumour type, and age at diagnosis) were obtained from clinical records, while the family history of cancer was obtained from interviews with the probands. People referred to the genetic counselling went through a cancer genetic risk assessment. The purpose was to identify individuals at elevated cancer risk who may benefit from genetic testing, additional screening or preventive interventions. Using clues from the personal and family history, the genetic counsellor classified individuals as average (general population), increased (moderate), or high (strong) risk patients according to the widely accepted National Comprehensive Cancer Centre (NCCN) Clinical Practice Guidelines in Oncology, which are available online for experts",{"xref":911,":@":915},[912],{"sup":913},[914],{"#text":782},{"@_ref-type":916,"@_rid":917},"fn","fn1",{"#text":919},". After risk assessment, individuals classified into the average risk level group were excluded from the study. We highlight the genetic risk stratification for HBOC in ",{"xref":921,":@":924},[922],{"#text":923},"Table 1",{"@_ref-type":925,"@_rid":926},"table","T1",{"#text":928},".",{"#text":692},{"table-wrap":931,":@":1208},[932,933,937,938,947,948,1185,1186,1207],{"#text":677},{"label":934},[935],{"#text":936},"TABLE 1",{"#text":677},{"caption":939},[940,942,946],{"#text":941},"\n            ",{"p":943},[944],{"#text":945},"Genetic risk stratification for HBOC patients.",{"#text":677},{"#text":677},{"table":949},[950,951,975,976,1184],{"#text":941},{"thead":952,":@":973},[953,955,972],{"#text":954},"\n              ",{"tr":956},[957,959,965,966,971],{"#text":958},"\n                ",{"th":960,":@":963},[961],{"#text":962},"Risk level",{"@_align":964},"left",{"#text":958},{"th":967,":@":970},[968],{"#text":969},"Personal and family history evidence",{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},"top",{"#text":941},{"tbody":977,":@":1183},[978,979,1005,1006,1015,1016,1031,1032,1041,1042,1051,1052,1061,1062,1078,1079,1088,1089,1098,1099,1108,1109,1118,1119,1128,1129,1138,1139,1148,1149,1162,1163,1172,1173,1182],{"#text":954},{"tr":980},[981,982,987,988,1004],{"#text":958},{"td":983,":@":986},[984],{"#text":985},"Average",{"@_rowspan":446,"@_align":964},{"#text":958},{"td":989,":@":1003},[990,992,1001],{"#text":991},"No first- or second-degree relatives",{"xref":993,":@":998},[994],{"sup":995},[996],{"#text":997},"a",{"@_ref-type":999,"@_rid":1000},"table-fn","Tfn1",{"#text":1002}," with breast or ovarian cancer; OR",{"@_align":964},{"#text":954},{"#text":954},{"tr":1007},[1008,1009,1014],{"#text":958},{"td":1010,":@":1013},[1011],{"#text":1012},"More distant relatives with a breast cancer diagnosis or diagnoses after age 50",{"@_align":964},{"#text":954},{"#text":954},{"tr":1017},[1018,1019,1024,1025,1030],{"#text":958},{"td":1020,":@":1023},[1021],{"#text":1022},"Increased (moderate)",{"@_rowspan":320,"@_align":964},{"#text":958},{"td":1026,":@":1029},[1027],{"#text":1028},"Prior history of breast cancer, lobular neoplasia (LCIS/ALH), or atypical ductal hyperplasia",{"@_align":964},{"#text":954},{"#text":954},{"tr":1033},[1034,1035,1040],{"#text":958},{"td":1036,":@":1039},[1037],{"#text":1038},"5-year risk 1.7% in women 35years using the Gail model, or 20% lifetime risk defined by risk models",{"@_align":964},{"#text":954},{"#text":954},{"tr":1043},[1044,1045,1050],{"#text":958},{"td":1046,":@":1049},[1047],{"#text":1048},"Thoracic radiotherapy \u003C30years",{"@_align":964},{"#text":954},{"#text":954},{"tr":1053},[1054,1055,1060],{"#text":958},{"td":1056,":@":1059},[1057],{"#text":1058},"One or two first- or second-degree relatives with breast cancer diagnosis after age 50",{"@_align":964},{"#text":954},{"#text":954},{"tr":1063},[1064,1065,1071,1072,1077],{"#text":958},{"td":1066,":@":1069},[1067],{"#text":1068},"High (strong)",{"@_rowspan":1070,"@_align":964},11,{"#text":958},{"td":1073,":@":1076},[1074],{"#text":1075},"Known pathogenic variant (mutation) in the family",{"@_align":964},{"#text":954},{"#text":954},{"tr":1080},[1081,1082,1087],{"#text":958},{"td":1083,":@":1086},[1084],{"#text":1085},"Somatic tumor testing suggesting a hereditary cancer syndrome",{"@_align":964},{"#text":954},{"#text":954},{"tr":1090},[1091,1092,1097],{"#text":958},{"td":1093,":@":1096},[1094],{"#text":1095},"Patient or first-degree relative diagnosed with exocrine pancreatic cancer",{"@_align":964},{"#text":954},{"#text":954},{"tr":1100},[1101,1102,1107],{"#text":958},{"td":1103,":@":1106},[1104],{"#text":1105},"Diagnosis in patient, or first- or second-degree relative with",{"@_align":964},{"#text":954},{"#text":954},{"tr":1110},[1111,1112,1117],{"#text":958},{"td":1113,":@":1116},[1114],{"#text":1115},"breast cancer at age 45 or younger",{"@_align":964},{"#text":954},{"#text":954},{"tr":1120},[1121,1122,1127],{"#text":958},{"td":1123,":@":1126},[1124],{"#text":1125},"triple negative breast cancer diagnosed at any age",{"@_align":964},{"#text":954},{"#text":954},{"tr":1130},[1131,1132,1137],{"#text":958},{"td":1133,":@":1136},[1134],{"#text":1135},"multiple primary breast cancers",{"@_align":964},{"#text":954},{"#text":954},{"tr":1140},[1141,1142,1147],{"#text":958},{"td":1143,":@":1146},[1144],{"#text":1145},"ovarian, certain prostate cancers, or male breast cancer at any age",{"@_align":964},{"#text":954},{"#text":954},{"tr":1150},[1151,1152,1161],{"#text":958},{"td":1153,":@":1160},[1154,1156,1158],{"#text":1155},"breast cancer or prostate cancer diagnosis at any age and Ashkenazi",{"break":1157},[],{"#text":1159},"Jewish ancestry",{"@_align":964},{"#text":954},{"#text":954},{"tr":1164},[1165,1166,1171],{"#text":958},{"td":1167,":@":1170},[1168],{"#text":1169},"Two or more first- or second-degree relatives on same side of family with breast cancer, if at least one was diagnosed  age 50",{"@_align":964},{"#text":954},{"#text":954},{"tr":1174},[1175,1176,1181],{"#text":958},{"td":1177,":@":1180},[1178],{"#text":1179},"Three or more total diagnoses of breast cancer in patient, first- or second-degree relatives on the same side of the family",{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},{"#text":677},{"table-wrap-foot":1187},[1188,1189,1206],{"#text":941},{"fn":1190,":@":1205},[1191,1192,1199,1200,1204],{"#text":954},{"label":1193},[1194,1195,1198],{"#text":958},{"sup":1196},[1197],{"#text":997},{"#text":954},{"#text":954},{"p":1201},[1202],{"#text":1203},"First-degree relatives are parents, children, and siblings. Second-degree relatives are grandparents, grandchildren, uncles and aunts.",{"#text":941},{"@_id":1000},{"#text":677},{"#text":692},{"@_id":926,"@_position":1209},"float",{"#text":692},{"p":1212},[1213],{"#text":1214},"Blood samples were taken from individuals with increased (moderate) and high (strong) risk for cancer and they were included in the study and for further examination. We collected 370 samples from patients with any cancer type. We classified the samples according to cancer types and we assorted 205 HBOC patients for further examination. Patients with other cancer types were excluded from the current analyses. Besides, we involved 70 healthy persons with a positive family history of HBOC-related cancer, e.g., breast, ovarian, prostate or pancreatic cancer into our examination.",{"#text":692},{"p":1217},[1218],{"#text":1219},"All individuals gave their consent to genetic testing and biobanking, which were conducted following the WMA Declaration of Helsinki - Ethical principles for medical research involving human subjects (2013) and the Hungarian genetic law (XXI/2008). The study was approved by the Regional Research Ethics Committee of the University of Pcs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU).",{"#text":763},{"@_id":1222},"s2-1",{"#text":763},{"sec":1225,":@":1400},[1226,1227,1231,1232,1236,1237,1267,1268,1336,1337,1368,1369,1373,1374,1389,1390,1394,1395,1399],{"#text":692},{"title":1228},[1229],{"#text":1230},"Methods",{"#text":692},{"p":1233},[1234],{"#text":1235},"Whole peripheral blood samples were taken from all patients. DNA was extracted from the blood leukocytes using E.Z.N.A. Blood DNA Maxi Kit (Omega Biotek, Norcross, GA, United States) according to the protocol. QubitTM 2.0 Fluorometric Quantitation system (Thermo Fisher Scientific Inc., Waltham, MA United States) was used to calculate the quantity and quality of genomic DNA samples (Qubit 1X dsDNA HS (High Sensitivity) Assay Kits) according to the protocol. The DNA samples were deposited into the biobank of the department.",{"#text":692},{"p":1238},[1239,1241,1245,1246,1250,1251,1255,1257,1261,1262,1265],{"#text":1240},"The patients were examined using Agilent SureMASTR Hereditary Cancer Kit previously, which was no longer manufactured (Agilent Technologies, Santa Clara, CA United States), thereafter we used TruSight Hereditary Cancer Kit (Illumina Inc., San Diego, CA United States). Both Kits are targeted sequencing panels. The SureMASTR Hereditary Cancer Kit contained 26 cancer-associated genes (",{"italic":1242},[1243],{"#text":1244},"ATM",{"#text":787},{"italic":1247},[1248],{"#text":1249},"BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM (3UTR), FAM175A, MEN1, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53,",{"#text":744},{"italic":1252},[1253],{"#text":1254},"XRCC2",{"#text":1256},"), the TruSight Hereditary Cancer Kit designed to assess germline mutations across 113 genes (",{"italic":1258},[1259],{"#text":1260},"ACD, AIP, AKT1, APC, ATM, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTRC, DDB2, DICER1, DIS3L2, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FAM175A, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GPC3, GREM1, HOXB13, KIF1B, KIT, LZTR1, MAX, MEN1, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NSD1, NTHL1, PALB2, PDGFRA, PHOX2B, PIK3CA, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RINT1, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPINK1, SPRED1, STK11, SUFU, TERF2IP, TERT, TMEM127, TP53, TSC1, TSC2, VHL, WT1, XPA, XPC,",{"#text":744},{"italic":1263},[1264],{"#text":1254},{"#text":1266},") commonly associated with hereditary predisposition to several cancers like breast, ovarian, colon, and gastric and tumour associated syndromes like tuberous sclerosis and neurofibromatosis. The SureMASTR Hereditary Cancer Kit assay uses amplicon sequencing method. The TruSight Hereditary Cancer Kit assay uses hybrid-capture chemistry integrated with Nextera Flex for Enrichment. We performed the assays according to the description of the manufacturer.",{"#text":692},{"p":1269},[1270,1272,1279,1281,1288,1290,1297,1299,1306,1308,1316,1318,1325,1327,1334],{"#text":1271},"After sequencing reactions base called raw sequencing data was transformed into FASTQ format using Illuminas software (bcl2fastq). Sequence reads of each sample were mapped to the human reference genome (GRCh37/hg19). Burrows-Wheeler Aligner (BWA-MEM) software was used for reading alignment. Duplicate read marking, local realignment around indels, base quality score recalibration and variant calling were performed using GATK algorithms (Sentieon Inc., California, United States). Variant data was annotated using a collection of tools (VcfAnno and VEP) with a variety of public variant databases including but not limited to gnomAD",{"xref":1273,":@":1277},[1274],{"sup":1275},[1276],{"#text":791},{"@_ref-type":916,"@_rid":1278},"fn2",{"#text":1280},", ClinVar",{"xref":1282,":@":1286},[1283],{"sup":1284},[1285],{"#text":799},{"@_ref-type":916,"@_rid":1287},"fn3",{"#text":1289}," and HGMD",{"xref":1291,":@":1295},[1292],{"sup":1293},[1294],{"#text":812},{"@_ref-type":916,"@_rid":1296},"fn4",{"#text":1298},". The variants detected were adapted to available public databases, depositories like Ensembl",{"xref":1300,":@":1304},[1301],{"sup":1302},[1303],{"#text":824},{"@_ref-type":916,"@_rid":1305},"fn5",{"#text":1307},", Varsome",{"xref":1309,":@":1314},[1310],{"sup":1311},[1312],{"#text":1313},"6",{"@_ref-type":916,"@_rid":1315},"fn6",{"#text":1317},", Franklin",{"xref":1319,":@":1323},[1320],{"sup":1321},[1322],{"#text":832},{"@_ref-type":916,"@_rid":1324},"fn7",{"#text":1326},"; and HGMD",{"xref":1328,":@":1332},[1329],{"sup":1330},[1331],{"#text":844},{"@_ref-type":916,"@_rid":1333},"fn8",{"#text":1335}," and were classified according to the latest guidelines and interpretation criteria established by the American College of Medical Genetics and Genomics. The variants received were matched to the clinical features of the patients and the persons with positive family history.",{"#text":692},{"p":1338},[1339,1341,1348,1350,1355,1357,1361,1362,1366],{"#text":1340},"We used PCR for validation of variants detected by NGS. The accession numbers of the gene reference sequences applied for designing methods were summarized in ",{"xref":1342,":@":1345},[1343],{"#text":1344},"Supplementary Table S1",{"@_ref-type":1346,"@_rid":1347},"sec","s11",{"#text":1349}," (",{"xref":1351,":@":1354},[1352],{"#text":1353},"Supplementary Material",{"@_ref-type":1346,"@_rid":1347},{"#text":1356},"). For amplification of the region of interest, we designed specific primers (Integrated DNA Technologies Inc., Coralville, IA, United States) using the NCBI-PRIMER-BLAST tool (NCBI, Bethesda, MD, United States). The sequences of the applied oligonucleotide primers were summarized in ",{"xref":1358,":@":1360},[1359],{"#text":1344},{"@_ref-type":1346,"@_rid":1347},{"#text":1349},{"xref":1363,":@":1365},[1364],{"#text":1353},{"@_ref-type":1346,"@_rid":1347},{"#text":1367},").",{"#text":692},{"p":1370},[1371],{"#text":1372},"We performed PCR reactions according to the protocol below:",{"#text":692},{"p":1375},[1376,1378,1382,1383,1387],{"#text":1377},"Final volume was 50L, which contained 200M of each dNTP (1L), 0.2mM of each primer (11L), 5L of reaction buffer (containing 500mM KCl, 10mM Tris-HCl, 14mmol/L MgCl2, pH 9.0), 1U of Taq polymerase (1L of 10U/L) and 1g extracted DNA as template (1L). The conditions of the polymerase chain reactions for the detection of HBOC variants were as follows: initial denaturation at 96C followed by 35 cycles of 30s at 95C; 30s at the annealing temperature; 30s at 72C and a final extension at 72C. The annealing temperatures applied for certain variants are indicated in ",{"xref":1379,":@":1381},[1380],{"#text":1344},{"@_ref-type":1346,"@_rid":1347},{"#text":1349},{"xref":1384,":@":1386},[1385],{"#text":1353},{"@_ref-type":1346,"@_rid":1347},{"#text":1388},"). The polymerase chain reactions were carried out using a SensoQuest Labcycler (SensoQuest GmBH, Gttingen, Germany).",{"#text":692},{"p":1391},[1392],{"#text":1393},"After the amplification reaction, the products were electrophoresed through an ethidium-bromide-stained 1.5%2% agarose gel and visualized by UVIdoc gel documentation system (UVITEC, Cambridge, UK).",{"#text":692},{"p":1396},[1397],{"#text":1398},"The sequencing reactions were performed by Sanger sequencing on an Applied BiosystemsTM 3500 Genetic Analyzer (Thermo Fisher Scientific Inc., Waltham, MA, United States) using BigDye Terminator Chemistry. The sequence alignments were made using the Winstar genetic program (DNASTAR Inc., Madison, WI, United States).",{"#text":763},{"@_id":1401},"s2-2",{"#text":766},{"@_id":1404},"s2",{"#text":766},{"sec":1407,":@":4579},[1408,1409,1413,1414,2194,2195,4578],{"#text":763},{"title":1410},[1411],{"#text":1412},"Results",{"#text":763},{"sec":1415,":@":2192},[1416,1417,1421,1422,1440,1441,1919,1920,1924,1925,1937,1938,2191],{"#text":692},{"title":1418},[1419],{"#text":1420},"General characterization",{"#text":692},{"p":1423},[1424,1426,1432,1434,1438],{"#text":1425},"We summarized the general characteristics of the study groups in ",{"xref":1427,":@":1430},[1428],{"#text":1429},"Table 2",{"@_ref-type":925,"@_rid":1431},"T2",{"#text":1433},". We have analysed a total of 275 samples with targeted next-generation sequencing panels of which, 205 agreed with HBOC criteria (HBOC cohort) and 70 were the sample of healthy persons with a positive family history of different cancers (non-HBOC cohort). The samples derived from non-consanguineous Hungarian people. HBOC patients data (age, tumour type and age at diagnosis) and non-HBOC persons data were summarized in ",{"xref":1435,":@":1437},[1436],{"#text":1429},{"@_ref-type":925,"@_rid":1431},{"#text":1439},". Among the HBOC cases, 193 (94.1%) were females and 12 (5.85%) were males, all with a history of HBOC-related cancer. The average age of HBOC cases was 56.0  15.0years. The lowest age discovered was 21years while the highest was 84years. The average age at diagnosis for HBOC cases was 46.3  11.7years (range = 1578years). Among HBOC patients, 51.2% had their primary cancer diagnosis at age 45years or younger. The types of cancers identified within the HBOC group were breast cancer (n = 179; 87.3%), ovarian cancer (n = 16; 7.81%), prostate cancer (n = 6; 2.93%), uterus cancer (n = 3; 1.47%) and endocervix cancer (n = 1; 0.49%).",{"#text":692},{"table-wrap":1442,":@":1918},[1443,1444,1448,1449,1457,1458,1877,1878,1917],{"#text":677},{"label":1445},[1446],{"#text":1447},"TABLE 2",{"#text":677},{"caption":1450},[1451,1452,1456],{"#text":941},{"p":1453},[1454],{"#text":1455},"Patient cohorts characteristics.",{"#text":677},{"#text":677},{"table":1459},[1460,1461,1482,1483,1876],{"#text":941},{"thead":1462,":@":1481},[1463,1464,1480],{"#text":954},{"tr":1465},[1466,1467,1479],{"#text":958},{"th":1468,":@":1478},[1469,1471],{"#text":1470},"Cohort of HBOC patients",{"xref":1472,":@":1476},[1473],{"sup":1474},[1475],{"#text":997},{"@_ref-type":999,"@_rid":1477},"Tfn2",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":1484,":@":1875},[1485,1486,1495,1496,1511,1512,1527,1528,1543,1544,1553,1554,1569,1570,1585,1586,1595,1596,1610,1611,1625,1626,1641,1642,1657,1658,1673,1674,1683,1684,1699,1700,1715,1716,1731,1732,1747,1748,1763,1764,1781,1782,1790,1791,1805,1806,1820,1821,1835,1836,1844,1845,1859,1860,1874],{"#text":954},{"tr":1487},[1488,1489,1494],{"#text":958},{"td":1490,":@":1493},[1491],{"#text":1492},"Gender n (%)",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1497},[1498,1499,1504,1505,1510],{"#text":958},{"td":1500,":@":1503},[1501],{"#text":1502},"Female",{"@_align":964},{"#text":958},{"td":1506,":@":1509},[1507],{"#text":1508},"193 (94.1%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1513},[1514,1515,1520,1521,1526],{"#text":958},{"td":1516,":@":1519},[1517],{"#text":1518},"Male",{"@_align":964},{"#text":958},{"td":1522,":@":1525},[1523],{"#text":1524},"12 (5.85%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1529},[1530,1531,1536,1537,1542],{"#text":958},{"td":1532,":@":1535},[1533],{"#text":1534},"total",{"@_align":964},{"#text":958},{"td":1538,":@":1541},[1539],{"#text":1540},"205",{"@_align":964},{"#text":954},{"#text":954},{"tr":1545},[1546,1547,1552],{"#text":958},{"td":1548,":@":1551},[1549],{"#text":1550},"Age (years)",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1555},[1556,1557,1562,1563,1568],{"#text":958},{"td":1558,":@":1561},[1559],{"#text":1560},"Average SD",{"@_align":964},{"#text":958},{"td":1564,":@":1567},[1565],{"#text":1566},"56.0  15.0",{"@_align":964},{"#text":954},{"#text":954},{"tr":1571},[1572,1573,1578,1579,1584],{"#text":958},{"td":1574,":@":1577},[1575],{"#text":1576},"Minmax",{"@_align":964},{"#text":958},{"td":1580,":@":1583},[1581],{"#text":1582},"2184",{"@_align":964},{"#text":954},{"#text":954},{"tr":1587},[1588,1589,1594],{"#text":958},{"td":1590,":@":1593},[1591],{"#text":1592},"Age at diagnosis (years)",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1597},[1598,1599,1603,1604,1609],{"#text":958},{"td":1600,":@":1602},[1601],{"#text":1560},{"@_align":964},{"#text":958},{"td":1605,":@":1608},[1606],{"#text":1607},"46.3  11.7",{"@_align":964},{"#text":954},{"#text":954},{"tr":1612},[1613,1614,1618,1619,1624],{"#text":958},{"td":1615,":@":1617},[1616],{"#text":1576},{"@_align":964},{"#text":958},{"td":1620,":@":1623},[1621],{"#text":1622},"1578",{"@_align":964},{"#text":954},{"#text":954},{"tr":1627},[1628,1629,1634,1635,1640],{"#text":958},{"td":1630,":@":1633},[1631],{"#text":1632},"45",{"@_align":964},{"#text":958},{"td":1636,":@":1639},[1637],{"#text":1638},"n = 105 (51.2%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1643},[1644,1645,1650,1651,1656],{"#text":958},{"td":1646,":@":1649},[1647],{"#text":1648},"4560",{"@_align":964},{"#text":958},{"td":1652,":@":1655},[1653],{"#text":1654},"n = 70 (34.2%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1659},[1660,1661,1666,1667,1672],{"#text":958},{"td":1662,":@":1665},[1663],{"#text":1664},">60",{"@_align":964},{"#text":958},{"td":1668,":@":1671},[1669],{"#text":1670},"n = 30 (14.6%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1675},[1676,1677,1682],{"#text":958},{"td":1678,":@":1681},[1679],{"#text":1680},"Tumour types n (%)",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1685},[1686,1687,1692,1693,1698],{"#text":958},{"td":1688,":@":1691},[1689],{"#text":1690},"Breast cancer",{"@_align":964},{"#text":958},{"td":1694,":@":1697},[1695],{"#text":1696},"179 (87.3%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1701},[1702,1703,1708,1709,1714],{"#text":958},{"td":1704,":@":1707},[1705],{"#text":1706},"Ovarian cancer",{"@_align":964},{"#text":958},{"td":1710,":@":1713},[1711],{"#text":1712},"16 (7.81%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1717},[1718,1719,1724,1725,1730],{"#text":958},{"td":1720,":@":1723},[1721],{"#text":1722},"Uterus cancer",{"@_align":964},{"#text":958},{"td":1726,":@":1729},[1727],{"#text":1728},"3 (1.47%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1733},[1734,1735,1740,1741,1746],{"#text":958},{"td":1736,":@":1739},[1737],{"#text":1738},"Prostate cancer",{"@_align":964},{"#text":958},{"td":1742,":@":1745},[1743],{"#text":1744},"6 (2.93%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1749},[1750,1751,1756,1757,1762],{"#text":958},{"td":1752,":@":1755},[1753],{"#text":1754},"Endocervix",{"@_align":964},{"#text":958},{"td":1758,":@":1761},[1759],{"#text":1760},"1 (0.49%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1765},[1766,1767,1780],{"#text":958},{"td":1768,":@":1779},[1769,1771],{"#text":1770},"Cohort of non-HBOC persons",{"xref":1772,":@":1777},[1773],{"sup":1774},[1775],{"#text":1776},"b",{"@_ref-type":999,"@_rid":1778},"Tfn3",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1783},[1784,1785,1789],{"#text":958},{"td":1786,":@":1788},[1787],{"#text":1492},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1792},[1793,1794,1798,1799,1804],{"#text":958},{"td":1795,":@":1797},[1796],{"#text":1502},{"@_align":964},{"#text":958},{"td":1800,":@":1803},[1801],{"#text":1802},"60 (85.7%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1807},[1808,1809,1813,1814,1819],{"#text":958},{"td":1810,":@":1812},[1811],{"#text":1518},{"@_align":964},{"#text":958},{"td":1815,":@":1818},[1816],{"#text":1817},"10 (14.3%)",{"@_align":964},{"#text":954},{"#text":954},{"tr":1822},[1823,1824,1828,1829,1834],{"#text":958},{"td":1825,":@":1827},[1826],{"#text":1534},{"@_align":964},{"#text":958},{"td":1830,":@":1833},[1831],{"#text":1832},"70",{"@_align":964},{"#text":954},{"#text":954},{"tr":1837},[1838,1839,1843],{"#text":958},{"td":1840,":@":1842},[1841],{"#text":1550},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1846},[1847,1848,1852,1853,1858],{"#text":958},{"td":1849,":@":1851},[1850],{"#text":1560},{"@_align":964},{"#text":958},{"td":1854,":@":1857},[1855],{"#text":1856},"49.0  14.0",{"@_align":964},{"#text":954},{"#text":954},{"tr":1861},[1862,1863,1867,1868,1873],{"#text":958},{"td":1864,":@":1866},[1865],{"#text":1576},{"@_align":964},{"#text":958},{"td":1869,":@":1872},[1870],{"#text":1871},"2081",{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},{"#text":677},{"table-wrap-foot":1879},[1880,1881,1898,1899,1916],{"#text":941},{"fn":1882,":@":1897},[1883,1884,1891,1892,1896],{"#text":954},{"label":1885},[1886,1887,1890],{"#text":958},{"sup":1888},[1889],{"#text":997},{"#text":954},{"#text":954},{"p":1893},[1894],{"#text":1895},"HBOC, cohort: hereditary breast and ovarian cancer.",{"#text":941},{"@_id":1477},{"#text":941},{"fn":1900,":@":1915},[1901,1902,1909,1910,1914],{"#text":954},{"label":1903},[1904,1905,1908],{"#text":958},{"sup":1906},[1907],{"#text":1776},{"#text":954},{"#text":954},{"p":1911},[1912],{"#text":1913},"non-HBOC: healthy persons with hereditary cancer relatives.",{"#text":941},{"@_id":1778},{"#text":677},{"#text":692},{"@_id":1431,"@_position":1209},{"#text":692},{"p":1921},[1922],{"#text":1923},"Among the healthy non-HBOC cases, there were 60 (85.7%) females and 10 (14.3%) males, all without personal breast and ovarian cancer history but with a positive family history of any cancer. The average age of non-HBOC cases was 49.0  14.0years, ranging from 20 to 81years.",{"#text":692},{"p":1926},[1927,1929,1935],{"#text":1928},"In ",{"xref":1930,":@":1933},[1931],{"#text":1932},"Table 3",{"@_ref-type":925,"@_rid":1934},"T3",{"#text":1936},", we summarized the distribution of genetic variants in all cohorts and the age at diagnosis in the HBOC cohort. The average age at diagnosis in the carrier HBOC group was 44.1  10.9years, where 25years was the minimum and 72years was the maximum age at diagnosis. The average age at diagnosis in non-carriers was 47.3  11.9years. The minimum age at diagnosis was 15years; however, the maximum age at diagnosis was 78years. There was no significant difference in the age at diagnosis between carrier and non-carrier HBOC groups.",{"#text":692},{"table-wrap":1939,":@":2190},[1940,1941,1945,1946,1954,1955,2189],{"#text":677},{"label":1942},[1943],{"#text":1944},"TABLE 3",{"#text":677},{"caption":1947},[1948,1949,1953],{"#text":941},{"p":1950},[1951],{"#text":1952},"Distribution of carriers and non-carriers in the cohorts.",{"#text":677},{"#text":677},{"table":1956},[1957,1958,2009,2010,2188],{"#text":941},{"thead":1959,":@":2008},[1960,1961,1976,1977,2007],{"#text":954},{"tr":1962},[1963,1964,1969,1970,1975],{"#text":958},{"th":1965,":@":1968},[1966],{"#text":1967},"",{"@_colspan":337,"@_align":964},{"#text":958},{"th":1971,":@":1974},[1972],{"#text":1973},"Age at diagnosis",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":1978},[1979,1980,1983,1984,1988,1989,1994,1995,2000,2001,2006],{"#text":958},{"th":1981,":@":1982},[],{"@_align":964},{"#text":958},{"th":1985,":@":1986},[],{"@_align":1987},"center",{"#text":958},{"th":1990,":@":1993},[1991],{"#text":1992},"Number of cases n (%)",{"@_align":964},{"#text":958},{"th":1996,":@":1999},[1997],{"#text":1998},"Average SD (years)",{"@_align":964},{"#text":958},{"th":2002,":@":2005},[2003],{"#text":2004},"Minmax (years)",{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":2011,":@":2187},[2012,2013,2046,2047,2073,2074,2105,2106,2130,2131,2161,2162,2186],{"#text":954},{"tr":2014},[2015,2016,2021,2022,2027,2028,2033,2034,2039,2040,2045],{"#text":958},{"td":2017,":@":2020},[2018],{"#text":2019},"HBOC patients (n = 205)",{"@_rowspan":446,"@_align":964},{"#text":958},{"td":2023,":@":2026},[2024],{"#text":2025},"Variant carriers",{"@_align":964},{"#text":958},{"td":2029,":@":2032},[2030],{"#text":2031},"62 (29.8)",{"@_align":964},{"#text":958},{"td":2035,":@":2038},[2036],{"#text":2037},"44.1  10.9",{"@_align":964},{"#text":958},{"td":2041,":@":2044},[2042],{"#text":2043},"2572",{"@_align":964},{"#text":954},{"#text":954},{"tr":2048},[2049,2050,2055,2056,2061,2062,2067,2068,2072],{"#text":958},{"td":2051,":@":2054},[2052],{"#text":2053},"Non-carriers",{"@_align":964},{"#text":958},{"td":2057,":@":2060},[2058],{"#text":2059},"143 (70.2)",{"@_align":964},{"#text":958},{"td":2063,":@":2066},[2064],{"#text":2065},"47.3  11.9",{"@_align":964},{"#text":958},{"td":2069,":@":2071},[2070],{"#text":1622},{"@_align":964},{"#text":954},{"#text":954},{"tr":2075},[2076,2077,2082,2083,2087,2088,2093,2094,2099,2100,2104],{"#text":958},{"td":2078,":@":2081},[2079],{"#text":2080},"non-HBOC persons (n = 70)",{"@_rowspan":446,"@_align":964},{"#text":958},{"td":2084,":@":2086},[2085],{"#text":2025},{"@_align":964},{"#text":958},{"td":2089,":@":2092},[2090],{"#text":2091},"20 (28.6)",{"@_align":964},{"#text":958},{"td":2095,":@":2098},[2096],{"#text":2097},"-",{"@_align":964},{"#text":958},{"td":2101,":@":2103},[2102],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":2107},[2108,2109,2113,2114,2119,2120,2124,2125,2129],{"#text":958},{"td":2110,":@":2112},[2111],{"#text":2053},{"@_align":964},{"#text":958},{"td":2115,":@":2118},[2116],{"#text":2117},"50 (71.4)",{"@_align":964},{"#text":958},{"td":2121,":@":2123},[2122],{"#text":2097},{"@_align":964},{"#text":958},{"td":2126,":@":2128},[2127],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":2132},[2133,2134,2139,2140,2144,2145,2150,2151,2155,2156,2160],{"#text":958},{"td":2135,":@":2138},[2136],{"#text":2137},"All participants (n = 275)",{"@_rowspan":446,"@_align":964},{"#text":958},{"td":2141,":@":2143},[2142],{"#text":2025},{"@_align":964},{"#text":958},{"td":2146,":@":2149},[2147],{"#text":2148},"82 (29.8)",{"@_align":964},{"#text":958},{"td":2152,":@":2154},[2153],{"#text":2097},{"@_align":964},{"#text":958},{"td":2157,":@":2159},[2158],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":2163},[2164,2165,2169,2170,2175,2176,2180,2181,2185],{"#text":958},{"td":2166,":@":2168},[2167],{"#text":2053},{"@_align":964},{"#text":958},{"td":2171,":@":2174},[2172],{"#text":2173},"193 (70.2)",{"@_align":964},{"#text":958},{"td":2177,":@":2179},[2178],{"#text":2097},{"@_align":964},{"#text":958},{"td":2182,":@":2184},[2183],{"#text":2097},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},{"#text":692},{"@_id":1934,"@_position":1209},{"#text":763},{"@_id":2193},"s3-1",{"#text":763},{"sec":2196,":@":4576},[2197,2198,2202,2203,2207,2208,2294,2295,3223,3224,3245,3246,3388,3389,3398,3399,3407,3408,3416,3417,3425,3426,3458,3459,4517,4518,4570,4571,4575],{"#text":692},{"title":2199},[2200],{"#text":2201},"Mutational profile of HBOC and non-HBOC study groups",{"#text":692},{"p":2204},[2205],{"#text":2206},"The number of cases of HBOC patients carrying any genetic variants were 61, which is 29.8% of all HBOC patients tested. In the non-HBOC study group, 20 individuals were found carrying any genetic variant in association of cancer predisposition, which is 28.6% of the tested non-HBOC persons. The total number of all variant carriers was 82 cases, which is the 29.8% of all cases.",{"#text":692},{"p":2209},[2210,2212,2218,2220,2223,2225,2229,2231,2234,2236,2239,2241,2245,2247,2251,2252,2256,2258,2262,2263,2267,2269,2272,2274,2277,2279,2282,2284,2287,2289,2292],{"#text":2211},"The complete record of the positive results of different tumour types is summarized in ",{"xref":2213,":@":2216},[2214],{"#text":2215},"Table 4",{"@_ref-type":925,"@_rid":2217},"T4",{"#text":2219},". The table shows the genes in which we detected variants and it contains the most prevalent variants, as well. Breast cancer was diagnosed in most of our cases (179/205; 87.3%), of which we identified genetic variants in 51 cases, representing 28.5% of the breast cancer patients: twelve ",{"italic":2221},[2222],{"#text":350},{"#text":2224}," (6.70%), eight ",{"italic":2226},[2227],{"#text":2228},"CHEK2",{"#text":2230}," (4.47%), eight ",{"italic":2232},[2233],{"#text":349},{"#text":2235}," (4.47%), seven ",{"italic":2237},[2238],{"#text":1244},{"#text":2240}," (3.91%), three ",{"italic":2242},[2243],{"#text":2244},"PALB2",{"#text":2246}," (1.68%), and 2-2 variants in ",{"italic":2248},[2249],{"#text":2250},"BARD1, FANCI",{"#text":744},{"italic":2253},[2254],{"#text":2255},"RAD51C",{"#text":2257}," genes (1.12%), and 1-1 variant in ",{"italic":2259},[2260],{"#text":2261},"APC, BLM, CDH1, ERCC2, KIT, MSH6,, PMS2, RAD50, RAD51B,",{"#text":744},{"italic":2264},[2265],{"#text":2266},"RET",{"#text":2268}," genes (0.56%). Besides, 9 out of 16 ovarian cancer cases (56.3%) harboured genetic variants: six ",{"italic":2270},[2271],{"#text":349},{"#text":2273}," (37.5%), two ",{"italic":2275},[2276],{"#text":2255},{"#text":2278}," (12.5%) and in one case ",{"italic":2280},[2281],{"#text":350},{"#text":2283}," (6.25%). The most prevalent variant was ",{"italic":2285},[2286],{"#text":349},{"#text":2288}," c.5266dupC in the cohorts. Of the six prostate cancer cases, only one carried a genetic variant in the oncogenes (16.7%). From the three cases diagnosed with uterus cancer, only one case revealed positivity, where a pathogenic variant was found in the ",{"italic":2290},[2291],{"#text":349},{"#text":2293}," gene. We could not detect any genetic alteration in the patients diagnosed with endocervix cancer by oncogenetic testing.",{"#text":692},{"table-wrap":2296,":@":3222},[2297,2298,2302,2303,2311,2312,3221],{"#text":677},{"label":2299},[2300],{"#text":2301},"TABLE 4",{"#text":677},{"caption":2304},[2305,2306,2310],{"#text":941},{"p":2307},[2308],{"#text":2309},"Carriers of pathogenic/likely pathogenic variants and variants of uncertain significance (VUS) according to tumour types in the HBOC cohort.",{"#text":677},{"#text":677},{"table":2313},[2314,2315,2357,2358,3220],{"#text":941},{"thead":2316,":@":2356},[2317,2318,2355],{"#text":954},{"tr":2319},[2320,2321,2326,2327,2336,2337,2342,2343,2348,2349,2354],{"#text":958},{"th":2322,":@":2325},[2323],{"#text":2324},"Tumour types",{"@_align":964},{"#text":958},{"th":2328,":@":2335},[2329,2331,2333],{"#text":2330},"Gene",{"break":2332},[],{"#text":2334},"Variant detected",{"@_align":964},{"#text":958},{"th":2338,":@":2341},[2339],{"#text":2340},"All carriers n (%)",{"@_align":964},{"#text":958},{"th":2344,":@":2347},[2345],{"#text":2346},"Carriers of p/LP n (%)",{"@_align":964},{"#text":958},{"th":2350,":@":2353},[2351],{"#text":2352},"Carriers of VUS n (%)",{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":2359,":@":3219},[2360,2361,2393,2394,2425,2426,2455,2456,2482,2483,2512,2513,2539,2540,2568,2569,2597,2598,2626,2627,2655,2656,2683,2684,2712,2713,2741,2742,2769,2770,2798,2799,2827,2828,2856,2857,2885,2886,2914,2915,2943,2944,2971,2972,3004,3005,3035,3036,3063,3064,3091,3092,3119,3120,3154,3155,3189,3190,3218],{"#text":954},{"tr":2362},[2363,2364,2370,2371,2374,2375,2380,2381,2386,2387,2392],{"#text":958},{"td":2365,":@":2368},[2366],{"#text":2367},"Breast cancer (n = 179)",{"@_rowspan":2369,"@_align":964},21,{"#text":958},{"td":2372,":@":2373},[],{"@_align":964},{"#text":958},{"td":2376,":@":2379},[2377],{"#text":2378},"51 (28.5)",{"@_align":964},{"#text":958},{"td":2382,":@":2385},[2383],{"#text":2384},"34 (19.0)",{"@_align":964},{"#text":958},{"td":2388,":@":2391},[2389],{"#text":2390},"17 (9.50)",{"@_align":964},{"#text":954},{"#text":954},{"tr":2395},[2396,2397,2406,2407,2412,2413,2418,2419,2424],{"#text":958},{"td":2398,":@":2405},[2399,2401,2404],{"#text":2400},"\n                  ",{"italic":2402},[2403],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":2408,":@":2411},[2409],{"#text":2410},"12 (6.70)",{"@_align":964},{"#text":958},{"td":2414,":@":2417},[2415],{"#text":2416},"9 (5.03)",{"@_align":964},{"#text":958},{"td":2420,":@":2423},[2421],{"#text":2422},"3 (1.68)",{"@_align":964},{"#text":954},{"#text":954},{"tr":2427},[2428,2429,2437,2438,2443,2444,2448,2449,2454],{"#text":958},{"td":2430,":@":2436},[2431,2432,2435],{"#text":2400},{"italic":2433},[2434],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":2439,":@":2442},[2440],{"#text":2441},"8 (4.47)",{"@_align":964},{"#text":958},{"td":2445,":@":2447},[2446],{"#text":2441},{"@_align":964},{"#text":958},{"td":2450,":@":2453},[2451],{"#text":2452},"0",{"@_align":964},{"#text":954},{"#text":954},{"tr":2457},[2458,2459,2468,2469,2473,2474,2477,2478,2481],{"#text":958},{"td":2460,":@":2467},[2461,2462,2466],{"#text":2400},{"italic":2463},[2464],{"#text":2465},"BRCA1 c.5266dupC",{"#text":958},{"@_align":964},{"#text":958},{"td":2470,":@":2472},[2471],{"#text":2422},{"@_align":964},{"#text":958},{"td":2475,":@":2476},[],{"@_align":1987},{"#text":958},{"td":2479,":@":2480},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":2484},[2485,2486,2494,2495,2499,2500,2505,2506,2511],{"#text":958},{"td":2487,":@":2493},[2488,2489,2492],{"#text":2400},{"italic":2490},[2491],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":2496,":@":2498},[2497],{"#text":2441},{"@_align":964},{"#text":958},{"td":2501,":@":2504},[2502],{"#text":2503},"7 (3.91)",{"@_align":964},{"#text":958},{"td":2507,":@":2510},[2508],{"#text":2509},"1 (0.56)",{"@_align":964},{"#text":954},{"#text":954},{"tr":2514},[2515,2516,2525,2526,2530,2531,2534,2535,2538],{"#text":958},{"td":2517,":@":2524},[2518,2519,2523],{"#text":2400},{"italic":2520},[2521],{"#text":2522},"CHEK2 c.599T>C",{"#text":958},{"@_align":964},{"#text":958},{"td":2527,":@":2529},[2528],{"#text":2422},{"@_align":964},{"#text":958},{"td":2532,":@":2533},[],{"@_align":1987},{"#text":958},{"td":2536,":@":2537},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":2541},[2542,2543,2551,2552,2556,2557,2562,2563,2567],{"#text":958},{"td":2544,":@":2550},[2545,2546,2549],{"#text":2400},{"italic":2547},[2548],{"#text":1244},{"#text":958},{"@_align":964},{"#text":958},{"td":2553,":@":2555},[2554],{"#text":2503},{"@_align":964},{"#text":958},{"td":2558,":@":2561},[2559],{"#text":2560},"4 (2.23)",{"@_align":964},{"#text":958},{"td":2564,":@":2566},[2565],{"#text":2422},{"@_align":964},{"#text":954},{"#text":954},{"tr":2570},[2571,2572,2580,2581,2585,2586,2590,2591,2596],{"#text":958},{"td":2573,":@":2579},[2574,2575,2578],{"#text":2400},{"italic":2576},[2577],{"#text":2244},{"#text":958},{"@_align":964},{"#text":958},{"td":2582,":@":2584},[2583],{"#text":2422},{"@_align":964},{"#text":958},{"td":2587,":@":2589},[2588],{"#text":2509},{"@_align":964},{"#text":958},{"td":2592,":@":2595},[2593],{"#text":2594},"2 (1.12)",{"@_align":964},{"#text":954},{"#text":954},{"tr":2599},[2600,2601,2610,2611,2615,2616,2620,2621,2625],{"#text":958},{"td":2602,":@":2609},[2603,2604,2608],{"#text":2400},{"italic":2605},[2606],{"#text":2607},"BARD1",{"#text":958},{"@_align":964},{"#text":958},{"td":2612,":@":2614},[2613],{"#text":2594},{"@_align":964},{"#text":958},{"td":2617,":@":2619},[2618],{"#text":2509},{"@_align":964},{"#text":958},{"td":2622,":@":2624},[2623],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2628},[2629,2630,2639,2640,2644,2645,2649,2650,2654],{"#text":958},{"td":2631,":@":2638},[2632,2633,2637],{"#text":2400},{"italic":2634},[2635],{"#text":2636},"FANCI",{"#text":958},{"@_align":964},{"#text":958},{"td":2641,":@":2643},[2642],{"#text":2594},{"@_align":964},{"#text":958},{"td":2646,":@":2648},[2647],{"#text":2509},{"@_align":964},{"#text":958},{"td":2651,":@":2653},[2652],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2657},[2658,2659,2667,2668,2672,2673,2677,2678,2682],{"#text":958},{"td":2660,":@":2666},[2661,2662,2665],{"#text":2400},{"italic":2663},[2664],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":2669,":@":2671},[2670],{"#text":2594},{"@_align":964},{"#text":958},{"td":2674,":@":2676},[2675],{"#text":2509},{"@_align":964},{"#text":958},{"td":2679,":@":2681},[2680],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2685},[2686,2687,2696,2697,2701,2702,2706,2707,2711],{"#text":958},{"td":2688,":@":2695},[2689,2690,2694],{"#text":2400},{"italic":2691},[2692],{"#text":2693},"APC",{"#text":958},{"@_align":964},{"#text":958},{"td":2698,":@":2700},[2699],{"#text":2509},{"@_align":964},{"#text":958},{"td":2703,":@":2705},[2704],{"#text":2452},{"@_align":964},{"#text":958},{"td":2708,":@":2710},[2709],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2714},[2715,2716,2725,2726,2730,2731,2735,2736,2740],{"#text":958},{"td":2717,":@":2724},[2718,2719,2723],{"#text":2400},{"italic":2720},[2721],{"#text":2722},"BLM",{"#text":958},{"@_align":964},{"#text":958},{"td":2727,":@":2729},[2728],{"#text":2509},{"@_align":964},{"#text":958},{"td":2732,":@":2734},[2733],{"#text":2509},{"@_align":964},{"#text":958},{"td":2737,":@":2739},[2738],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":2743},[2744,2745,2753,2754,2758,2759,2763,2764,2768],{"#text":958},{"td":2746,":@":2752},[2747,2748,2751],{"#text":2400},{"italic":2749},[2750],{"#text":753},{"#text":958},{"@_align":964},{"#text":958},{"td":2755,":@":2757},[2756],{"#text":2509},{"@_align":964},{"#text":958},{"td":2760,":@":2762},[2761],{"#text":2509},{"@_align":964},{"#text":958},{"td":2765,":@":2767},[2766],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":2771},[2772,2773,2782,2783,2787,2788,2792,2793,2797],{"#text":958},{"td":2774,":@":2781},[2775,2776,2780],{"#text":2400},{"italic":2777},[2778],{"#text":2779},"ERCC2",{"#text":958},{"@_align":964},{"#text":958},{"td":2784,":@":2786},[2785],{"#text":2509},{"@_align":964},{"#text":958},{"td":2789,":@":2791},[2790],{"#text":2509},{"@_align":964},{"#text":958},{"td":2794,":@":2796},[2795],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":2800},[2801,2802,2811,2812,2816,2817,2821,2822,2826],{"#text":958},{"td":2803,":@":2810},[2804,2805,2809],{"#text":2400},{"italic":2806},[2807],{"#text":2808},"KIT",{"#text":958},{"@_align":964},{"#text":958},{"td":2813,":@":2815},[2814],{"#text":2509},{"@_align":964},{"#text":958},{"td":2818,":@":2820},[2819],{"#text":2452},{"@_align":964},{"#text":958},{"td":2823,":@":2825},[2824],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2829},[2830,2831,2840,2841,2845,2846,2850,2851,2855],{"#text":958},{"td":2832,":@":2839},[2833,2834,2838],{"#text":2400},{"italic":2835},[2836],{"#text":2837},"MSH6",{"#text":958},{"@_align":964},{"#text":958},{"td":2842,":@":2844},[2843],{"#text":2509},{"@_align":964},{"#text":958},{"td":2847,":@":2849},[2848],{"#text":2452},{"@_align":964},{"#text":958},{"td":2852,":@":2854},[2853],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2858},[2859,2860,2869,2870,2874,2875,2879,2880,2884],{"#text":958},{"td":2861,":@":2868},[2862,2863,2867],{"#text":2400},{"italic":2864},[2865],{"#text":2866},"PMS2",{"#text":958},{"@_align":964},{"#text":958},{"td":2871,":@":2873},[2872],{"#text":2509},{"@_align":964},{"#text":958},{"td":2876,":@":2878},[2877],{"#text":2452},{"@_align":964},{"#text":958},{"td":2881,":@":2883},[2882],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2887},[2888,2889,2898,2899,2903,2904,2908,2909,2913],{"#text":958},{"td":2890,":@":2897},[2891,2892,2896],{"#text":2400},{"italic":2893},[2894],{"#text":2895},"RAD50",{"#text":958},{"@_align":964},{"#text":958},{"td":2900,":@":2902},[2901],{"#text":2509},{"@_align":964},{"#text":958},{"td":2905,":@":2907},[2906],{"#text":2452},{"@_align":964},{"#text":958},{"td":2910,":@":2912},[2911],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2916},[2917,2918,2927,2928,2932,2933,2937,2938,2942],{"#text":958},{"td":2919,":@":2926},[2920,2921,2925],{"#text":2400},{"italic":2922},[2923],{"#text":2924},"RAD51B",{"#text":958},{"@_align":964},{"#text":958},{"td":2929,":@":2931},[2930],{"#text":2509},{"@_align":964},{"#text":958},{"td":2934,":@":2936},[2935],{"#text":2452},{"@_align":964},{"#text":958},{"td":2939,":@":2941},[2940],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2945},[2946,2947,2955,2956,2960,2961,2965,2966,2970],{"#text":958},{"td":2948,":@":2954},[2949,2950,2953],{"#text":2400},{"italic":2951},[2952],{"#text":2266},{"#text":958},{"@_align":964},{"#text":958},{"td":2957,":@":2959},[2958],{"#text":2509},{"@_align":964},{"#text":958},{"td":2962,":@":2964},[2963],{"#text":2452},{"@_align":964},{"#text":958},{"td":2967,":@":2969},[2968],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":2973},[2974,2975,2981,2982,2985,2986,2991,2992,2997,2998,3003],{"#text":958},{"td":2976,":@":2979},[2977],{"#text":2978},"Ovarian cancer (n = 16)",{"@_rowspan":2980,"@_align":964},5,{"#text":958},{"td":2983,":@":2984},[],{"@_align":964},{"#text":958},{"td":2987,":@":2990},[2988],{"#text":2989},"9 (56.3)",{"@_align":964},{"#text":958},{"td":2993,":@":2996},[2994],{"#text":2995},"7 (43.8)",{"@_align":964},{"#text":958},{"td":2999,":@":3002},[3000],{"#text":3001},"2 (12.5)",{"@_align":964},{"#text":954},{"#text":954},{"tr":3006},[3007,3008,3016,3017,3022,3023,3028,3029,3034],{"#text":958},{"td":3009,":@":3015},[3010,3011,3014],{"#text":2400},{"italic":3012},[3013],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":3018,":@":3021},[3019],{"#text":3020},"6 (37.5)",{"@_align":964},{"#text":958},{"td":3024,":@":3027},[3025],{"#text":3026},"5 (31.3)",{"@_align":964},{"#text":958},{"td":3030,":@":3033},[3031],{"#text":3032},"1 (6.25)",{"@_align":964},{"#text":954},{"#text":954},{"tr":3037},[3038,3039,3048,3049,3054,3055,3058,3059,3062],{"#text":958},{"td":3040,":@":3047},[3041,3042,3045],{"#text":2400},{"italic":3043},[3044],{"#text":349},{"#text":3046}," c.5266dupC",{"@_align":964},{"#text":958},{"td":3050,":@":3053},[3051],{"#text":3052},"3 (18.8)",{"@_align":964},{"#text":958},{"td":3056,":@":3057},[],{"@_align":1987},{"#text":958},{"td":3060,":@":3061},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":3065},[3066,3067,3075,3076,3080,3081,3085,3086,3090],{"#text":958},{"td":3068,":@":3074},[3069,3070,3073],{"#text":2400},{"italic":3071},[3072],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":3077,":@":3079},[3078],{"#text":3001},{"@_align":964},{"#text":958},{"td":3082,":@":3084},[3083],{"#text":3032},{"@_align":964},{"#text":958},{"td":3087,":@":3089},[3088],{"#text":3032},{"@_align":964},{"#text":954},{"#text":954},{"tr":3093},[3094,3095,3103,3104,3108,3109,3113,3114,3118],{"#text":958},{"td":3096,":@":3102},[3097,3098,3101],{"#text":2400},{"italic":3099},[3100],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":3105,":@":3107},[3106],{"#text":3032},{"@_align":964},{"#text":958},{"td":3110,":@":3112},[3111],{"#text":3032},{"@_align":964},{"#text":958},{"td":3115,":@":3117},[3116],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":3121},[3122,3123,3128,3129,3137,3138,3143,3144,3148,3149,3153],{"#text":958},{"td":3124,":@":3127},[3125],{"#text":3126},"Prostate cancer (n = 6)",{"@_align":964},{"#text":958},{"td":3130,":@":3136},[3131,3132,3135],{"#text":2400},{"italic":3133},[3134],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":3139,":@":3142},[3140],{"#text":3141},"1 (16.7)",{"@_align":964},{"#text":958},{"td":3145,":@":3147},[3146],{"#text":3141},{"@_align":964},{"#text":958},{"td":3150,":@":3152},[3151],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":3156},[3157,3158,3163,3164,3172,3173,3178,3179,3183,3184,3188],{"#text":958},{"td":3159,":@":3162},[3160],{"#text":3161},"Uterus cancer (n = 3)",{"@_align":964},{"#text":958},{"td":3165,":@":3171},[3166,3167,3170],{"#text":2400},{"italic":3168},[3169],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":3174,":@":3177},[3175],{"#text":3176},"1 (33.3)",{"@_align":964},{"#text":958},{"td":3180,":@":3182},[3181],{"#text":3176},{"@_align":964},{"#text":958},{"td":3185,":@":3187},[3186],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":3191},[3192,3193,3198,3199,3202,3203,3207,3208,3212,3213,3217],{"#text":958},{"td":3194,":@":3197},[3195],{"#text":3196},"Endocervix (n = 1)",{"@_align":964},{"#text":958},{"td":3200,":@":3201},[],{"@_align":964},{"#text":958},{"td":3204,":@":3206},[3205],{"#text":2452},{"@_align":964},{"#text":958},{"td":3209,":@":3211},[3210],{"#text":2452},{"@_align":964},{"#text":958},{"td":3214,":@":3216},[3215],{"#text":2452},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},{"#text":692},{"@_id":2217,"@_position":1209},{"#text":692},{"p":3225},[3226,3228,3233,3234,3238,3240,3243],{"#text":3227},"The identified genetic variants in the HBOC and non-HBOC groups are listed in ",{"xref":3229,":@":3232},[3230],{"#text":3231},"Supplementary Table S2",{"@_ref-type":1346,"@_rid":1347},{"#text":1349},{"xref":3235,":@":3237},[3236],{"#text":1353},{"@_ref-type":1346,"@_rid":1347},{"#text":3239},"). The table contains the clinical significance of the variants, which were predicted by the ClinVar database and Franklin interpretation tool. The clinical significance of most of the variants can be determined unanimously based on the data from ClinVar and Franklin. In some cases, there were discrepancies between the interpretation of ClinVar and Franklin (pathogenic-likely pathogenic, pathogenic-VUS). Based on the analysis, Franklin proved to be more permissive in most cases. In the ClinVar database, no records were found for the ",{"italic":3241},[3242],{"#text":753},{"#text":3244}," c.2499delT variant; however, after classification according to the ACMG guidelines, we interpreted it as a likely pathogenic/pathogenic variant, as was predicted by the Franklin prediction tool.",{"#text":692},{"p":3247},[3248,3250,3254,3255,3258,3259,3263,3264,3267,3268,3271,3272,3275,3276,3280,3281,3284,3285,3288,3289,3292,3293,3297,3298,3301,3303,3306,3307,3310,3311,3314,3315,3319,3320,3324,3325,3329,3330,3334,3336,3339,3340,3343,3344,3347,3348,3351,3352,3355,3357,3361,3362,3366,3367,3371,3372,3376,3377,3381,3382,3386],{"#text":3249},"We identified pathogenic/likely pathogenic and VUS genetic variants in ",{"italic":3251},[3252],{"#text":3253},"APC, ATM",{"#text":787},{"italic":3256},[3257],{"#text":2607},{"#text":787},{"italic":3260},[3261],{"#text":3262},"BLM, BRCA1",{"#text":787},{"italic":3265},[3266],{"#text":350},{"#text":787},{"italic":3269},[3270],{"#text":2228},{"#text":787},{"italic":3273},[3274],{"#text":753},{"#text":787},{"italic":3277},[3278],{"#text":3279},"ERCC2, FANCI, KIT",{"#text":787},{"italic":3282},[3283],{"#text":2837},{"#text":787},{"italic":3286},[3287],{"#text":2244},{"#text":787},{"italic":3290},[3291],{"#text":2866},{"#text":787},{"italic":3294},[3295],{"#text":3296},"RAD50, RAD51B, RAD51C,",{"#text":744},{"italic":3299},[3300],{"#text":2266},{"#text":3302}," in the HBOC group. The non-HBOC patients harbour pathogenic/likely pathogenic and VUS genetic variants in ",{"italic":3304},[3305],{"#text":349},{"#text":787},{"italic":3308},[3309],{"#text":350},{"#text":787},{"italic":3312},[3313],{"#text":2228},{"#text":787},{"italic":3316},[3317],{"#text":3318},"EPCAM, ERCC3, FANCD2, MSH6",{"#text":787},{"italic":3321},[3322],{"#text":3323},"MUTYH, PALB2",{"#text":787},{"italic":3326},[3327],{"#text":3328},"POLE, PTCH1,",{"#text":744},{"italic":3331},[3332],{"#text":3333},"RAD51C.",{"#text":3335}," Genetic variants in ",{"italic":3337},[3338],{"#text":2607},{"#text":787},{"italic":3341},[3342],{"#text":753},{"#text":787},{"italic":3345},[3346],{"#text":2866},{"#text":787},{"italic":3349},[3350],{"#text":2808},{"#text":744},{"italic":3353},[3354],{"#text":2266},{"#text":3356}," genes were identified in HBOC patients only. Variants in ",{"italic":3358},[3359],{"#text":3360},"MUTYH",{"#text":787},{"italic":3363},[3364],{"#text":3365},"EPCAM",{"#text":787},{"italic":3368},[3369],{"#text":3370},"FANCD2",{"#text":787},{"italic":3373},[3374],{"#text":3375},"POLE",{"#text":787},{"italic":3378},[3379],{"#text":3380},"ERCC3,",{"#text":744},{"italic":3383},[3384],{"#text":3385},"PTCH1",{"#text":3387}," were reported in the non-HBOC persons only. Overall, we identified 67 unique pathogenic/likely pathogenic variants and VUS carried by 82 individuals: 35 missense (52.2%), 15 frameshift (22.4%), 10 nonsense (14.9%), 2 synonymous (2.99%), 4 splice site variants (5.97%) and one three basepair deletion (1.49%), which cause one amino acid deletion, but not frameshift.",{"#text":692},{"p":3390},[3391,3393,3396],{"#text":3392},"For ",{"italic":3394},[3395],{"#text":350},{"#text":3397},", 16 distinct variants in the association of cancer were identified in 17 individuals. The majority of the variants had pathogenic or likely pathogenic clinical significance. Only two variants were VUS (c.1012 G>A; c.3042 T>G). The most prevalent variant was the c.1408dupG, which were detected in two breast cancer cases, representing 2.98% of all variants detected.",{"#text":692},{"p":3400},[3401,3402,3405],{"#text":3392},{"italic":3403},[3404],{"#text":349},{"#text":3406},", 10 different variants in association of cancer were identified in 17 individuals. Almost all variants were predicted to be pathogenic, and only one was predicted to be VUS (c.734 A>T). In the case of c.845 C>T, Franklin predicted it as VUS; however, it was mentioned as pathogenic in ClinVar. One of the variants (c.5266dupC) was present in seven samples, representing approximately 10.4% of all variants detected.",{"#text":692},{"p":3409},[3410,3411,3414],{"#text":677},{"italic":3412},[3413],{"#text":2228},{"#text":3415}," is the third gene, in which we most frequently identified variants in association with cancer. We detected 6 different variants in 11 individuals, from which five were pathogenic/likely pathogenic, one was VUS (c.1039 A>G) and one had conflicting interpretations of pathogenicity (c.1684 C>G; ClinVar: pathogenic/likely pathogenic, Franklin: VUS). One of the variants (c.599 T>C) was present in six samples, representing approximately 8.96% of all variants detected.",{"#text":692},{"p":3418},[3419,3420,3423],{"#text":3392},{"italic":3421},[3422],{"#text":1244},{"#text":3424}," gene, 7 distinct variants in the association of cancer were identified in 7 individuals, from which three were pathogenic/likely pathogenic and four were VUS according to ClinVar and Franklin.",{"#text":692},{"p":3427},[3428,3430,3436,3438,3441,3442,3445,3447,3450,3452,3456],{"#text":3429},"We compared the numbers of detected cases and allele frequencies of the pathogenic/likely pathogenic variants for each gene in the study groups, which are summarized in ",{"xref":3431,":@":3434},[3432],{"#text":3433},"Table 5",{"@_ref-type":925,"@_rid":3435},"T5",{"#text":3437},". Pathogenic/likely pathogenic variants of ",{"italic":3439},[3440],{"#text":349},{"#text":744},{"italic":3443},[3444],{"#text":350},{"#text":3446}," showed similar allele frequencies, which shared the highest frequencies among the genes in the HBOC cohort. In the non-HBOC group, ",{"italic":3448},[3449],{"#text":349},{"#text":3451}," showed the highest frequency. Additionally, we assessed the allele frequencies of the genes in the gnomAD non-cancer cohort (n = 134 187), which showed significant differences in ",{"italic":3453},[3454],{"#text":3455},"BRCA1, BRCA2, CHEK2, MUTYH, MSH6, POLE, and ERCC3",{"#text":3457}," genes in comparison to our non-HBOC groups.",{"#text":692},{"table-wrap":3460,":@":4516},[3461,3462,3466,3467,3521,3522,4484,4485,4515],{"#text":677},{"label":3463},[3464],{"#text":3465},"TABLE 5",{"#text":677},{"caption":3468},[3469,3470,3520],{"#text":941},{"p":3471},[3472,3474,3477,3478,3481,3482,3485,3486,3489,3490,3493,3494,3497,3498,3501,3502,3505,3506,3509,3510,3513,3514,3518],{"#text":3473},"Detection ratio of ",{"italic":3475},[3476],{"#text":349},{"#text":787},{"italic":3479},[3480],{"#text":350},{"#text":787},{"italic":3483},[3484],{"#text":2244},{"#text":787},{"italic":3487},[3488],{"#text":1244},{"#text":787},{"italic":3491},[3492],{"#text":2228},{"#text":787},{"italic":3495},[3496],{"#text":3360},{"#text":787},{"italic":3499},[3500],{"#text":2837},{"#text":787},{"italic":3503},[3504],{"#text":2255},{"#text":787},{"italic":3507},[3508],{"#text":2607},{"#text":787},{"italic":3511},[3512],{"#text":753},{"#text":787},{"italic":3515},[3516],{"#text":3517},"POLE and ERCC3",{"#text":3519}," P/LP variants in the study groups and gnomAD non-cancer population.",{"#text":677},{"#text":677},{"table":3523},[3524,3525,3608,3609,4483],{"#text":941},{"thead":3526,":@":3607},[3527,3528,3560,3561,3606],{"#text":954},{"tr":3529},[3530,3531,3536,3537,3542,3543,3548,3549,3553,3554,3559],{"#text":958},{"th":3532,":@":3535},[3533],{"#text":3534},"Gene name",{"@_rowspan":446,"@_align":964},{"#text":958},{"th":3538,":@":3541},[3539],{"#text":3540},"HBOC cohort (n = 205)",{"@_colspan":446,"@_align":964},{"#text":958},{"th":3544,":@":3547},[3545],{"#text":3546},"Non-HBOC cohort (n = 70)",{"@_colspan":446,"@_align":964},{"#text":958},{"th":3550,":@":3552},[3551],{"#text":2137},{"@_colspan":446,"@_align":964},{"#text":958},{"th":3555,":@":3558},[3556],{"#text":3557},"GnomAD non-cancer cohort (n = 134 187)",{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":3562},[3563,3564,3569,3570,3575,3576,3580,3581,3585,3586,3590,3591,3595,3596,3600,3601,3605],{"#text":958},{"th":3565,":@":3568},[3566],{"#text":3567},"Detected cases",{"@_align":964},{"#text":958},{"th":3571,":@":3574},[3572],{"#text":3573},"Allele frequency",{"@_align":964},{"#text":958},{"th":3577,":@":3579},[3578],{"#text":3567},{"@_align":964},{"#text":958},{"th":3582,":@":3584},[3583],{"#text":3573},{"@_align":964},{"#text":958},{"th":3587,":@":3589},[3588],{"#text":3567},{"@_align":964},{"#text":958},{"th":3592,":@":3594},[3593],{"#text":3573},{"@_align":964},{"#text":958},{"th":3597,":@":3599},[3598],{"#text":3567},{"@_align":964},{"#text":958},{"th":3602,":@":3604},[3603],{"#text":3573},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":3610,":@":4482},[3611,3612,3678,3679,3742,3743,3799,3800,3856,3857,3920,3921,3981,3982,4043,4044,4097,4098,4152,4153,4206,4207,4267,4268,4329,4330,4380,4381,4431,4432,4481],{"#text":954},{"tr":3613},[3614,3615,3623,3624,3629,3630,3635,3636,3640,3641,3653,3654,3659,3660,3665,3666,3671,3672,3677],{"#text":958},{"td":3616,":@":3622},[3617,3618,3621],{"#text":2400},{"italic":3619},[3620],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":3625,":@":3628},[3626],{"#text":3627},"13",{"@_align":964},{"#text":958},{"td":3631,":@":3634},[3632],{"#text":3633},"0.03170",{"@_align":964},{"#text":958},{"td":3637,":@":3639},[3638],{"#text":799},{"@_align":964},{"#text":958},{"td":3642,":@":3652},[3643,3645],{"#text":3644},"0.02143",{"xref":3646,":@":3650},[3647],{"sup":3648},[3649],{"#text":997},{"@_ref-type":999,"@_rid":3651},"Tfn4",{"@_align":964},{"#text":958},{"td":3655,":@":3658},[3656],{"#text":3657},"16",{"@_align":964},{"#text":958},{"td":3661,":@":3664},[3662],{"#text":3663},"0.02909",{"@_align":964},{"#text":958},{"td":3667,":@":3670},[3668],{"#text":3669},"295",{"@_align":964},{"#text":958},{"td":3673,":@":3676},[3674],{"#text":3675},"0.00110",{"@_align":964},{"#text":954},{"#text":954},{"tr":3680},[3681,3682,3690,3691,3695,3696,3700,3701,3705,3706,3717,3718,3723,3724,3729,3730,3735,3736,3741],{"#text":958},{"td":3683,":@":3689},[3684,3685,3688],{"#text":2400},{"italic":3686},[3687],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":3692,":@":3694},[3693],{"#text":3627},{"@_align":964},{"#text":958},{"td":3697,":@":3699},[3698],{"#text":3633},{"@_align":964},{"#text":958},{"td":3702,":@":3704},[3703],{"#text":791},{"@_align":964},{"#text":958},{"td":3707,":@":3716},[3708,3710],{"#text":3709},"0.01429",{"xref":3711,":@":3715},[3712],{"sup":3713},[3714],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":3719,":@":3722},[3720],{"#text":3721},"15",{"@_align":964},{"#text":958},{"td":3725,":@":3728},[3726],{"#text":3727},"0.02727",{"@_align":964},{"#text":958},{"td":3731,":@":3734},[3732],{"#text":3733},"411",{"@_align":964},{"#text":958},{"td":3737,":@":3740},[3738],{"#text":3739},"0.00153",{"@_align":964},{"#text":954},{"#text":954},{"tr":3744},[3745,3746,3754,3755,3759,3760,3765,3766,3770,3771,3775,3776,3780,3781,3786,3787,3792,3793,3798],{"#text":958},{"td":3747,":@":3753},[3748,3749,3752],{"#text":2400},{"italic":3750},[3751],{"#text":2244},{"#text":958},{"@_align":964},{"#text":958},{"td":3756,":@":3758},[3757],{"#text":782},{"@_align":964},{"#text":958},{"td":3761,":@":3764},[3762],{"#text":3763},"0.00244",{"@_align":964},{"#text":958},{"td":3767,":@":3769},[3768],{"#text":2452},{"@_align":964},{"#text":958},{"td":3772,":@":3774},[3773],{"#text":2452},{"@_align":964},{"#text":958},{"td":3777,":@":3779},[3778],{"#text":782},{"@_align":964},{"#text":958},{"td":3782,":@":3785},[3783],{"#text":3784},"0.00182",{"@_align":964},{"#text":958},{"td":3788,":@":3791},[3789],{"#text":3790},"200",{"@_align":964},{"#text":958},{"td":3794,":@":3797},[3795],{"#text":3796},"0.00075",{"@_align":964},{"#text":954},{"#text":954},{"tr":3801},[3802,3803,3811,3812,3816,3817,3822,3823,3827,3828,3832,3833,3837,3838,3843,3844,3849,3850,3855],{"#text":958},{"td":3804,":@":3810},[3805,3806,3809],{"#text":2400},{"italic":3807},[3808],{"#text":1244},{"#text":958},{"@_align":964},{"#text":958},{"td":3813,":@":3815},[3814],{"#text":799},{"@_align":964},{"#text":958},{"td":3818,":@":3821},[3819],{"#text":3820},"0.00730",{"@_align":964},{"#text":958},{"td":3824,":@":3826},[3825],{"#text":2452},{"@_align":964},{"#text":958},{"td":3829,":@":3831},[3830],{"#text":2452},{"@_align":964},{"#text":958},{"td":3834,":@":3836},[3835],{"#text":799},{"@_align":964},{"#text":958},{"td":3839,":@":3842},[3840],{"#text":3841},"0.00545",{"@_align":964},{"#text":958},{"td":3845,":@":3848},[3846],{"#text":3847},"428",{"@_align":964},{"#text":958},{"td":3851,":@":3854},[3852],{"#text":3853},"0.00160",{"@_align":964},{"#text":954},{"#text":954},{"tr":3858},[3859,3860,3868,3869,3873,3874,3879,3880,3884,3885,3896,3897,3901,3902,3907,3908,3913,3914,3919],{"#text":958},{"td":3861,":@":3867},[3862,3863,3866],{"#text":2400},{"italic":3864},[3865],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":3870,":@":3872},[3871],{"#text":844},{"@_align":964},{"#text":958},{"td":3875,":@":3878},[3876],{"#text":3877},"0.01950",{"@_align":964},{"#text":958},{"td":3881,":@":3883},[3882],{"#text":782},{"@_align":964},{"#text":958},{"td":3886,":@":3895},[3887,3889],{"#text":3888},"0.00714",{"xref":3890,":@":3894},[3891],{"sup":3892},[3893],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":3898,":@":3900},[3899],{"#text":851},{"@_align":964},{"#text":958},{"td":3903,":@":3906},[3904],{"#text":3905},"0.01636",{"@_align":964},{"#text":958},{"td":3909,":@":3912},[3910],{"#text":3911},"207",{"@_align":964},{"#text":958},{"td":3915,":@":3918},[3916],{"#text":3917},"0.00077",{"@_align":964},{"#text":954},{"#text":954},{"tr":3922},[3923,3924,3932,3933,3937,3938,3942,3943,3947,3948,3958,3959,3963,3964,3968,3969,3974,3975,3980],{"#text":958},{"td":3925,":@":3931},[3926,3927,3930],{"#text":2400},{"italic":3928},[3929],{"#text":3360},{"#text":958},{"@_align":964},{"#text":958},{"td":3934,":@":3936},[3935],{"#text":2452},{"@_align":964},{"#text":958},{"td":3939,":@":3941},[3940],{"#text":2452},{"@_align":964},{"#text":958},{"td":3944,":@":3946},[3945],{"#text":782},{"@_align":964},{"#text":958},{"td":3949,":@":3957},[3950,3951],{"#text":3709},{"xref":3952,":@":3956},[3953],{"sup":3954},[3955],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":3960,":@":3962},[3961],{"#text":782},{"@_align":964},{"#text":958},{"td":3965,":@":3967},[3966],{"#text":3784},{"@_align":964},{"#text":958},{"td":3970,":@":3973},[3971],{"#text":3972},"1,536",{"@_align":964},{"#text":958},{"td":3976,":@":3979},[3977],{"#text":3978},"0.00572",{"@_align":964},{"#text":954},{"#text":954},{"tr":3983},[3984,3985,3993,3994,3998,3999,4003,4004,4008,4009,4019,4020,4024,4025,4030,4031,4036,4037,4042],{"#text":958},{"td":3986,":@":3992},[3987,3988,3991],{"#text":2400},{"italic":3989},[3990],{"#text":2837},{"#text":958},{"@_align":964},{"#text":958},{"td":3995,":@":3997},[3996],{"#text":2452},{"@_align":964},{"#text":958},{"td":4000,":@":4002},[4001],{"#text":2452},{"@_align":964},{"#text":958},{"td":4005,":@":4007},[4006],{"#text":791},{"@_align":964},{"#text":958},{"td":4010,":@":4018},[4011,4012],{"#text":3709},{"xref":4013,":@":4017},[4014],{"sup":4015},[4016],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":4021,":@":4023},[4022],{"#text":791},{"@_align":964},{"#text":958},{"td":4026,":@":4029},[4027],{"#text":4028},"0.00363",{"@_align":964},{"#text":958},{"td":4032,":@":4035},[4033],{"#text":4034},"119",{"@_align":964},{"#text":958},{"td":4038,":@":4041},[4039],{"#text":4040},"0.00044",{"@_align":964},{"#text":954},{"#text":954},{"tr":4045},[4046,4047,4055,4056,4060,4061,4065,4066,4070,4071,4075,4076,4080,4081,4085,4086,4091,4092,4096],{"#text":958},{"td":4048,":@":4054},[4049,4050,4053],{"#text":2400},{"italic":4051},[4052],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":4057,":@":4059},[4058],{"#text":782},{"@_align":964},{"#text":958},{"td":4062,":@":4064},[4063],{"#text":3763},{"@_align":964},{"#text":958},{"td":4067,":@":4069},[4068],{"#text":2452},{"@_align":964},{"#text":958},{"td":4072,":@":4074},[4073],{"#text":2452},{"@_align":964},{"#text":958},{"td":4077,":@":4079},[4078],{"#text":782},{"@_align":964},{"#text":958},{"td":4082,":@":4084},[4083],{"#text":3784},{"@_align":964},{"#text":958},{"td":4087,":@":4090},[4088],{"#text":4089},"118",{"@_align":964},{"#text":958},{"td":4093,":@":4095},[4094],{"#text":4040},{"@_align":964},{"#text":954},{"#text":954},{"tr":4099},[4100,4101,4109,4110,4114,4115,4119,4120,4124,4125,4129,4130,4134,4135,4139,4140,4145,4146,4151],{"#text":958},{"td":4102,":@":4108},[4103,4104,4107],{"#text":2400},{"italic":4105},[4106],{"#text":2607},{"#text":958},{"@_align":964},{"#text":958},{"td":4111,":@":4113},[4112],{"#text":782},{"@_align":964},{"#text":958},{"td":4116,":@":4118},[4117],{"#text":3763},{"@_align":964},{"#text":958},{"td":4121,":@":4123},[4122],{"#text":2452},{"@_align":964},{"#text":958},{"td":4126,":@":4128},[4127],{"#text":2452},{"@_align":964},{"#text":958},{"td":4131,":@":4133},[4132],{"#text":782},{"@_align":964},{"#text":958},{"td":4136,":@":4138},[4137],{"#text":3784},{"@_align":964},{"#text":958},{"td":4141,":@":4144},[4142],{"#text":4143},"84",{"@_align":964},{"#text":958},{"td":4147,":@":4150},[4148],{"#text":4149},"0.00031",{"@_align":964},{"#text":954},{"#text":954},{"tr":4154},[4155,4156,4164,4165,4169,4170,4174,4175,4179,4180,4184,4185,4189,4190,4194,4195,4199,4200,4205],{"#text":958},{"td":4157,":@":4163},[4158,4159,4162],{"#text":2400},{"italic":4160},[4161],{"#text":753},{"#text":958},{"@_align":964},{"#text":958},{"td":4166,":@":4168},[4167],{"#text":782},{"@_align":964},{"#text":958},{"td":4171,":@":4173},[4172],{"#text":3763},{"@_align":964},{"#text":958},{"td":4176,":@":4178},[4177],{"#text":2452},{"@_align":964},{"#text":958},{"td":4181,":@":4183},[4182],{"#text":2452},{"@_align":964},{"#text":958},{"td":4186,":@":4188},[4187],{"#text":782},{"@_align":964},{"#text":958},{"td":4191,":@":4193},[4192],{"#text":3784},{"@_align":964},{"#text":958},{"td":4196,":@":4198},[4197],{"#text":851},{"@_align":964},{"#text":958},{"td":4201,":@":4204},[4202],{"#text":4203},"0.00003",{"@_align":964},{"#text":954},{"#text":954},{"tr":4208},[4209,4210,4218,4219,4223,4224,4228,4229,4233,4234,4244,4245,4249,4250,4254,4255,4260,4261,4266],{"#text":958},{"td":4211,":@":4217},[4212,4213,4216],{"#text":2400},{"italic":4214},[4215],{"#text":3375},{"#text":958},{"@_align":964},{"#text":958},{"td":4220,":@":4222},[4221],{"#text":2452},{"@_align":964},{"#text":958},{"td":4225,":@":4227},[4226],{"#text":2452},{"@_align":964},{"#text":958},{"td":4230,":@":4232},[4231],{"#text":782},{"@_align":964},{"#text":958},{"td":4235,":@":4243},[4236,4237],{"#text":3888},{"xref":4238,":@":4242},[4239],{"sup":4240},[4241],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":4246,":@":4248},[4247],{"#text":782},{"@_align":964},{"#text":958},{"td":4251,":@":4253},[4252],{"#text":3784},{"@_align":964},{"#text":958},{"td":4256,":@":4259},[4257],{"#text":4258},"48",{"@_align":964},{"#text":958},{"td":4262,":@":4265},[4263],{"#text":4264},"0.00018",{"@_align":964},{"#text":954},{"#text":954},{"tr":4269},[4270,4271,4280,4281,4285,4286,4290,4291,4295,4296,4306,4307,4311,4312,4316,4317,4322,4323,4328],{"#text":958},{"td":4272,":@":4279},[4273,4274,4278],{"#text":2400},{"italic":4275},[4276],{"#text":4277},"ERCC3",{"#text":958},{"@_align":964},{"#text":958},{"td":4282,":@":4284},[4283],{"#text":2452},{"@_align":964},{"#text":958},{"td":4287,":@":4289},[4288],{"#text":2452},{"@_align":964},{"#text":958},{"td":4292,":@":4294},[4293],{"#text":782},{"@_align":964},{"#text":958},{"td":4297,":@":4305},[4298,4299],{"#text":3888},{"xref":4300,":@":4304},[4301],{"sup":4302},[4303],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":4308,":@":4310},[4309],{"#text":782},{"@_align":964},{"#text":958},{"td":4313,":@":4315},[4314],{"#text":3784},{"@_align":964},{"#text":958},{"td":4318,":@":4321},[4319],{"#text":4320},"247",{"@_align":964},{"#text":958},{"td":4324,":@":4327},[4325],{"#text":4326},"0.00092",{"@_align":964},{"#text":954},{"#text":954},{"tr":4331},[4332,4333,4341,4342,4346,4347,4351,4352,4356,4357,4361,4362,4366,4367,4371,4372,4375,4376,4379],{"#text":958},{"td":4334,":@":4340},[4335,4336,4339],{"#text":2400},{"italic":4337},[4338],{"#text":2636},{"#text":958},{"@_align":964},{"#text":958},{"td":4343,":@":4345},[4344],{"#text":782},{"@_align":964},{"#text":958},{"td":4348,":@":4350},[4349],{"#text":3763},{"@_align":964},{"#text":958},{"td":4353,":@":4355},[4354],{"#text":2452},{"@_align":964},{"#text":958},{"td":4358,":@":4360},[4359],{"#text":2452},{"@_align":964},{"#text":958},{"td":4363,":@":4365},[4364],{"#text":782},{"@_align":964},{"#text":958},{"td":4368,":@":4370},[4369],{"#text":3784},{"@_align":964},{"#text":958},{"td":4373,":@":4374},[],{"@_align":1987},{"#text":958},{"td":4377,":@":4378},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":4382},[4383,4384,4392,4393,4397,4398,4402,4403,4407,4408,4412,4413,4417,4418,4422,4423,4426,4427,4430],{"#text":958},{"td":4385,":@":4391},[4386,4387,4390],{"#text":2400},{"italic":4388},[4389],{"#text":2779},{"#text":958},{"@_align":964},{"#text":958},{"td":4394,":@":4396},[4395],{"#text":782},{"@_align":964},{"#text":958},{"td":4399,":@":4401},[4400],{"#text":3763},{"@_align":964},{"#text":958},{"td":4404,":@":4406},[4405],{"#text":2452},{"@_align":964},{"#text":958},{"td":4409,":@":4411},[4410],{"#text":2452},{"@_align":964},{"#text":958},{"td":4414,":@":4416},[4415],{"#text":782},{"@_align":964},{"#text":958},{"td":4419,":@":4421},[4420],{"#text":3784},{"@_align":964},{"#text":958},{"td":4424,":@":4425},[],{"@_align":1987},{"#text":958},{"td":4428,":@":4429},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":4433},[4434,4435,4443,4444,4448,4449,4452,4453,4457,4458,4462,4463,4467,4468,4472,4473,4476,4477,4480],{"#text":958},{"td":4436,":@":4442},[4437,4438,4441],{"#text":2400},{"italic":4439},[4440],{"#text":2722},{"#text":958},{"@_align":964},{"#text":958},{"td":4445,":@":4447},[4446],{"#text":782},{"@_align":964},{"#text":958},{"td":4450,":@":4451},[],{"@_align":1987},{"#text":958},{"td":4454,":@":4456},[4455],{"#text":2452},{"@_align":964},{"#text":958},{"td":4459,":@":4461},[4460],{"#text":2452},{"@_align":964},{"#text":958},{"td":4464,":@":4466},[4465],{"#text":782},{"@_align":964},{"#text":958},{"td":4469,":@":4471},[4470],{"#text":3784},{"@_align":964},{"#text":958},{"td":4474,":@":4475},[],{"@_align":1987},{"#text":958},{"td":4478,":@":4479},[],{"@_align":1987},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},{"#text":677},{"table-wrap-foot":4486},[4487,4488,4496,4497,4514],{"#text":941},{"fn":4489},[4490,4491,4495],{"#text":954},{"p":4492},[4493],{"#text":4494},"All individuals carried the variants in heterozygous form.",{"#text":941},{"#text":941},{"fn":4498,":@":4513},[4499,4500,4507,4508,4512],{"#text":954},{"label":4501},[4502,4503,4506],{"#text":958},{"sup":4504},[4505],{"#text":997},{"#text":954},{"#text":954},{"p":4509},[4510],{"#text":4511},"Chi-square tests were used for comparison of the allele frequencies between GnomAD, Non-Cancer Group and our non-HBOC, group.",{"#text":941},{"@_id":3651},{"#text":677},{"#text":692},{"@_id":3435,"@_position":1209},{"#text":692},{"p":4519},[4520,4522,4525,4526,4529,4531,4534,4535,4538,4540,4543,4545,4548,4550,4553,4555,4558,4560,4563,4565,4568],{"#text":4521},"Remarkably, ",{"italic":4523},[4524],{"#text":349},{"#text":744},{"italic":4527},[4528],{"#text":350},{"#text":4530}," are the genes that explain almost half of the positive cases (17 + 17/82; 41.5%). ",{"italic":4532},[4533],{"#text":349},{"#text":744},{"italic":4536},[4537],{"#text":350},{"#text":4539}," were the genes with the highest rate of pathogenic/likely pathogenic variants. Three patients diagnosed with breast cancer in the HBOC group harboured two genetic variants concomitantly (double heterozygotes; DH): 1. patient: ",{"italic":4541},[4542],{"#text":349},{"#text":4544}," c.5266dupC het, p.Gln1756Profs*74 and ",{"italic":4546},[4547],{"#text":2722},{"#text":4549}," c.1642C>T het, p.Gln548Ter, which are known pathogenic variants; the patient was diagnosed with Grade 3 triple negative, invasive ductal carcinoma at the age of 32years. 2. patient: ",{"italic":4551},[4552],{"#text":350},{"#text":4554}," c.7976G>A het, p.Arg2659Lys and ",{"italic":4556},[4557],{"#text":2895},{"#text":4559}," c.287T>C het, p.Val96Ala, which are pathogenic and VUS, respectively; the patient has been receiving treatment for Grade 3 triple negative, invasive ductal carcinoma as well, which was diagnosed at the age of 29years. 3. patient: ",{"italic":4561},[4562],{"#text":350},{"#text":4564}," c.3042T>G het, p.Asn1014Lys and ",{"italic":4566},[4567],{"#text":1244},{"#text":4569}," c.5890A>G het, p.Lys1964Glu, which are VUSs. The patient was first diagnosed with Grade 3 triple negative invasive ductal carcinoma at the age of 35years, and a contralateral Grade 3 triple negative ductal breast cancer at the age of 44years. Though there were suspicions for causality based on the patients phenotype, the initial classification of these variants remained unchanged upon reevaluation.",{"#text":692},{"p":4572},[4573],{"#text":4574},"Besides, we identified other variants with benign clinical significance by next-generation testing, which were not confirmed by Sanger sequencing and they are not the part of this study.",{"#text":763},{"@_id":4577},"s3-2",{"#text":766},{"@_sec-type":4580,"@_id":4581},"results","s3",{"#text":766},{"sec":4584,":@":4981},[4585,4586,4590,4591,4595,4596,4600,4601,4656,4657,4711,4712,4789,4790,4830,4831,4857,4858,4912,4913,4975,4976,4980],{"#text":763},{"title":4587},[4588],{"#text":4589},"Discussion",{"#text":763},{"p":4592},[4593],{"#text":4594},"Over the last decade, the spreading of new techniques such as NGS that allows the simultaneous analysis of multiple genes in panels as well as whole exome/genome are more cost-effective and efficient compared to Sanger sequencing. The use of these techniques probably contributes to faster recognition of the genetic cause of rare or ultra-rare disorders and to broadening the genetic screening of certain disorders, like cancers, where rapid diagnosis is extremely important for further care and the selection of appropriate therapy.",{"#text":763},{"p":4597},[4598],{"#text":4599},"In our work, NGS allows us to determine the prevalence of genetic variants of HBOC-associated genes in the Hungarian patient cohort. Such data were not available for the Hungarian population, so far. We focused on the prevalence of genetic variants, predominantly pathogenic/likely pathogenic variants in cancer susceptibility genes in a Hungarian patient cohort selected from gathering increased (moderate) and high (strong) risk criteria for HBOC and a healthy individuals cohort, whose family history was positive for any cancer.",{"#text":763},{"p":4602},[4603,4605,4608,4609,4612,4613,4616,4617,4620,4621,4624,4625,4629,4630,4634,4636,4642,4644,4649,4650,4655],{"#text":4604},"Pathogenic/likely pathogenic variants and VUSs were found in almost 50% of all individuals in HBOC as well as in non-HBOC groups. We found variants in the following genes: ",{"italic":4606},[4607],{"#text":2693},{"#text":787},{"italic":4610},[4611],{"#text":1244},{"#text":787},{"italic":4614},[4615],{"#text":2607},{"#text":787},{"italic":4618},[4619],{"#text":2722},{"#text":787},{"italic":4622},[4623],{"#text":349},{"#text":744},{"italic":4626},[4627],{"#text":4628},"BRCA2, CDH1, CHEK2, EPCAM, ERCC3, FANCD2, KIT, MSH6, MUTYH, PALB2, PMS2, POLE, PTCH1, RAD, RAD51B, RAD51C,",{"#text":744},{"italic":4631},[4632],{"#text":4633},"RET.",{"#text":4635}," These genes are involved in repairing DNA damage and maintaining the stability of the cells genetic material [",{"xref":4637,":@":4640},[4638],{"#text":4639},"12",{"@_ref-type":784,"@_rid":4641},"B12",{"#text":4643},"]. Some of these genes play important roles particularly in the homologous recombination-, base excision- and mismatch repair pathway (HRR, BER, MMR), which are important for maintaining genomic stability [",{"xref":4645,":@":4647},[4646],{"#text":3627},{"@_ref-type":784,"@_rid":4648},"B13",{"#text":828},{"xref":4651,":@":4653},[4652],{"#text":3721},{"@_ref-type":784,"@_rid":4654},"B15",{"#text":803},{"#text":763},{"p":4658},[4659,4661,4664,4665,4668,4670,4673,4674,4677,4679,4682,4684,4689,4690,4696,4698,4701,4703,4706,4707,4710],{"#text":4660},"It is well-established that due to pathogenic germline variants detected in these genes, cells can grow uncontrolled and carrying these variants can confer predisposition for the development of hereditary cancer syndromes, which affects 5% of all HBOC cases. In the Hungarian HBOC group, ",{"italic":4662},[4663],{"#text":349},{"#text":744},{"italic":4666},[4667],{"#text":350},{"#text":4669}," genes proved to be highly penetrant genes with their pathogenic detection rate of 6.34% (13/205, each). While ",{"italic":4671},[4672],{"#text":2228},{"#text":744},{"italic":4675},[4676],{"#text":1244},{"#text":4678}," have moderate penetrance in HBOC (3.90%, 8/205; 1.46%, 3/205, respectively); in turn, the ",{"italic":4680},[4681],{"#text":2244},{"#text":4683}," gene has a lower detection rate of 0.48% (1/205). These results are consistent with others findings in European populations with HBOC [",{"xref":4685,":@":4687},[4686],{"#text":3657},{"@_ref-type":784,"@_rid":4688},"B16",{"#text":787},{"xref":4691,":@":4694},[4692],{"#text":4693},"17",{"@_ref-type":784,"@_rid":4695},"B17",{"#text":4697},"]. In the non-HBOC group, we obtained similar results regarding the ",{"italic":4699},[4700],{"#text":349},{"#text":4702}," gene (4.29%, 3/70); however, there are differences in the prevalence of other genes. These differences can result from the fact, that in this group there were healthy people, who have a positive family history with a wide range of tumour spectrum including colorectal, pancreatic or gastric cancers, which have been associated with other genes such as ",{"italic":4704},[4705],{"#text":3360},{"#text":744},{"italic":4708},[4709],{"#text":2837},{"#text":928},{"#text":763},{"p":4713},[4714,4716,4719,4720,4723,4725,4728,4730,4733,4734,4737,4738,4741,4742,4745,4746,4750,4751,4754,4756,4762,4764,4767,4769,4773,4775,4781,4782,4788],{"#text":4715},"Furthermore, the HBOC group was divided into subgroups according to the type of cancer: breast, ovarian, prostate, uterus and endocervix subgroups, and we evaluated the prevalence of genetic variants in each group. In the breast cancer subgroup, variants in ",{"italic":4717},[4718],{"#text":350},{"#text":744},{"italic":4721},[4722],{"#text":349},{"#text":4724}," were the most frequently detected. In the ovarian cancer subgroup, ",{"italic":4726},[4727],{"#text":349},{"#text":4729}," variants, mainly c.5266dupC was found. Besides, rare variants in other genes like ",{"italic":4731},[4732],{"#text":1244},{"#text":787},{"italic":4735},[4736],{"#text":2228},{"#text":787},{"italic":4739},[4740],{"#text":753},{"#text":787},{"italic":4743},[4744],{"#text":2244},{"#text":787},{"italic":4747},[4748],{"#text":4749},"RAD50,",{"#text":744},{"italic":4752},[4753],{"#text":2255},{"#text":4755}," have been detected mainly in the breast cancer subgroup. Most of these variants detected are variants of uncertain significance (VUS). In clinical practice, VUSs represent a challenge, because they must be indicated on medical results; however, - according to ACMG recommendations - VUSs are not used to guide clinical management until the clarification of their exact role [",{"xref":4757,":@":4760},[4758],{"#text":4759},"18",{"@_ref-type":784,"@_rid":4761},"B18",{"#text":4763},"]. Almost all of the VUSs detected in the study are located within important regions of the genes or functional domains of the proteins and could affect biochemical properties and biological functions. Even though we cannot determine their clinical significance with current evidence, functional studies on these variants would be necessary to explore their phenotype consequences. In our study, these variants of uncertain significance account for high percentage of the positive cases, furthermore we detected a surprising number of pathogenic variants in moderate-, and low penetrant genes. There are differences among European countries in the judgement of involving low penetrance genes in the first-line genetic HBOC screening. In some countries (e.g., Austria, Estonia, Finland, Poland), the hotspot and/or founder variants of BRCA or HBOC genes are tested first. In other countries like Finland and the Netherland, WES is executed and evaluated as an oncogenetic panel. However, it may vary among laboratories within a given country. Our findings highlight the possible benefits of including other genes besides ",{"italic":4765},[4766],{"#text":759},{"#text":4768},"s in routine genetic testing. However, incorporation testing of several genes into multigene (",{"italic":4770},[4771],{"#text":4772},"PMS2, RET, KIT",{"#text":4774},") for which the evidence of risk-association is weak or absent can result in information that might not be clinically relevant to the affected patients and their families [",{"xref":4776,":@":4779},[4777],{"#text":4778},"19",{"@_ref-type":784,"@_rid":4780},"B19",{"#text":787},{"xref":4783,":@":4786},[4784],{"#text":4785},"20",{"@_ref-type":784,"@_rid":4787},"B20",{"#text":803},{"#text":763},{"p":4791},[4792,4794,4797,4799,4805,4807,4813,4814,4820,4822,4828],{"#text":4793},"In the Hungarian cohorts, the c.5266dupC in the ",{"italic":4795},[4796],{"#text":349},{"#text":4798}," gene was detected most frequently (7/82, 8.54%). This variant is an insertion of one cytosine resulting in a frameshift and the creation of a novel translational termination codon after 74 amino acid residues. It is predicted to encode a truncated non-functional protein due to nonsense-mediated mRNA decay, which is a commonly known mechanism for disease. Functional studies have shown activity of the protein is significantly impaired by this variant [",{"xref":4800,":@":4803},[4801],{"#text":4802},"21",{"@_ref-type":784,"@_rid":4804},"B21",{"#text":4806},"]. This mutation has been described in individuals with HBOC, including individuals with male breast cancer, pancreatic cancer, and prostate cancer [",{"xref":4808,":@":4811},[4809],{"#text":4810},"22",{"@_ref-type":784,"@_rid":4812},"B22",{"#text":828},{"xref":4815,":@":4818},[4816],{"#text":4817},"27",{"@_ref-type":784,"@_rid":4819},"B27",{"#text":4821},"], and has been shown to be a founder mutation in several ethnic groups [",{"xref":4823,":@":4826},[4824],{"#text":4825},"28",{"@_ref-type":784,"@_rid":4827},"B28",{"#text":4829},"]. The high prevalence of this variant in our cohort and the fact that this variant has been reported several times in the literature state the probability of being a founder mutation of our population or maybe for a specific ethnicity; however, we did not collect information about the patients origin. To confirm this hypothesis, further studies are required.",{"#text":763},{"p":4832},[4833,4835,4841,4843,4848,4849,4855],{"#text":4834},"To evaluate the association between familial history of cancer and accumulation of the genetic variants, we assessed allele frequency data between our non-HBOC group and the gnomAD non-cancer non-Finnish European population as a group of healthy (non-cancer) individuals without any family history of cancer [",{"xref":4836,":@":4839},[4837],{"#text":4838},"29",{"@_ref-type":784,"@_rid":4840},"B29",{"#text":4842},"]. The findings revealed significant differences in allele frequencies between the two study groups, so the healthy persons with elevated risk for cancer (because of positive family history) carry the pathogenic variants in a higher proportion than people in the average population. Generally, indications of testing for high-penetrance susceptibility genes include a personal history of cancer at a young age, triple-negative or male breast cancer, epithelial ovarian cancer, multiple primary malignancies, or a positive family anamnesis. Based on these facts, genetic screening of predisposing genes in healthy but elevated-risk persons would be necessary to prevent developing tumours. After screening, healthy carriers can be easily managed and can be involved in surveillance programs and preventive follow-up care. Recognizing at-risk patients who carry the aforementioned genetic variants has important consequences on an individual level and on a larger scale as well. Affected individuals, who are already undergoing treatment can receive targeted therapy based on their genetic results, which usually leads to better outcomes and higher probability of long-term survival. Since their risk for developing other malignancies is also elevated, a positive genetic result also warrants a multidisciplinary approach to their surveillance. Identification of healthy carriers offers patients an opportunity to attend regular screening from a young age and the possibility of certain, primary preventive measures, including chemoprevention and risk-reducing surgery [",{"xref":4844,":@":4846},[4845],{"#text":520},{"@_ref-type":784,"@_rid":4847},"B30",{"#text":828},{"xref":4850,":@":4853},[4851],{"#text":4852},"33",{"@_ref-type":784,"@_rid":4854},"B33",{"#text":4856},"]. These surveillance strategies lead to earlier detection and better prognosis, reducing premature mortality and prolonged disability, while also easing the strain of costs on the healthcare system.",{"#text":763},{"p":4859},[4860,4862,4865,4867,4873,4874,4880,4882,4885,4887,4891,4893,4899,4901,4905,4907,4910],{"#text":4861},"Besides, we detected a novel germline variant (",{"italic":4863},[4864],{"#text":753},{"#text":4866}," c.2499delT), which is not yet recorded in variant databases. We interpreted and classified this sequence variant according to the standards and guidelines published by the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG-AMP) [",{"xref":4868,":@":4871},[4869],{"#text":4870},"34",{"@_ref-type":784,"@_rid":4872},"B34",{"#text":787},{"xref":4875,":@":4878},[4876],{"#text":4877},"35",{"@_ref-type":784,"@_rid":4879},"B35",{"#text":4881},"]. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay resulting in an absent or non-functional protein product (PVS1). Other frameshift variants in the nearby region have been reported in individuals with hereditary cancer-predisposing syndrome, and Familial cancer of breast, loss-of-function of ",{"italic":4883},[4884],{"#text":753},{"#text":4886}," is a well-established mechanism leading to the disorder. This variant has not been observed in the large reference population cohorts of the Genome Aggregation Database (gnomAD, n > 120 000 exomes and n > 15 000 genomes) (PM2). To our knowledge, the variant has not been published in the relevant medical literature or reported in disease-related variation databases such as HGMD or ClinVar. To assess the impact of the missense change, we applied a combination of some of the most widely used ",{"italic":4888},[4889],{"#text":4890},"in silico",{"#text":4892}," computational prediction tools like PolyPhen, Provean and MutationTaster [",{"xref":4894,":@":4897},[4895],{"#text":4896},"36",{"@_ref-type":784,"@_rid":4898},"B36",{"#text":4900},"]. These algorithms support obvious evidence that the c.2499delT variant is a protein damaging, disease-causing variant (PP3). To our best knowledge, there are no ",{"italic":4902},[4903],{"#text":4904},"in vitro",{"#text":4906}," functional studies which investigate the damaging effect of this variant on the gene product (PS3). The classification of this ",{"italic":4908},[4909],{"#text":753},{"#text":4911}," variant provides strong evidence of pathogenicity. The patient was diagnosed with metastasizing lobular breast carcinoma at the age of 48years. The histological subtype of her tumour suggests furthermore, that there is a cause-effect relation between her illness and the detected germline variant.",{"#text":763},{"p":4914},[4915,4917,4920,4921,4924,4926,4929,4931,4934,4936,4939,4941,4947,4948,4954,4956,4960,4962,4966,4968,4974],{"#text":4916},"Double heterozygosity (DH) in a high-, or moderate penetrance gene is a rare event; however, its number is likely to increase due to the use of NGS. In our study, we report three breast cancer cases (3/205; 1.46%) with (1) two VUSs in ",{"italic":4918},[4919],{"#text":350},{"#text":744},{"italic":4922},[4923],{"#text":1244},{"#text":4925}," genes; (2) one pathogenic variant in the ",{"italic":4927},[4928],{"#text":350},{"#text":4930}," gene and one VUS in the ",{"italic":4932},[4933],{"#text":2895},{"#text":4935}," gene; (3) two pathogenic variant in ",{"italic":4937},[4938],{"#text":349},{"#text":4940}," gene. Some studies showed no significant differences in risk for HBOC in DH carriers when compared with those carrying only one germline variant [",{"xref":4942,":@":4945},[4943],{"#text":4944},"37",{"@_ref-type":784,"@_rid":4946},"B37",{"#text":787},{"xref":4949,":@":4952},[4950],{"#text":4951},"38",{"@_ref-type":784,"@_rid":4953},"B38",{"#text":4955},"]. Others suggest that this genotype is not associated with early disease onset or a more severe phenotype [",{"xref":4957,":@":4959},[4958],{"#text":4951},{"@_ref-type":784,"@_rid":4953},{"#text":4961},"]. In regards to our patients, all three were diagnosed with high grade, triple negative ductal carcinoma at a very young age. However, ethnic differences have been described as Caucasian DH females might develop breast cancer at an earlier age and have more severe disease in contrast to e.g., Ashkenazi Jewish females [",{"xref":4963,":@":4965},[4964],{"#text":4944},{"@_ref-type":784,"@_rid":4946},{"#text":4967},"]. However, despite the little information about phenotype of DH carriers, we should not ignore their assumed risk modifier role and their possible cumulative impact on the development of the phenotype supporting a polygenic risk that should be considered in risk prediction in genetic counselling. Furthermore, DHs should be involved in more intensive surveillance programs/follow-up care and may need more severe prophylactic surgery [",{"xref":4969,":@":4972},[4970],{"#text":4971},"39",{"@_ref-type":784,"@_rid":4973},"B39",{"#text":803},{"#text":763},{"p":4977},[4978],{"#text":4979},"The limitation of our study is the small number of individuals in certain groups with cancer types, which does not allow us to make profound genotype-phenotype associations. Besides, associations assumed in this study can be reliably assessed with information on other extrinsic contributing factors like smoking, alcohol consumption and dietary habits of the patients. These should be evaluated on a larger cohort of cancer patients.",{"#text":766},{"@_sec-type":4982,"@_id":4983},"discussion","s4",{"#text":766},{"sec":4986,":@":5012},[4987,4988,4992,4993,5006,5007,5011],{"#text":763},{"title":4989},[4990],{"#text":4991},"Conclusion",{"#text":763},{"p":4994},[4995,4997,5000,5001,5004],{"#text":4996},"The prevalence of hereditary mutations in breast, ovarian, endometrial and prostate cancer highlights the significance of genetic counselling and molecular genetic testing concerning these malignancies. Our study demonstrates a considerable percentage of pathogenic mutation carriers, emphasizing the benefits of molecular screening tests. The expansions of the diagnostic field revealed many other pathogenic variants associated with HBOC cancer that could have been missed if only ",{"italic":4998},[4999],{"#text":349},{"#text":744},{"italic":5002},[5003],{"#text":350},{"#text":5005}," genes had been analysed. In this context, the appearance of next-generation sequencing methods has great potential. Thanks to its expansion, many new variants have been discovered in previously undiagnosed patients. Besides, comprehensive genetic diagnostics have long-term clinical benefits like increased patient cure rates, better patient surveillance, reduced cancer mortality rates, more effective treatments, and rapid recognition of high-risk families to reduce the risk of developing cancer. However, new challenges are generated in emerging next-generation sequencing like the interpretation of the huge amount of data derived from NGS, which highlights the need for highly skilled professionals in genetic counselling and molecular diagnostics with close cooperation of a multidisciplinary team.",{"#text":763},{"p":5008},[5009],{"#text":5010},"Our results provide important new information to ethnic-specific cancer risk profiling and to determining even polygenic risk scores for HBOC, which can increase the sensitivity and specificity of cancer diagnostics as well as lowering the cost. However, several rare variants were identified with uncertain clinical significance, evaluation of the biological impact of these variants, further functional assays or robust segregation studies are needed.",{"#text":766},{"@_sec-type":5013,"@_id":5014},"conclusion","s5",{"#text":5016},"\n  ",[],[5019,5037,5050,5063,5076,5090,5116],{"title":5020,"order":480,"content":5021},"Data availability statement",[5022,5023,5026,5027,5036],{"#text":763},{"title":5024},[5025],{"#text":5020},{"#text":763},{"p":5028},[5029,5031,5035],{"#text":5030},"The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/",{"xref":5032,":@":5034},[5033],{"#text":1353},{"@_ref-type":1346,"@_rid":1347},{"#text":928},{"#text":766},{"title":5038,"order":446,"content":5039},"Ethics statement",[5040,5041,5044,5045,5049],{"#text":763},{"title":5042},[5043],{"#text":5038},{"#text":763},{"p":5046},[5047],{"#text":5048},"The studies involving humans were approved by the Regional Research Ethics Committee of the University of Pcs (8770-PTE2021) and by the Medical Research Council (IV/3831-3/2021/EKU). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.",{"#text":766},{"title":5051,"order":337,"content":5052},"Author contributions",[5053,5054,5057,5058,5062],{"#text":763},{"title":5055},[5056],{"#text":5051},{"#text":763},{"p":5059},[5060],{"#text":5061},"AnM and KH devised the main conceptual ideas and the outlines of the manuscript. AlM, LB, and KH conducted genetic counsultations, AnM and JB conducted sample preparation and genetic testing. Data collection about patient cohort and genetic results was performed mainly by SK. Patients of the cohort were referred to our institution by LM and EB as well. Manuscript written mainly by SK, AnM, AlM, LB, and KH. All authors contributed to the article and approved the submitted version.",{"#text":766},{"title":5064,"order":2980,"content":5065},"Funding",[5066,5067,5070,5071,5075],{"#text":763},{"title":5068},[5069],{"#text":5064},{"#text":763},{"p":5072},[5073],{"#text":5074},"The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work is supported (not financially) by the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS). This study was supported by the Medical School of the University of Pcs, OK-KA Research Program; KA-2023-22.",{"#text":766},{"title":5077,"order":5078,"content":5079},"Conflict of interest",8,[5080,5081,5084,5085,5089],{"#text":763},{"title":5082},[5083],{"#text":5077},{"#text":763},{"p":5086},[5087],{"#text":5088},"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",{"#text":766},{"title":5091,"order":5092,"content":5093},"Supplementary material",14,[5094,5095,5098,5099,5108,5109,5115],{"#text":763},{"title":5096},[5097],{"#text":5091},{"#text":763},{"p":5100},[5101,5103],{"#text":5102},"The Supplementary Material for this article can be found online at: ",{"ext-link":5104,":@":5107},[5105],{"#text":5106},"https://www.por-journal.com/articles/10.3389/pore.2024.1611813/full#supplementary-material",{"@_ext-link-type":686,"@_xmlns:xlink":687,"@_xlink:href":5106},{"#text":763},{"supplementary-material":5110,":@":5111},[],{"@_xlink:href":5112,"@_id":5113,"@_mimetype":5114,"@_xmlns:xlink":687},"DataSheet1.docx","SM1","application/docx",{"#text":766},{"title":5117,"order":5118,"content":5119},"Footnotes",19,[5120,5121,5140,5141,5159,5160,5178,5179,5197,5198,5216,5217,5235,5236,5254,5255,5273],{"#text":763},{"fn":5122,":@":5139},[5123,5124,5127,5128,5138],{"#text":692},{"label":5125},[5126],{"#text":782},{"#text":692},{"p":5129},[5130,5131,5137],{"#text":677},{"ext-link":5132,":@":5135},[5133],{"#text":5134},"www.nccn.org",{"@_ext-link-type":686,"@_xmlns:xlink":687,"@_xlink:href":5136},"http://www.nccn.org",{"#text":692},{"#text":763},{"@_id":917},{"#text":763},{"fn":5142,":@":5158},[5143,5144,5147,5148,5157],{"#text":692},{"label":5145},[5146],{"#text":791},{"#text":692},{"p":5149},[5150,5151,5156],{"#text":677},{"ext-link":5152,":@":5155},[5153],{"#text":5154},"https://gnomad.broadinstitute.org/",{"@_ext-link-type":686,"@_xlink:href":5154},{"#text":692},{"#text":763},{"@_id":1278},{"#text":763},{"fn":5161,":@":5177},[5162,5163,5166,5167,5176],{"#text":692},{"label":5164},[5165],{"#text":799},{"#text":692},{"p":5168},[5169,5170,5175],{"#text":677},{"ext-link":5171,":@":5174},[5172],{"#text":5173},"https://www.ncbi.nlm.nih.gov/clinvar/",{"@_ext-link-type":686,"@_xlink:href":5173},{"#text":692},{"#text":763},{"@_id":1287},{"#text":763},{"fn":5180,":@":5196},[5181,5182,5185,5186,5195],{"#text":692},{"label":5183},[5184],{"#text":812},{"#text":692},{"p":5187},[5188,5189,5194],{"#text":677},{"ext-link":5190,":@":5193},[5191],{"#text":5192},"https://www.hgmd.cf.ac.uk/ac/index.php",{"@_ext-link-type":686,"@_xlink:href":5192},{"#text":692},{"#text":763},{"@_id":1296},{"#text":763},{"fn":5199,":@":5215},[5200,5201,5204,5205,5214],{"#text":692},{"label":5202},[5203],{"#text":824},{"#text":692},{"p":5206},[5207,5208,5213],{"#text":677},{"ext-link":5209,":@":5212},[5210],{"#text":5211},"https://ensemble.org",{"@_ext-link-type":686,"@_xlink:href":5211},{"#text":692},{"#text":763},{"@_id":1305},{"#text":763},{"fn":5218,":@":5234},[5219,5220,5223,5224,5233],{"#text":692},{"label":5221},[5222],{"#text":1313},{"#text":692},{"p":5225},[5226,5227,5232],{"#text":677},{"ext-link":5228,":@":5231},[5229],{"#text":5230},"https://varsome.com/",{"@_ext-link-type":686,"@_xlink:href":5230},{"#text":692},{"#text":763},{"@_id":1315},{"#text":763},{"fn":5237,":@":5253},[5238,5239,5242,5243,5252],{"#text":692},{"label":5240},[5241],{"#text":832},{"#text":692},{"p":5244},[5245,5246,5251],{"#text":677},{"ext-link":5247,":@":5250},[5248],{"#text":5249},"https://franklin.genoox.com/clinical-db/home",{"@_ext-link-type":686,"@_xlink:href":5249},{"#text":692},{"#text":763},{"@_id":1324},{"#text":763},{"fn":5256,":@":5272},[5257,5258,5261,5262,5271],{"#text":692},{"label":5259},[5260],{"#text":844},{"#text":692},{"p":5263},[5264,5265,5270],{"#text":677},{"ext-link":5266,":@":5269},[5267],{"#text":5268},"http://www.hgmd.cf.ac.uk/ac/index.php",{"@_ext-link-type":686,"@_xlink:href":5268},{"#text":692},{"#text":763},{"@_id":1333},{"#text":766},[5275,5365,5512,5653,5695,5834,5912,5989,6131,6277,6413,6497,6635,6727,6869,7009,7145,7279,7418,7557,7699,7840,7982,8123,8265,8395,8539,8682,8823,8965,9059,9182,9324,9466,9605,9743,9884,10022,10125],{"content":5276,"id":785,"index":5361,"authors":5362,"title":5320,"source":5325,"volume":851,"year":5330,"fpage":5346,"lpage":4810,"doi":5355,"pmid":26},[5277,5279,5360],{"#text":5278},"\n        \n        ",{"citation":5280,":@":5358},[5281,5282,5315,5317,5321,5322,5326,5327,5331,5333,5336,5338,5341,5343,5347,5348,5351,5352],{"#text":677},{"person-group":5283,":@":5313},[5284,5285,5298,5299,5312],{"#text":941},{"name":5286},[5287,5288,5292,5293,5297],{"#text":954},{"surname":5289},[5290],{"#text":5291},"Mattiuzzi",{"#text":954},{"given-names":5294},[5295],{"#text":5296},"C",{"#text":941},{"#text":941},{"name":5300},[5301,5302,5306,5307,5311],{"#text":954},{"surname":5303},[5304],{"#text":5305},"Lippi",{"#text":954},{"given-names":5308},[5309],{"#text":5310},"G",{"#text":941},{"#text":677},{"@_person-group-type":5314},"author",{"#text":5316},". ",{"article-title":5318},[5319],{"#text":5320},"Current cancer epidemiology",{"#text":5316},{"source":5323},[5324],{"#text":5325},"J Epidemiol Glob Health",{"#text":1349},{"year":5328},[5329],{"#text":5330},"2019",{"#text":5332},") ",{"volume":5334},[5335],{"#text":851},{"#text":5337},"(",{"issue":5339},[5340],{"#text":812},{"#text":5342},"):",{"fpage":5344},[5345],{"#text":5346},"217",{"#text":828},{"lpage":5349},[5350],{"#text":4810},{"#text":5316},{"pub-id":5353,":@":5356},[5354],{"#text":5355},"10.2991/jegh.k.191008.001",{"@_pub-id-type":5357},"doi",{"@_citation-type":5359},"journal",{"#text":763},"1.",[5363,5364],{"surname":5291,"givenNames":5296},{"surname":5305,"givenNames":5310},{"content":5366,"id":793,"index":5504,"authors":5505,"title":5466,"source":5471,"volume":5481,"year":5476,"fpage":5490,"lpage":5495,"doi":5500,"pmid":26},[5367,5368,5503],{"#text":5278},{"citation":5369,":@":5502},[5370,5371,5462,5463,5467,5468,5472,5473,5477,5478,5482,5483,5486,5487,5491,5492,5496,5497],{"#text":677},{"person-group":5372,":@":5461},[5373,5374,5387,5388,5401,5402,5415,5416,5429,5430,5443,5444,5457,5458,5460],{"#text":941},{"name":5375},[5376,5377,5381,5382,5386],{"#text":954},{"surname":5378},[5379],{"#text":5380},"Sung",{"#text":954},{"given-names":5383},[5384],{"#text":5385},"H",{"#text":941},{"#text":941},{"name":5389},[5390,5391,5395,5396,5400],{"#text":954},{"surname":5392},[5393],{"#text":5394},"Ferlay",{"#text":954},{"given-names":5397},[5398],{"#text":5399},"J",{"#text":941},{"#text":941},{"name":5403},[5404,5405,5409,5410,5414],{"#text":954},{"surname":5406},[5407],{"#text":5408},"Siegel",{"#text":954},{"given-names":5411},[5412],{"#text":5413},"RL",{"#text":941},{"#text":941},{"name":5417},[5418,5419,5423,5424,5428],{"#text":954},{"surname":5420},[5421],{"#text":5422},"Laversanne",{"#text":954},{"given-names":5425},[5426],{"#text":5427},"M",{"#text":941},{"#text":941},{"name":5431},[5432,5433,5437,5438,5442],{"#text":954},{"surname":5434},[5435],{"#text":5436},"Soerjomataram",{"#text":954},{"given-names":5439},[5440],{"#text":5441},"I",{"#text":941},{"#text":941},{"name":5445},[5446,5447,5451,5452,5456],{"#text":954},{"surname":5448},[5449],{"#text":5450},"Jemal",{"#text":954},{"given-names":5453},[5454],{"#text":5455},"A",{"#text":941},{"#text":941},{"etal":5459},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":5464},[5465],{"#text":5466},"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",{"#text":5316},{"source":5469},[5470],{"#text":5471},"CA: a Cancer J clinicians",{"#text":1349},{"year":5474},[5475],{"#text":5476},"2021",{"#text":5332},{"volume":5479},[5480],{"#text":5481},"71",{"#text":5337},{"issue":5484},[5485],{"#text":799},{"#text":5342},{"fpage":5488},[5489],{"#text":5490},"209",{"#text":828},{"lpage":5493},[5494],{"#text":5495},"49",{"#text":5316},{"pub-id":5498,":@":5501},[5499],{"#text":5500},"10.3322/caac.21660",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"2.",[5506,5507,5508,5509,5510,5511],{"surname":5380,"givenNames":5385},{"surname":5394,"givenNames":5399},{"surname":5408,"givenNames":5413},{"surname":5422,"givenNames":5427},{"surname":5436,"givenNames":5441},{"surname":5450,"givenNames":5455},{"content":5513,"id":801,"index":5645,"authors":5646,"title":5612,"source":5617,"volume":5627,"year":5622,"fpage":5636,"lpage":26,"doi":5641,"pmid":26},[5514,5515,5644],{"#text":5278},{"citation":5516,":@":5643},[5517,5518,5608,5609,5613,5614,5618,5619,5623,5624,5628,5629,5632,5633,5637,5638],{"#text":677},{"person-group":5519,":@":5607},[5520,5521,5534,5535,5548,5549,5562,5563,5576,5577,5589,5590,5603,5604,5606],{"#text":941},{"name":5522},[5523,5524,5528,5529,5533],{"#text":954},{"surname":5525},[5526],{"#text":5527},"Garner",{"#text":954},{"given-names":5530},[5531],{"#text":5532},"WB",{"#text":941},{"#text":941},{"name":5536},[5537,5538,5542,5543,5547],{"#text":954},{"surname":5539},[5540],{"#text":5541},"Smith",{"#text":954},{"given-names":5544},[5545],{"#text":5546},"BD",{"#text":941},{"#text":941},{"name":5550},[5551,5552,5556,5557,5561],{"#text":954},{"surname":5553},[5554],{"#text":5555},"Ludmir",{"#text":954},{"given-names":5558},[5559],{"#text":5560},"EB",{"#text":941},{"#text":941},{"name":5564},[5565,5566,5570,5571,5575],{"#text":954},{"surname":5567},[5568],{"#text":5569},"Wakefield",{"#text":954},{"given-names":5572},[5573],{"#text":5574},"DV",{"#text":941},{"#text":941},{"name":5578},[5579,5580,5584,5585,5588],{"#text":954},{"surname":5581},[5582],{"#text":5583},"Shabason",{"#text":954},{"given-names":5586},[5587],{"#text":5399},{"#text":941},{"#text":941},{"name":5591},[5592,5593,5597,5598,5602],{"#text":954},{"surname":5594},[5595],{"#text":5596},"Williams",{"#text":954},{"given-names":5599},[5600],{"#text":5601},"GR",{"#text":941},{"#text":941},{"etal":5605},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":5610},[5611],{"#text":5612},"Predicting future cancer incidence by age, race, ethnicity, and sex",{"#text":5316},{"source":5615},[5616],{"#text":5617},"J Geriatr Oncol",{"#text":1349},{"year":5620},[5621],{"#text":5622},"2023",{"#text":5332},{"volume":5625},[5626],{"#text":5627},"14",{"#text":5337},{"issue":5630},[5631],{"#text":782},{"#text":5342},{"fpage":5634},[5635],{"#text":5636},"101393",{"#text":5316},{"pub-id":5639,":@":5642},[5640],{"#text":5641},"10.1016/j.jgo.2022.10.008",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"3.",[5647,5648,5649,5650,5651,5652],{"surname":5527,"givenNames":5532},{"surname":5541,"givenNames":5546},{"surname":5555,"givenNames":5560},{"surname":5569,"givenNames":5574},{"surname":5583,"givenNames":5399},{"surname":5596,"givenNames":5601},{"content":5654,"id":814,"index":5693,"authors":5694,"title":26,"source":5667,"volume":26,"year":5672,"fpage":26,"lpage":26,"doi":26,"pmid":26},[5655,5656,5692],{"#text":5278},{"citation":5657,":@":5690},[5658,5659,5663,5664,5668,5669,5673,5675,5684,5685,5689],{"#text":677},{"collab":5660},[5661],{"#text":5662},"Nemzeti Rkregiszter",{"#text":5316},{"source":5665},[5666],{"#text":5667},"Nemzeti rkregiszter",{"#text":1349},{"year":5670},[5671],{"#text":5672},"2022",{"#text":5674},"). ",{"comment":5676},[5677,5679],{"#text":5678},"Available from: ",{"ext-link":5680,":@":5683},[5681],{"#text":5682},"http://stat.nrr.hu/",{"@_ext-link-type":686,"@_xmlns:xlink":687,"@_xlink:href":5682},{"#text":1349},{"comment":5686},[5687],{"#text":5688},"Accessed May 26, 2022",{"#text":1367},{"@_citation-type":5691},"book",{"#text":763},"4.",[],{"content":5696,"id":826,"index":5826,"authors":5827,"title":5794,"source":5799,"volume":3657,"year":5804,"fpage":5817,"lpage":26,"doi":5822,"pmid":26},[5697,5698,5825],{"#text":5278},{"citation":5699,":@":5824},[5700,5701,5790,5791,5795,5796,5800,5801,5805,5806,5809,5810,5813,5814,5818,5819],{"#text":677},{"person-group":5702,":@":5789},[5703,5704,5716,5717,5730,5731,5744,5745,5758,5759,5772,5773,5785,5786,5788],{"#text":941},{"name":5705},[5706,5707,5711,5712,5715],{"#text":954},{"surname":5708},[5709],{"#text":5710},"Howell",{"#text":954},{"given-names":5713},[5714],{"#text":5455},{"#text":941},{"#text":941},{"name":5718},[5719,5720,5724,5725,5729],{"#text":954},{"surname":5721},[5722],{"#text":5723},"Anderson",{"#text":954},{"given-names":5726},[5727],{"#text":5728},"AS",{"#text":941},{"#text":941},{"name":5732},[5733,5734,5738,5739,5743],{"#text":954},{"surname":5735},[5736],{"#text":5737},"Clarke",{"#text":954},{"given-names":5740},[5741],{"#text":5742},"RB",{"#text":941},{"#text":941},{"name":5746},[5747,5748,5752,5753,5757],{"#text":954},{"surname":5749},[5750],{"#text":5751},"Duffy",{"#text":954},{"given-names":5754},[5755],{"#text":5756},"SW",{"#text":941},{"#text":941},{"name":5760},[5761,5762,5766,5767,5771],{"#text":954},{"surname":5763},[5764],{"#text":5765},"Evans",{"#text":954},{"given-names":5768},[5769],{"#text":5770},"DG",{"#text":941},{"#text":941},{"name":5774},[5775,5776,5780,5781,5784],{"#text":954},{"surname":5777},[5778],{"#text":5779},"Garcia-Closas",{"#text":954},{"given-names":5782},[5783],{"#text":5427},{"#text":941},{"#text":941},{"etal":5787},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":5792},[5793],{"#text":5794},"Risk determination and prevention of breast cancer",{"#text":5316},{"source":5797},[5798],{"#text":5799},"Breast Cancer Res : BCR",{"#text":1349},{"year":5802},[5803],{"#text":5804},"2014",{"#text":5332},{"volume":5807},[5808],{"#text":3657},{"#text":5337},{"issue":5811},[5812],{"#text":824},{"#text":5342},{"fpage":5815},[5816],{"#text":5817},"446",{"#text":5316},{"pub-id":5820,":@":5823},[5821],{"#text":5822},"10.1186/s13058-014-0446-2",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"5.",[5828,5829,5830,5831,5832,5833],{"surname":5710,"givenNames":5455},{"surname":5723,"givenNames":5728},{"surname":5737,"givenNames":5742},{"surname":5751,"givenNames":5756},{"surname":5765,"givenNames":5770},{"surname":5779,"givenNames":5427},{"content":5835,"id":5907,"index":5908,"authors":5909,"title":5875,"source":5880,"volume":791,"year":5885,"fpage":799,"lpage":4802,"doi":5903,"pmid":26},[5836,5837,5906],{"#text":5278},{"citation":5838,":@":5905},[5839,5840,5871,5872,5876,5877,5881,5882,5886,5887,5890,5892,5895,5896,5899,5900],{"#text":677},{"person-group":5841,":@":5870},[5842,5843,5855,5856,5869],{"#text":941},{"name":5844},[5845,5846,5850,5851,5854],{"#text":954},{"surname":5847},[5848],{"#text":5849},"Kruk",{"#text":954},{"given-names":5852},[5853],{"#text":5399},{"#text":941},{"#text":941},{"name":5857},[5858,5859,5863,5864,5868],{"#text":954},{"surname":5860},[5861],{"#text":5862},"Aboul-Enein",{"#text":954},{"given-names":5865},[5866],{"#text":5867},"HY",{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":5873},[5874],{"#text":5875},"Environmental exposure, and other behavioral risk factors in breast cancer",{"#text":5316},{"source":5878},[5879],{"#text":5880},"Curr Cancer Ther Rev",{"#text":1349},{"year":5883},[5884],{"#text":5885},"2006",{"#text":5332},{"volume":5888},[5889],{"#text":791},{"#text":5891},":",{"fpage":5893},[5894],{"#text":799},{"#text":828},{"lpage":5897},[5898],{"#text":4802},{"#text":5316},{"pub-id":5901,":@":5904},[5902],{"#text":5903},"10.2174/157339406775471795",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B6","6.",[5910,5911],{"surname":5849,"givenNames":5399},{"surname":5862,"givenNames":5867},{"content":5913,"id":834,"index":5985,"authors":5986,"title":5953,"source":5958,"volume":867,"year":5330,"fpage":5971,"lpage":5976,"doi":5981,"pmid":26},[5914,5915,5984],{"#text":5278},{"citation":5916,":@":5983},[5917,5918,5949,5950,5954,5955,5959,5960,5963,5964,5967,5968,5972,5973,5977,5978],{"#text":677},{"person-group":5919,":@":5948},[5920,5921,5934,5935,5947],{"#text":941},{"name":5922},[5923,5924,5928,5929,5933],{"#text":954},{"surname":5925},[5926],{"#text":5927},"Momenimovahed",{"#text":954},{"given-names":5930},[5931],{"#text":5932},"Z",{"#text":941},{"#text":941},{"name":5936},[5937,5938,5942,5943,5946],{"#text":954},{"surname":5939},[5940],{"#text":5941},"Salehiniya",{"#text":954},{"given-names":5944},[5945],{"#text":5385},{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":5951},[5952],{"#text":5953},"Epidemiological characteristics of and risk factors for breast cancer in the world",{"#text":5316},{"source":5956},[5957],{"#text":5958},"Breast Cancer (Dove Med Press)",{"#text":1349},{"year":5961},[5962],{"#text":5330},{"#text":5332},{"volume":5965},[5966],{"#text":867},{"#text":5891},{"fpage":5969},[5970],{"#text":5971},"151",{"#text":828},{"lpage":5974},[5975],{"#text":5976},"64",{"#text":5316},{"pub-id":5979,":@":5982},[5980],{"#text":5981},"10.2147/BCTT.S176070",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"7.",[5987,5988],{"surname":5927,"givenNames":5932},{"surname":5941,"givenNames":5385},{"content":5990,"id":846,"index":6123,"authors":6124,"title":6086,"source":6091,"volume":5817,"year":6096,"fpage":6110,"lpage":844,"doi":6119,"pmid":26},[5991,5992,6122],{"#text":5278},{"citation":5993,":@":6121},[5994,5995,6082,6083,6087,6088,6092,6093,6097,6098,6101,6102,6106,6107,6111,6112,6115,6116],{"#text":677},{"person-group":5996,":@":6081},[5997,5998,6010,6011,6024,6025,6037,6038,6051,6052,6064,6065,6077,6078,6080],{"#text":941},{"name":5999},[6000,6001,6005,6006,6009],{"#text":954},{"surname":6002},[6003],{"#text":6004},"Greenman",{"#text":954},{"given-names":6007},[6008],{"#text":5296},{"#text":941},{"#text":941},{"name":6012},[6013,6014,6018,6019,6023],{"#text":954},{"surname":6015},[6016],{"#text":6017},"Stephens",{"#text":954},{"given-names":6020},[6021],{"#text":6022},"P",{"#text":941},{"#text":941},{"name":6026},[6027,6028,6031,6032,6036],{"#text":954},{"surname":6029},[6030],{"#text":5541},{"#text":954},{"given-names":6033},[6034],{"#text":6035},"R",{"#text":941},{"#text":941},{"name":6039},[6040,6041,6045,6046,6050],{"#text":954},{"surname":6042},[6043],{"#text":6044},"Dalgliesh",{"#text":954},{"given-names":6047},[6048],{"#text":6049},"GL",{"#text":941},{"#text":941},{"name":6053},[6054,6055,6059,6060,6063],{"#text":954},{"surname":6056},[6057],{"#text":6058},"Hunter",{"#text":954},{"given-names":6061},[6062],{"#text":5296},{"#text":941},{"#text":941},{"name":6066},[6067,6068,6072,6073,6076],{"#text":954},{"surname":6069},[6070],{"#text":6071},"Bignell",{"#text":954},{"given-names":6074},[6075],{"#text":5310},{"#text":941},{"#text":941},{"etal":6079},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6084},[6085],{"#text":6086},"Patterns of somatic mutation in human cancer genomes",{"#text":5316},{"source":6089},[6090],{"#text":6091},"Nature",{"#text":1349},{"year":6094},[6095],{"#text":6096},"2007",{"#text":5332},{"volume":6099},[6100],{"#text":5817},{"#text":5337},{"issue":6103},[6104],{"#text":6105},"7132",{"#text":5342},{"fpage":6108},[6109],{"#text":6110},"153",{"#text":828},{"lpage":6113},[6114],{"#text":844},{"#text":5316},{"pub-id":6117,":@":6120},[6118],{"#text":6119},"10.1038/nature05610",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"8.",[6125,6126,6127,6128,6129,6130],{"surname":6004,"givenNames":5296},{"surname":6017,"givenNames":6022},{"surname":5541,"givenNames":6035},{"surname":6044,"givenNames":6049},{"surname":6058,"givenNames":5296},{"surname":6071,"givenNames":5310},{"content":6132,"id":853,"index":6269,"authors":6270,"title":6231,"source":6236,"volume":6245,"year":5330,"fpage":6255,"lpage":6260,"doi":6265,"pmid":26},[6133,6134,6268],{"#text":5278},{"citation":6135,":@":6267},[6136,6137,6227,6228,6232,6233,6237,6238,6241,6242,6246,6247,6251,6252,6256,6257,6261,6262],{"#text":677},{"person-group":6138,":@":6226},[6139,6140,6153,6154,6167,6168,6181,6182,6194,6195,6208,6209,6222,6223,6225],{"#text":941},{"name":6141},[6142,6143,6147,6148,6152],{"#text":954},{"surname":6144},[6145],{"#text":6146},"Tate",{"#text":954},{"given-names":6149},[6150],{"#text":6151},"JG",{"#text":941},{"#text":941},{"name":6155},[6156,6157,6161,6162,6166],{"#text":954},{"surname":6158},[6159],{"#text":6160},"Bamford",{"#text":954},{"given-names":6163},[6164],{"#text":6165},"S",{"#text":941},{"#text":941},{"name":6169},[6170,6171,6175,6176,6180],{"#text":954},{"surname":6172},[6173],{"#text":6174},"Jubb",{"#text":954},{"given-names":6177},[6178],{"#text":6179},"HC",{"#text":941},{"#text":941},{"name":6183},[6184,6185,6189,6190,6193],{"#text":954},{"surname":6186},[6187],{"#text":6188},"Sondka",{"#text":954},{"given-names":6191},[6192],{"#text":5932},{"#text":941},{"#text":941},{"name":6196},[6197,6198,6202,6203,6207],{"#text":954},{"surname":6199},[6200],{"#text":6201},"Beare",{"#text":954},{"given-names":6204},[6205],{"#text":6206},"DM",{"#text":941},{"#text":941},{"name":6210},[6211,6212,6216,6217,6221],{"#text":954},{"surname":6213},[6214],{"#text":6215},"Bindal",{"#text":954},{"given-names":6218},[6219],{"#text":6220},"N",{"#text":941},{"#text":941},{"etal":6224},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6229},[6230],{"#text":6231},"COSMIC: the catalogue of somatic mutations in cancer",{"#text":5316},{"source":6234},[6235],{"#text":6236},"Nucleic Acids Res",{"#text":1349},{"year":6239},[6240],{"#text":5330},{"#text":5332},{"volume":6243},[6244],{"#text":6245},"47",{"#text":5337},{"issue":6248},[6249],{"#text":6250},"D1",{"#text":5342},{"fpage":6253},[6254],{"#text":6255},"D941",{"#text":828},{"lpage":6258},[6259],{"#text":6260},"947",{"#text":5316},{"pub-id":6263,":@":6266},[6264],{"#text":6265},"10.1093/nar/gky1015",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"9.",[6271,6272,6273,6274,6275,6276],{"surname":6146,"givenNames":6151},{"surname":6160,"givenNames":6165},{"surname":6174,"givenNames":6179},{"surname":6188,"givenNames":5932},{"surname":6201,"givenNames":6206},{"surname":6215,"givenNames":6220},{"content":6278,"id":861,"index":6405,"authors":6406,"title":6374,"source":6379,"volume":824,"year":5476,"fpage":6396,"lpage":26,"doi":6401,"pmid":26},[6279,6280,6404],{"#text":5278},{"citation":6281,":@":6403},[6282,6283,6370,6371,6375,6376,6380,6381,6384,6385,6388,6389,6392,6393,6397,6398],{"#text":677},{"person-group":6284,":@":6369},[6285,6286,6299,6300,6312,6313,6325,6326,6338,6339,6351,6352,6365,6366,6368],{"#text":941},{"name":6287},[6288,6289,6293,6294,6298],{"#text":954},{"surname":6290},[6291],{"#text":6292},"Fan",{"#text":954},{"given-names":6295},[6296],{"#text":6297},"X",{"#text":941},{"#text":941},{"name":6301},[6302,6303,6307,6308,6311],{"#text":954},{"surname":6304},[6305],{"#text":6306},"Wynn",{"#text":954},{"given-names":6309},[6310],{"#text":5399},{"#text":941},{"#text":941},{"name":6314},[6315,6316,6320,6321,6324],{"#text":954},{"surname":6317},[6318],{"#text":6319},"Shang",{"#text":954},{"given-names":6322},[6323],{"#text":6220},{"#text":941},{"#text":941},{"name":6327},[6328,6329,6333,6334,6337],{"#text":954},{"surname":6330},[6331],{"#text":6332},"Liu",{"#text":954},{"given-names":6335},[6336],{"#text":5296},{"#text":941},{"#text":941},{"name":6340},[6341,6342,6346,6347,6350],{"#text":954},{"surname":6343},[6344],{"#text":6345},"Fedotov",{"#text":954},{"given-names":6348},[6349],{"#text":5455},{"#text":941},{"#text":941},{"name":6353},[6354,6355,6359,6360,6364],{"#text":954},{"surname":6356},[6357],{"#text":6358},"Hallquist",{"#text":954},{"given-names":6361},[6362],{"#text":6363},"MLG",{"#text":941},{"#text":941},{"etal":6367},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6372},[6373],{"#text":6374},"Penetrance of breast cancer susceptibility genes from the eMERGE III Network",{"#text":5316},{"source":6377},[6378],{"#text":6379},"JNCI Cancer Spectr",{"#text":1349},{"year":6382},[6383],{"#text":5476},{"#text":5332},{"volume":6386},[6387],{"#text":824},{"#text":5337},{"issue":6390},[6391],{"#text":812},{"#text":5342},{"fpage":6394},[6395],{"#text":6396},"pkab044",{"#text":5316},{"pub-id":6399,":@":6402},[6400],{"#text":6401},"10.1093/jncics/pkab044",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"10.",[6407,6408,6409,6410,6411,6412],{"surname":6292,"givenNames":6297},{"surname":6306,"givenNames":5399},{"surname":6319,"givenNames":6220},{"surname":6332,"givenNames":5296},{"surname":6345,"givenNames":5455},{"surname":6358,"givenNames":6363},{"content":6414,"id":869,"index":6493,"authors":6494,"title":6455,"source":6460,"volume":6470,"year":6465,"fpage":6479,"lpage":6484,"doi":6489,"pmid":26},[6415,6416,6492],{"#text":5278},{"citation":6417,":@":6491},[6418,6419,6451,6452,6456,6457,6461,6462,6466,6467,6471,6472,6475,6476,6480,6481,6485,6486],{"#text":677},{"person-group":6420,":@":6450},[6421,6422,6435,6436,6449],{"#text":941},{"name":6423},[6424,6425,6429,6430,6434],{"#text":954},{"surname":6426},[6427],{"#text":6428},"Garber",{"#text":954},{"given-names":6431},[6432],{"#text":6433},"JE",{"#text":941},{"#text":941},{"name":6437},[6438,6439,6443,6444,6448],{"#text":954},{"surname":6440},[6441],{"#text":6442},"Offit",{"#text":954},{"given-names":6445},[6446],{"#text":6447},"K",{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":6453},[6454],{"#text":6455},"Hereditary cancer predisposition syndromes",{"#text":5316},{"source":6458},[6459],{"#text":6460},"J Clin Oncol",{"#text":1349},{"year":6463},[6464],{"#text":6465},"2005",{"#text":5332},{"volume":6468},[6469],{"#text":6470},"23",{"#text":5337},{"issue":6473},[6474],{"#text":791},{"#text":5342},{"fpage":6477},[6478],{"#text":6479},"276",{"#text":828},{"lpage":6482},[6483],{"#text":6484},"92",{"#text":5316},{"pub-id":6487,":@":6490},[6488],{"#text":6489},"10.1200/JCO.2005.10.042",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"11.",[6495,6496],{"surname":6428,"givenNames":6433},{"surname":6442,"givenNames":6447},{"content":6498,"id":4641,"index":6627,"authors":6628,"title":6596,"source":5799,"volume":4759,"year":6605,"fpage":6618,"lpage":26,"doi":6623,"pmid":26},[6499,6500,6626],{"#text":5278},{"citation":6501,":@":6625},[6502,6503,6592,6593,6597,6598,6601,6602,6606,6607,6610,6611,6614,6615,6619,6620],{"#text":677},{"person-group":6504,":@":6591},[6505,6506,6519,6520,6533,6534,6546,6547,6560,6561,6573,6574,6587,6588,6590],{"#text":941},{"name":6507},[6508,6509,6513,6514,6518],{"#text":954},{"surname":6510},[6511],{"#text":6512},"Rebbeck",{"#text":954},{"given-names":6515},[6516],{"#text":6517},"TR",{"#text":941},{"#text":941},{"name":6521},[6522,6523,6527,6528,6532],{"#text":954},{"surname":6524},[6525],{"#text":6526},"Friebel",{"#text":954},{"given-names":6529},[6530],{"#text":6531},"TM",{"#text":941},{"#text":941},{"name":6535},[6536,6537,6541,6542,6545],{"#text":954},{"surname":6538},[6539],{"#text":6540},"Mitra",{"#text":954},{"given-names":6543},[6544],{"#text":6220},{"#text":941},{"#text":941},{"name":6548},[6549,6550,6554,6555,6559],{"#text":954},{"surname":6551},[6552],{"#text":6553},"Wan",{"#text":954},{"given-names":6556},[6557],{"#text":6558},"F",{"#text":941},{"#text":941},{"name":6562},[6563,6564,6568,6569,6572],{"#text":954},{"surname":6565},[6566],{"#text":6567},"Chen",{"#text":954},{"given-names":6570},[6571],{"#text":6165},{"#text":941},{"#text":941},{"name":6575},[6576,6577,6581,6582,6586],{"#text":954},{"surname":6578},[6579],{"#text":6580},"Andrulis",{"#text":954},{"given-names":6583},[6584],{"#text":6585},"IL",{"#text":941},{"#text":941},{"etal":6589},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6594},[6595],{"#text":6596},"Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women",{"#text":5316},{"source":6599},[6600],{"#text":5799},{"#text":1349},{"year":6603},[6604],{"#text":6605},"2016",{"#text":5332},{"volume":6608},[6609],{"#text":4759},{"#text":5337},{"issue":6612},[6613],{"#text":782},{"#text":5342},{"fpage":6616},[6617],{"#text":6618},"112",{"#text":5316},{"pub-id":6621,":@":6624},[6622],{"#text":6623},"10.1186/s13058-016-0768-3",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"12.",[6629,6630,6631,6632,6633,6634],{"surname":6512,"givenNames":6517},{"surname":6526,"givenNames":6531},{"surname":6540,"givenNames":6220},{"surname":6553,"givenNames":6558},{"surname":6567,"givenNames":6165},{"surname":6580,"givenNames":6585},{"content":6636,"id":4648,"index":6722,"authors":6723,"title":6690,"source":6695,"volume":6704,"year":5622,"fpage":6713,"lpage":26,"doi":6718,"pmid":26},[6637,6638,6721],{"#text":5278},{"citation":6639,":@":6720},[6640,6641,6686,6687,6691,6692,6696,6697,6700,6701,6705,6706,6709,6710,6714,6715],{"#text":677},{"person-group":6642,":@":6685},[6643,6644,6657,6658,6671,6672,6684],{"#text":941},{"name":6645},[6646,6647,6651,6652,6656],{"#text":954},{"surname":6648},[6649],{"#text":6650},"Gohil",{"#text":954},{"given-names":6653},[6654],{"#text":6655},"D",{"#text":941},{"#text":941},{"name":6659},[6660,6661,6665,6666,6670],{"#text":954},{"surname":6662},[6663],{"#text":6664},"Sarker",{"#text":954},{"given-names":6667},[6668],{"#text":6669},"AH",{"#text":941},{"#text":941},{"name":6673},[6674,6675,6679,6680,6683],{"#text":954},{"surname":6676},[6677],{"#text":6678},"Roy",{"#text":954},{"given-names":6681},[6682],{"#text":6035},{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":6688},[6689],{"#text":6690},"Base excision repair: mechanisms and impact in biology, disease, and medicine",{"#text":5316},{"source":6693},[6694],{"#text":6695},"Int J Mol Sci",{"#text":1349},{"year":6698},[6699],{"#text":5622},{"#text":5332},{"volume":6702},[6703],{"#text":6704},"24",{"#text":5337},{"issue":6707},[6708],{"#text":4759},{"#text":5342},{"fpage":6711},[6712],{"#text":6713},"14186",{"#text":5316},{"pub-id":6716,":@":6719},[6717],{"#text":6718},"10.3390/ijms241814186",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"13.",[6724,6725,6726],{"surname":6650,"givenNames":6655},{"surname":6664,"givenNames":6669},{"surname":6678,"givenNames":6035},{"content":6728,"id":6860,"index":6861,"authors":6862,"title":6823,"source":6828,"volume":6838,"year":6833,"fpage":6847,"lpage":851,"doi":6856,"pmid":26},[6729,6730,6859],{"#text":5278},{"citation":6731,":@":6858},[6732,6733,6819,6820,6824,6825,6829,6830,6834,6835,6839,6840,6843,6844,6848,6849,6852,6853],{"#text":677},{"person-group":6734,":@":6818},[6735,6736,6749,6750,6762,6763,6775,6776,6788,6789,6801,6802,6814,6815,6817],{"#text":941},{"name":6737},[6738,6739,6743,6744,6748],{"#text":954},{"surname":6740},[6741],{"#text":6742},"Hirai",{"#text":954},{"given-names":6745},[6746],{"#text":6747},"Y",{"#text":941},{"#text":941},{"name":6751},[6752,6753,6757,6758,6761],{"#text":954},{"surname":6754},[6755],{"#text":6756},"Banno",{"#text":954},{"given-names":6759},[6760],{"#text":6447},{"#text":941},{"#text":941},{"name":6764},[6765,6766,6770,6771,6774],{"#text":954},{"surname":6767},[6768],{"#text":6769},"Suzuki",{"#text":954},{"given-names":6772},[6773],{"#text":5427},{"#text":941},{"#text":941},{"name":6777},[6778,6779,6783,6784,6787],{"#text":954},{"surname":6780},[6781],{"#text":6782},"Ichikawa",{"#text":954},{"given-names":6785},[6786],{"#text":6747},{"#text":941},{"#text":941},{"name":6790},[6791,6792,6796,6797,6800],{"#text":954},{"surname":6793},[6794],{"#text":6795},"Udagawa",{"#text":954},{"given-names":6798},[6799],{"#text":6747},{"#text":941},{"#text":941},{"name":6803},[6804,6805,6809,6810,6813],{"#text":954},{"surname":6806},[6807],{"#text":6808},"Sugano",{"#text":954},{"given-names":6811},[6812],{"#text":6447},{"#text":941},{"#text":941},{"etal":6816},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6821},[6822],{"#text":6823},"Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer",{"#text":5316},{"source":6826},[6827],{"#text":6828},"Cancer Sci",{"#text":1349},{"year":6831},[6832],{"#text":6833},"2008",{"#text":5332},{"volume":6836},[6837],{"#text":6838},"99",{"#text":5337},{"issue":6841},[6842],{"#text":851},{"#text":5342},{"fpage":6845},[6846],{"#text":6847},"1715",{"#text":828},{"lpage":6850},[6851],{"#text":851},{"#text":5316},{"pub-id":6854,":@":6857},[6855],{"#text":6856},"10.1111/j.1349-7006.2008.00886.x",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B14","14.",[6863,6864,6865,6866,6867,6868],{"surname":6742,"givenNames":6747},{"surname":6756,"givenNames":6447},{"surname":6769,"givenNames":5427},{"surname":6782,"givenNames":6747},{"surname":6795,"givenNames":6747},{"surname":6808,"givenNames":6447},{"content":6870,"id":4654,"index":7001,"authors":7002,"title":6965,"source":6970,"volume":6979,"year":5672,"fpage":6988,"lpage":3657,"doi":6997,"pmid":26},[6871,6872,7000],{"#text":5278},{"citation":6873,":@":6999},[6874,6875,6961,6962,6966,6967,6971,6972,6975,6976,6980,6981,6984,6985,6989,6990,6993,6994],{"#text":677},{"person-group":6876,":@":6960},[6877,6878,6890,6891,6902,6903,6916,6917,6929,6930,6943,6944,6956,6957,6959],{"#text":941},{"name":6879},[6880,6881,6885,6886,6889],{"#text":954},{"surname":6882},[6883],{"#text":6884},"Shao",{"#text":954},{"given-names":6887},[6888],{"#text":5296},{"#text":941},{"#text":941},{"name":6892},[6893,6894,6897,6898,6901],{"#text":954},{"surname":6895},[6896],{"#text":6553},{"#text":954},{"given-names":6899},[6900],{"#text":5399},{"#text":941},{"#text":941},{"name":6904},[6905,6906,6910,6911,6915],{"#text":954},{"surname":6907},[6908],{"#text":6909},"Lam",{"#text":954},{"given-names":6912},[6913],{"#text":6914},"FC",{"#text":941},{"#text":941},{"name":6918},[6919,6920,6924,6925,6928],{"#text":954},{"surname":6921},[6922],{"#text":6923},"Tang",{"#text":954},{"given-names":6926},[6927],{"#text":5385},{"#text":941},{"#text":941},{"name":6931},[6932,6933,6937,6938,6942],{"#text":954},{"surname":6934},[6935],{"#text":6936},"Marley",{"#text":954},{"given-names":6939},[6940],{"#text":6941},"AR",{"#text":941},{"#text":941},{"name":6945},[6946,6947,6951,6952,6955],{"#text":954},{"surname":6948},[6949],{"#text":6950},"Song",{"#text":954},{"given-names":6953},[6954],{"#text":6747},{"#text":941},{"#text":941},{"etal":6958},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":6963},[6964],{"#text":6965},"A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies",{"#text":5316},{"source":6968},[6969],{"#text":6970},"Environ Mol mutagenesis",{"#text":1349},{"year":6973},[6974],{"#text":5672},{"#text":5332},{"volume":6977},[6978],{"#text":6979},"63",{"#text":5337},{"issue":6982},[6983],{"#text":1313},{"#text":5342},{"fpage":6986},[6987],{"#text":6988},"308",{"#text":828},{"lpage":6991},[6992],{"#text":3657},{"#text":5316},{"pub-id":6995,":@":6998},[6996],{"#text":6997},"10.1002/em.22505",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"15.",[7003,7004,7005,7006,7007,7008],{"surname":6884,"givenNames":5296},{"surname":6553,"givenNames":5399},{"surname":6909,"givenNames":6914},{"surname":6923,"givenNames":5385},{"surname":6936,"givenNames":6941},{"surname":6950,"givenNames":6747},{"content":7010,"id":4688,"index":7137,"authors":7138,"title":7106,"source":7111,"volume":3721,"year":5622,"fpage":7128,"lpage":26,"doi":7133,"pmid":26},[7011,7012,7136],{"#text":5278},{"citation":7013,":@":7135},[7014,7015,7102,7103,7107,7108,7112,7113,7116,7117,7120,7121,7124,7125,7129,7130],{"#text":677},{"person-group":7016,":@":7101},[7017,7018,7030,7031,7043,7044,7056,7057,7069,7070,7083,7084,7097,7098,7100],{"#text":941},{"name":7019},[7020,7021,7025,7026,7029],{"#text":954},{"surname":7022},[7023],{"#text":7024},"Butz",{"#text":954},{"given-names":7027},[7028],{"#text":5385},{"#text":941},{"#text":941},{"name":7032},[7033,7034,7038,7039,7042],{"#text":954},{"surname":7035},[7036],{"#text":7037},"Nagy",{"#text":954},{"given-names":7040},[7041],{"#text":6022},{"#text":941},{"#text":941},{"name":7045},[7046,7047,7051,7052,7055],{"#text":954},{"surname":7048},[7049],{"#text":7050},"Papp",{"#text":954},{"given-names":7053},[7054],{"#text":5399},{"#text":941},{"#text":941},{"name":7058},[7059,7060,7064,7065,7068],{"#text":954},{"surname":7061},[7062],{"#text":7063},"Bozsik",{"#text":954},{"given-names":7066},[7067],{"#text":5455},{"#text":941},{"#text":941},{"name":7071},[7072,7073,7077,7078,7082],{"#text":954},{"surname":7074},[7075],{"#text":7076},"Grolmusz",{"#text":954},{"given-names":7079},[7080],{"#text":7081},"VK",{"#text":941},{"#text":941},{"name":7085},[7086,7087,7091,7092,7096],{"#text":954},{"surname":7088},[7089],{"#text":7090},"Pcza",{"#text":954},{"given-names":7093},[7094],{"#text":7095},"T",{"#text":941},{"#text":941},{"etal":7099},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7104},[7105],{"#text":7106},"PALB2 variants extend the mutational profile of Hungarian patients with breast and ovarian cancer",{"#text":5316},{"source":7109},[7110],{"#text":7111},"Cancers",{"#text":1349},{"year":7114},[7115],{"#text":5622},{"#text":5332},{"volume":7118},[7119],{"#text":3721},{"#text":5337},{"issue":7122},[7123],{"#text":4693},{"#text":5342},{"fpage":7126},[7127],{"#text":7128},"4350",{"#text":5316},{"pub-id":7131,":@":7134},[7132],{"#text":7133},"10.3390/cancers15174350",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"16.",[7139,7140,7141,7142,7143,7144],{"surname":7024,"givenNames":5385},{"surname":7037,"givenNames":6022},{"surname":7050,"givenNames":5399},{"surname":7063,"givenNames":5455},{"surname":7076,"givenNames":7081},{"surname":7090,"givenNames":7095},{"content":7146,"id":4695,"index":7271,"authors":7272,"title":7244,"source":7249,"volume":799,"year":7254,"fpage":4810,"lpage":26,"doi":7267,"pmid":26},[7147,7148,7270],{"#text":5278},{"citation":7149,":@":7269},[7150,7151,7240,7241,7245,7246,7250,7251,7255,7256,7259,7260,7263,7264],{"#text":677},{"person-group":7152,":@":7239},[7153,7154,7167,7168,7181,7182,7194,7195,7207,7208,7221,7222,7235,7236,7238],{"#text":941},{"name":7155},[7156,7157,7161,7162,7166],{"#text":954},{"surname":7158},[7159],{"#text":7160},"Slavin",{"#text":954},{"given-names":7163},[7164],{"#text":7165},"TP",{"#text":941},{"#text":941},{"name":7169},[7170,7171,7175,7176,7180],{"#text":954},{"surname":7172},[7173],{"#text":7174},"Maxwell",{"#text":954},{"given-names":7177},[7178],{"#text":7179},"KN",{"#text":941},{"#text":941},{"name":7183},[7184,7185,7189,7190,7193],{"#text":954},{"surname":7186},[7187],{"#text":7188},"Lilyquist",{"#text":954},{"given-names":7191},[7192],{"#text":5399},{"#text":941},{"#text":941},{"name":7196},[7197,7198,7202,7203,7206],{"#text":954},{"surname":7199},[7200],{"#text":7201},"Vijai",{"#text":954},{"given-names":7204},[7205],{"#text":5399},{"#text":941},{"#text":941},{"name":7209},[7210,7211,7215,7216,7220],{"#text":954},{"surname":7212},[7213],{"#text":7214},"Neuhausen",{"#text":954},{"given-names":7217},[7218],{"#text":7219},"SL",{"#text":941},{"#text":941},{"name":7223},[7224,7225,7229,7230,7234],{"#text":954},{"surname":7226},[7227],{"#text":7228},"Hart",{"#text":954},{"given-names":7231},[7232],{"#text":7233},"SN",{"#text":941},{"#text":941},{"etal":7237},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7242},[7243],{"#text":7244},"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk",{"#text":5316},{"source":7247},[7248],{"#text":7249},"NPJ breast cancer",{"#text":1349},{"year":7252},[7253],{"#text":7254},"2017",{"#text":5332},{"volume":7257},[7258],{"#text":799},{"#text":5891},{"fpage":7261},[7262],{"#text":4810},{"#text":5316},{"pub-id":7265,":@":7268},[7266],{"#text":7267},"10.1038/s41523-017-0024-8",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"17.",[7273,7274,7275,7276,7277,7278],{"surname":7160,"givenNames":7165},{"surname":7174,"givenNames":7179},{"surname":7188,"givenNames":5399},{"surname":7201,"givenNames":5399},{"surname":7214,"givenNames":7219},{"surname":7228,"givenNames":7233},{"content":7280,"id":4761,"index":7410,"authors":7411,"title":7375,"source":7380,"volume":6470,"year":5476,"fpage":7397,"lpage":6470,"doi":7406,"pmid":26},[7281,7282,7409],{"#text":5278},{"citation":7283,":@":7408},[7284,7285,7371,7372,7376,7377,7381,7382,7385,7386,7389,7390,7393,7394,7398,7399,7402,7403],{"#text":677},{"person-group":7286,":@":7370},[7287,7288,7300,7301,7313,7314,7327,7328,7340,7341,7353,7354,7366,7367,7369],{"#text":941},{"name":7289},[7290,7291,7295,7296,7299],{"#text":954},{"surname":7292},[7293],{"#text":7294},"Tischkowitz",{"#text":954},{"given-names":7297},[7298],{"#text":5427},{"#text":941},{"#text":941},{"name":7302},[7303,7304,7308,7309,7312],{"#text":954},{"surname":7305},[7306],{"#text":7307},"Balmaa",{"#text":954},{"given-names":7310},[7311],{"#text":5399},{"#text":941},{"#text":941},{"name":7315},[7316,7317,7321,7322,7326],{"#text":954},{"surname":7318},[7319],{"#text":7320},"Foulkes",{"#text":954},{"given-names":7323},[7324],{"#text":7325},"WD",{"#text":941},{"#text":941},{"name":7329},[7330,7331,7335,7336,7339],{"#text":954},{"surname":7332},[7333],{"#text":7334},"James",{"#text":954},{"given-names":7337},[7338],{"#text":6022},{"#text":941},{"#text":941},{"name":7342},[7343,7344,7348,7349,7352],{"#text":954},{"surname":7345},[7346],{"#text":7347},"Ngeow",{"#text":954},{"given-names":7350},[7351],{"#text":5399},{"#text":941},{"#text":941},{"name":7355},[7356,7357,7361,7362,7365],{"#text":954},{"surname":7358},[7359],{"#text":7360},"Schmutzler",{"#text":954},{"given-names":7363},[7364],{"#text":6035},{"#text":941},{"#text":941},{"etal":7368},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7373},[7374],{"#text":7375},"Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)",{"#text":5316},{"source":7378},[7379],{"#text":7380},"Genet Med",{"#text":1349},{"year":7383},[7384],{"#text":5476},{"#text":5332},{"volume":7387},[7388],{"#text":6470},{"#text":5337},{"issue":7391},[7392],{"#text":844},{"#text":5342},{"fpage":7395},[7396],{"#text":7397},"1416",{"#text":828},{"lpage":7400},[7401],{"#text":6470},{"#text":5316},{"pub-id":7404,":@":7407},[7405],{"#text":7406},"10.1038/s41436-021-01151-8",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"18.",[7412,7413,7414,7415,7416,7417],{"surname":7294,"givenNames":5427},{"surname":7307,"givenNames":5399},{"surname":7320,"givenNames":7325},{"surname":7334,"givenNames":6022},{"surname":7347,"givenNames":5399},{"surname":7360,"givenNames":6035},{"content":7419,"id":4780,"index":7549,"authors":7550,"title":7516,"source":7521,"volume":7530,"year":5672,"fpage":7535,"lpage":7540,"doi":7545,"pmid":26},[7420,7421,7548],{"#text":5278},{"citation":7422,":@":7547},[7423,7424,7512,7513,7517,7518,7522,7523,7526,7527,7531,7532,7536,7537,7541,7542],{"#text":677},{"person-group":7425,":@":7511},[7426,7427,7439,7440,7453,7454,7466,7467,7480,7481,7494,7495,7507,7508,7510],{"#text":941},{"name":7428},[7429,7430,7434,7435,7438],{"#text":954},{"surname":7431},[7432],{"#text":7433},"Graffeo",{"#text":954},{"given-names":7436},[7437],{"#text":6035},{"#text":941},{"#text":941},{"name":7441},[7442,7443,7447,7448,7452],{"#text":954},{"surname":7444},[7445],{"#text":7446},"Rana",{"#text":954},{"given-names":7449},[7450],{"#text":7451},"HQ",{"#text":941},{"#text":941},{"name":7455},[7456,7457,7461,7462,7465],{"#text":954},{"surname":7458},[7459],{"#text":7460},"Conforti",{"#text":954},{"given-names":7463},[7464],{"#text":6558},{"#text":941},{"#text":941},{"name":7468},[7469,7470,7474,7475,7479],{"#text":954},{"surname":7471},[7472],{"#text":7473},"Bonanni",{"#text":954},{"given-names":7476},[7477],{"#text":7478},"B",{"#text":941},{"#text":941},{"name":7482},[7483,7484,7488,7489,7493],{"#text":954},{"surname":7485},[7486],{"#text":7487},"Cardoso",{"#text":954},{"given-names":7490},[7491],{"#text":7492},"MJ",{"#text":941},{"#text":941},{"name":7496},[7497,7498,7502,7503,7506],{"#text":954},{"surname":7499},[7500],{"#text":7501},"Paluch-Shimon",{"#text":954},{"given-names":7504},[7505],{"#text":6165},{"#text":941},{"#text":941},{"etal":7509},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7514},[7515],{"#text":7516},"Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D",{"#text":5316},{"source":7519},[7520],{"#text":7521},"Breast (Edinburgh, Scotland)",{"#text":1349},{"year":7524},[7525],{"#text":5672},{"#text":5332},{"volume":7528},[7529],{"#text":7530},"65",{"#text":5891},{"fpage":7533},[7534],{"#text":7535},"32",{"#text":828},{"lpage":7538},[7539],{"#text":7540},"40",{"#text":5316},{"pub-id":7543,":@":7546},[7544],{"#text":7545},"10.1016/j.breast.2022.06.003",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"19.",[7551,7552,7553,7554,7555,7556],{"surname":7433,"givenNames":6035},{"surname":7446,"givenNames":7451},{"surname":7460,"givenNames":6558},{"surname":7473,"givenNames":7478},{"surname":7487,"givenNames":7492},{"surname":7501,"givenNames":6165},{"content":7558,"id":4787,"index":7691,"authors":7692,"title":7655,"source":7660,"volume":7669,"year":5672,"fpage":7678,"lpage":4896,"doi":7687,"pmid":26},[7559,7560,7690],{"#text":5278},{"citation":7561,":@":7689},[7562,7563,7651,7652,7656,7657,7661,7662,7665,7666,7670,7671,7674,7675,7679,7680,7683,7684],{"#text":677},{"person-group":7564,":@":7650},[7565,7566,7578,7579,7592,7593,7605,7606,7619,7620,7633,7634,7646,7647,7649],{"#text":941},{"name":7567},[7568,7569,7573,7574,7577],{"#text":954},{"surname":7570},[7571],{"#text":7572},"Grafodatskaya",{"#text":954},{"given-names":7575},[7576],{"#text":6655},{"#text":941},{"#text":941},{"name":7580},[7581,7582,7586,7587,7591],{"#text":954},{"surname":7583},[7584],{"#text":7585},"O'Rielly",{"#text":954},{"given-names":7588},[7589],{"#text":7590},"DD",{"#text":941},{"#text":941},{"name":7594},[7595,7596,7600,7601,7604],{"#text":954},{"surname":7597},[7598],{"#text":7599},"Bedard",{"#text":954},{"given-names":7602},[7603],{"#text":6447},{"#text":941},{"#text":941},{"name":7607},[7608,7609,7613,7614,7618],{"#text":954},{"surname":7610},[7611],{"#text":7612},"Butcher",{"#text":954},{"given-names":7615},[7616],{"#text":7617},"DT",{"#text":941},{"#text":941},{"name":7621},[7622,7623,7627,7628,7632],{"#text":954},{"surname":7624},[7625],{"#text":7626},"Howlett",{"#text":954},{"given-names":7629},[7630],{"#text":7631},"CJ",{"#text":941},{"#text":941},{"name":7635},[7636,7637,7641,7642,7645],{"#text":954},{"surname":7638},[7639],{"#text":7640},"Lytwyn",{"#text":954},{"given-names":7643},[7644],{"#text":5455},{"#text":941},{"#text":941},{"etal":7648},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7653},[7654],{"#text":7655},"Practice guidelines for BRCA1/2 tumour testing in ovarian cancer",{"#text":5316},{"source":7658},[7659],{"#text":7660},"J Med Genet",{"#text":1349},{"year":7663},[7664],{"#text":5672},{"#text":5332},{"volume":7667},[7668],{"#text":7669},"59",{"#text":5337},{"issue":7672},[7673],{"#text":844},{"#text":5342},{"fpage":7676},[7677],{"#text":7678},"727",{"#text":828},{"lpage":7681},[7682],{"#text":4896},{"#text":5316},{"pub-id":7685,":@":7688},[7686],{"#text":7687},"10.1136/jmedgenet-2021-108238",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"20.",[7693,7694,7695,7696,7697,7698],{"surname":7572,"givenNames":6655},{"surname":7585,"givenNames":7590},{"surname":7599,"givenNames":6447},{"surname":7612,"givenNames":7617},{"surname":7626,"givenNames":7631},{"surname":7640,"givenNames":5455},{"content":7700,"id":4804,"index":7832,"authors":7833,"title":7795,"source":7800,"volume":799,"year":7805,"fpage":7818,"lpage":7823,"doi":7828,"pmid":26},[7701,7702,7831],{"#text":5278},{"citation":7703,":@":7830},[7704,7705,7791,7792,7796,7797,7801,7802,7806,7807,7810,7811,7814,7815,7819,7820,7824,7825],{"#text":677},{"person-group":7706,":@":7790},[7707,7708,7720,7721,7733,7734,7746,7747,7759,7760,7773,7774,7786,7787,7789],{"#text":941},{"name":7709},[7710,7711,7715,7716,7719],{"#text":954},{"surname":7712},[7713],{"#text":7714},"Bouwman",{"#text":954},{"given-names":7717},[7718],{"#text":6022},{"#text":941},{"#text":941},{"name":7722},[7723,7724,7728,7729,7732],{"#text":954},{"surname":7725},[7726],{"#text":7727},"van der Gulden",{"#text":954},{"given-names":7730},[7731],{"#text":5385},{"#text":941},{"#text":941},{"name":7735},[7736,7737,7741,7742,7745],{"#text":954},{"surname":7738},[7739],{"#text":7740},"van der Heijden",{"#text":954},{"given-names":7743},[7744],{"#text":5441},{"#text":941},{"#text":941},{"name":7748},[7749,7750,7754,7755,7758],{"#text":954},{"surname":7751},[7752],{"#text":7753},"Drost",{"#text":954},{"given-names":7756},[7757],{"#text":6035},{"#text":941},{"#text":941},{"name":7761},[7762,7763,7767,7768,7772],{"#text":954},{"surname":7764},[7765],{"#text":7766},"Klijn",{"#text":954},{"given-names":7769},[7770],{"#text":7771},"CN",{"#text":941},{"#text":941},{"name":7775},[7776,7777,7781,7782,7785],{"#text":954},{"surname":7778},[7779],{"#text":7780},"Prasetyanti",{"#text":954},{"given-names":7783},[7784],{"#text":6022},{"#text":941},{"#text":941},{"etal":7788},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7793},[7794],{"#text":7795},"A high-throughput functional complementation assay for classification of BRCA1 missense variants",{"#text":5316},{"source":7798},[7799],{"#text":7800},"Cancer Discov",{"#text":1349},{"year":7803},[7804],{"#text":7805},"2013",{"#text":5332},{"volume":7808},[7809],{"#text":799},{"#text":5337},{"issue":7812},[7813],{"#text":859},{"#text":5342},{"fpage":7816},[7817],{"#text":7818},"1142",{"#text":828},{"lpage":7821},[7822],{"#text":7823},"55",{"#text":5316},{"pub-id":7826,":@":7829},[7827],{"#text":7828},"10.1158/2159-8290.CD-13-0094",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"21.",[7834,7835,7836,7837,7838,7839],{"surname":7714,"givenNames":6022},{"surname":7727,"givenNames":5385},{"surname":7740,"givenNames":5441},{"surname":7753,"givenNames":6035},{"surname":7766,"givenNames":7771},{"surname":7780,"givenNames":6022},{"content":7841,"id":4812,"index":7974,"authors":7975,"title":7939,"source":7660,"volume":7952,"year":6465,"fpage":7961,"lpage":799,"doi":7970,"pmid":26},[7842,7843,7973],{"#text":5278},{"citation":7844,":@":7972},[7845,7846,7935,7936,7940,7941,7944,7945,7948,7949,7953,7954,7957,7958,7962,7963,7966,7967],{"#text":677},{"person-group":7847,":@":7934},[7848,7849,7862,7863,7876,7877,7889,7890,7903,7904,7916,7917,7930,7931,7933],{"#text":941},{"name":7850},[7851,7852,7856,7857,7861],{"#text":954},{"surname":7853},[7854],{"#text":7855},"Antoniou",{"#text":954},{"given-names":7858},[7859],{"#text":7860},"AC",{"#text":941},{"#text":941},{"name":7864},[7865,7866,7870,7871,7875],{"#text":954},{"surname":7867},[7868],{"#text":7869},"Pharoah",{"#text":954},{"given-names":7872},[7873],{"#text":7874},"PD",{"#text":941},{"#text":941},{"name":7878},[7879,7880,7884,7885,7888],{"#text":954},{"surname":7881},[7882],{"#text":7883},"Narod",{"#text":954},{"given-names":7886},[7887],{"#text":6165},{"#text":941},{"#text":941},{"name":7891},[7892,7893,7897,7898,7902],{"#text":954},{"surname":7894},[7895],{"#text":7896},"Risch",{"#text":954},{"given-names":7899},[7900],{"#text":7901},"HA",{"#text":941},{"#text":941},{"name":7905},[7906,7907,7911,7912,7915],{"#text":954},{"surname":7908},[7909],{"#text":7910},"Eyfjord",{"#text":954},{"given-names":7913},[7914],{"#text":6433},{"#text":941},{"#text":941},{"name":7918},[7919,7920,7924,7925,7929],{"#text":954},{"surname":7921},[7922],{"#text":7923},"Hopper",{"#text":954},{"given-names":7926},[7927],{"#text":7928},"JL",{"#text":941},{"#text":941},{"etal":7932},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":7937},[7938],{"#text":7939},"Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies",{"#text":5316},{"source":7942},[7943],{"#text":7660},{"#text":1349},{"year":7946},[7947],{"#text":6465},{"#text":5332},{"volume":7950},[7951],{"#text":7952},"42",{"#text":5337},{"issue":7955},[7956],{"#text":832},{"#text":5342},{"fpage":7959},[7960],{"#text":7961},"602",{"#text":828},{"lpage":7964},[7965],{"#text":799},{"#text":5316},{"pub-id":7968,":@":7971},[7969],{"#text":7970},"10.1136/jmg.2004.024133",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"22.",[7976,7977,7978,7979,7980,7981],{"surname":7855,"givenNames":7860},{"surname":7869,"givenNames":7874},{"surname":7883,"givenNames":6165},{"surname":7896,"givenNames":7901},{"surname":7910,"givenNames":6433},{"surname":7923,"givenNames":7928},{"content":7983,"id":8114,"index":8115,"authors":8116,"title":8079,"source":6460,"volume":520,"year":8088,"fpage":8101,"lpage":844,"doi":8110,"pmid":26},[7984,7985,8113],{"#text":5278},{"citation":7986,":@":8112},[7987,7988,8075,8076,8080,8081,8084,8085,8089,8090,8093,8094,8097,8098,8102,8103,8106,8107],{"#text":677},{"person-group":7989,":@":8074},[7990,7991,8004,8005,8018,8019,8031,8032,8043,8044,8056,8057,8070,8071,8073],{"#text":941},{"name":7992},[7993,7994,7998,7999,8003],{"#text":954},{"surname":7995},[7996],{"#text":7997},"Finkelman",{"#text":954},{"given-names":8000},[8001],{"#text":8002},"BS",{"#text":941},{"#text":941},{"name":8006},[8007,8008,8012,8013,8017],{"#text":954},{"surname":8009},[8010],{"#text":8011},"Rubinstein",{"#text":954},{"given-names":8014},[8015],{"#text":8016},"WS",{"#text":941},{"#text":941},{"name":8020},[8021,8022,8026,8027,8030],{"#text":954},{"surname":8023},[8024],{"#text":8025},"Friedman",{"#text":954},{"given-names":8028},[8029],{"#text":6165},{"#text":941},{"#text":941},{"name":8033},[8034,8035,8038,8039,8042],{"#text":954},{"surname":8036},[8037],{"#text":6526},{"#text":954},{"given-names":8040},[8041],{"#text":6531},{"#text":941},{"#text":941},{"name":8045},[8046,8047,8051,8052,8055],{"#text":954},{"surname":8048},[8049],{"#text":8050},"Dubitsky",{"#text":954},{"given-names":8053},[8054],{"#text":6165},{"#text":941},{"#text":941},{"name":8058},[8059,8060,8064,8065,8069],{"#text":954},{"surname":8061},[8062],{"#text":8063},"Schonberger",{"#text":954},{"given-names":8066},[8067],{"#text":8068},"NS",{"#text":941},{"#text":941},{"etal":8072},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8077},[8078],{"#text":8079},"Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers",{"#text":5316},{"source":8082},[8083],{"#text":6460},{"#text":1349},{"year":8086},[8087],{"#text":8088},"2012",{"#text":5332},{"volume":8091},[8092],{"#text":520},{"#text":5337},{"issue":8095},[8096],{"#text":4639},{"#text":5342},{"fpage":8099},[8100],{"#text":8101},"1321",{"#text":828},{"lpage":8104},[8105],{"#text":844},{"#text":5316},{"pub-id":8108,":@":8111},[8109],{"#text":8110},"10.1200/jco.2011.37.8133",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B23","23.",[8117,8118,8119,8120,8121,8122],{"surname":7997,"givenNames":8002},{"surname":8011,"givenNames":8016},{"surname":8025,"givenNames":6165},{"surname":6526,"givenNames":6531},{"surname":8050,"givenNames":6165},{"surname":8063,"givenNames":8068},{"content":8124,"id":8256,"index":8257,"authors":8258,"title":8219,"source":8224,"volume":8234,"year":8229,"fpage":8243,"lpage":3627,"doi":8252,"pmid":26},[8125,8126,8255],{"#text":5278},{"citation":8127,":@":8254},[8128,8129,8215,8216,8220,8221,8225,8226,8230,8231,8235,8236,8239,8240,8244,8245,8248,8249],{"#text":677},{"person-group":8130,":@":8214},[8131,8132,8144,8145,8158,8159,8171,8172,8184,8185,8197,8198,8210,8211,8213],{"#text":941},{"name":8133},[8134,8135,8139,8140,8143],{"#text":954},{"surname":8136},[8137],{"#text":8138},"Fostira",{"#text":954},{"given-names":8141},[8142],{"#text":6558},{"#text":941},{"#text":941},{"name":8146},[8147,8148,8152,8153,8157],{"#text":954},{"surname":8149},[8150],{"#text":8151},"Saloustros",{"#text":954},{"given-names":8154},[8155],{"#text":8156},"E",{"#text":941},{"#text":941},{"name":8160},[8161,8162,8166,8167,8170],{"#text":954},{"surname":8163},[8164],{"#text":8165},"Apostolou",{"#text":954},{"given-names":8168},[8169],{"#text":6022},{"#text":941},{"#text":941},{"name":8173},[8174,8175,8179,8180,8183],{"#text":954},{"surname":8176},[8177],{"#text":8178},"Vagena",{"#text":954},{"given-names":8181},[8182],{"#text":5455},{"#text":941},{"#text":941},{"name":8186},[8187,8188,8192,8193,8196],{"#text":954},{"surname":8189},[8190],{"#text":8191},"Kalfakakou",{"#text":954},{"given-names":8194},[8195],{"#text":6655},{"#text":941},{"#text":941},{"name":8199},[8200,8201,8205,8206,8209],{"#text":954},{"surname":8202},[8203],{"#text":8204},"Mauri",{"#text":954},{"given-names":8207},[8208],{"#text":6655},{"#text":941},{"#text":941},{"etal":8212},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8217},[8218],{"#text":8219},"Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer",{"#text":5316},{"source":8222},[8223],{"#text":8224},"Breast Cancer Res Treat",{"#text":1349},{"year":8227},[8228],{"#text":8229},"2018",{"#text":5332},{"volume":8232},[8233],{"#text":8234},"169",{"#text":5337},{"issue":8237},[8238],{"#text":782},{"#text":5342},{"fpage":8241},[8242],{"#text":8243},"105",{"#text":828},{"lpage":8246},[8247],{"#text":3627},{"#text":5316},{"pub-id":8250,":@":8253},[8251],{"#text":8252},"10.1007/s10549-018-4661-x",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B24","24.",[8259,8260,8261,8262,8263,8264],{"surname":8138,"givenNames":6558},{"surname":8151,"givenNames":8156},{"surname":8165,"givenNames":6022},{"surname":8178,"givenNames":5455},{"surname":8191,"givenNames":6655},{"surname":8204,"givenNames":6655},{"content":8266,"id":8386,"index":8387,"authors":8388,"title":8360,"source":8365,"volume":3657,"year":8229,"fpage":1313,"lpage":26,"doi":8382,"pmid":26},[8267,8268,8385],{"#text":5278},{"citation":8269,":@":8384},[8270,8271,8356,8357,8361,8362,8366,8367,8370,8371,8374,8375,8378,8379],{"#text":677},{"person-group":8272,":@":8355},[8273,8274,8286,8287,8299,8300,8312,8313,8325,8326,8338,8339,8351,8352,8354],{"#text":941},{"name":8275},[8276,8277,8281,8282,8285],{"#text":954},{"surname":8278},[8279],{"#text":8280},"Kluz",{"#text":954},{"given-names":8283},[8284],{"#text":7095},{"#text":941},{"#text":941},{"name":8288},[8289,8290,8294,8295,8298],{"#text":954},{"surname":8291},[8292],{"#text":8293},"Jasiewicz",{"#text":954},{"given-names":8296},[8297],{"#text":5455},{"#text":941},{"#text":941},{"name":8301},[8302,8303,8307,8308,8311],{"#text":954},{"surname":8304},[8305],{"#text":8306},"Marczyk",{"#text":954},{"given-names":8309},[8310],{"#text":8156},{"#text":941},{"#text":941},{"name":8314},[8315,8316,8320,8321,8324],{"#text":954},{"surname":8317},[8318],{"#text":8319},"Jach",{"#text":954},{"given-names":8322},[8323],{"#text":6035},{"#text":941},{"#text":941},{"name":8327},[8328,8329,8333,8334,8337],{"#text":954},{"surname":8330},[8331],{"#text":8332},"Jakubowska",{"#text":954},{"given-names":8335},[8336],{"#text":5455},{"#text":941},{"#text":941},{"name":8340},[8341,8342,8346,8347,8350],{"#text":954},{"surname":8343},[8344],{"#text":8345},"Lubiski",{"#text":954},{"given-names":8348},[8349],{"#text":5399},{"#text":941},{"#text":941},{"etal":8353},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8358},[8359],{"#text":8360},"Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland",{"#text":5316},{"source":8363},[8364],{"#text":8365},"Hereditary Cancer Clin Pract",{"#text":1349},{"year":8368},[8369],{"#text":8229},{"#text":5332},{"volume":8372},[8373],{"#text":3657},{"#text":5891},{"fpage":8376},[8377],{"#text":1313},{"#text":5316},{"pub-id":8380,":@":8383},[8381],{"#text":8382},"10.1186/s13053-018-0089-x",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B25","25.",[8389,8390,8391,8392,8393,8394],{"surname":8280,"givenNames":7095},{"surname":8293,"givenNames":5455},{"surname":8306,"givenNames":8156},{"surname":8319,"givenNames":6035},{"surname":8332,"givenNames":5455},{"surname":8345,"givenNames":5399},{"content":8396,"id":8530,"index":8531,"authors":8532,"title":8493,"source":8498,"volume":8507,"year":6605,"fpage":8516,"lpage":8521,"doi":8526,"pmid":26},[8397,8398,8529],{"#text":5278},{"citation":8399,":@":8528},[8400,8401,8489,8490,8494,8495,8499,8500,8503,8504,8508,8509,8512,8513,8517,8518,8522,8523],{"#text":677},{"person-group":8402,":@":8488},[8403,8404,8417,8418,8430,8431,8444,8445,8457,8458,8471,8472,8484,8485,8487],{"#text":941},{"name":8405},[8406,8407,8411,8412,8416],{"#text":954},{"surname":8408},[8409],{"#text":8410},"Pritchard",{"#text":954},{"given-names":8413},[8414],{"#text":8415},"CC",{"#text":941},{"#text":941},{"name":8419},[8420,8421,8425,8426,8429],{"#text":954},{"surname":8422},[8423],{"#text":8424},"Mateo",{"#text":954},{"given-names":8427},[8428],{"#text":5399},{"#text":941},{"#text":941},{"name":8432},[8433,8434,8438,8439,8443],{"#text":954},{"surname":8435},[8436],{"#text":8437},"Walsh",{"#text":954},{"given-names":8440},[8441],{"#text":8442},"MF",{"#text":941},{"#text":941},{"name":8446},[8447,8448,8452,8453,8456],{"#text":954},{"surname":8449},[8450],{"#text":8451},"De Sarkar",{"#text":954},{"given-names":8454},[8455],{"#text":6220},{"#text":941},{"#text":941},{"name":8459},[8460,8461,8465,8466,8470],{"#text":954},{"surname":8462},[8463],{"#text":8464},"Abida",{"#text":954},{"given-names":8467},[8468],{"#text":8469},"W",{"#text":941},{"#text":941},{"name":8473},[8474,8475,8479,8480,8483],{"#text":954},{"surname":8476},[8477],{"#text":8478},"Beltran",{"#text":954},{"given-names":8481},[8482],{"#text":5385},{"#text":941},{"#text":941},{"etal":8486},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8491},[8492],{"#text":8493},"Inherited DNA-repair gene mutations in men with metastatic prostate cancer",{"#text":5316},{"source":8496},[8497],{"#text":8498},"New Engl J Med",{"#text":1349},{"year":8501},[8502],{"#text":6605},{"#text":5332},{"volume":8505},[8506],{"#text":8507},"375",{"#text":5337},{"issue":8510},[8511],{"#text":824},{"#text":5342},{"fpage":8514},[8515],{"#text":8516},"443",{"#text":828},{"lpage":8519},[8520],{"#text":8521},"53",{"#text":5316},{"pub-id":8524,":@":8527},[8525],{"#text":8526},"10.1056/NEJMoa1603144",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B26","26.",[8533,8534,8535,8536,8537,8538],{"surname":8410,"givenNames":8415},{"surname":8424,"givenNames":5399},{"surname":8437,"givenNames":8442},{"surname":8451,"givenNames":6220},{"surname":8464,"givenNames":8469},{"surname":8478,"givenNames":5385},{"content":8540,"id":4819,"index":8674,"authors":8675,"title":8640,"source":7380,"volume":4802,"year":5330,"fpage":8661,"lpage":6470,"doi":8670,"pmid":26},[8541,8542,8673],{"#text":5278},{"citation":8543,":@":8672},[8544,8545,8636,8637,8641,8642,8645,8646,8649,8650,8653,8654,8657,8658,8662,8663,8666,8667],{"#text":677},{"person-group":8546,":@":8635},[8547,8548,8561,8562,8575,8576,8589,8590,8603,8604,8617,8618,8631,8632,8634],{"#text":941},{"name":8549},[8550,8551,8555,8556,8560],{"#text":954},{"surname":8552},[8553],{"#text":8554},"Yurgelun",{"#text":954},{"given-names":8557},[8558],{"#text":8559},"MB",{"#text":941},{"#text":941},{"name":8563},[8564,8565,8569,8570,8574],{"#text":954},{"surname":8566},[8567],{"#text":8568},"Chittenden",{"#text":954},{"given-names":8571},[8572],{"#text":8573},"AB",{"#text":941},{"#text":941},{"name":8577},[8578,8579,8583,8584,8588],{"#text":954},{"surname":8580},[8581],{"#text":8582},"Morales-Oyarvide",{"#text":954},{"given-names":8585},[8586],{"#text":8587},"V",{"#text":941},{"#text":941},{"name":8591},[8592,8593,8597,8598,8602],{"#text":954},{"surname":8594},[8595],{"#text":8596},"Rubinson",{"#text":954},{"given-names":8599},[8600],{"#text":8601},"DA",{"#text":941},{"#text":941},{"name":8605},[8606,8607,8611,8612,8616],{"#text":954},{"surname":8608},[8609],{"#text":8610},"Dunne",{"#text":954},{"given-names":8613},[8614],{"#text":8615},"RF",{"#text":941},{"#text":941},{"name":8619},[8620,8621,8625,8626,8630],{"#text":954},{"surname":8622},[8623],{"#text":8624},"Kozak",{"#text":954},{"given-names":8627},[8628],{"#text":8629},"MM",{"#text":941},{"#text":941},{"etal":8633},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8638},[8639],{"#text":8640},"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer",{"#text":5316},{"source":8643},[8644],{"#text":7380},{"#text":1349},{"year":8647},[8648],{"#text":5330},{"#text":5332},{"volume":8651},[8652],{"#text":4802},{"#text":5337},{"issue":8655},[8656],{"#text":782},{"#text":5342},{"fpage":8659},[8660],{"#text":8661},"213",{"#text":828},{"lpage":8664},[8665],{"#text":6470},{"#text":5316},{"pub-id":8668,":@":8671},[8669],{"#text":8670},"10.1038/s41436-018-0009-5",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"27.",[8676,8677,8678,8679,8680,8681],{"surname":8554,"givenNames":8559},{"surname":8568,"givenNames":8573},{"surname":8582,"givenNames":8587},{"surname":8596,"givenNames":8601},{"surname":8610,"givenNames":8615},{"surname":8624,"givenNames":8629},{"content":8683,"id":4827,"index":8815,"authors":8816,"title":8778,"source":8783,"volume":8793,"year":8788,"fpage":8802,"lpage":1832,"doi":8811,"pmid":26},[8684,8685,8814],{"#text":5278},{"citation":8686,":@":8813},[8687,8688,8774,8775,8779,8780,8784,8785,8789,8790,8794,8795,8798,8799,8803,8804,8807,8808],{"#text":677},{"person-group":8689,":@":8773},[8690,8691,8703,8704,8716,8717,8729,8730,8743,8744,8756,8757,8769,8770,8772],{"#text":941},{"name":8692},[8693,8694,8698,8699,8702],{"#text":954},{"surname":8695},[8696],{"#text":8697},"Ladopoulou",{"#text":954},{"given-names":8700},[8701],{"#text":5455},{"#text":941},{"#text":941},{"name":8705},[8706,8707,8711,8712,8715],{"#text":954},{"surname":8708},[8709],{"#text":8710},"Kroupis",{"#text":954},{"given-names":8713},[8714],{"#text":5296},{"#text":941},{"#text":941},{"name":8718},[8719,8720,8724,8725,8728],{"#text":954},{"surname":8721},[8722],{"#text":8723},"Konstantopoulou",{"#text":954},{"given-names":8726},[8727],{"#text":5441},{"#text":941},{"#text":941},{"name":8731},[8732,8733,8737,8738,8742],{"#text":954},{"surname":8734},[8735],{"#text":8736},"Ioannidou-Mouzaka",{"#text":954},{"given-names":8739},[8740],{"#text":8741},"L",{"#text":941},{"#text":941},{"name":8745},[8746,8747,8751,8752,8755],{"#text":954},{"surname":8748},[8749],{"#text":8750},"Schofield",{"#text":954},{"given-names":8753},[8754],{"#text":7860},{"#text":941},{"#text":941},{"name":8758},[8759,8760,8764,8765,8768],{"#text":954},{"surname":8761},[8762],{"#text":8763},"Pantazidis",{"#text":954},{"given-names":8766},[8767],{"#text":5455},{"#text":941},{"#text":941},{"etal":8771},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8776},[8777],{"#text":8778},"Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed",{"#text":5316},{"source":8781},[8782],{"#text":8783},"Cancer Lett",{"#text":1349},{"year":8786},[8787],{"#text":8788},"2002",{"#text":5332},{"volume":8791},[8792],{"#text":8793},"185",{"#text":5337},{"issue":8796},[8797],{"#text":782},{"#text":5342},{"fpage":8800},[8801],{"#text":8802},"61",{"#text":828},{"lpage":8805},[8806],{"#text":1832},{"#text":5316},{"pub-id":8809,":@":8812},[8810],{"#text":8811},"10.1016/s0304-3835(01)00845-x",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"28.",[8817,8818,8819,8820,8821,8822],{"surname":8697,"givenNames":5455},{"surname":8710,"givenNames":5296},{"surname":8723,"givenNames":5441},{"surname":8736,"givenNames":8741},{"surname":8750,"givenNames":7860},{"surname":8763,"givenNames":5455},{"content":8824,"id":4840,"index":8957,"authors":8958,"title":8920,"source":6091,"volume":8934,"year":8929,"fpage":6484,"lpage":8948,"doi":8953,"pmid":26},[8825,8826,8956],{"#text":5278},{"citation":8827,":@":8955},[8828,8829,8916,8917,8921,8922,8925,8926,8930,8931,8935,8936,8940,8941,8944,8945,8949,8950],{"#text":677},{"person-group":8830,":@":8915},[8831,8832,8843,8844,8857,8858,8871,8872,8884,8885,8897,8898,8911,8912,8914],{"#text":941},{"name":8833},[8834,8835,8838,8839,8842],{"#text":954},{"surname":8836},[8837],{"#text":6567},{"#text":954},{"given-names":8840},[8841],{"#text":6165},{"#text":941},{"#text":941},{"name":8845},[8846,8847,8851,8852,8856],{"#text":954},{"surname":8848},[8849],{"#text":8850},"Francioli",{"#text":954},{"given-names":8853},[8854],{"#text":8855},"LC",{"#text":941},{"#text":941},{"name":8859},[8860,8861,8865,8866,8870],{"#text":954},{"surname":8862},[8863],{"#text":8864},"Goodrich",{"#text":954},{"given-names":8867},[8868],{"#text":8869},"JK",{"#text":941},{"#text":941},{"name":8873},[8874,8875,8879,8880,8883],{"#text":954},{"surname":8876},[8877],{"#text":8878},"Collins",{"#text":954},{"given-names":8881},[8882],{"#text":5413},{"#text":941},{"#text":941},{"name":8886},[8887,8888,8892,8893,8896],{"#text":954},{"surname":8889},[8890],{"#text":8891},"Kanai",{"#text":954},{"given-names":8894},[8895],{"#text":5427},{"#text":941},{"#text":941},{"name":8899},[8900,8901,8905,8906,8910],{"#text":954},{"surname":8902},[8903],{"#text":8904},"Wang",{"#text":954},{"given-names":8907},[8908],{"#text":8909},"Q",{"#text":941},{"#text":941},{"etal":8913},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":8918},[8919],{"#text":8920},"A genomic mutational constraint map using variation in 76,156 human genomes",{"#text":5316},{"source":8923},[8924],{"#text":6091},{"#text":1349},{"year":8927},[8928],{"#text":8929},"2024",{"#text":5332},{"volume":8932},[8933],{"#text":8934},"625",{"#text":5337},{"issue":8937},[8938],{"#text":8939},"7993",{"#text":5342},{"fpage":8942},[8943],{"#text":6484},{"#text":828},{"lpage":8946},[8947],{"#text":8948},"100",{"#text":5316},{"pub-id":8951,":@":8954},[8952],{"#text":8953},"10.1038/s41586-023-06045-0",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"29.",[8959,8960,8961,8962,8963,8964],{"surname":6567,"givenNames":6165},{"surname":8850,"givenNames":8855},{"surname":8864,"givenNames":8869},{"surname":8878,"givenNames":5413},{"surname":8891,"givenNames":5427},{"surname":8904,"givenNames":8909},{"content":8966,"id":4847,"index":9054,"authors":9055,"title":9018,"source":9023,"volume":9032,"year":6833,"fpage":9041,"lpage":7952,"doi":9050,"pmid":26},[8967,8968,9053],{"#text":5278},{"citation":8969,":@":9052},[8970,8971,9014,9015,9019,9020,9024,9025,9028,9029,9033,9034,9037,9038,9042,9043,9046,9047],{"#text":677},{"person-group":8972,":@":9013},[8973,8974,8987,8988,8999,9000,9012],{"#text":941},{"name":8975},[8976,8977,8981,8982,8986],{"#text":954},{"surname":8978},[8979],{"#text":8980},"Campeau",{"#text":954},{"given-names":8983},[8984],{"#text":8985},"PM",{"#text":941},{"#text":941},{"name":8989},[8990,8991,8994,8995,8998],{"#text":954},{"surname":8992},[8993],{"#text":7320},{"#text":954},{"given-names":8996},[8997],{"#text":7325},{"#text":941},{"#text":941},{"name":9001},[9002,9003,9006,9007,9011],{"#text":954},{"surname":9004},[9005],{"#text":7294},{"#text":954},{"given-names":9008},[9009],{"#text":9010},"MD",{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":9016},[9017],{"#text":9018},"Hereditary breast cancer: new genetic developments, new therapeutic avenues",{"#text":5316},{"source":9021},[9022],{"#text":9023},"Hum Genet",{"#text":1349},{"year":9026},[9027],{"#text":6833},{"#text":5332},{"volume":9030},[9031],{"#text":9032},"124",{"#text":5337},{"issue":9035},[9036],{"#text":782},{"#text":5342},{"fpage":9039},[9040],{"#text":9041},"31",{"#text":828},{"lpage":9044},[9045],{"#text":7952},{"#text":5316},{"pub-id":9048,":@":9051},[9049],{"#text":9050},"10.1007/s00439-008-0529-1",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"30.",[9056,9057,9058],{"surname":8980,"givenNames":8985},{"surname":7320,"givenNames":7325},{"surname":7294,"givenNames":9010},{"content":9060,"id":9174,"index":9175,"authors":9176,"title":9143,"source":9148,"volume":5976,"year":5476,"fpage":9165,"lpage":26,"doi":9170,"pmid":26},[9061,9062,9173],{"#text":5278},{"citation":9063,":@":9172},[9064,9065,9134,9135,9139,9140,9144,9145,9149,9150,9153,9154,9157,9158,9161,9162,9166,9167],{"#text":677},{"person-group":9066,":@":9133},[9067,9068,9081,9082,9095,9096,9108,9109,9120,9121,9132],{"#text":941},{"name":9069},[9070,9071,9075,9076,9080],{"#text":954},{"surname":9072},[9073],{"#text":9074},"Marmolejo",{"#text":954},{"given-names":9077},[9078],{"#text":9079},"DH",{"#text":941},{"#text":941},{"name":9083},[9084,9085,9089,9090,9094],{"#text":954},{"surname":9086},[9087],{"#text":9088},"Wong",{"#text":954},{"given-names":9091},[9092],{"#text":9093},"MYZ",{"#text":941},{"#text":941},{"name":9097},[9098,9099,9103,9104,9107],{"#text":954},{"surname":9100},[9101],{"#text":9102},"Bajalica-Lagercrantz",{"#text":954},{"given-names":9105},[9106],{"#text":6165},{"#text":941},{"#text":941},{"name":9110},[9111,9112,9115,9116,9119],{"#text":954},{"surname":9113},[9114],{"#text":7294},{"#text":954},{"given-names":9117},[9118],{"#text":5427},{"#text":941},{"#text":941},{"name":9122},[9123,9124,9127,9128,9131],{"#text":954},{"surname":9125},[9126],{"#text":7307},{"#text":954},{"given-names":9129},[9130],{"#text":5399},{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":787},{"collab":9136},[9137],{"#text":9138},"extended ERN-GENTURIS Thematic Group 3",{"#text":5316},{"article-title":9141},[9142],{"#text":9143},"Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe",{"#text":5316},{"source":9146},[9147],{"#text":9148},"Eur J Med Genet",{"#text":1349},{"year":9151},[9152],{"#text":5476},{"#text":5332},{"volume":9155},[9156],{"#text":5976},{"#text":5337},{"issue":9159},[9160],{"#text":4639},{"#text":5342},{"fpage":9163},[9164],{"#text":9165},"104350",{"#text":5316},{"pub-id":9168,":@":9171},[9169],{"#text":9170},"10.1016/j.ejmg.2021.104350",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B31","31.",[9177,9178,9179,9180,9181],{"surname":9074,"givenNames":9079},{"surname":9088,"givenNames":9093},{"surname":9102,"givenNames":6165},{"surname":7294,"givenNames":5427},{"surname":7307,"givenNames":5399},{"content":9183,"id":9315,"index":9316,"authors":9317,"title":9279,"source":9284,"volume":9293,"year":5330,"fpage":9302,"lpage":7530,"doi":9311,"pmid":26},[9184,9185,9314],{"#text":5278},{"citation":9186,":@":9313},[9187,9188,9275,9276,9280,9281,9285,9286,9289,9290,9294,9295,9298,9299,9303,9304,9307,9308],{"#text":677},{"person-group":9189,":@":9274},[9190,9191,9204,9205,9218,9219,9231,9232,9244,9245,9257,9258,9270,9271,9273],{"#text":941},{"name":9192},[9193,9194,9198,9199,9203],{"#text":954},{"surname":9195},[9196],{"#text":9197},"Owens",{"#text":954},{"given-names":9200},[9201],{"#text":9202},"DK",{"#text":941},{"#text":941},{"name":9206},[9207,9208,9212,9213,9217],{"#text":954},{"surname":9209},[9210],{"#text":9211},"Davidson",{"#text":954},{"given-names":9214},[9215],{"#text":9216},"KW",{"#text":941},{"#text":941},{"name":9220},[9221,9222,9226,9227,9230],{"#text":954},{"surname":9223},[9224],{"#text":9225},"Krist",{"#text":954},{"given-names":9228},[9229],{"#text":6669},{"#text":941},{"#text":941},{"name":9233},[9234,9235,9239,9240,9243],{"#text":954},{"surname":9236},[9237],{"#text":9238},"Barry",{"#text":954},{"given-names":9241},[9242],{"#text":7492},{"#text":941},{"#text":941},{"name":9246},[9247,9248,9252,9253,9256],{"#text":954},{"surname":9249},[9250],{"#text":9251},"Cabana",{"#text":954},{"given-names":9254},[9255],{"#text":5427},{"#text":941},{"#text":941},{"name":9259},[9260,9261,9265,9266,9269],{"#text":954},{"surname":9262},[9263],{"#text":9264},"Caughey",{"#text":954},{"given-names":9267},[9268],{"#text":8573},{"#text":941},{"#text":941},{"etal":9272},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9277},[9278],{"#text":9279},"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement",{"#text":5316},{"source":9282},[9283],{"#text":9284},"Jama",{"#text":1349},{"year":9287},[9288],{"#text":5330},{"#text":5332},{"volume":9291},[9292],{"#text":9293},"322",{"#text":5337},{"issue":9296},[9297],{"#text":832},{"#text":5342},{"fpage":9300},[9301],{"#text":9302},"652",{"#text":828},{"lpage":9305},[9306],{"#text":7530},{"#text":5316},{"pub-id":9309,":@":9312},[9310],{"#text":9311},"10.1001/jama.2019.10987",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"B32","32.",[9318,9319,9320,9321,9322,9323],{"surname":9197,"givenNames":9202},{"surname":9211,"givenNames":9216},{"surname":9225,"givenNames":6669},{"surname":9238,"givenNames":7492},{"surname":9251,"givenNames":5427},{"surname":9264,"givenNames":8573},{"content":9325,"id":4854,"index":9458,"authors":9459,"title":9421,"source":9426,"volume":4693,"year":9431,"fpage":9444,"lpage":9449,"doi":9454,"pmid":26},[9326,9327,9457],{"#text":5278},{"citation":9328,":@":9456},[9329,9330,9417,9418,9422,9423,9427,9428,9432,9433,9436,9437,9440,9441,9445,9446,9450,9451],{"#text":677},{"person-group":9331,":@":9416},[9332,9333,9345,9346,9357,9358,9371,9372,9385,9386,9399,9400,9412,9413,9415],{"#text":941},{"name":9334},[9335,9336,9340,9341,9344],{"#text":954},{"surname":9337},[9338],{"#text":9339},"Pashayan",{"#text":954},{"given-names":9342},[9343],{"#text":6220},{"#text":941},{"#text":941},{"name":9347},[9348,9349,9352,9353,9356],{"#text":954},{"surname":9350},[9351],{"#text":7855},{"#text":954},{"given-names":9354},[9355],{"#text":7860},{"#text":941},{"#text":941},{"name":9359},[9360,9361,9365,9366,9370],{"#text":954},{"surname":9362},[9363],{"#text":9364},"Ivanus",{"#text":954},{"given-names":9367},[9368],{"#text":9369},"U",{"#text":941},{"#text":941},{"name":9373},[9374,9375,9379,9380,9384],{"#text":954},{"surname":9376},[9377],{"#text":9378},"Esserman",{"#text":954},{"given-names":9381},[9382],{"#text":9383},"LJ",{"#text":941},{"#text":941},{"name":9387},[9388,9389,9393,9394,9398],{"#text":954},{"surname":9390},[9391],{"#text":9392},"Easton",{"#text":954},{"given-names":9395},[9396],{"#text":9397},"DF",{"#text":941},{"#text":941},{"name":9401},[9402,9403,9407,9408,9411],{"#text":954},{"surname":9404},[9405],{"#text":9406},"French",{"#text":954},{"given-names":9409},[9410],{"#text":6655},{"#text":941},{"#text":941},{"etal":9414},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9419},[9420],{"#text":9421},"Personalized early detection and prevention of breast cancer: ENVISION consensus statement",{"#text":5316},{"source":9424},[9425],{"#text":9426},"Nat Rev Clin Oncol",{"#text":1349},{"year":9429},[9430],{"#text":9431},"2020",{"#text":5332},{"volume":9434},[9435],{"#text":4693},{"#text":5337},{"issue":9438},[9439],{"#text":867},{"#text":5342},{"fpage":9442},[9443],{"#text":9444},"687",{"#text":828},{"lpage":9447},[9448],{"#text":9449},"705",{"#text":5316},{"pub-id":9452,":@":9455},[9453],{"#text":9454},"10.1038/s41571-020-0388-9",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"33.",[9460,9461,9462,9463,9464,9465],{"surname":9339,"givenNames":6220},{"surname":7855,"givenNames":7860},{"surname":9364,"givenNames":9369},{"surname":9378,"givenNames":9383},{"surname":9392,"givenNames":9397},{"surname":9406,"givenNames":6655},{"content":9467,"id":4872,"index":9597,"authors":9598,"title":9563,"source":7380,"volume":6704,"year":5672,"fpage":9584,"lpage":5627,"doi":9593,"pmid":26},[9468,9469,9596],{"#text":5278},{"citation":9470,":@":9595},[9471,9472,9559,9560,9564,9565,9568,9569,9572,9573,9576,9577,9580,9581,9585,9586,9589,9590],{"#text":677},{"person-group":9473,":@":9558},[9474,9475,9487,9488,9500,9501,9513,9514,9527,9528,9540,9541,9554,9555,9557],{"#text":941},{"name":9476},[9477,9478,9482,9483,9486],{"#text":954},{"surname":9479},[9480],{"#text":9481},"Miller",{"#text":954},{"given-names":9484},[9485],{"#text":7617},{"#text":941},{"#text":941},{"name":9489},[9490,9491,9495,9496,9499],{"#text":954},{"surname":9492},[9493],{"#text":9494},"Lee",{"#text":954},{"given-names":9497},[9498],{"#text":6447},{"#text":941},{"#text":941},{"name":9502},[9503,9504,9508,9509,9512],{"#text":954},{"surname":9505},[9506],{"#text":9507},"Abul-Husn",{"#text":954},{"given-names":9510},[9511],{"#text":8068},{"#text":941},{"#text":941},{"name":9515},[9516,9517,9521,9522,9526],{"#text":954},{"surname":9518},[9519],{"#text":9520},"Amendola",{"#text":954},{"given-names":9523},[9524],{"#text":9525},"LM",{"#text":941},{"#text":941},{"name":9529},[9530,9531,9535,9536,9539],{"#text":954},{"surname":9532},[9533],{"#text":9534},"Brothers",{"#text":954},{"given-names":9537},[9538],{"#text":6447},{"#text":941},{"#text":941},{"name":9542},[9543,9544,9548,9549,9553],{"#text":954},{"surname":9545},[9546],{"#text":9547},"Chung",{"#text":954},{"given-names":9550},[9551],{"#text":9552},"WK",{"#text":941},{"#text":941},{"etal":9556},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9561},[9562],{"#text":9563},"ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)",{"#text":5316},{"source":9566},[9567],{"#text":7380},{"#text":1349},{"year":9570},[9571],{"#text":5672},{"#text":5332},{"volume":9574},[9575],{"#text":6704},{"#text":5337},{"issue":9578},[9579],{"#text":832},{"#text":5342},{"fpage":9582},[9583],{"#text":9584},"1407",{"#text":828},{"lpage":9587},[9588],{"#text":5627},{"#text":5316},{"pub-id":9591,":@":9594},[9592],{"#text":9593},"10.1016/j.gim.2022.04.006",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"34.",[9599,9600,9601,9602,9603,9604],{"surname":9481,"givenNames":7617},{"surname":9494,"givenNames":6447},{"surname":9507,"givenNames":8068},{"surname":9520,"givenNames":9525},{"surname":9534,"givenNames":6447},{"surname":9547,"givenNames":9552},{"content":9606,"id":4879,"index":9735,"authors":9736,"title":9700,"source":7380,"volume":4693,"year":9709,"fpage":9722,"lpage":6704,"doi":9731,"pmid":26},[9607,9608,9734],{"#text":5278},{"citation":9609,":@":9733},[9610,9611,9696,9697,9701,9702,9705,9706,9710,9711,9714,9715,9718,9719,9723,9724,9727,9728],{"#text":677},{"person-group":9612,":@":9695},[9613,9614,9626,9627,9639,9640,9652,9653,9665,9666,9678,9679,9691,9692,9694],{"#text":941},{"name":9615},[9616,9617,9621,9622,9625],{"#text":954},{"surname":9618},[9619],{"#text":9620},"Richards",{"#text":954},{"given-names":9623},[9624],{"#text":6165},{"#text":941},{"#text":941},{"name":9628},[9629,9630,9634,9635,9638],{"#text":954},{"surname":9631},[9632],{"#text":9633},"Aziz",{"#text":954},{"given-names":9636},[9637],{"#text":6220},{"#text":941},{"#text":941},{"name":9641},[9642,9643,9647,9648,9651],{"#text":954},{"surname":9644},[9645],{"#text":9646},"Bale",{"#text":954},{"given-names":9649},[9650],{"#text":6165},{"#text":941},{"#text":941},{"name":9654},[9655,9656,9660,9661,9664],{"#text":954},{"surname":9657},[9658],{"#text":9659},"Bick",{"#text":954},{"given-names":9662},[9663],{"#text":6655},{"#text":941},{"#text":941},{"name":9667},[9668,9669,9673,9674,9677],{"#text":954},{"surname":9670},[9671],{"#text":9672},"Das",{"#text":954},{"given-names":9675},[9676],{"#text":6165},{"#text":941},{"#text":941},{"name":9680},[9681,9682,9686,9687,9690],{"#text":954},{"surname":9683},[9684],{"#text":9685},"Gastier-Foster",{"#text":954},{"given-names":9688},[9689],{"#text":5399},{"#text":941},{"#text":941},{"etal":9693},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9698},[9699],{"#text":9700},"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular Pathology",{"#text":5316},{"source":9703},[9704],{"#text":7380},{"#text":1349},{"year":9707},[9708],{"#text":9709},"2015",{"#text":5332},{"volume":9712},[9713],{"#text":4693},{"#text":5337},{"issue":9716},[9717],{"#text":824},{"#text":5342},{"fpage":9720},[9721],{"#text":9722},"405",{"#text":828},{"lpage":9725},[9726],{"#text":6704},{"#text":5316},{"pub-id":9729,":@":9732},[9730],{"#text":9731},"10.1038/gim.2015.30",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"35.",[9737,9738,9739,9740,9741,9742],{"surname":9620,"givenNames":6165},{"surname":9633,"givenNames":6220},{"surname":9646,"givenNames":6165},{"surname":9659,"givenNames":6655},{"surname":9672,"givenNames":6165},{"surname":9685,"givenNames":5399},{"content":9744,"id":4898,"index":9876,"authors":9877,"title":9840,"source":9845,"volume":832,"year":9850,"fpage":9863,"lpage":851,"doi":9872,"pmid":26},[9745,9746,9875],{"#text":5278},{"citation":9747,":@":9874},[9748,9749,9836,9837,9841,9842,9846,9847,9851,9852,9855,9856,9859,9860,9864,9865,9868,9869],{"#text":677},{"person-group":9750,":@":9835},[9751,9752,9765,9766,9778,9779,9791,9792,9805,9806,9818,9819,9831,9832,9834],{"#text":941},{"name":9753},[9754,9755,9759,9760,9764],{"#text":954},{"surname":9756},[9757],{"#text":9758},"Adzhubei",{"#text":954},{"given-names":9761},[9762],{"#text":9763},"IA",{"#text":941},{"#text":941},{"name":9767},[9768,9769,9773,9774,9777],{"#text":954},{"surname":9770},[9771],{"#text":9772},"Schmidt",{"#text":954},{"given-names":9775},[9776],{"#text":6165},{"#text":941},{"#text":941},{"name":9780},[9781,9782,9786,9787,9790],{"#text":954},{"surname":9783},[9784],{"#text":9785},"Peshkin",{"#text":954},{"given-names":9788},[9789],{"#text":8741},{"#text":941},{"#text":941},{"name":9793},[9794,9795,9799,9800,9804],{"#text":954},{"surname":9796},[9797],{"#text":9798},"Ramensky",{"#text":954},{"given-names":9801},[9802],{"#text":9803},"VE",{"#text":941},{"#text":941},{"name":9807},[9808,9809,9813,9814,9817],{"#text":954},{"surname":9810},[9811],{"#text":9812},"Gerasimova",{"#text":954},{"given-names":9815},[9816],{"#text":5455},{"#text":941},{"#text":941},{"name":9820},[9821,9822,9826,9827,9830],{"#text":954},{"surname":9823},[9824],{"#text":9825},"Bork",{"#text":954},{"given-names":9828},[9829],{"#text":6022},{"#text":941},{"#text":941},{"etal":9833},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9838},[9839],{"#text":9840},"A method and server for predicting damaging missense mutations",{"#text":5316},{"source":9843},[9844],{"#text":9845},"Nat Methods",{"#text":1349},{"year":9848},[9849],{"#text":9850},"2010",{"#text":5332},{"volume":9853},[9854],{"#text":832},{"#text":5337},{"issue":9857},[9858],{"#text":812},{"#text":5342},{"fpage":9861},[9862],{"#text":9863},"248",{"#text":828},{"lpage":9866},[9867],{"#text":851},{"#text":5316},{"pub-id":9870,":@":9873},[9871],{"#text":9872},"10.1038/nmeth0410-248",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"36.",[9878,9879,9880,9881,9882,9883],{"surname":9758,"givenNames":9763},{"surname":9772,"givenNames":6165},{"surname":9785,"givenNames":8741},{"surname":9798,"givenNames":9803},{"surname":9812,"givenNames":5455},{"surname":9825,"givenNames":6022},{"content":9885,"id":4946,"index":10014,"authors":10015,"title":9978,"source":8224,"volume":9991,"year":5476,"fpage":10000,"lpage":10005,"doi":10010,"pmid":26},[9886,9887,10013],{"#text":5278},{"citation":9888,":@":10012},[9889,9890,9974,9975,9979,9980,9983,9984,9987,9988,9992,9993,9996,9997,10001,10002,10006,10007],{"#text":677},{"person-group":9891,":@":9973},[9892,9893,9905,9906,9917,9918,9930,9931,9943,9944,9956,9957,9969,9970,9972],{"#text":941},{"name":9894},[9895,9896,9900,9901,9904],{"#text":954},{"surname":9897},[9898],{"#text":9899},"Laish",{"#text":954},{"given-names":9902},[9903],{"#text":5441},{"#text":941},{"#text":941},{"name":9907},[9908,9909,9912,9913,9916],{"#text":954},{"surname":9910},[9911],{"#text":8025},{"#text":954},{"given-names":9914},[9915],{"#text":8156},{"#text":941},{"#text":941},{"name":9919},[9920,9921,9925,9926,9929],{"#text":954},{"surname":9922},[9923],{"#text":9924},"Levi-Reznick",{"#text":954},{"given-names":9927},[9928],{"#text":5310},{"#text":941},{"#text":941},{"name":9932},[9933,9934,9938,9939,9942],{"#text":954},{"surname":9935},[9936],{"#text":9937},"Kedar",{"#text":954},{"given-names":9940},[9941],{"#text":5441},{"#text":941},{"#text":941},{"name":9945},[9946,9947,9951,9952,9955],{"#text":954},{"surname":9948},[9949],{"#text":9950},"Katz",{"#text":954},{"given-names":9953},[9954],{"#text":8741},{"#text":941},{"#text":941},{"name":9958},[9959,9960,9964,9965,9968],{"#text":954},{"surname":9961},[9962],{"#text":9963},"Levi",{"#text":954},{"given-names":9966},[9967],{"#text":5932},{"#text":941},{"#text":941},{"etal":9971},[],{"#text":677},{"@_person-group-type":5314},{"#text":677},{"article-title":9976},[9977],{"#text":9978},"Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications",{"#text":5316},{"source":9981},[9982],{"#text":8224},{"#text":1349},{"year":9985},[9986],{"#text":5476},{"#text":5332},{"volume":9989},[9990],{"#text":9991},"188",{"#text":5337},{"issue":9994},[9995],{"#text":799},{"#text":5342},{"fpage":9998},[9999],{"#text":10000},"685",{"#text":828},{"lpage":10003},[10004],{"#text":10005},"94",{"#text":5316},{"pub-id":10008,":@":10011},[10009],{"#text":10010},"10.1007/s10549-021-06258-9",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"37.",[10016,10017,10018,10019,10020,10021],{"surname":9899,"givenNames":5441},{"surname":8025,"givenNames":8156},{"surname":9924,"givenNames":5310},{"surname":9937,"givenNames":5441},{"surname":9950,"givenNames":8741},{"surname":9963,"givenNames":5932},{"content":10023,"id":4953,"index":10119,"authors":10120,"title":10092,"source":10097,"volume":4639,"year":5672,"fpage":10110,"lpage":26,"doi":10115,"pmid":26},[10024,10025,10118],{"#text":5278},{"citation":10026,":@":10117},[10027,10028,10088,10089,10093,10094,10098,10099,10102,10103,10106,10107,10111,10112],{"#text":677},{"person-group":10029,":@":10087},[10030,10031,10044,10045,10058,10059,10072,10073,10086],{"#text":941},{"name":10032},[10033,10034,10038,10039,10043],{"#text":954},{"surname":10035},[10036],{"#text":10037},"Megid",{"#text":954},{"given-names":10040},[10041],{"#text":10042},"TBC",{"#text":941},{"#text":941},{"name":10046},[10047,10048,10052,10053,10057],{"#text":954},{"surname":10049},[10050],{"#text":10051},"Barros-Filho",{"#text":954},{"given-names":10054},[10055],{"#text":10056},"MC",{"#text":941},{"#text":941},{"name":10060},[10061,10062,10066,10067,10071],{"#text":954},{"surname":10063},[10064],{"#text":10065},"Pisani",{"#text":954},{"given-names":10068},[10069],{"#text":10070},"JP",{"#text":941},{"#text":941},{"name":10074},[10075,10076,10080,10081,10085],{"#text":954},{"surname":10077},[10078],{"#text":10079},"Achatz",{"#text":954},{"given-names":10082},[10083],{"#text":10084},"MI",{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":5316},{"article-title":10090},[10091],{"#text":10092},"Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer",{"#text":5316},{"source":10095},[10096],{"#text":10097},"Front Oncol",{"#text":1349},{"year":10100},[10101],{"#text":5672},{"#text":5332},{"volume":10104},[10105],{"#text":4639},{"#text":5891},{"fpage":10108},[10109],{"#text":10110},"873395",{"#text":5316},{"pub-id":10113,":@":10116},[10114],{"#text":10115},"10.3389/fonc.2022.873395",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"38.",[10121,10122,10123,10124],{"surname":10037,"givenNames":10042},{"surname":10051,"givenNames":10056},{"surname":10065,"givenNames":10070},{"surname":10079,"givenNames":10084},{"content":10126,"id":4973,"index":10245,"authors":10246,"title":10210,"source":10215,"volume":4759,"year":5330,"fpage":10232,"lpage":812,"doi":10241,"pmid":26},[10127,10128,10244],{"#text":5278},{"citation":10129,":@":10243},[10130,10131,10201,10202,10206,10207,10211,10212,10216,10217,10220,10221,10224,10225,10228,10229,10233,10234,10237,10238],{"#text":677},{"person-group":10132,":@":10200},[10133,10134,10147,10148,10160,10161,10173,10174,10186,10187,10199],{"#text":941},{"name":10135},[10136,10137,10141,10142,10146],{"#text":954},{"surname":10138},[10139],{"#text":10140},"Vos",{"#text":954},{"given-names":10143},[10144],{"#text":10145},"JR",{"#text":941},{"#text":941},{"name":10149},[10150,10151,10155,10156,10159],{"#text":954},{"surname":10152},[10153],{"#text":10154},"Giepmans",{"#text":954},{"given-names":10157},[10158],{"#text":8741},{"#text":941},{"#text":941},{"name":10162},[10163,10164,10168,10169,10172],{"#text":954},{"surname":10165},[10166],{"#text":10167},"Rhl",{"#text":954},{"given-names":10170},[10171],{"#text":5296},{"#text":941},{"#text":941},{"name":10175},[10176,10177,10181,10182,10185],{"#text":954},{"surname":10178},[10179],{"#text":10180},"Geverink",{"#text":954},{"given-names":10183},[10184],{"#text":6220},{"#text":941},{"#text":941},{"name":10188},[10189,10190,10194,10195,10198],{"#text":954},{"surname":10191},[10192],{"#text":10193},"Hoogerbrugge",{"#text":954},{"given-names":10196},[10197],{"#text":6220},{"#text":941},{"#text":677},{"@_person-group-type":5314},{"#text":787},{"collab":10203},[10204],{"#text":10205},"ERN GENTURIS",{"#text":5316},{"article-title":10208},[10209],{"#text":10210},"Boosting care and knowledge about hereditary cancer: European reference Network on genetic tumour risk syndromes",{"#text":5316},{"source":10213},[10214],{"#text":10215},"Fam Cancer",{"#text":1349},{"year":10218},[10219],{"#text":5330},{"#text":5332},{"volume":10222},[10223],{"#text":4759},{"#text":5337},{"issue":10226},[10227],{"#text":791},{"#text":5342},{"fpage":10230},[10231],{"#text":10232},"281",{"#text":828},{"lpage":10235},[10236],{"#text":812},{"#text":5316},{"pub-id":10239,":@":10242},[10240],{"#text":10241},"10.1007/s10689-018-0110-6",{"@_pub-id-type":5357},{"@_citation-type":5359},{"#text":763},"39.",[10247,10248,10249,10250,10251],{"surname":10140,"givenNames":10145},{"surname":10154,"givenNames":8741},{"surname":10167,"givenNames":5296},{"surname":10180,"givenNames":6220},{"surname":10193,"givenNames":6220},[],[10254,10487,10908,11130,12000],{"id":926,"type":10255,"title":936,"description":945,"descriptionNodes":10256,"tableNodes":10262,"tableFootNodes":10468,"imageUrl":26},"Table",[10257,10258,10261],{"#text":941},{"p":10259},[10260],{"#text":945},{"#text":677},[10263],{"table":10264},[10265,10266,10284,10285,10467],{"#text":941},{"thead":10267,":@":10283},[10268,10269,10282],{"#text":954},{"tr":10270},[10271,10272,10276,10277,10281],{"#text":958},{"th":10273,":@":10275},[10274],{"#text":962},{"@_align":964},{"#text":958},{"th":10278,":@":10280},[10279],{"#text":969},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":10286,":@":10466},[10287,10288,10308,10309,10317,10318,10331,10332,10340,10341,10349,10350,10358,10359,10372,10373,10381,10382,10390,10391,10399,10400,10408,10409,10417,10418,10426,10427,10435,10436,10447,10448,10456,10457,10465],{"#text":954},{"tr":10289},[10290,10291,10295,10296,10307],{"#text":958},{"td":10292,":@":10294},[10293],{"#text":985},{"@_rowspan":446,"@_align":964},{"#text":958},{"td":10297,":@":10306},[10298,10299,10305],{"#text":991},{"xref":10300,":@":10304},[10301],{"sup":10302},[10303],{"#text":997},{"@_ref-type":999,"@_rid":1000},{"#text":1002},{"@_align":964},{"#text":954},{"#text":954},{"tr":10310},[10311,10312,10316],{"#text":958},{"td":10313,":@":10315},[10314],{"#text":1012},{"@_align":964},{"#text":954},{"#text":954},{"tr":10319},[10320,10321,10325,10326,10330],{"#text":958},{"td":10322,":@":10324},[10323],{"#text":1022},{"@_rowspan":320,"@_align":964},{"#text":958},{"td":10327,":@":10329},[10328],{"#text":1028},{"@_align":964},{"#text":954},{"#text":954},{"tr":10333},[10334,10335,10339],{"#text":958},{"td":10336,":@":10338},[10337],{"#text":1038},{"@_align":964},{"#text":954},{"#text":954},{"tr":10342},[10343,10344,10348],{"#text":958},{"td":10345,":@":10347},[10346],{"#text":1048},{"@_align":964},{"#text":954},{"#text":954},{"tr":10351},[10352,10353,10357],{"#text":958},{"td":10354,":@":10356},[10355],{"#text":1058},{"@_align":964},{"#text":954},{"#text":954},{"tr":10360},[10361,10362,10366,10367,10371],{"#text":958},{"td":10363,":@":10365},[10364],{"#text":1068},{"@_rowspan":1070,"@_align":964},{"#text":958},{"td":10368,":@":10370},[10369],{"#text":1075},{"@_align":964},{"#text":954},{"#text":954},{"tr":10374},[10375,10376,10380],{"#text":958},{"td":10377,":@":10379},[10378],{"#text":1085},{"@_align":964},{"#text":954},{"#text":954},{"tr":10383},[10384,10385,10389],{"#text":958},{"td":10386,":@":10388},[10387],{"#text":1095},{"@_align":964},{"#text":954},{"#text":954},{"tr":10392},[10393,10394,10398],{"#text":958},{"td":10395,":@":10397},[10396],{"#text":1105},{"@_align":964},{"#text":954},{"#text":954},{"tr":10401},[10402,10403,10407],{"#text":958},{"td":10404,":@":10406},[10405],{"#text":1115},{"@_align":964},{"#text":954},{"#text":954},{"tr":10410},[10411,10412,10416],{"#text":958},{"td":10413,":@":10415},[10414],{"#text":1125},{"@_align":964},{"#text":954},{"#text":954},{"tr":10419},[10420,10421,10425],{"#text":958},{"td":10422,":@":10424},[10423],{"#text":1135},{"@_align":964},{"#text":954},{"#text":954},{"tr":10428},[10429,10430,10434],{"#text":958},{"td":10431,":@":10433},[10432],{"#text":1145},{"@_align":964},{"#text":954},{"#text":954},{"tr":10437},[10438,10439,10446],{"#text":958},{"td":10440,":@":10445},[10441,10442,10444],{"#text":1155},{"break":10443},[],{"#text":1159},{"@_align":964},{"#text":954},{"#text":954},{"tr":10449},[10450,10451,10455],{"#text":958},{"td":10452,":@":10454},[10453],{"#text":1169},{"@_align":964},{"#text":954},{"#text":954},{"tr":10458},[10459,10460,10464],{"#text":958},{"td":10461,":@":10463},[10462],{"#text":1179},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},[10469,10470,10486],{"#text":941},{"fn":10471,":@":10485},[10472,10473,10480,10481,10484],{"#text":954},{"label":10474},[10475,10476,10479],{"#text":958},{"sup":10477},[10478],{"#text":997},{"#text":954},{"#text":954},{"p":10482},[10483],{"#text":1203},{"#text":941},{"@_id":1000},{"#text":677},{"id":1431,"type":10255,"title":1447,"description":1455,"descriptionNodes":10488,"tableNodes":10494,"tableFootNodes":10872,"imageUrl":26},[10489,10490,10493],{"#text":941},{"p":10491},[10492],{"#text":1455},{"#text":677},[10495],{"table":10496},[10497,10498,10517,10518,10871],{"#text":941},{"thead":10499,":@":10516},[10500,10501,10515],{"#text":954},{"tr":10502},[10503,10504,10514],{"#text":958},{"th":10505,":@":10513},[10506,10507],{"#text":1470},{"xref":10508,":@":10512},[10509],{"sup":10510},[10511],{"#text":997},{"@_ref-type":999,"@_rid":1477},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":10519,":@":10870},[10520,10521,10529,10530,10543,10544,10557,10558,10571,10572,10580,10581,10594,10595,10608,10609,10617,10618,10631,10632,10645,10646,10659,10660,10673,10674,10687,10688,10696,10697,10710,10711,10724,10725,10738,10739,10752,10753,10766,10767,10781,10782,10790,10791,10804,10805,10818,10819,10832,10833,10841,10842,10855,10856,10869],{"#text":954},{"tr":10522},[10523,10524,10528],{"#text":958},{"td":10525,":@":10527},[10526],{"#text":1492},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10531},[10532,10533,10537,10538,10542],{"#text":958},{"td":10534,":@":10536},[10535],{"#text":1502},{"@_align":964},{"#text":958},{"td":10539,":@":10541},[10540],{"#text":1508},{"@_align":964},{"#text":954},{"#text":954},{"tr":10545},[10546,10547,10551,10552,10556],{"#text":958},{"td":10548,":@":10550},[10549],{"#text":1518},{"@_align":964},{"#text":958},{"td":10553,":@":10555},[10554],{"#text":1524},{"@_align":964},{"#text":954},{"#text":954},{"tr":10559},[10560,10561,10565,10566,10570],{"#text":958},{"td":10562,":@":10564},[10563],{"#text":1534},{"@_align":964},{"#text":958},{"td":10567,":@":10569},[10568],{"#text":1540},{"@_align":964},{"#text":954},{"#text":954},{"tr":10573},[10574,10575,10579],{"#text":958},{"td":10576,":@":10578},[10577],{"#text":1550},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10582},[10583,10584,10588,10589,10593],{"#text":958},{"td":10585,":@":10587},[10586],{"#text":1560},{"@_align":964},{"#text":958},{"td":10590,":@":10592},[10591],{"#text":1566},{"@_align":964},{"#text":954},{"#text":954},{"tr":10596},[10597,10598,10602,10603,10607],{"#text":958},{"td":10599,":@":10601},[10600],{"#text":1576},{"@_align":964},{"#text":958},{"td":10604,":@":10606},[10605],{"#text":1582},{"@_align":964},{"#text":954},{"#text":954},{"tr":10610},[10611,10612,10616],{"#text":958},{"td":10613,":@":10615},[10614],{"#text":1592},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10619},[10620,10621,10625,10626,10630],{"#text":958},{"td":10622,":@":10624},[10623],{"#text":1560},{"@_align":964},{"#text":958},{"td":10627,":@":10629},[10628],{"#text":1607},{"@_align":964},{"#text":954},{"#text":954},{"tr":10633},[10634,10635,10639,10640,10644],{"#text":958},{"td":10636,":@":10638},[10637],{"#text":1576},{"@_align":964},{"#text":958},{"td":10641,":@":10643},[10642],{"#text":1622},{"@_align":964},{"#text":954},{"#text":954},{"tr":10647},[10648,10649,10653,10654,10658],{"#text":958},{"td":10650,":@":10652},[10651],{"#text":1632},{"@_align":964},{"#text":958},{"td":10655,":@":10657},[10656],{"#text":1638},{"@_align":964},{"#text":954},{"#text":954},{"tr":10661},[10662,10663,10667,10668,10672],{"#text":958},{"td":10664,":@":10666},[10665],{"#text":1648},{"@_align":964},{"#text":958},{"td":10669,":@":10671},[10670],{"#text":1654},{"@_align":964},{"#text":954},{"#text":954},{"tr":10675},[10676,10677,10681,10682,10686],{"#text":958},{"td":10678,":@":10680},[10679],{"#text":1664},{"@_align":964},{"#text":958},{"td":10683,":@":10685},[10684],{"#text":1670},{"@_align":964},{"#text":954},{"#text":954},{"tr":10689},[10690,10691,10695],{"#text":958},{"td":10692,":@":10694},[10693],{"#text":1680},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10698},[10699,10700,10704,10705,10709],{"#text":958},{"td":10701,":@":10703},[10702],{"#text":1690},{"@_align":964},{"#text":958},{"td":10706,":@":10708},[10707],{"#text":1696},{"@_align":964},{"#text":954},{"#text":954},{"tr":10712},[10713,10714,10718,10719,10723],{"#text":958},{"td":10715,":@":10717},[10716],{"#text":1706},{"@_align":964},{"#text":958},{"td":10720,":@":10722},[10721],{"#text":1712},{"@_align":964},{"#text":954},{"#text":954},{"tr":10726},[10727,10728,10732,10733,10737],{"#text":958},{"td":10729,":@":10731},[10730],{"#text":1722},{"@_align":964},{"#text":958},{"td":10734,":@":10736},[10735],{"#text":1728},{"@_align":964},{"#text":954},{"#text":954},{"tr":10740},[10741,10742,10746,10747,10751],{"#text":958},{"td":10743,":@":10745},[10744],{"#text":1738},{"@_align":964},{"#text":958},{"td":10748,":@":10750},[10749],{"#text":1744},{"@_align":964},{"#text":954},{"#text":954},{"tr":10754},[10755,10756,10760,10761,10765],{"#text":958},{"td":10757,":@":10759},[10758],{"#text":1754},{"@_align":964},{"#text":958},{"td":10762,":@":10764},[10763],{"#text":1760},{"@_align":964},{"#text":954},{"#text":954},{"tr":10768},[10769,10770,10780],{"#text":958},{"td":10771,":@":10779},[10772,10773],{"#text":1770},{"xref":10774,":@":10778},[10775],{"sup":10776},[10777],{"#text":1776},{"@_ref-type":999,"@_rid":1778},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10783},[10784,10785,10789],{"#text":958},{"td":10786,":@":10788},[10787],{"#text":1492},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10792},[10793,10794,10798,10799,10803],{"#text":958},{"td":10795,":@":10797},[10796],{"#text":1502},{"@_align":964},{"#text":958},{"td":10800,":@":10802},[10801],{"#text":1802},{"@_align":964},{"#text":954},{"#text":954},{"tr":10806},[10807,10808,10812,10813,10817],{"#text":958},{"td":10809,":@":10811},[10810],{"#text":1518},{"@_align":964},{"#text":958},{"td":10814,":@":10816},[10815],{"#text":1817},{"@_align":964},{"#text":954},{"#text":954},{"tr":10820},[10821,10822,10826,10827,10831],{"#text":958},{"td":10823,":@":10825},[10824],{"#text":1534},{"@_align":964},{"#text":958},{"td":10828,":@":10830},[10829],{"#text":1832},{"@_align":964},{"#text":954},{"#text":954},{"tr":10834},[10835,10836,10840],{"#text":958},{"td":10837,":@":10839},[10838],{"#text":1550},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10843},[10844,10845,10849,10850,10854],{"#text":958},{"td":10846,":@":10848},[10847],{"#text":1560},{"@_align":964},{"#text":958},{"td":10851,":@":10853},[10852],{"#text":1856},{"@_align":964},{"#text":954},{"#text":954},{"tr":10857},[10858,10859,10863,10864,10868],{"#text":958},{"td":10860,":@":10862},[10861],{"#text":1576},{"@_align":964},{"#text":958},{"td":10865,":@":10867},[10866],{"#text":1871},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},[10873,10874,10890,10891,10907],{"#text":941},{"fn":10875,":@":10889},[10876,10877,10884,10885,10888],{"#text":954},{"label":10878},[10879,10880,10883],{"#text":958},{"sup":10881},[10882],{"#text":997},{"#text":954},{"#text":954},{"p":10886},[10887],{"#text":1895},{"#text":941},{"@_id":1477},{"#text":941},{"fn":10892,":@":10906},[10893,10894,10901,10902,10905],{"#text":954},{"label":10895},[10896,10897,10900],{"#text":958},{"sup":10898},[10899],{"#text":1776},{"#text":954},{"#text":954},{"p":10903},[10904],{"#text":1913},{"#text":941},{"@_id":1778},{"#text":677},{"id":1934,"type":10255,"title":1944,"description":1952,"descriptionNodes":10909,"tableNodes":10915,"tableFootNodes":11129,"imageUrl":26},[10910,10911,10914],{"#text":941},{"p":10912},[10913],{"#text":1952},{"#text":677},[10916],{"table":10917},[10918,10919,10964,10965,11128],{"#text":941},{"thead":10920,":@":10963},[10921,10922,10935,10936,10962],{"#text":954},{"tr":10923},[10924,10925,10929,10930,10934],{"#text":958},{"th":10926,":@":10928},[10927],{"#text":1967},{"@_colspan":337,"@_align":964},{"#text":958},{"th":10931,":@":10933},[10932],{"#text":1973},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":10937},[10938,10939,10942,10943,10946,10947,10951,10952,10956,10957,10961],{"#text":958},{"th":10940,":@":10941},[],{"@_align":964},{"#text":958},{"th":10944,":@":10945},[],{"@_align":1987},{"#text":958},{"th":10948,":@":10950},[10949],{"#text":1992},{"@_align":964},{"#text":958},{"th":10953,":@":10955},[10954],{"#text":1998},{"@_align":964},{"#text":958},{"th":10958,":@":10960},[10959],{"#text":2004},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":10966,":@":11127},[10967,10968,10996,10997,11020,11021,11049,11050,11073,11074,11102,11103,11126],{"#text":954},{"tr":10969},[10970,10971,10975,10976,10980,10981,10985,10986,10990,10991,10995],{"#text":958},{"td":10972,":@":10974},[10973],{"#text":2019},{"@_rowspan":446,"@_align":964},{"#text":958},{"td":10977,":@":10979},[10978],{"#text":2025},{"@_align":964},{"#text":958},{"td":10982,":@":10984},[10983],{"#text":2031},{"@_align":964},{"#text":958},{"td":10987,":@":10989},[10988],{"#text":2037},{"@_align":964},{"#text":958},{"td":10992,":@":10994},[10993],{"#text":2043},{"@_align":964},{"#text":954},{"#text":954},{"tr":10998},[10999,11000,11004,11005,11009,11010,11014,11015,11019],{"#text":958},{"td":11001,":@":11003},[11002],{"#text":2053},{"@_align":964},{"#text":958},{"td":11006,":@":11008},[11007],{"#text":2059},{"@_align":964},{"#text":958},{"td":11011,":@":11013},[11012],{"#text":2065},{"@_align":964},{"#text":958},{"td":11016,":@":11018},[11017],{"#text":1622},{"@_align":964},{"#text":954},{"#text":954},{"tr":11022},[11023,11024,11028,11029,11033,11034,11038,11039,11043,11044,11048],{"#text":958},{"td":11025,":@":11027},[11026],{"#text":2080},{"@_rowspan":446,"@_align":964},{"#text":958},{"td":11030,":@":11032},[11031],{"#text":2025},{"@_align":964},{"#text":958},{"td":11035,":@":11037},[11036],{"#text":2091},{"@_align":964},{"#text":958},{"td":11040,":@":11042},[11041],{"#text":2097},{"@_align":964},{"#text":958},{"td":11045,":@":11047},[11046],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":11051},[11052,11053,11057,11058,11062,11063,11067,11068,11072],{"#text":958},{"td":11054,":@":11056},[11055],{"#text":2053},{"@_align":964},{"#text":958},{"td":11059,":@":11061},[11060],{"#text":2117},{"@_align":964},{"#text":958},{"td":11064,":@":11066},[11065],{"#text":2097},{"@_align":964},{"#text":958},{"td":11069,":@":11071},[11070],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":11075},[11076,11077,11081,11082,11086,11087,11091,11092,11096,11097,11101],{"#text":958},{"td":11078,":@":11080},[11079],{"#text":2137},{"@_rowspan":446,"@_align":964},{"#text":958},{"td":11083,":@":11085},[11084],{"#text":2025},{"@_align":964},{"#text":958},{"td":11088,":@":11090},[11089],{"#text":2148},{"@_align":964},{"#text":958},{"td":11093,":@":11095},[11094],{"#text":2097},{"@_align":964},{"#text":958},{"td":11098,":@":11100},[11099],{"#text":2097},{"@_align":964},{"#text":954},{"#text":954},{"tr":11104},[11105,11106,11110,11111,11115,11116,11120,11121,11125],{"#text":958},{"td":11107,":@":11109},[11108],{"#text":2053},{"@_align":964},{"#text":958},{"td":11112,":@":11114},[11113],{"#text":2173},{"@_align":964},{"#text":958},{"td":11117,":@":11119},[11118],{"#text":2097},{"@_align":964},{"#text":958},{"td":11122,":@":11124},[11123],{"#text":2097},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},[],{"id":2217,"type":10255,"title":2301,"description":2309,"descriptionNodes":11131,"tableNodes":11137,"tableFootNodes":11999,"imageUrl":26},[11132,11133,11136],{"#text":941},{"p":11134},[11135],{"#text":2309},{"#text":677},[11138],{"table":11139},[11140,11141,11177,11178,11998],{"#text":941},{"thead":11142,":@":11176},[11143,11144,11175],{"#text":954},{"tr":11145},[11146,11147,11151,11152,11159,11160,11164,11165,11169,11170,11174],{"#text":958},{"th":11148,":@":11150},[11149],{"#text":2324},{"@_align":964},{"#text":958},{"th":11153,":@":11158},[11154,11155,11157],{"#text":2330},{"break":11156},[],{"#text":2334},{"@_align":964},{"#text":958},{"th":11161,":@":11163},[11162],{"#text":2340},{"@_align":964},{"#text":958},{"th":11166,":@":11168},[11167],{"#text":2346},{"@_align":964},{"#text":958},{"th":11171,":@":11173},[11172],{"#text":2352},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":11179,":@":11997},[11180,11181,11208,11209,11236,11237,11264,11265,11290,11291,11318,11319,11344,11345,11372,11373,11400,11401,11428,11429,11456,11457,11484,11485,11512,11513,11540,11541,11568,11569,11596,11597,11624,11625,11652,11653,11680,11681,11708,11709,11736,11737,11764,11765,11792,11793,11820,11821,11846,11847,11874,11875,11902,11903,11935,11936,11968,11969,11996],{"#text":954},{"tr":11182},[11183,11184,11188,11189,11192,11193,11197,11198,11202,11203,11207],{"#text":958},{"td":11185,":@":11187},[11186],{"#text":2367},{"@_rowspan":2369,"@_align":964},{"#text":958},{"td":11190,":@":11191},[],{"@_align":964},{"#text":958},{"td":11194,":@":11196},[11195],{"#text":2378},{"@_align":964},{"#text":958},{"td":11199,":@":11201},[11200],{"#text":2384},{"@_align":964},{"#text":958},{"td":11204,":@":11206},[11205],{"#text":2390},{"@_align":964},{"#text":954},{"#text":954},{"tr":11210},[11211,11212,11220,11221,11225,11226,11230,11231,11235],{"#text":958},{"td":11213,":@":11219},[11214,11215,11218],{"#text":2400},{"italic":11216},[11217],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":11222,":@":11224},[11223],{"#text":2410},{"@_align":964},{"#text":958},{"td":11227,":@":11229},[11228],{"#text":2416},{"@_align":964},{"#text":958},{"td":11232,":@":11234},[11233],{"#text":2422},{"@_align":964},{"#text":954},{"#text":954},{"tr":11238},[11239,11240,11248,11249,11253,11254,11258,11259,11263],{"#text":958},{"td":11241,":@":11247},[11242,11243,11246],{"#text":2400},{"italic":11244},[11245],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":11250,":@":11252},[11251],{"#text":2441},{"@_align":964},{"#text":958},{"td":11255,":@":11257},[11256],{"#text":2441},{"@_align":964},{"#text":958},{"td":11260,":@":11262},[11261],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11266},[11267,11268,11276,11277,11281,11282,11285,11286,11289],{"#text":958},{"td":11269,":@":11275},[11270,11271,11274],{"#text":2400},{"italic":11272},[11273],{"#text":2465},{"#text":958},{"@_align":964},{"#text":958},{"td":11278,":@":11280},[11279],{"#text":2422},{"@_align":964},{"#text":958},{"td":11283,":@":11284},[],{"@_align":1987},{"#text":958},{"td":11287,":@":11288},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":11292},[11293,11294,11302,11303,11307,11308,11312,11313,11317],{"#text":958},{"td":11295,":@":11301},[11296,11297,11300],{"#text":2400},{"italic":11298},[11299],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":11304,":@":11306},[11305],{"#text":2441},{"@_align":964},{"#text":958},{"td":11309,":@":11311},[11310],{"#text":2503},{"@_align":964},{"#text":958},{"td":11314,":@":11316},[11315],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11320},[11321,11322,11330,11331,11335,11336,11339,11340,11343],{"#text":958},{"td":11323,":@":11329},[11324,11325,11328],{"#text":2400},{"italic":11326},[11327],{"#text":2522},{"#text":958},{"@_align":964},{"#text":958},{"td":11332,":@":11334},[11333],{"#text":2422},{"@_align":964},{"#text":958},{"td":11337,":@":11338},[],{"@_align":1987},{"#text":958},{"td":11341,":@":11342},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":11346},[11347,11348,11356,11357,11361,11362,11366,11367,11371],{"#text":958},{"td":11349,":@":11355},[11350,11351,11354],{"#text":2400},{"italic":11352},[11353],{"#text":1244},{"#text":958},{"@_align":964},{"#text":958},{"td":11358,":@":11360},[11359],{"#text":2503},{"@_align":964},{"#text":958},{"td":11363,":@":11365},[11364],{"#text":2560},{"@_align":964},{"#text":958},{"td":11368,":@":11370},[11369],{"#text":2422},{"@_align":964},{"#text":954},{"#text":954},{"tr":11374},[11375,11376,11384,11385,11389,11390,11394,11395,11399],{"#text":958},{"td":11377,":@":11383},[11378,11379,11382],{"#text":2400},{"italic":11380},[11381],{"#text":2244},{"#text":958},{"@_align":964},{"#text":958},{"td":11386,":@":11388},[11387],{"#text":2422},{"@_align":964},{"#text":958},{"td":11391,":@":11393},[11392],{"#text":2509},{"@_align":964},{"#text":958},{"td":11396,":@":11398},[11397],{"#text":2594},{"@_align":964},{"#text":954},{"#text":954},{"tr":11402},[11403,11404,11412,11413,11417,11418,11422,11423,11427],{"#text":958},{"td":11405,":@":11411},[11406,11407,11410],{"#text":2400},{"italic":11408},[11409],{"#text":2607},{"#text":958},{"@_align":964},{"#text":958},{"td":11414,":@":11416},[11415],{"#text":2594},{"@_align":964},{"#text":958},{"td":11419,":@":11421},[11420],{"#text":2509},{"@_align":964},{"#text":958},{"td":11424,":@":11426},[11425],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11430},[11431,11432,11440,11441,11445,11446,11450,11451,11455],{"#text":958},{"td":11433,":@":11439},[11434,11435,11438],{"#text":2400},{"italic":11436},[11437],{"#text":2636},{"#text":958},{"@_align":964},{"#text":958},{"td":11442,":@":11444},[11443],{"#text":2594},{"@_align":964},{"#text":958},{"td":11447,":@":11449},[11448],{"#text":2509},{"@_align":964},{"#text":958},{"td":11452,":@":11454},[11453],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11458},[11459,11460,11468,11469,11473,11474,11478,11479,11483],{"#text":958},{"td":11461,":@":11467},[11462,11463,11466],{"#text":2400},{"italic":11464},[11465],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":11470,":@":11472},[11471],{"#text":2594},{"@_align":964},{"#text":958},{"td":11475,":@":11477},[11476],{"#text":2509},{"@_align":964},{"#text":958},{"td":11480,":@":11482},[11481],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11486},[11487,11488,11496,11497,11501,11502,11506,11507,11511],{"#text":958},{"td":11489,":@":11495},[11490,11491,11494],{"#text":2400},{"italic":11492},[11493],{"#text":2693},{"#text":958},{"@_align":964},{"#text":958},{"td":11498,":@":11500},[11499],{"#text":2509},{"@_align":964},{"#text":958},{"td":11503,":@":11505},[11504],{"#text":2452},{"@_align":964},{"#text":958},{"td":11508,":@":11510},[11509],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11514},[11515,11516,11524,11525,11529,11530,11534,11535,11539],{"#text":958},{"td":11517,":@":11523},[11518,11519,11522],{"#text":2400},{"italic":11520},[11521],{"#text":2722},{"#text":958},{"@_align":964},{"#text":958},{"td":11526,":@":11528},[11527],{"#text":2509},{"@_align":964},{"#text":958},{"td":11531,":@":11533},[11532],{"#text":2509},{"@_align":964},{"#text":958},{"td":11536,":@":11538},[11537],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11542},[11543,11544,11552,11553,11557,11558,11562,11563,11567],{"#text":958},{"td":11545,":@":11551},[11546,11547,11550],{"#text":2400},{"italic":11548},[11549],{"#text":753},{"#text":958},{"@_align":964},{"#text":958},{"td":11554,":@":11556},[11555],{"#text":2509},{"@_align":964},{"#text":958},{"td":11559,":@":11561},[11560],{"#text":2509},{"@_align":964},{"#text":958},{"td":11564,":@":11566},[11565],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11570},[11571,11572,11580,11581,11585,11586,11590,11591,11595],{"#text":958},{"td":11573,":@":11579},[11574,11575,11578],{"#text":2400},{"italic":11576},[11577],{"#text":2779},{"#text":958},{"@_align":964},{"#text":958},{"td":11582,":@":11584},[11583],{"#text":2509},{"@_align":964},{"#text":958},{"td":11587,":@":11589},[11588],{"#text":2509},{"@_align":964},{"#text":958},{"td":11592,":@":11594},[11593],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11598},[11599,11600,11608,11609,11613,11614,11618,11619,11623],{"#text":958},{"td":11601,":@":11607},[11602,11603,11606],{"#text":2400},{"italic":11604},[11605],{"#text":2808},{"#text":958},{"@_align":964},{"#text":958},{"td":11610,":@":11612},[11611],{"#text":2509},{"@_align":964},{"#text":958},{"td":11615,":@":11617},[11616],{"#text":2452},{"@_align":964},{"#text":958},{"td":11620,":@":11622},[11621],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11626},[11627,11628,11636,11637,11641,11642,11646,11647,11651],{"#text":958},{"td":11629,":@":11635},[11630,11631,11634],{"#text":2400},{"italic":11632},[11633],{"#text":2837},{"#text":958},{"@_align":964},{"#text":958},{"td":11638,":@":11640},[11639],{"#text":2509},{"@_align":964},{"#text":958},{"td":11643,":@":11645},[11644],{"#text":2452},{"@_align":964},{"#text":958},{"td":11648,":@":11650},[11649],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11654},[11655,11656,11664,11665,11669,11670,11674,11675,11679],{"#text":958},{"td":11657,":@":11663},[11658,11659,11662],{"#text":2400},{"italic":11660},[11661],{"#text":2866},{"#text":958},{"@_align":964},{"#text":958},{"td":11666,":@":11668},[11667],{"#text":2509},{"@_align":964},{"#text":958},{"td":11671,":@":11673},[11672],{"#text":2452},{"@_align":964},{"#text":958},{"td":11676,":@":11678},[11677],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11682},[11683,11684,11692,11693,11697,11698,11702,11703,11707],{"#text":958},{"td":11685,":@":11691},[11686,11687,11690],{"#text":2400},{"italic":11688},[11689],{"#text":2895},{"#text":958},{"@_align":964},{"#text":958},{"td":11694,":@":11696},[11695],{"#text":2509},{"@_align":964},{"#text":958},{"td":11699,":@":11701},[11700],{"#text":2452},{"@_align":964},{"#text":958},{"td":11704,":@":11706},[11705],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11710},[11711,11712,11720,11721,11725,11726,11730,11731,11735],{"#text":958},{"td":11713,":@":11719},[11714,11715,11718],{"#text":2400},{"italic":11716},[11717],{"#text":2924},{"#text":958},{"@_align":964},{"#text":958},{"td":11722,":@":11724},[11723],{"#text":2509},{"@_align":964},{"#text":958},{"td":11727,":@":11729},[11728],{"#text":2452},{"@_align":964},{"#text":958},{"td":11732,":@":11734},[11733],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11738},[11739,11740,11748,11749,11753,11754,11758,11759,11763],{"#text":958},{"td":11741,":@":11747},[11742,11743,11746],{"#text":2400},{"italic":11744},[11745],{"#text":2266},{"#text":958},{"@_align":964},{"#text":958},{"td":11750,":@":11752},[11751],{"#text":2509},{"@_align":964},{"#text":958},{"td":11755,":@":11757},[11756],{"#text":2452},{"@_align":964},{"#text":958},{"td":11760,":@":11762},[11761],{"#text":2509},{"@_align":964},{"#text":954},{"#text":954},{"tr":11766},[11767,11768,11772,11773,11776,11777,11781,11782,11786,11787,11791],{"#text":958},{"td":11769,":@":11771},[11770],{"#text":2978},{"@_rowspan":2980,"@_align":964},{"#text":958},{"td":11774,":@":11775},[],{"@_align":964},{"#text":958},{"td":11778,":@":11780},[11779],{"#text":2989},{"@_align":964},{"#text":958},{"td":11783,":@":11785},[11784],{"#text":2995},{"@_align":964},{"#text":958},{"td":11788,":@":11790},[11789],{"#text":3001},{"@_align":964},{"#text":954},{"#text":954},{"tr":11794},[11795,11796,11804,11805,11809,11810,11814,11815,11819],{"#text":958},{"td":11797,":@":11803},[11798,11799,11802],{"#text":2400},{"italic":11800},[11801],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":11806,":@":11808},[11807],{"#text":3020},{"@_align":964},{"#text":958},{"td":11811,":@":11813},[11812],{"#text":3026},{"@_align":964},{"#text":958},{"td":11816,":@":11818},[11817],{"#text":3032},{"@_align":964},{"#text":954},{"#text":954},{"tr":11822},[11823,11824,11832,11833,11837,11838,11841,11842,11845],{"#text":958},{"td":11825,":@":11831},[11826,11827,11830],{"#text":2400},{"italic":11828},[11829],{"#text":349},{"#text":3046},{"@_align":964},{"#text":958},{"td":11834,":@":11836},[11835],{"#text":3052},{"@_align":964},{"#text":958},{"td":11839,":@":11840},[],{"@_align":1987},{"#text":958},{"td":11843,":@":11844},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":11848},[11849,11850,11858,11859,11863,11864,11868,11869,11873],{"#text":958},{"td":11851,":@":11857},[11852,11853,11856],{"#text":2400},{"italic":11854},[11855],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":11860,":@":11862},[11861],{"#text":3001},{"@_align":964},{"#text":958},{"td":11865,":@":11867},[11866],{"#text":3032},{"@_align":964},{"#text":958},{"td":11870,":@":11872},[11871],{"#text":3032},{"@_align":964},{"#text":954},{"#text":954},{"tr":11876},[11877,11878,11886,11887,11891,11892,11896,11897,11901],{"#text":958},{"td":11879,":@":11885},[11880,11881,11884],{"#text":2400},{"italic":11882},[11883],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":11888,":@":11890},[11889],{"#text":3032},{"@_align":964},{"#text":958},{"td":11893,":@":11895},[11894],{"#text":3032},{"@_align":964},{"#text":958},{"td":11898,":@":11900},[11899],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11904},[11905,11906,11910,11911,11919,11920,11924,11925,11929,11930,11934],{"#text":958},{"td":11907,":@":11909},[11908],{"#text":3126},{"@_align":964},{"#text":958},{"td":11912,":@":11918},[11913,11914,11917],{"#text":2400},{"italic":11915},[11916],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":11921,":@":11923},[11922],{"#text":3141},{"@_align":964},{"#text":958},{"td":11926,":@":11928},[11927],{"#text":3141},{"@_align":964},{"#text":958},{"td":11931,":@":11933},[11932],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11937},[11938,11939,11943,11944,11952,11953,11957,11958,11962,11963,11967],{"#text":958},{"td":11940,":@":11942},[11941],{"#text":3161},{"@_align":964},{"#text":958},{"td":11945,":@":11951},[11946,11947,11950],{"#text":2400},{"italic":11948},[11949],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":11954,":@":11956},[11955],{"#text":3176},{"@_align":964},{"#text":958},{"td":11959,":@":11961},[11960],{"#text":3176},{"@_align":964},{"#text":958},{"td":11964,":@":11966},[11965],{"#text":2452},{"@_align":964},{"#text":954},{"#text":954},{"tr":11970},[11971,11972,11976,11977,11980,11981,11985,11986,11990,11991,11995],{"#text":958},{"td":11973,":@":11975},[11974],{"#text":3196},{"@_align":964},{"#text":958},{"td":11978,":@":11979},[],{"@_align":964},{"#text":958},{"td":11982,":@":11984},[11983],{"#text":2452},{"@_align":964},{"#text":958},{"td":11987,":@":11989},[11988],{"#text":2452},{"@_align":964},{"#text":958},{"td":11992,":@":11994},[11993],{"#text":2452},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},[],{"id":3435,"type":10255,"title":3465,"description":12001,"descriptionNodes":12002,"tableNodes":12052,"tableFootNodes":12969,"imageUrl":26},"Detection ratio of BRCA1, BRCA2, PALB2, ATM, CHEK2, MUTYH, MSH6, RAD51C, BARD1, CDH1, POLE and ERCC3 P/LP variants in the study groups and gnomAD non-cancer population.",[12003,12004,12051],{"#text":941},{"p":12005},[12006,12007,12010,12011,12014,12015,12018,12019,12022,12023,12026,12027,12030,12031,12034,12035,12038,12039,12042,12043,12046,12047,12050],{"#text":3473},{"italic":12008},[12009],{"#text":349},{"#text":787},{"italic":12012},[12013],{"#text":350},{"#text":787},{"italic":12016},[12017],{"#text":2244},{"#text":787},{"italic":12020},[12021],{"#text":1244},{"#text":787},{"italic":12024},[12025],{"#text":2228},{"#text":787},{"italic":12028},[12029],{"#text":3360},{"#text":787},{"italic":12032},[12033],{"#text":2837},{"#text":787},{"italic":12036},[12037],{"#text":2255},{"#text":787},{"italic":12040},[12041],{"#text":2607},{"#text":787},{"italic":12044},[12045],{"#text":753},{"#text":787},{"italic":12048},[12049],{"#text":3517},{"#text":3519},{"#text":677},[12053],{"table":12054},[12055,12056,12133,12134,12968],{"#text":941},{"thead":12057,":@":12132},[12058,12059,12087,12088,12131],{"#text":954},{"tr":12060},[12061,12062,12066,12067,12071,12072,12076,12077,12081,12082,12086],{"#text":958},{"th":12063,":@":12065},[12064],{"#text":3534},{"@_rowspan":446,"@_align":964},{"#text":958},{"th":12068,":@":12070},[12069],{"#text":3540},{"@_colspan":446,"@_align":964},{"#text":958},{"th":12073,":@":12075},[12074],{"#text":3546},{"@_colspan":446,"@_align":964},{"#text":958},{"th":12078,":@":12080},[12079],{"#text":2137},{"@_colspan":446,"@_align":964},{"#text":958},{"th":12083,":@":12085},[12084],{"#text":3557},{"@_colspan":446,"@_align":964},{"#text":954},{"#text":954},{"tr":12089},[12090,12091,12095,12096,12100,12101,12105,12106,12110,12111,12115,12116,12120,12121,12125,12126,12130],{"#text":958},{"th":12092,":@":12094},[12093],{"#text":3567},{"@_align":964},{"#text":958},{"th":12097,":@":12099},[12098],{"#text":3573},{"@_align":964},{"#text":958},{"th":12102,":@":12104},[12103],{"#text":3567},{"@_align":964},{"#text":958},{"th":12107,":@":12109},[12108],{"#text":3573},{"@_align":964},{"#text":958},{"th":12112,":@":12114},[12113],{"#text":3567},{"@_align":964},{"#text":958},{"th":12117,":@":12119},[12118],{"#text":3573},{"@_align":964},{"#text":958},{"th":12122,":@":12124},[12123],{"#text":3567},{"@_align":964},{"#text":958},{"th":12127,":@":12129},[12128],{"#text":3573},{"@_align":964},{"#text":954},{"#text":941},{"@_valign":974},{"#text":941},{"tbody":12135,":@":12967},[12136,12137,12195,12196,12254,12255,12307,12308,12360,12361,12419,12420,12478,12479,12537,12538,12590,12591,12643,12644,12696,12697,12755,12756,12814,12815,12865,12866,12916,12917,12966],{"#text":954},{"tr":12138},[12139,12140,12148,12149,12153,12154,12158,12159,12163,12164,12174,12175,12179,12180,12184,12185,12189,12190,12194],{"#text":958},{"td":12141,":@":12147},[12142,12143,12146],{"#text":2400},{"italic":12144},[12145],{"#text":349},{"#text":958},{"@_align":964},{"#text":958},{"td":12150,":@":12152},[12151],{"#text":3627},{"@_align":964},{"#text":958},{"td":12155,":@":12157},[12156],{"#text":3633},{"@_align":964},{"#text":958},{"td":12160,":@":12162},[12161],{"#text":799},{"@_align":964},{"#text":958},{"td":12165,":@":12173},[12166,12167],{"#text":3644},{"xref":12168,":@":12172},[12169],{"sup":12170},[12171],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12176,":@":12178},[12177],{"#text":3657},{"@_align":964},{"#text":958},{"td":12181,":@":12183},[12182],{"#text":3663},{"@_align":964},{"#text":958},{"td":12186,":@":12188},[12187],{"#text":3669},{"@_align":964},{"#text":958},{"td":12191,":@":12193},[12192],{"#text":3675},{"@_align":964},{"#text":954},{"#text":954},{"tr":12197},[12198,12199,12207,12208,12212,12213,12217,12218,12222,12223,12233,12234,12238,12239,12243,12244,12248,12249,12253],{"#text":958},{"td":12200,":@":12206},[12201,12202,12205],{"#text":2400},{"italic":12203},[12204],{"#text":350},{"#text":958},{"@_align":964},{"#text":958},{"td":12209,":@":12211},[12210],{"#text":3627},{"@_align":964},{"#text":958},{"td":12214,":@":12216},[12215],{"#text":3633},{"@_align":964},{"#text":958},{"td":12219,":@":12221},[12220],{"#text":791},{"@_align":964},{"#text":958},{"td":12224,":@":12232},[12225,12226],{"#text":3709},{"xref":12227,":@":12231},[12228],{"sup":12229},[12230],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12235,":@":12237},[12236],{"#text":3721},{"@_align":964},{"#text":958},{"td":12240,":@":12242},[12241],{"#text":3727},{"@_align":964},{"#text":958},{"td":12245,":@":12247},[12246],{"#text":3733},{"@_align":964},{"#text":958},{"td":12250,":@":12252},[12251],{"#text":3739},{"@_align":964},{"#text":954},{"#text":954},{"tr":12256},[12257,12258,12266,12267,12271,12272,12276,12277,12281,12282,12286,12287,12291,12292,12296,12297,12301,12302,12306],{"#text":958},{"td":12259,":@":12265},[12260,12261,12264],{"#text":2400},{"italic":12262},[12263],{"#text":2244},{"#text":958},{"@_align":964},{"#text":958},{"td":12268,":@":12270},[12269],{"#text":782},{"@_align":964},{"#text":958},{"td":12273,":@":12275},[12274],{"#text":3763},{"@_align":964},{"#text":958},{"td":12278,":@":12280},[12279],{"#text":2452},{"@_align":964},{"#text":958},{"td":12283,":@":12285},[12284],{"#text":2452},{"@_align":964},{"#text":958},{"td":12288,":@":12290},[12289],{"#text":782},{"@_align":964},{"#text":958},{"td":12293,":@":12295},[12294],{"#text":3784},{"@_align":964},{"#text":958},{"td":12298,":@":12300},[12299],{"#text":3790},{"@_align":964},{"#text":958},{"td":12303,":@":12305},[12304],{"#text":3796},{"@_align":964},{"#text":954},{"#text":954},{"tr":12309},[12310,12311,12319,12320,12324,12325,12329,12330,12334,12335,12339,12340,12344,12345,12349,12350,12354,12355,12359],{"#text":958},{"td":12312,":@":12318},[12313,12314,12317],{"#text":2400},{"italic":12315},[12316],{"#text":1244},{"#text":958},{"@_align":964},{"#text":958},{"td":12321,":@":12323},[12322],{"#text":799},{"@_align":964},{"#text":958},{"td":12326,":@":12328},[12327],{"#text":3820},{"@_align":964},{"#text":958},{"td":12331,":@":12333},[12332],{"#text":2452},{"@_align":964},{"#text":958},{"td":12336,":@":12338},[12337],{"#text":2452},{"@_align":964},{"#text":958},{"td":12341,":@":12343},[12342],{"#text":799},{"@_align":964},{"#text":958},{"td":12346,":@":12348},[12347],{"#text":3841},{"@_align":964},{"#text":958},{"td":12351,":@":12353},[12352],{"#text":3847},{"@_align":964},{"#text":958},{"td":12356,":@":12358},[12357],{"#text":3853},{"@_align":964},{"#text":954},{"#text":954},{"tr":12362},[12363,12364,12372,12373,12377,12378,12382,12383,12387,12388,12398,12399,12403,12404,12408,12409,12413,12414,12418],{"#text":958},{"td":12365,":@":12371},[12366,12367,12370],{"#text":2400},{"italic":12368},[12369],{"#text":2228},{"#text":958},{"@_align":964},{"#text":958},{"td":12374,":@":12376},[12375],{"#text":844},{"@_align":964},{"#text":958},{"td":12379,":@":12381},[12380],{"#text":3877},{"@_align":964},{"#text":958},{"td":12384,":@":12386},[12385],{"#text":782},{"@_align":964},{"#text":958},{"td":12389,":@":12397},[12390,12391],{"#text":3888},{"xref":12392,":@":12396},[12393],{"sup":12394},[12395],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12400,":@":12402},[12401],{"#text":851},{"@_align":964},{"#text":958},{"td":12405,":@":12407},[12406],{"#text":3905},{"@_align":964},{"#text":958},{"td":12410,":@":12412},[12411],{"#text":3911},{"@_align":964},{"#text":958},{"td":12415,":@":12417},[12416],{"#text":3917},{"@_align":964},{"#text":954},{"#text":954},{"tr":12421},[12422,12423,12431,12432,12436,12437,12441,12442,12446,12447,12457,12458,12462,12463,12467,12468,12472,12473,12477],{"#text":958},{"td":12424,":@":12430},[12425,12426,12429],{"#text":2400},{"italic":12427},[12428],{"#text":3360},{"#text":958},{"@_align":964},{"#text":958},{"td":12433,":@":12435},[12434],{"#text":2452},{"@_align":964},{"#text":958},{"td":12438,":@":12440},[12439],{"#text":2452},{"@_align":964},{"#text":958},{"td":12443,":@":12445},[12444],{"#text":782},{"@_align":964},{"#text":958},{"td":12448,":@":12456},[12449,12450],{"#text":3709},{"xref":12451,":@":12455},[12452],{"sup":12453},[12454],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12459,":@":12461},[12460],{"#text":782},{"@_align":964},{"#text":958},{"td":12464,":@":12466},[12465],{"#text":3784},{"@_align":964},{"#text":958},{"td":12469,":@":12471},[12470],{"#text":3972},{"@_align":964},{"#text":958},{"td":12474,":@":12476},[12475],{"#text":3978},{"@_align":964},{"#text":954},{"#text":954},{"tr":12480},[12481,12482,12490,12491,12495,12496,12500,12501,12505,12506,12516,12517,12521,12522,12526,12527,12531,12532,12536],{"#text":958},{"td":12483,":@":12489},[12484,12485,12488],{"#text":2400},{"italic":12486},[12487],{"#text":2837},{"#text":958},{"@_align":964},{"#text":958},{"td":12492,":@":12494},[12493],{"#text":2452},{"@_align":964},{"#text":958},{"td":12497,":@":12499},[12498],{"#text":2452},{"@_align":964},{"#text":958},{"td":12502,":@":12504},[12503],{"#text":791},{"@_align":964},{"#text":958},{"td":12507,":@":12515},[12508,12509],{"#text":3709},{"xref":12510,":@":12514},[12511],{"sup":12512},[12513],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12518,":@":12520},[12519],{"#text":791},{"@_align":964},{"#text":958},{"td":12523,":@":12525},[12524],{"#text":4028},{"@_align":964},{"#text":958},{"td":12528,":@":12530},[12529],{"#text":4034},{"@_align":964},{"#text":958},{"td":12533,":@":12535},[12534],{"#text":4040},{"@_align":964},{"#text":954},{"#text":954},{"tr":12539},[12540,12541,12549,12550,12554,12555,12559,12560,12564,12565,12569,12570,12574,12575,12579,12580,12584,12585,12589],{"#text":958},{"td":12542,":@":12548},[12543,12544,12547],{"#text":2400},{"italic":12545},[12546],{"#text":2255},{"#text":958},{"@_align":964},{"#text":958},{"td":12551,":@":12553},[12552],{"#text":782},{"@_align":964},{"#text":958},{"td":12556,":@":12558},[12557],{"#text":3763},{"@_align":964},{"#text":958},{"td":12561,":@":12563},[12562],{"#text":2452},{"@_align":964},{"#text":958},{"td":12566,":@":12568},[12567],{"#text":2452},{"@_align":964},{"#text":958},{"td":12571,":@":12573},[12572],{"#text":782},{"@_align":964},{"#text":958},{"td":12576,":@":12578},[12577],{"#text":3784},{"@_align":964},{"#text":958},{"td":12581,":@":12583},[12582],{"#text":4089},{"@_align":964},{"#text":958},{"td":12586,":@":12588},[12587],{"#text":4040},{"@_align":964},{"#text":954},{"#text":954},{"tr":12592},[12593,12594,12602,12603,12607,12608,12612,12613,12617,12618,12622,12623,12627,12628,12632,12633,12637,12638,12642],{"#text":958},{"td":12595,":@":12601},[12596,12597,12600],{"#text":2400},{"italic":12598},[12599],{"#text":2607},{"#text":958},{"@_align":964},{"#text":958},{"td":12604,":@":12606},[12605],{"#text":782},{"@_align":964},{"#text":958},{"td":12609,":@":12611},[12610],{"#text":3763},{"@_align":964},{"#text":958},{"td":12614,":@":12616},[12615],{"#text":2452},{"@_align":964},{"#text":958},{"td":12619,":@":12621},[12620],{"#text":2452},{"@_align":964},{"#text":958},{"td":12624,":@":12626},[12625],{"#text":782},{"@_align":964},{"#text":958},{"td":12629,":@":12631},[12630],{"#text":3784},{"@_align":964},{"#text":958},{"td":12634,":@":12636},[12635],{"#text":4143},{"@_align":964},{"#text":958},{"td":12639,":@":12641},[12640],{"#text":4149},{"@_align":964},{"#text":954},{"#text":954},{"tr":12645},[12646,12647,12655,12656,12660,12661,12665,12666,12670,12671,12675,12676,12680,12681,12685,12686,12690,12691,12695],{"#text":958},{"td":12648,":@":12654},[12649,12650,12653],{"#text":2400},{"italic":12651},[12652],{"#text":753},{"#text":958},{"@_align":964},{"#text":958},{"td":12657,":@":12659},[12658],{"#text":782},{"@_align":964},{"#text":958},{"td":12662,":@":12664},[12663],{"#text":3763},{"@_align":964},{"#text":958},{"td":12667,":@":12669},[12668],{"#text":2452},{"@_align":964},{"#text":958},{"td":12672,":@":12674},[12673],{"#text":2452},{"@_align":964},{"#text":958},{"td":12677,":@":12679},[12678],{"#text":782},{"@_align":964},{"#text":958},{"td":12682,":@":12684},[12683],{"#text":3784},{"@_align":964},{"#text":958},{"td":12687,":@":12689},[12688],{"#text":851},{"@_align":964},{"#text":958},{"td":12692,":@":12694},[12693],{"#text":4203},{"@_align":964},{"#text":954},{"#text":954},{"tr":12698},[12699,12700,12708,12709,12713,12714,12718,12719,12723,12724,12734,12735,12739,12740,12744,12745,12749,12750,12754],{"#text":958},{"td":12701,":@":12707},[12702,12703,12706],{"#text":2400},{"italic":12704},[12705],{"#text":3375},{"#text":958},{"@_align":964},{"#text":958},{"td":12710,":@":12712},[12711],{"#text":2452},{"@_align":964},{"#text":958},{"td":12715,":@":12717},[12716],{"#text":2452},{"@_align":964},{"#text":958},{"td":12720,":@":12722},[12721],{"#text":782},{"@_align":964},{"#text":958},{"td":12725,":@":12733},[12726,12727],{"#text":3888},{"xref":12728,":@":12732},[12729],{"sup":12730},[12731],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12736,":@":12738},[12737],{"#text":782},{"@_align":964},{"#text":958},{"td":12741,":@":12743},[12742],{"#text":3784},{"@_align":964},{"#text":958},{"td":12746,":@":12748},[12747],{"#text":4258},{"@_align":964},{"#text":958},{"td":12751,":@":12753},[12752],{"#text":4264},{"@_align":964},{"#text":954},{"#text":954},{"tr":12757},[12758,12759,12767,12768,12772,12773,12777,12778,12782,12783,12793,12794,12798,12799,12803,12804,12808,12809,12813],{"#text":958},{"td":12760,":@":12766},[12761,12762,12765],{"#text":2400},{"italic":12763},[12764],{"#text":4277},{"#text":958},{"@_align":964},{"#text":958},{"td":12769,":@":12771},[12770],{"#text":2452},{"@_align":964},{"#text":958},{"td":12774,":@":12776},[12775],{"#text":2452},{"@_align":964},{"#text":958},{"td":12779,":@":12781},[12780],{"#text":782},{"@_align":964},{"#text":958},{"td":12784,":@":12792},[12785,12786],{"#text":3888},{"xref":12787,":@":12791},[12788],{"sup":12789},[12790],{"#text":997},{"@_ref-type":999,"@_rid":3651},{"@_align":964},{"#text":958},{"td":12795,":@":12797},[12796],{"#text":782},{"@_align":964},{"#text":958},{"td":12800,":@":12802},[12801],{"#text":3784},{"@_align":964},{"#text":958},{"td":12805,":@":12807},[12806],{"#text":4320},{"@_align":964},{"#text":958},{"td":12810,":@":12812},[12811],{"#text":4326},{"@_align":964},{"#text":954},{"#text":954},{"tr":12816},[12817,12818,12826,12827,12831,12832,12836,12837,12841,12842,12846,12847,12851,12852,12856,12857,12860,12861,12864],{"#text":958},{"td":12819,":@":12825},[12820,12821,12824],{"#text":2400},{"italic":12822},[12823],{"#text":2636},{"#text":958},{"@_align":964},{"#text":958},{"td":12828,":@":12830},[12829],{"#text":782},{"@_align":964},{"#text":958},{"td":12833,":@":12835},[12834],{"#text":3763},{"@_align":964},{"#text":958},{"td":12838,":@":12840},[12839],{"#text":2452},{"@_align":964},{"#text":958},{"td":12843,":@":12845},[12844],{"#text":2452},{"@_align":964},{"#text":958},{"td":12848,":@":12850},[12849],{"#text":782},{"@_align":964},{"#text":958},{"td":12853,":@":12855},[12854],{"#text":3784},{"@_align":964},{"#text":958},{"td":12858,":@":12859},[],{"@_align":1987},{"#text":958},{"td":12862,":@":12863},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":12867},[12868,12869,12877,12878,12882,12883,12887,12888,12892,12893,12897,12898,12902,12903,12907,12908,12911,12912,12915],{"#text":958},{"td":12870,":@":12876},[12871,12872,12875],{"#text":2400},{"italic":12873},[12874],{"#text":2779},{"#text":958},{"@_align":964},{"#text":958},{"td":12879,":@":12881},[12880],{"#text":782},{"@_align":964},{"#text":958},{"td":12884,":@":12886},[12885],{"#text":3763},{"@_align":964},{"#text":958},{"td":12889,":@":12891},[12890],{"#text":2452},{"@_align":964},{"#text":958},{"td":12894,":@":12896},[12895],{"#text":2452},{"@_align":964},{"#text":958},{"td":12899,":@":12901},[12900],{"#text":782},{"@_align":964},{"#text":958},{"td":12904,":@":12906},[12905],{"#text":3784},{"@_align":964},{"#text":958},{"td":12909,":@":12910},[],{"@_align":1987},{"#text":958},{"td":12913,":@":12914},[],{"@_align":1987},{"#text":954},{"#text":954},{"tr":12918},[12919,12920,12928,12929,12933,12934,12937,12938,12942,12943,12947,12948,12952,12953,12957,12958,12961,12962,12965],{"#text":958},{"td":12921,":@":12927},[12922,12923,12926],{"#text":2400},{"italic":12924},[12925],{"#text":2722},{"#text":958},{"@_align":964},{"#text":958},{"td":12930,":@":12932},[12931],{"#text":782},{"@_align":964},{"#text":958},{"td":12935,":@":12936},[],{"@_align":1987},{"#text":958},{"td":12939,":@":12941},[12940],{"#text":2452},{"@_align":964},{"#text":958},{"td":12944,":@":12946},[12945],{"#text":2452},{"@_align":964},{"#text":958},{"td":12949,":@":12951},[12950],{"#text":782},{"@_align":964},{"#text":958},{"td":12954,":@":12956},[12955],{"#text":3784},{"@_align":964},{"#text":958},{"td":12959,":@":12960},[],{"@_align":1987},{"#text":958},{"td":12963,":@":12964},[],{"@_align":1987},{"#text":954},{"#text":941},{"@_valign":974},{"#text":677},[12970,12971,12978,12979,12995],{"#text":941},{"fn":12972},[12973,12974,12977],{"#text":954},{"p":12975},[12976],{"#text":4494},{"#text":941},{"#text":941},{"fn":12980,":@":12994},[12981,12982,12989,12990,12993],{"#text":954},{"label":12983},[12984,12985,12988],{"#text":958},{"sup":12986},[12987],{"#text":997},{"#text":954},{"#text":954},{"p":12991},[12992],{"#text":4511},{"#text":941},{"@_id":3651},{"#text":677},[12997,13000,13001,13002,13003,13004,13005,13007,13009,13011,13013,13015,13016,13018],{"title":12998,"id":12999},"Abstract","h1",{"title":773,"id":888},{"title":896,"id":1404},{"title":1412,"id":4581},{"title":4589,"id":4983},{"title":4991,"id":5014},{"title":5020,"id":13006},"s6",{"title":5038,"id":13008},"s7",{"title":5051,"id":13010},"s8",{"title":5064,"id":13012},"s9",{"title":5077,"id":13014},"s10",{"title":5091,"id":1347},{"title":5117,"id":13017},"h13",{"title":13019,"id":13020},"References","h14",[13022,13024],{"#text":13023},"*Correspondence: Lszl Barti, ",{"email":13025},[13026],{"#text":13027},"YmFyYXRpLmxhc3psb0BwdGUuaHU=",{"articleHubSlug":26,"articleHubPage":13029,"articleHubArticlesList":13030,"canJournalHasArticleHub":155,"articleDoiList":13031},{},[],[],{"title":26,"image":-1,"breadcrumbs":13033,"linksCollection":13034,"metricsCollection":13036},[],{"total":8,"items":13035},[],{"total":8,"items":13037},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.por-journal.com",domain:"por-journal.com",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:4,spaceName:"Pathology & Oncology Research",liveSpaceId:4,tenantLogoUrl:"https://brand.frontiersin.org/m/54cf682e9cbe653/original/POR-Logo.svg",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.por-journal.com",emailDigestApiUrl:"https://api-email-digest.por-journal.com",journalFilesApiUrl:"https://files-journal-api.por-journal.com",publicPagesFilesUrl:"https://public-pages-files-2025.por-journal.com",searchApiUrl:"https://search-api.por-journal.com",productionForumApiUrl:"https://production-forum-api-v2.por-journal.com",gtmServerUrl:"",gtmId:"",gtmAuth:"",gtmPreview:"",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.por-journal.com/static-resources/tenants/por/favicon_16-tenantFavicon-POR2.png",faviconSize32:"https://static2.por-journal.com/static-resources/tenants/por/favicon_32-tenantFavicon-POR2.png",faviconSize180:"https://static2.por-journal.com/static-resources/tenants/por/favicon_180-tenantFavicon-POR2.png",faviconSize192:"https://static2.por-journal.com/static-resources/tenants/por/favicon_192-tenantFavicon-POR2.png",faviconSize512:"https://static2.por-journal.com/static-resources/tenants/por/favicon_512-tenantFavicon-POR2.png",socialMediaImg:"https://static2.por-journal.com/static-resources/tenants/por/FAAS_POR_Logo_1200x628_1.91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'null'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>>",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":false,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":false,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"POR\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my account\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"special issue management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Editor-in-Chief\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Editors-in-Chief\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Editor-in-Chief\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Editors-in-Chief\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"special issue\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"special issues\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Issue Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"issue\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"issue summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Issue Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"reviewer list\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Editor-in-Chief\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Editors-in-Chief\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"finalize\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"finalized\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"finalize review\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"finalized review\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Submissions Team Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team\",\"tenantTerm\":\"Submission Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"topic_coordinator\",\"tenantTerm\":\"special issue coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinators\",\"tenantTerm\":\"special issue coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":274,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"",impactGtmAuth:"",impactGtmPreview:"",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":false,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v4"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/pore.2024.1611813?callback=_altmetric.embed_callback&domain=www.por-journal.com&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>